Masaryk University

Publication Records

česky | in English

Filter publications

    2024

    1. A novel thrombocytopenia-4-causing CYCS gene variant decreases caspase activity: Three-generation study
      ŠTIKA, Jiří, Michaela PEŠOVÁ, Kateřina STAŇO KOZUBÍK, Magdalena SKALNÍKOVÁ, Lenka DOSTÁLOVÁ, Tomas LOJA, Lenka RADOVÁ, Veronika PALUŠOVÁ, Kamila RÉBLOVÁ, Zuzana VRZALOVÁ, Ivona BLAHÁKOVÁ, Jakub TRIZULJAK, Stjepan ULDRIJAN, Jan BLATNÝ, Michal ŠMÍDA, Šárka POSPÍŠILOVÁ and Michael DOUBEK. A novel thrombocytopenia-4-causing CYCS gene variant decreases caspase activity: Three-generation study. British journal of haematology. Hoboken: Wiley-Blackwell, 2024, 9 pp. ISSN 0007-1048. Available from: https://dx.doi.org/10.1111/bjh.19694.
      More: https://is.muni.cz/publication/2430437/en
    2. Asciminib in Newly Diagnosed Chronic Myeloid Leukemia
      HOCHHAUS, Andreas, Jianxiang WANG, Dong-Wook KIM, Dennis Dong Hwan KIM, Jiří MAYER, Yeow-Tee GOH, le Coutre PHILIPP, Naoto TAKAHASHI, Inho KIM, Gabriel ETIENNE, David ANDORSKY, Ghayas C ISSA, Richard A LARSON, Felice BOMBACI, Shruti KAPOOR, Tracey MCCULLOCH, Kamel MALEK, Lillian YAU, Sophie IFRAH, Matthias HOCH, Jorge E CORTES and Timothy P HUGHES. Asciminib in Newly Diagnosed Chronic Myeloid Leukemia. New England Journal of Medicine. Waltham: Massachussetts Medical Society, 2024, p. 1-14. ISSN 0028-4793. Available from: https://dx.doi.org/10.1056/NEJMoa2400858.
      More: https://is.muni.cz/publication/2424062/en
    3. Blockage of BCL-XL overcomes venetoclax resistance across BCL2+lymphoid malignancies irrespective of BIM status
      DOLNIKOVA, Alexandra, Dmitry KAZANTSEV, Magdalena KLANOVA, Eva POKORNA, Dana SOVILJ, Cristina Daniela KELEMEN, Liliana TUSKOVA, Eva HOFERKOVÁ, Marek MRÁZ, Karel HELMAN, Nikola CURIK, Katerina MACHOVA POLAKOVA, Ladislav ANDERA, Marek TRNENY and Pavel KLENER. Blockage of BCL-XL overcomes venetoclax resistance across BCL2+lymphoid malignancies irrespective of BIM status. Blood advances. AMSTERDAM: ELSEVIER, 2024, vol. 8, No 13, p. 3532-3543. ISSN 2473-9529. Available from: https://dx.doi.org/10.1182/bloodadvances.2024012906.
      More: https://is.muni.cz/publication/2447799/en
    4. Blockage of BCL-XL overcomes venetoclax resistance across BCL2-positive lymphoid malignancies irrespective of BIM status
      DOLNIKOVA, Alexandra, Dmitry KAZANTSEV, Magdalena KLANOVA, Eva POKORNA, Dana SOVILJ, Cristina Daniela KELEMEN, Liliana TUSKOVA, Eva HOFERKOVÁ, Marek MRÁZ, Karel HELMAN, Nikola CURIK, Katerina MACHOVA POLAKOVA, Ladislav ANDĚRA, Marek TRNĚNÝ and Pavel KLENER. Blockage of BCL-XL overcomes venetoclax resistance across BCL2-positive lymphoid malignancies irrespective of BIM status. Blood advances. AMSTERDAM: ELSEVIER, 2024, vol. 8, No 13, p. 1-12. ISSN 2473-9529. Available from: https://dx.doi.org/10.1182/bloodadvances.2024012906.
      More: https://is.muni.cz/publication/2412657/en
    5. Clinical efficacy and safety of first-line nilotinib or imatinib therapy in patients with chronic myeloid leukemia-Nationwide real life data
      BELOHLAVKOVA, Petra, Daniela ŽÁČKOVÁ, Hana KLAMOVA, Edgar FABER, Michal KARAS, Lukas STEJSKAL, Eduard CMUNT, Olga CERNA, Ivana JEŽÍŠKOVÁ, Katerina MACHOVA POLAKOVA, Pavel ZAK, Tereza JURKOVÁ, Marika CHRÁPAVÁ and Jiří MAYER. Clinical efficacy and safety of first-line nilotinib or imatinib therapy in patients with chronic myeloid leukemia-Nationwide real life data. Cancer Medicine. Hoboken: John Wiley & Sons Ltd., 2024, vol. 13, No 17, p. 1-10. ISSN 2045-7634. Available from: https://dx.doi.org/10.1002/cam4.70158.
      More: https://is.muni.cz/publication/2436698/en
    6. Computational Design of Pore-Forming Peptides with Potent Antimicrobial and Anticancer Activities
      DEB, Rahul, Marcelo D T TORRES, Miroslav BOUDNÝ, Marketa KOBERSKA, Floriana CAPPIELLO, Miroslav POPPER, Katerina DVORAKOVA BENDOVA, Martina DRABINOVÁ, Adelheid HANACKOVA, Katy JEANNOT, Milos PETRIK, Maria Luisa MANGONI, Gabriela BALIKOVA NOVOTNA, Marek MRÁZ, Cesar DE LA FUENTE-NUNEZ and Robert VÁCHA. Computational Design of Pore-Forming Peptides with Potent Antimicrobial and Anticancer Activities. Journal of Medicinal Chemistry. Washington: American Chemical Society, 2024, vol. 67, No 16, p. 14040-14061. ISSN 0022-2623. Available from: https://dx.doi.org/10.1021/acs.jmedchem.4c00912.
      More: https://is.muni.cz/publication/2430458/en
    7. Cultivation driven transcriptomic changes in the wild-type and mutant strains of Rhodospirillum rubrum
      JURECKOVA, Katerina, Marketa NYKRYNOVA, Eva SLANINOVA, Hugo FLEURIOT-BLITMAN, Veronique AMSTUTZ, Kristyna HERMANKOVA, Matěj BEZDÍČEK, Katerina MRAZOVA, Kamila HRUBANOVA, Manfred ZINN, Stanislav OBRUCA and Karel SEDLAR. Cultivation driven transcriptomic changes in the wild-type and mutant strains of Rhodospirillum rubrum. Computational and Structural Biotechnology Journal. AMSTERDAM: Elsevier, 2024, vol. 23, December 2024, p. 2681-2694. ISSN 2001-0370. Available from: https://dx.doi.org/10.1016/j.csbj.2024.06.023.
      More: https://is.muni.cz/publication/2423158/en
    8. De novo accelerated phase of chronic myeloid leukemia should be recognized even in the era of tyrosine kinase inhibitors
      HORŇÁK, Tomáš, Jiří MAYER, Petra ČIČÁTKOVÁ, Lukáš SEMERÁD, Anežka KVETKOVÁ, Hana KLAMOVA, Edgar FABER, Petra BELOHLAVKOVA, Michal KARAS, Lukas STEJSKAL, Eduard CMUNT, Olga CERNA, Dana SRBOVA, Hana ZIZKOVA, Lucia VRABLOVA, Ivana SKOUMALOVA, Jaroslava VOGLOVA, Tereza JURKOVA, Marika CHRAPAVA, Tomáš JURČEK, Ivana JEŽÍŠKOVÁ, Marie JAROŠOVÁ, Katerina MACHOVA POLAKOVA, Tomas PAPAJIK, Pavel ZAK, Pavel JINDRA and Daniela ŽÁČKOVÁ. De novo accelerated phase of chronic myeloid leukemia should be recognized even in the era of tyrosine kinase inhibitors. American Journal of Hematology. Hoboken: Wiley-Blackwell, 2024, vol. 99, No 4, p. 763-766. ISSN 0361-8609. Available from: https://dx.doi.org/10.1002/ajh.27229.
      More: https://is.muni.cz/publication/2376680/en
    9. Decoding the historical tale: COVID-19 impact on haematological malignancy patients-EPICOVIDEHA insights from 2020 to 2022
      SALMANTON-GARCIA, Jon, Francesco MARCHESI, Francesca FARINA, Barbora WEINBERGEROVÁ, Federico ITRI, Julio DAVILA-VALLS, Sonia MARTIN-PEREZ, Andreas GLENTHOJ, Ditte Stampe HERSBY, Da Silva Maria GOMES, Raquel Nunes RODRIGUES, Alberto LOPEZ-GARCIA, Raul CORDOBA, Yavuz M BILGIN, Iker FALCES-ROMERO, Shaimaa EL-ASHWAH, Ziad EMARAH, Caroline BESSON, Milena KOHN, Van Doesum JAAP, Emanuele AMMATUNA, Monia MARCHETTI, Jorge LABRADOR, Giovanni Paolo Maria ZAMBROTTA, Luisa VERGA, Ozren JAKSIC, Marcio NUCCI, Klara PIUKOVICS, Alba CABIRTA-TOUZON, Moraima JIMENEZ, Elena ARELLANO, Ildefonso ESPIGADO, Ola BLENNOW, Anna NORDLANDER, Stef MEERS, Jens Vian PRAET, Francesco Aiello TOMMASO, Carolina GARCIA-VIDAL, Nicola S FRACCHIOLLA, Mariarita SCIUME, Guldane Cengiz SEVAL, Pavel ZAK, Caterina BUQUICCHIO, Carlo TASCINI, Stefanie K GRAEFE, Martin SCHOENLEIN, Tatjana ADZIC-VUKICEVIC, Valentina BONUOMO, Chiara CATTANEO, Summiya NIZAMUDDIN, Martin CERNAN, Gaetan PLANTEFEVE, Romane PRIN, Tomas SZOTKOVSKI, Graham P COLLINS, Michelina DARGENIO, Verena PETZER, Dominik WOLF, Natasha COLOVIC, Lucia PREZIOSO, Toni VALKOVIC, Francesco PASSAMONTI, Gustavo-Adolfo MENDEZ, Uluhan SILI, Antonio VENA, Martina BAVASTRO, Alessandro LIMONGELLI, Rafael F DUARTE, Marie-Pierre LEDOUX, Milche CVETANOSKI, Zlate STOJANOSKI, Marina MACHADO, Josip BATINIC, Gabriele MAGLIANO, Monika M BIERNAT, Nikola PANTIC, Christian Bjorn POULSEN, Annarosa CUCCARO, Del Principe Maria ILARIA, Austin KULASEKARARAJ, Irati ORMAZABAL-VELEZ, Alessandro BUSCA, Fatih DEMIRKAN, Marriyam IJAZ, Nikolai KLIMKO, Igor STOMA, Sofya KHOSTELIDI, Noemi FERNANDEZ, Ali S OMRANI, Rui BERGANTIM, De Jonge NICK, Guillemette FOUQUET, Milan NAVRATIL, Ghaith ABU-ZEINAH, Michail SAMARKOS, Johan MAERTENS, De Ramon CRISTINA, Anna GUIDETTI, Ferenc MAGYARI, Tomas Jose GONZALEZ-LOPEZ, Tobias LAHMER, Olimpia FINIZIO, Natasha ALI, Laszlo Imre PINCZES, Esperanza LAVILLA-RUBIRA, Alessandra ROMANO, Maria MERELLI, Mario DELIA, Maria CALBACHO, Joseph MELETIADIS, Darko ANTIC, Jose-Angel HERNANDEZ-RIVAS, De Almeida Joyce MARQUES, Murtadha AL-KHABORI, Martin HOENIGL, Maria Chiara TISI, Nina KHANNA, Aleksandra BARAC, Noha EISA, Di Blasi ROBERTA, Raphael LIEVIN, Carolina MIRANDA-CASTILLO, Nathan C BAHR, Sylvain LAMURE, Mario Virgilio PAPA, Ayel YAHYA, Avinash AUJAYEB, Jan NOVAK, Nurettin ERBEN, Maria FERNANDEZ-GALAN, Susana Jose-Maria RIBERA-SANTA, Ikhwan RINALDI, Rita FAZZI, Monica PIEDIMONTE, Remy DULERY, Yung GONZAGA, Andres SOTO-SILVA, Giuseppe SAPIENZA, Alexandra SERRIS, Lubos DRGONA, Ana GROH, Laura SERRANO, Eleni GAVRIILAKI, Athanasios TRAGIANNIDIS, Juergen PRATTES, Nicola COPPOLA, Vladimir OTASEVIC, Milos MLADENOVIC, Mirjana MITROVIC, Bojana MISKOVIC, Pavel JINDRA, Sofia ZOMPI, Maria Vittoria SACCHI, Carolin KREKELER, Evgenii SHUMILOV, Stefania Infante MARIA, Daniel GARCIA-BORDALLO, Gokce Melis COLAK, Antonella CINGOLANI, Jiri MAYER, Marianna CRISCUOLO, Marietta NYGAARD, Michaela HANAKOVA, Luana FIANCHI, Zdeněk RÁČIL, Antonio GIORDANO, Martina QUATTRONE, Matteo BONANNI, Philipp KOEHLER, Laman RAHIMLI, Oliver A CORNELY and Livio PAGANO. Decoding the historical tale: COVID-19 impact on haematological malignancy patients-EPICOVIDEHA insights from 2020 to 2022. EClinicalMedicine. AMSTERDAM: ELSEVIER, 2024, vol. 74, May 2024, p. 1-20. ISSN 2589-5370. Available from: https://dx.doi.org/10.1016/j.eclinm.2024.102553.
      More: https://is.muni.cz/publication/2446235/en
    10. Del(1p32) is an early and high-risk event in multiple myeloma patients with extraosseous disease
      ŠTORK, Martin, Eva ONDROUŠKOVÁ, Michaela BOHÚNOVÁ, Ivanna BOICHUK, Dominik FRIČ, Zdeněk ADAM, Marta KREJČÍ, Viera SANDECKÁ, Zdeňka KNECHTOVÁ, Lenka RADOVÁ, Zuzana JELÍNKOVÁ, Taťána ADLEROVÁ, Milan KRTIČKA, Vladimír NEKUDA, Marek BORSKÝ, Sabina ŠEVČÍKOVÁ, Marie JAROŠOVÁ and Luděk POUR. Del(1p32) is an early and high-risk event in multiple myeloma patients with extraosseous disease. Blood Cancer Journal. LONDON: SPRINGERNATURE, 2024, vol. 14, No 1, p. 1-3. ISSN 2044-5385. Available from: https://dx.doi.org/10.1038/s41408-024-01131-6.
      More: https://is.muni.cz/publication/2427897/en
    11. Detecting familial hypercholesterolemia: An observational study leveraging mandatory universal pediatric total cholesterol screening in Slovakia
      RASLOVA, Katarina, Viera DONICOVA, Katarina GONOVA, Alexander KLABNIK, Lukáš TICHÝ, Ian BRIDGES, Dagmar BUCKOVA, Marie ZACHLEDEROVA, Tomáš FREIBERGER and Branislav VOHNOUT. Detecting familial hypercholesterolemia: An observational study leveraging mandatory universal pediatric total cholesterol screening in Slovakia. Journal of Clinical Lipidology. New York: ELSEVIER SCIENCE INC, 2024, vol. 18, No 4, p. "e537"-"e547", 11 pp. ISSN 1933-2874. Available from: https://dx.doi.org/10.1016/j.jacl.2024.03.009.
      More: https://is.muni.cz/publication/2431917/en
    12. Efficacy and safety of melflufen plus daratumumab and dexamethasone in relapsed/refractory multiple myeloma: results from the randomized, open-label, phase III LIGHTHOUSE study
      POUR, Luděk, Monika SZAREJKO, Jelena BILA, Fredrik H SCHJESVOLD, Ivan SPICKA, Vladimir MAISNAR, Artur JURCZYSZYN, Zhanet GRUDEVA-POPOVA, Roman HAJEK, Ganna USENKO, Marcas THURESSON, Stefan NORIN, Sara JAREFORS, Nicolaas A BAKKER, Paul G RICHARDSON and Maria-Victoria MATEOS. Efficacy and safety of melflufen plus daratumumab and dexamethasone in relapsed/refractory multiple myeloma: results from the randomized, open-label, phase III LIGHTHOUSE study. Haematologica. PAVIA: FERRATA STORTI FOUNDATION, 2024, vol. 109, No 3, p. 895-905. ISSN 0390-6078. Available from: https://dx.doi.org/10.3324/haematol.2023.283509.
      More: https://is.muni.cz/publication/2417620/en
    13. Efficacy of ixazomib, lenalidomide, dexamethasone regimen in daratumumab-exposed relapsed/refractory multiple myeloma patients: A retrospective analysis
      FRIČ, Dominik, Martin ŠTORK, Ivanna BOICHUK, Viera SANDECKÁ, Zdeněk ADAM, Marta KREJČÍ, Eva ONDROUŠKOVÁ, Anna FIDRICHOVA, Lenka RADOVÁ, Zdeňka KNECHTOVÁ, Marie JAROŠOVÁ and Luděk POUR. Efficacy of ixazomib, lenalidomide, dexamethasone regimen in daratumumab-exposed relapsed/refractory multiple myeloma patients: A retrospective analysis. European Journal of Haematology. Hoboken: Wiley-Blackwell, 2024, 7 pp. ISSN 0902-4441. Available from: https://dx.doi.org/10.1111/ejh.14292.
      More: https://is.muni.cz/publication/2431577/en
    14. ERIC recommendations for TP53 mutation analysis in chronic lymphocytic leukemia-2024 update
      MALČÍKOVÁ, Jitka, Šárka PAVLOVÁ, Panagiotis BALIAKAS, Thomas CHATZIKONSTANTINOU, Eugen TAUSCH, Mark CATHERWOOD, Davide ROSSI, Thierry SOUSSI, Boris TICHY, Arnon P KATER, Carsten U NIEMANN, Frederic DAVI, Gianluca GAIDANO, Stephan STILGENBAUER, Richard ROSENQUIST, Kostas STAMATOPOULOS, Paolo GHIA and Šárka POSPÍŠILOVÁ. ERIC recommendations for TP53 mutation analysis in chronic lymphocytic leukemia-2024 update. Leukemia. London: Nature Publishing Group, 2024, 14 pp. ISSN 0887-6924. Available from: https://dx.doi.org/10.1038/s41375-024-02267-x.
      More: https://is.muni.cz/publication/2409843/en
    15. European Stop Tyrosine Kinase Inhibitor Trial (EURO-SKI) in Chronic Myeloid Leukemia: Final Analysis and Novel Prognostic Factors for Treatment-Free Remission
      MAHON, Francois-Xavier, Markus PFIRRMANN, Stephanie DULUCQ, Andreas HOCHHAUS, Panayiotis PANAYIOTIDIS, Antonio ALMEIDA, Jiří MAYER, Henrik HJORTH-HANSEN, Jeroen J W M JANSSEN, Satu MUSTJOKI, Joaquin MARTINEZ-LOPEZ, Hanne VESTERGAARD, Hans EHRENCRONA, Katerina Machova POLAKOVA, Ulla OLSSON-STROEMBERG, Gert OSSENKOPPELE, Marc G BERGER, Gabriel ETIENNE, Jolanta DENGLER, Tim H BRUEMMENDORF, Andreas BURCHERT, Delphine REA, Philippe ROUSSELOT, Franck E NICOLINI, Wolf-Karsten HOFMANN, Johan RICHTER and Susanne SAUSSELE. European Stop Tyrosine Kinase Inhibitor Trial (EURO-SKI) in Chronic Myeloid Leukemia: Final Analysis and Novel Prognostic Factors for Treatment-Free Remission. Journal of clinical oncology. PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS, 2024, vol. 42, No 16, p. 1-11. ISSN 0732-183X. Available from: https://dx.doi.org/10.1200/JCO.23.01647.
      More: https://is.muni.cz/publication/2423182/en
    16. Ex-vivo 3D cellular models of pancreatic ductal adenocarcinoma: from embryonic development to precision oncology
      AĆIMOVIĆ, Ivana, Viktorie GABRIELOVÁ, Stanislava MARTÍNKOVÁ, Michal EID, Jakub VLAŽNÝ, Petr MORAVČÍK, Jan HLAVSA, Lukáš MORÁŇ, Riza Can CAKMAKCI, Peter STAŇO, Vladimír PROCHÁZKA, Zdeněk KALA, Jan TRNKA and Petr VAŇHARA. Ex-vivo 3D cellular models of pancreatic ductal adenocarcinoma: from embryonic development to precision oncology. PANCREAS. PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS, 2024. ISSN 0885-3177. Available from: https://dx.doi.org/10.1097/MPA.0000000000002393.
      More: https://is.muni.cz/publication/2420798/en
    17. Faktory zvyšující riziko malignity při nálezu endometriálního polypu v ultrazvukovém obraze (Ultrasound finding of endometrial polyp and factors increasing risk of malignancy)
      KOBLÍŽKOVÁ, Michaela, Petra BRETOVÁ, Michal FELSINGER, Luboš MINÁŘ, Markéta BEDNAŘÍKOVÁ and Vít WEINBERGER. Faktory zvyšující riziko malignity při nálezu endometriálního polypu v ultrazvukovém obraze (Ultrasound finding of endometrial polyp and factors increasing risk of malignancy). Česká gynekologie-Czech Gynecology. Praha: Nakladatelské středisko ČLS JEP, 2024, vol. 89, No 1, p. 44-51. ISSN 1210-7832. Available from: https://dx.doi.org/10.48095/cccg202444.
      More: https://is.muni.cz/publication/2404537/en
    18. Fungal infection frequency in newly diagnosed acute myeloid leukaemia patients treated with venetoclax plus azacitidine with or without antifungal prophylaxis
      WEINBERGEROVÁ, Barbora, Jiří MAYER, Tomas KABUT, Wolfgang R SPERR, Jana STEVKOVA, Anna JONASOVA, Martin CERNAN, Susanne HERNDLHOFER, Iveta ORAVCOVA, Jiri SRAMEK, Jan NOVAK, Radka ŠTĚPÁNOVÁ, Tomas SZOTKOWSKI, Lubos DRGONA, Pavel ZAK and Peter VALENT. Fungal infection frequency in newly diagnosed acute myeloid leukaemia patients treated with venetoclax plus azacitidine with or without antifungal prophylaxis. British journal of haematology. Hoboken: Wiley-Blackwell, 2024, 5 pp. ISSN 0007-1048. Available from: https://dx.doi.org/10.1111/bjh.19670.
      More: https://is.muni.cz/publication/2421644/en
    19. Generation of human induced pluripotent stem cell lines from patients with a RYR2 gene variant c.14201A>G (p.Y4734C): Implications for idiopathic ventricular fibrillation and catecholaminergic polymorphic ventricular tachycardia
      ÇELIKER, Canan, Štefan ZELENÁK, Samuel LIETAVA, Jiří PACHERNÍK, Markéta BÉBAROVÁ, Jana ZÍDKOVÁ, Tomáš NOVOTNÝ and Tomáš BÁRTA. Generation of human induced pluripotent stem cell lines from patients with a RYR2 gene variant c.14201A>G (p.Y4734C): Implications for idiopathic ventricular fibrillation and catecholaminergic polymorphic ventricular tachycardia. Stem cell research. Amsterdam: Elsevier, 2024, vol. 81, December 2024, p. 1-5. ISSN 1873-5061. Available from: https://dx.doi.org/10.1016/j.scr.2024.103541.
      More: https://is.muni.cz/publication/2436157/en
    20. Health-related quality of life and symptoms of chronic myeloid leukemia patients after discontinuation of tyrosine kinase inhibitors: results from the EURO-SKI Trial
      EFFICACE, Fabio, Francois-Xavier MAHON, Johan RICHTER, Alfonso PICIOCCHI, Marta CIPRIANI, Franck E NICOLINI, Jiří MAYER, Daniela ŽÁČKOVÁ, Jeroen J W M JANSSEN, Panayiotis PANAYIOTIDIS, Hanne VESTERGAARD, Perttu KOSKENVESA, Antonio ALMEIDA, Henrik HJORTH-HANSEN, Joaquin MARTINEZ-LOPEZ, Ulla OLSSON-STROMBERG, Andreas HOCHHAUS, Marc G BERGER, Gabriel ETIENNE, Hana KLAMOVA, Edgar FABER, Philippe ROUSSELOT, Markus PFIRRMANN and Susanne SAUSSELE. Health-related quality of life and symptoms of chronic myeloid leukemia patients after discontinuation of tyrosine kinase inhibitors: results from the EURO-SKI Trial. Leukemia. London: Nature Publishing Group, 2024, vol. 38, No 8, p. 1722-1730. ISSN 0887-6924. Available from: https://dx.doi.org/10.1038/s41375-024-02341-4.
      More: https://is.muni.cz/publication/2421678/en
    21. Health-related quality of life in relapsed/refractory multiple myeloma treated with melflufen and dexamethasone: analyses from the phase III OCEAN study
      SCHJESVOLD, Fredrik H, Heinz LUDWIG, Sossana DELIMPASI, Pawel ROBAK, Daniel CORIU, Waldemar TOMCZAK, Luděk POUR, Ivan SPICKA, Meletios-Athanasios DIMOPOULOS, Tamas MASSZI, Natalia G CHERNOVA, Anna SANDBERG, Marcus THURESSON, Stefan NORIN, Nicolaas A BAKKER, Maria-Victoria MATEOS, Paul G RICHARDSON and Pieter SONNEVELD. Health-related quality of life in relapsed/refractory multiple myeloma treated with melflufen and dexamethasone: analyses from the phase III OCEAN study. Haematologica. PAVIA: FERRATA STORTI FOUNDATION, 2024, vol. 109, No 7, p. 2331-2336. ISSN 0390-6078. Available from: https://dx.doi.org/10.3324/haematol.2023.284635.
      More: https://is.muni.cz/publication/2423151/en
    22. Changes in bone marrow fibrosis during momelotinib or ruxolitinib therapy do not correlate with efficacy outcomes in patients with myelofibrosis
      OH, Stephen T, Srdan VERSTOVSEK, Vikas GUPTA, Uwe PLATZBECKER, Timothy DEVOS, Jean-Jacques KILADJIAN, Donal P MCLORNAN, Andrew PERKINS, Maria Laura FOX, Mary Frances MCMULLIN, Adam J MEAD, Miklos EGYED, Jiří MAYER, Tomasz SACHA, Jun KAWASHIMA, Mei HUANG, Bryan STROUSE and Ruben MESA. Changes in bone marrow fibrosis during momelotinib or ruxolitinib therapy do not correlate with efficacy outcomes in patients with myelofibrosis. eJHaem. Hoboken: Wiley, 2024, vol. 5, No 1, p. 105-116. ISSN 2688-6146. Available from: https://dx.doi.org/10.1002/jha2.854.
      More: https://is.muni.cz/publication/2423778/en
    23. Impact of thrombocytopenia-associated c.-118C>T and c.-140C>G ANKRD26 5’UTR variants in three-generational pedigree
      TRIZULJAK, Jakub, Paulína LIKAVCOVÁ, Kateřina STAŇO KOZUBÍK, Zuzana VRZALOVÁ, Jakub HYNŠT, Tereza DEISSOVÁ, Jiří ŠTIKA, Lenka RADOVÁ, Marie PRUDKOVÁ, Jana VACULOVA, Ivona BLAHÁKOVÁ, Petr SMEJKAL, Jan KAMELANDER, Šárka POSPÍŠILOVÁ and Michael DOUBEK. Impact of thrombocytopenia-associated c.-118C>T and c.-140C>G ANKRD26 5’UTR variants in three-generational pedigree. Platelets. PHILADELPHIA: TAYLOR & FRANCIS INC, 2024, vol. 35, No 1, p. 1-6. ISSN 0953-7104. Available from: https://dx.doi.org/10.1080/09537104.2024.2388103.
      More: https://is.muni.cz/publication/2431581/en
    24. Improved outcome of COVID-19 over time in patients treated with CAR T-cell therapy: Update of the European COVID-19 multicenter study on behalf of the European Society for Blood and Marrow Transplantation (EBMT) Infectious Diseases Working Party (IDWP) and the European Hematology Association (EHA) Lymphoma Group
      SPANJAART, Anne Mea, Per LJUNGMAN, Gloria TRIDELLO, Juana SCHWARTZ, Nuria MARTINEZ-CIBRIAN, Pere BARBA, Mi KWON, Lucia LOPEZ-CORRAL, Joaquin MARTINEZ-LOPEZ, Christelle FERRA, Di Blasi ROBERTA, Herve GHESQUIERES, Pim MUTSAERS, Friso CALKOEN, Margot JAK, van Doesum JAAP, Joost S P VERMAAT, van der Poel MARJOLEIN, Johan MAERTENS, Massimiliano GAMBELLA, Elisabetta METAFUNI, Fabio CICERI, Riccardo SACCARDI, Emma NICHOLSON, Eleni THOLOULI, Collin MATTHEW, Victoria POTTER, Adrian BLOOR, Caroline BESLEY, Claire RODDIE, Keith WILSON, Arnon NAGLER, Antonio CAMPOS, Soeren Lykke PETERSEN, František FOLBER, Peter BADER, Jurgen FINKE, Nicolaus KROGER, Nina KNELANGE, de la Camara RAFAEL, Marie Jose KERSTEN and Stephan MIELKE. Improved outcome of COVID-19 over time in patients treated with CAR T-cell therapy: Update of the European COVID-19 multicenter study on behalf of the European Society for Blood and Marrow Transplantation (EBMT) Infectious Diseases Working Party (IDWP) and the European Hematology Association (EHA) Lymphoma Group. Leukemia. London: SPRINGERNATURE, 2024, p. 1-7. ISSN 0887-6924. Available from: https://dx.doi.org/10.1038/s41375-024-02336-1.
      More: https://is.muni.cz/publication/2421646/en
    25. Incidence, risk factors, and outcomes of second neoplasms in patients with acute promyelocytic leukemia: the PETHEMA-PALG experience
      SOBAS, Marta, Wanda KNOPINSKA-POSLUSZNY, Beata PIATKOWSKA-JAKUBAS, Flor GARCIA-ALVAREZ, Maria Elena Amutio DIEZ, Mar CABALLERO, David MARTINEZ-CUADRON, Eliana AGUIAR, Jose GONZALEZ-CAMPOS, Ana GARRIDO, Lorenzo ALGARRA, Olga SALAMERO, de la Serna JAVIER, Maria Jose SAYAS, Manuel Mateo PEREZ-ENCINAS, Susana VIVES, Belen VIDRIALES, Jorge LABRADOR, Ana Ines PRADO, Lucia CELEBRIN, Jiří MAYER, Joana BRIOSO, de Laiglesia ALMUDENA, Juan Miguel BERGUA, Maria Luz AMIGO, Carlos RODRIGUEZ-MEDINA, Marta POLO, Agnieszka PLUTA, Edyta CICHOCKA, Marek SKARUPSKI, Miguel A SANZ, Agnieszka WIERZBOWSKA and Pau MONTESINOS. Incidence, risk factors, and outcomes of second neoplasms in patients with acute promyelocytic leukemia: the PETHEMA-PALG experience. Annals of hematology. New York: Springer Verlag, 2024, vol. 103, No 2, p. 451-461. ISSN 0939-5555. Available from: https://dx.doi.org/10.1007/s00277-023-05582-y.
      More: https://is.muni.cz/publication/2371843/en
    26. Incidental Germline Findings During Comprehensive Genomic Profiling of Pancreatic and Colorectal Cancer: Single-center, Molecular Tumor Board Experience
      EID, Michal, Jakub TRIZULJAK, Renata TASLEROVÁ, Martin GRYC, Jakub VLAŽNÝ, Sára VILMANOVÁ, Martina JELÍNKOVÁ, Alena HOMOLOVÁ, Štěpán TUČEK, Jan HLAVSA, Tomáš GROLICH, Zdeněk KALA, Zdeněk KRÁL and Ondřej SLABÝ. Incidental Germline Findings During Comprehensive Genomic Profiling of Pancreatic and Colorectal Cancer: Single-center, Molecular Tumor Board Experience. Mutagenesis. OXFORD: OXFORD UNIV PRESS, 2024. ISSN 0267-8357. Available from: https://dx.doi.org/10.1093/mutage/geae014.
      More: https://is.muni.cz/publication/2414077/en
    27. Integrative NGS testing reveals clonal dynamics of adverse genomic defects contributing to a natural progression in treatment-naïve CLL patients
      NAVRKALOVÁ, Veronika, Karla PLEVOVÁ, Lenka RADOVÁ, Jakub Paweł PORC, Karol PÁL, Jitka MALČÍKOVÁ, Šárka PAVLOVÁ, Michael DOUBEK, Anna PANOVSKÁ, Jana KOTAŠKOVÁ and Šárka POSPÍŠILOVÁ. Integrative NGS testing reveals clonal dynamics of adverse genomic defects contributing to a natural progression in treatment-naïve CLL patients. British journal of haematology. Hoboken: Wiley-Blackwell, 2024, vol. 204, No 1, p. 240-249. ISSN 0007-1048. Available from: https://dx.doi.org/10.1111/bjh.19191.
      More: https://is.muni.cz/publication/2372237/en
    28. Isoelectric focusing followed by affinity immunoblotting to detect monoclonal free light chains in monoclonal gammopathies: Comparison with immunofixation electrophoresis and free light chain ratio
      ZEMAN, David, Martin ŠTORK, Lenka ŠVANCAROVÁ, Marek BORSKÝ, Michaela POSPÍŠILOVÁ, Zdeněk ADAM, Miroslava BEŇOVSKÁ and Luděk POUR. Isoelectric focusing followed by affinity immunoblotting to detect monoclonal free light chains in monoclonal gammopathies: Comparison with immunofixation electrophoresis and free light chain ratio. Annals of Clinical Biochemistry. THOUSAND OAKS: SAGE PUBLICATIONS INC, 2024, 12 pp. ISSN 0004-5632. Available from: https://dx.doi.org/10.1177/00045632231221439.
      More: https://is.muni.cz/publication/2409339/en
    29. Long-term follow-up of VIALE-A: Venetoclax and azacitidine in chemotherapy-ineligible untreated acute myeloid leukemia
      PRATZ, Keith W, Brian A JONAS, Vinod PULLARKAT, Michael J THIRMAN, Jacqueline S GARCIA, Hartmut DOEHNER, Christian RECHER, Walter FIEDLER, Kazuhito YAMAMOTO, Jianxiang WANG, Sung-Soo YOON, Ofir WOLACH, Su-Peng YEH, Brian LEBER, Jordi ESTEVE, Jiří MAYER, Kimmo PORKKA, Arpad ILLES, Roberto M LEMOLI, Mehmet TURGUT, Grace KU, Catherine MILLER, Ying ZHOU, Meng ZHANG, Brenda CHYLA, Jalaja POTLURI and Courtney D DINARDO. Long-term follow-up of VIALE-A: Venetoclax and azacitidine in chemotherapy-ineligible untreated acute myeloid leukemia. American Journal of Hematology. Hoboken: Wiley-Blackwell, 2024, vol. 99, No 4, p. 615-624. ISSN 0361-8609. Available from: https://dx.doi.org/10.1002/ajh.27246.
      More: https://is.muni.cz/publication/2407782/en
    30. Long-term treatment with rilzabrutinib in patients with immune thrombocytopenia
      KUTER, David J, Jiří MAYER, Merlin EFRAIM, Lachezar H BOGDANOV, Ross BAKER, Zane KAPLAN, Mamta GARG, A J Gerard JANSEN, Marek TRNENY, Philip Y CHOI, Vickie MCDONALD, Jaromir GUMULEC, Milan KOSTAL, Terry GERNSHEIMER, Waleed GHANIMA, Ahmed DAAK and Nichola COOPER. Long-term treatment with rilzabrutinib in patients with immune thrombocytopenia. Blood advances. AMSTERDAM: ELSEVIER, 2024, vol. 8, No 7, p. 1715-1724. ISSN 2473-9529. Available from: https://dx.doi.org/10.1182/bloodadvances.2023012044.
      More: https://is.muni.cz/publication/2407799/en
    31. Management and outcome of patients with chronic myeloid leukemia in blast phase in the tyrosine kinase inhibitor era - analysis of the European LeukemiaNet Blast Phase Registry
      BRIOLI, Annamaria, Elza LOMAIA, Christian FABISCH, Tomasz SACHA, Hana KLAMOVA, Elena MOROZOVA, Aleksandra GOLOS, Philipp ERNST, Ulla OLSSON-STROMBERG, Daniela ŽÁČKOVÁ, Franck E NICOLINI, Han BAO, Fausto CASTAGNETTI, Elzbieta PATKOWSKA, Jiří MAYER, Klaus HIRSCHBUEHL, Helena PODGORNIK, Edyta PACZKOWSKA, Anne PARRY, Thomas ERNST, Astghik VOSKANYAN, Elzbieta SZCZEPANEK, Susanne SAUSSELE, Georg-Nikolaus FRANKE, Alexander KIANI, Edgar FABER, Stefan KRAUSE, Luis Felipe CASADO, Krzysztof LEWANDOWSKI, Matthias EDER, Peter ANHUT, Justyna GIL, Thomas SUEDHOFF, Holger HEBART, Sonja HEIBL, Markus PFIRRMANN, Andreas HOCHHAUS and Michael LAUSEKER. Management and outcome of patients with chronic myeloid leukemia in blast phase in the tyrosine kinase inhibitor era - analysis of the European LeukemiaNet Blast Phase Registry. Leukemia. London: Nature Publishing Group, 2024, vol. 38, No 5, p. 1072-1080. ISSN 0887-6924. Available from: https://dx.doi.org/10.1038/s41375-024-02204-y.
      More: https://is.muni.cz/publication/2407802/en
    32. MethScore as a new comprehensive DNA methylation-based value refining the prognosis in acute myeloid leukemia
      SESTAKOVA, Sarka, Cyril SALEK, David KUNDRAT, Ela CEROVSKA, Jan VYDRA, Ivana JEŽÍŠKOVÁ, Adam FOLTA, Jiří MAYER, Petr CETKOVSKY and Hana REMESOVA. MethScore as a new comprehensive DNA methylation-based value refining the prognosis in acute myeloid leukemia. CLINICAL EPIGENETICS. LONDON: BMC, 2024, vol. 16, No 1, p. 1-12. ISSN 1868-7075. Available from: https://dx.doi.org/10.1186/s13148-024-01625-x.
      More: https://is.muni.cz/publication/2376682/en
    33. Minimal Residual Disease Status Predicts Outcome in Patients With Previously Untreated Follicular Lymphoma: A Prospective Analysis of the Phase III GALLIUM Study
      POTT, Christiane, Vindi JURINOVIC, Judith TROTMAN, Britta KEHDEN, Michael UNTERHALT, Michael HEROLD, van der Jagt RICHARD, Ann JANSSENS, Michael KNEBA, Jiří MAYER, Moya YOUNG, Christian SCHMIDT, Andrea KNAPP, Tina NIELSEN, Helen BROWN, Nathalie SPIELEWOY, Chris HARBRON, Alessia BOTTOS, Kirsten MUNDT, Robert MARCUS, Wolfgang HIDDEMANN and Eva HOSTER. Minimal Residual Disease Status Predicts Outcome in Patients With Previously Untreated Follicular Lymphoma: A Prospective Analysis of the Phase III GALLIUM Study. Journal of clinical oncology. PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS, 2024, vol. 42, No 5, p. 1-13. ISSN 0732-183X. Available from: https://dx.doi.org/10.1200/JCO.23.00838.
      More: https://is.muni.cz/publication/2409573/en
    34. Mutations in myeloid transcription factors and activated signaling genes predict chronic myeloid leukemia outcomes
      PERUSINI, Maria Agustina, Daniela ŽÁČKOVÁ, TaeHyung KIM, Katia B B PAGNANO, Carolina PAVLOVSKY, Ivana JEŽÍŠKOVÁ, Anežka KVETKOVÁ, Tomáš JURČEK, Jaeyoon John KIM, Young Seok YOO, Seongyoon YI, Hyewon LEE, Kyoung Ha KIM, Myunghee CHANG, Capo-Chichi JOSE-MARIO, Jessie MEDEIROS, Andrea ARRUDA, Mark D MINDEN, Zhaolei ZHANG, Sagi ABELSON, Jiří MAYER and Dennis Dong Hwan KIM. Mutations in myeloid transcription factors and activated signaling genes predict chronic myeloid leukemia outcomes. Blood advances. AMSTERDAM: ELSEVIER, 2024, vol. 8, No 10, p. 2361-2372. ISSN 2473-9529. Available from: https://dx.doi.org/10.1182/bloodadvances.2023012127.
      More: https://is.muni.cz/publication/2387637/en
    35. Need for ICU and outcome of critically ill patients with COVID-19 and haematological malignancies: results from the EPICOVIDEHA survey
      LAHMER, Tobias, Jon SALMANTON-GARCIA, Francesco MARCHESI, Shaimaa EL-ASHWAH, Marcio NUCCI, Caroline BESSON, Federico ITRI, Ozren JAKSIC, Natasha COLOVIC, Barbora WEINBERGEROVÁ, Guldane Cengiz SEVAL, Tatjana ADZIC-VUKICEVIC, Tomas SZOTKOWSKI, Uluhan SILI, Michelina DARGENIO, van Praet JENS, van Doesum JAAP, Martin SCHOENLEIN, Zdenek RACIL, Pavel ZAK, Christian Bjorn POULSEN, Gabriele MAGLIANO, Moraima JIMENEZ, Valentina BONUOMO, Klara PIUKOVICS, Giulia DRAGONETTI, Fatih DEMIRKAN, Ola BLENNOW, Toni VALKOVIC, Da Silva Maria GOMES, Johan MAERTENS, Andreas GLENTHOJ, Noemi FERNANDEZ, Rui BERGANTIM, Luisa VERGA, Verena PETZER, Ali S OMRANI, Gustavo-Adolfo MENDEZ, Marina MACHADO, Marie-Pierre LEDOUX, Rebeca BAILEN, Rafael F DUARTE, Del Principe Maria ILARIA, Francesca FARINA, Sonia MARTIN-PEREZ, Julio DAVILA-VALLS, Monia MARCHETTI, Yavuz M BILGIN, Nicola S FRACCHIOLLA, Chiara CATTANEO, Ildefonso ESPIGADO, Raul CORDOBA, Graham P COLLINS, Jorge LABRADOR, Iker FALCES-ROMERO, Lucia PREZIOSO, Stef MEERS, Francesco PASSAMONTI, Caterina BUQUICCHIO, Alberto LOPEZ-GARCIA, Austin KULASEKARARAJ, Irati ORMAZABAL-VELEZ, Annarosa CUCCARO, Carolina GARCIA-VIDAL, Alessandro BUSCA, Milan NAVRATIL, de Jonge NICK, Monika M BIERNAT, Anna GUIDETTI, Ghaith ABU-ZEINAH, Michail SAMARKOS, Amalia ANASTASOPOULOU, de Ramon CRISTINA, Tomas Jose GONZALEZ-LOPEZ, Martin HOENIGL, Olimpia FINIZIO, Laszlo Imre PINCZES, Natasha ALI, Antonio VENA, Carlo TASCINI, Zlate STOJANOSKI, Maria MERELLI, Ziad EMARAH, Milena KOHN, Aleksandra BARAC, Milos MLADENOVIC, Bojana MISKOVIC, Osman ILHAN, Gokce Melis COLAK, Martin CERNAN, Stefanie K GRAEFE, Emanuele AMMATUNA, Michaela HANAKOVA, Benjamin VISEK, Alba CABIRTA, Anna NORDLANDER, Raquel Nunes RODRIGUES, Ditte Stampe HERSBY, Giovanni Paolo Maria ZAMBROTTA, Dominik WOLF, Lucia NUNEZ-MARTIN-BUITRAGO, Elena ARELLANO, Francesco Aiello TOMMASO, Ramon GARCIA-SANZ, Juergen PRATTES, Matthias EGGER, Alessandro LIMONGELLI, Martina BAVASTRO, Milche CVETANOSKI, Miriam DIBOS, Sebastian RASCH, Laman RAHIMLI, Oliver A CORNELY and Livio PAGANO. Need for ICU and outcome of critically ill patients with COVID-19 and haematological malignancies: results from the EPICOVIDEHA survey. Infection. HEIDELBERG: Springer, 2024, vol. 52, No 3, p. 1125-1141. ISSN 0300-8126. Available from: https://dx.doi.org/10.1007/s15010-023-02169-7.
      More: https://is.muni.cz/publication/2409570/en
    36. Operační léčba recidivujících gynekologických zhoubných nádorů (Surgical treatment of recurrent gynecological malignancies)
      CRHA, Tomáš, Vít WEINBERGER, Luboš MINÁŘ, Michal FELSINGER, Markéta BEDNAŘÍKOVÁ and Jitka HAUSNEROVÁ. Operační léčba recidivujících gynekologických zhoubných nádorů (Surgical treatment of recurrent gynecological malignancies). Ceska Gynekologie-Czech Gynaecology. PRAGUE: NAKLADATELSKE STREDISKO C L S J E PURKYNE, 2024, vol. 89, No 4, p. 309-318. ISSN 1210-7832. Available from: https://dx.doi.org/10.48095/cccg2024309.
      More: https://is.muni.cz/publication/2447401/en
    37. Oral decitabine/cedazuridine versus intravenous decitabine for acute myeloid leukaemia: A randomised, crossover, registration, pharmacokinetics study
      GEISSLER, Klaus, Zdenek KORISTEK, del Castillo Teresa BERNAL, Jan NOVAK, Gabriela RODRIGUEZ-MACIAS, Stephan K METZELDER, Arpad ILLES, Jiří MAYER, Montserrat ARNAN, Mary-Margaret KEATING, Juergen KRAUTER, Monia LUNGHI, Nicola Stefano FRACCHIOLLA, Uwe PLATZBECKER, Valeria SANTINI, Yuri SANO, Aram OGANESIAN, Harold KEER and Michael LUEBBERT. Oral decitabine/cedazuridine versus intravenous decitabine for acute myeloid leukaemia: A randomised, crossover, registration, pharmacokinetics study. British journal of haematology. Hoboken: Wiley-Blackwell, 2024, p. 1-12. ISSN 0007-1048. Available from: https://dx.doi.org/10.1111/bjh.19741.
      More: https://is.muni.cz/publication/2439078/en
    38. Outcome of patients with diffuse large B-cell lymphoma and testicular involvement - real world data
      MOCIKOVA, Heidi, Andrea JANÍKOVÁ, Alice SYKOROVA, Vit PROCHAZKA, Jan PIRNOS, Juraj DURAS, Katerina KOPECKOVA, Katerina STEINEROVA, Robert PYTLIK, Petra BLAHOVCOVA, David ŠÁLEK, Tomas KOZAK, Veronika BACHANOVA and David BELADA. Outcome of patients with diffuse large B-cell lymphoma and testicular involvement - real world data. Annals of Hematology. New York: Springer, 2024, 10 pp. ISSN 0939-5555. Available from: https://dx.doi.org/10.1007/s00277-024-06025-y.
      More: https://is.muni.cz/publication/2446185/en
    39. Oxidative stress, microparticles, and E-selectin do not depend on HIV suppression
      HAVLÍČKOVÁ, Kateřina, Svatava SNOPKOVÁ, Miroslav POHANKA, Radek SVAČINKA, David VYDRÁŘ, Petr HUSA, Jiřina ZAVŘELOVÁ, Filip ZLÁMAL, Lenka FABIANOVÁ, Miroslav PENKA and Petr HUSA. Oxidative stress, microparticles, and E-selectin do not depend on HIV suppression. Biomedical Papers, Olomouc: Palacky University. Olomouc: Palacky University, 2024, vol. 168, No 2, p. 1-9. ISSN 1213-8118. Available from: https://dx.doi.org/10.5507/bp.2024.002.
      More: https://is.muni.cz/publication/2378959/en
    40. Patient-reported outcomes in patients with relapsed or refractory follicular lymphoma treated with zanubrutinib plus obinutuzumab versus obinutuzumab monotherapy: results from the ROSEWOOD trial
      TROTMAN, Judith, Pier Luigi ZINZANI, Yuqin SONG, Richard DELARUE, Pil KIM, Elena IVANOVA, Rasika KORDE, Jiří MAYER, Ana C DE OLIVEIRA, Sarit E ASSOULINE, Christopher R FLOWERS and Gisoo BARNES. Patient-reported outcomes in patients with relapsed or refractory follicular lymphoma treated with zanubrutinib plus obinutuzumab versus obinutuzumab monotherapy: results from the ROSEWOOD trial. Current medical research and opinion. Oxon: Taylor & Francis, 2024, 9 pp. ISSN 0300-7995. Available from: https://dx.doi.org/10.1080/03007995.2024.2409837.
      More: https://is.muni.cz/publication/2447847/en
    41. Pembrolizumab or placebo with chemoradiotherapy followed by pembrolizumab or placebo for newly diagnosed high-risk, locally advanced cervical cancer (ENGOT-cx11/ GOG-3047/KEYNOTE-A18): overall survival results from a randomised, double-blind, placebo-controlled, phase 3 trial
      LORUSSO, Domenica, Yang XIANG, Kosei HASEGAWA, Giovanni SCAMBIA, Manuel LEIVA, Pier RAMOS-ELIAS, Alejandro ACEVEDO, Jakub CVEK, Leslie RANDALL, Andrea Juliana Pereira de Santana GOMES, Fernando Contreras MEJIA, Limor HELPMAN, Huseyin AKILLI, Jung-Yun LEE, Valeriya SAEVETS, Flora ZAGOURI, Lucy GILBERT, Jalid SEHOULI, Ekkasit THARAVICHITKUL, Kristina LINDEMANN, Nicoletta COLOMBO, Chih-Long CHANG, Markéta BEDNAŘÍKOVÁ, Hong ZHU, Ana OAKNIN, Melissa CHRISTIAENS, Edgar PETRU, Tomoka USAMI, Peng LIU, Karin YAMADA, Sarper TOKER, Stephen M KEEFE, Sandro PIGNATA and Linda R DUSKA. Pembrolizumab or placebo with chemoradiotherapy followed by pembrolizumab or placebo for newly diagnosed high-risk, locally advanced cervical cancer (ENGOT-cx11/ GOG-3047/KEYNOTE-A18): overall survival results from a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet. New York: Elsevier Science Inc., 2024, vol. 404, No 10460, p. 1321-1332. ISSN 0140-6736. Available from: https://dx.doi.org/10.1016/S0140-6736(24)01808-7.
      More: https://is.muni.cz/publication/2446260/en
    42. Precision immuno-oncology approach for four malignant tumors in siblings with constitutional mismatch repair deficiency syndrome
      PÁLOVÁ, Hana, Anirban DAS, Petra POKORNÁ, Viera BAJČIOVÁ, Zdenek PAVELKA, Marta JEŽOVÁ, Karol PÁL, Jose R DIMAYACYAC, Logine NEGM, Lucie STENGS, Vanessa BIANCHI, Klára VEJMĚLKOVÁ, Kristýna NOSKOVÁ, Marie JAROŠOVÁ, Soňa MEJSTŘÍKOVÁ, Peter MÚDRY, Michal KÝR, Tomáš MERTA, Pavel TINKA, Klára DRÁBOVÁ, Štefánia AULICKÁ, Robin JUGAS, Uri TABORI, Ondřej SLABÝ and Jaroslav ŠTĚRBA. Precision immuno-oncology approach for four malignant tumors in siblings with constitutional mismatch repair deficiency syndrome. NPJ PRECISION ONCOLOGY. Belin: NATURE PORTFOLIO, 2024, vol. 8, No 1, p. 1-9. ISSN 2397-768X. Available from: https://dx.doi.org/10.1038/s41698-024-00597-8.
      More: https://is.muni.cz/publication/2409797/en
    43. Prevalence of fungal DNAemia mediated by putatively non-pathogenic fungi in immunocompromised patients with febrile neutropenia: a prospective cohort study
      LUCINI, Chantal, Klara OBROVA, Isabella KRICKL, Filomena NOGUEIRA, Iva KOCMANOVA, Susanne HERNDLHOFER, Karoline V GLEIXNER, Wolfgang R SPERR, Tijana FRANK, Nuno ANDRADE, Christina PETERS, Gernot ENGSTLER, Michael DWORZAK, Andishe ATTARBASCHI, Martine VAN GROTEL, Marry M VAN DEN HEUVEL-EIBRINK, Ivan S MOISEEV, Yuliya ROGACHEVA, Ludmilla ZUBAROVSKAYA, Natalia ZUBAROVSKAYA, Herbert PICHLER, Anita LAWITSCHKA, Elisabeth KOLLER, Felix KEIL, Jiří MAYER, Barbora WEINBERGEROVÁ, Peter VALENT and Thomas LION. Prevalence of fungal DNAemia mediated by putatively non-pathogenic fungi in immunocompromised patients with febrile neutropenia: a prospective cohort study. JOURNAL OF HEMATOLOGY & ONCOLOGY. LONDON: BMC, 2024, vol. 17, No 1, p. 1-6. ISSN 1756-8722. Available from: https://dx.doi.org/10.1186/s13045-024-01583-0.
      More: https://is.muni.cz/publication/2424021/en
    44. Proteomic analysis of ascitic extracellular vesicles describes tumour microenvironment and predicts patient survival in ovarian cancer
      VYHLÍDALOVÁ KOTRBOVÁ, Anna, Kristína GÖMÖRYOVÁ, Antónia MIKULOVÁ, Hana PLEŠINGEROVÁ, Stanislava SLADEČEK, Marek KRAVEC, Šárka HRACHOVINOVÁ, David POTĚŠIL, Garett DUNSMORE, Camille BLERIOT, Mathilde BIED, Jan KOTOUČEK, Markéta BEDNAŘÍKOVÁ, Jitka HAUSNEROVÁ, Luboš MINÁŘ, Igor CRHA, Michal FELSINGER, Zbyněk ZDRÁHAL, Florent GINHOUX, Vít WEINBERGER, Vítězslav BRYJA and Vendula HLAVÁČKOVÁ POSPÍCHALOVÁ. Proteomic analysis of ascitic extracellular vesicles describes tumour microenvironment and predicts patient survival in ovarian cancer. Journal of Extracellular Vesicles. Wiley, 2024, vol. 13, No 3, p. 1-22. ISSN 2001-3078. Available from: https://dx.doi.org/10.1002/jev2.12420.
      More: https://is.muni.cz/publication/2392978/en
    45. Rare multi-fungal sepsis: a case of triple-impact immunoparalysis
      LIPOVÝ, Břetislav, Martin HLADÍK, Kateřina VYKLICKÁ, Iva KOCMANOVÁ, Martina LENGEROVÁ, Leoš KŘEN, Michal SRNÍK, Jan BÖHM, Petr ANDRLA and Petra BOŘILOVÁ LINHARTOVÁ. Rare multi-fungal sepsis: a case of triple-impact immunoparalysis. Folia microbiologica. Praha: Mikrobiologický ústav Praha AV ČR, 2024, vol. 69, No 4, p. 903-911. ISSN 0015-5632. Available from: https://dx.doi.org/10.1007/s12223-024-01165-0.
      More: https://is.muni.cz/publication/2423021/en
    46. Realizing precision medicine in chronic lymphocytic leukemia: Remaining challenges and potential opportunities
      STAMATOPOULOS, Kostas, Šárka PAVLOVÁ, Othman AL-SAWAF, Thomas CHATZIKONSTANTINOU, Christina KARAMANIDOU, Gianluca GAIDANO, Florence CYMBALISTA, Arnon P KATER, Andy RAWSTRON, Lydia SCARFO, Paolo GHIA and Richard ROSENQUIST. Realizing precision medicine in chronic lymphocytic leukemia: Remaining challenges and potential opportunities. HemaSphere. Philadelphia: Lippincott Williams & Wilkins, 2024, vol. 8, No 7, p. 1-12. ISSN 2572-9241. Available from: https://dx.doi.org/10.1002/hem3.113.
      More: https://is.muni.cz/publication/2421701/en
    47. Real-world data on diagnostics, treatment and outcomes of patients with hairy cell leukemia: The HCL-CLLEAR study
      PANOVSKÁ, Anna, Pavel ZAK, Tereza JURKOVA, Tomáš ARPÁŠ, Yvona BRYCHTOVÁ, Alžběta VAŠÍKOVÁ, Viera HRABČÁKOVÁ, Adéla PRCHLÍKOVÁ, Martina FILIPOVÁ and Michael DOUBEK. Real-world data on diagnostics, treatment and outcomes of patients with hairy cell leukemia: The HCL-CLLEAR study. Hematological Oncology. Hoboken: WILEY-BLACKWELL, 2024, vol. 42, No 3, p. 1-9. ISSN 0278-0232. Available from: https://dx.doi.org/10.1002/hon.3280.
      More: https://is.muni.cz/publication/2409777/en
    48. Real-World Evidence on Prognostic Value of MRD in Multiple Myeloma Using Flow Cytometry
      MURONOVA, Ludmila, Ondrej SOUCEK, David ZIHALA, Tereza SEVCIKOVA, Tereza POPKOVA, Hana PLONKOVA, Ondrej VENGLAR, Luděk POUR, Martin ŠTORK, Lucie RIHOVA, Renata BEZDEKOVA, Jiri MINARIK, Vojtech LATAL, Martin NOVAK, Alexandra JUNGOVA, Tereza DEKOJOVA, Jan STRAUB, Martin SPACEK, Vladimira REZACOVA, Vladimir MAISNAR, Jakub RADOCHA, Roman HAJEK and Tomas JELINEK. Real-World Evidence on Prognostic Value of MRD in Multiple Myeloma Using Flow Cytometry. European Journal of Haematology. Hoboken: Wiley-Blackwell, 2024, 9 pp. ISSN 0902-4441. Available from: https://dx.doi.org/10.1111/ejh.14316.
      More: https://is.muni.cz/publication/2447837/en
    49. ROP-ET: a prospective phase III trial investigating the efficacy and safety of ropeginterferon alfa-2b in essential thrombocythemia patients with limited treatment options
      KILADJIAN, Jean-Jacques, Francisca Ferrer MARIN, Haifa Kathrin AL-ALI, Alberto ALVAREZ-LARRAN, Eloise BEGGIATO, Maria BIENIASZEWSKA, Massimo BRECCIA, Veronika BUXHOFER-AUSCH, Olga CERNA, Ana-Manuela CRISAN, Catalin Doru DANAILA, De Stefano VALERIO, Konstanze DOEHNER, Victoria EMPSON, Joanna GORA-TYBOR, Martin GRIESSHAMMER, Sebastian GROSICKI, Paola GUGLIELMELLI, Valentin GARCIA-GUTIERREZ, Florian H HEIDEL, Arpad ILLES, Ciprian TOMULEASA, Chloe JAMES, Steffen KOSCHMIEDER, Maria-Theresa KRAUTH, Kurt KREJCY, Mihaela-Cornelia LAZAROIU, Jiří MAYER, Zsolt Gyoergy NAGY, Franck-Emmanuel NICOLINI, Francesca PALANDRI, Vassiliki PAPPA, Andreas Johannes REITER, Tomasz SACHA, Stefanie SCHLAGER, Stefan SCHMIDT, Evangelos TERPOS, Martin UNGER, Albert WOELFLER, Blanca Xicoy CIRICI and Christoph KLADE. ROP-ET: a prospective phase III trial investigating the efficacy and safety of ropeginterferon alfa-2b in essential thrombocythemia patients with limited treatment options. Annals of hematology. New York: Springer Verlag, 2024, vol. 103, No 7, p. 2299-2310. ISSN 0939-5555. Available from: https://dx.doi.org/10.1007/s00277-024-05665-4.
      More: https://is.muni.cz/publication/2418102/en
    50. Serum chemistry profiling and prognostication in systemic mastocytosis: a registry-based study of the ECNM and GREM
      LUEBKE, Johannes, Alicia SCHMID, Deborah CHRISTEN, Hanneke N G Oude ELBERINK, Lambert F R SPAN, Marek NIEDOSZYTKO, Aleksandra GORSKA, Magdalena LANGE, Karoline V GLEIXNER, Emir HADZIJUSUFOVIC, Alex STEFAN, Irena ANGELOVA-FISCHER, Roberta ZANOTTI, Massimiliano BONIFACIO, Patrizia BONADONNA, Khalid SHOUMARIYEH, von Bubnoff NIKOLAS, Sabine MUELLER, Cecelia PERKINS, Chiara ELENA, Luca MALCOVATI, Hans HAGGLUND, Mattias MATTSSON, Roberta PARENTE, Judit VARKONYI, Anna Belloni FORTINA, Francesca CAROPPO, Knut BROCKOW, Alexander ZINK, Christine BREYNAERT, Toon LEVEN, Akif Selim YAVUZ, Michael DOUBEK, Vito SABATO, Tanja SCHUG, Karin HARTMANN, Massimo TRIGGIANI, Jason GOTLIB, Olivier HERMINE, Michel AROCK, Hanneke C KLUIN-NELEMANS, Jens PANSE, Wolfgang R SPERR, Peter VALENT, Andreas REITER and Juliana SCHWAAB. Serum chemistry profiling and prognostication in systemic mastocytosis: a registry-based study of the ECNM and GREM. Blood advances. AMSTERDAM: ELSEVIER, 2024, vol. 8, No 11, p. 2890-2900. ISSN 2473-9529. Available from: https://dx.doi.org/10.1182/bloodadvances.2024012756.
      More: https://is.muni.cz/publication/2418100/en
    51. Several factors that predict the outcome of large B-cell lymphoma patients who relapse/progress after chimeric antigen receptor (CAR) T-cell therapy can be identified before cell administration
      SYKOROVA, Alice, František FOLBER, Kamila POLGAROVA, Heidi MOCIKOVA, Juraj DURAS, Katerina STEINEROVA, Ales OBR, Adriana HEINDORFER, Miriam LADICKA, Lubica LUKACOVA, Erika CELLAROVA, Ivana PLAMENOVA, David BELADA, Andrea JANÍKOVÁ, Marek TRNENY, Tereza JANCARKOVA, Vit PROCHAZKA, Andrej VRANOVSKY, Margareta KRALIKOVA, Jan VYDRA, Lukas SMOLEJ, Lubos DRGONA, Martin SEDMINA, Eva CERMAKOVA and Robert PYTLIK. Several factors that predict the outcome of large B-cell lymphoma patients who relapse/progress after chimeric antigen receptor (CAR) T-cell therapy can be identified before cell administration. Cancer Medicine. Hoboken: Wiley, 2024, vol. 13, No 17, p. 1-15. ISSN 2045-7634. Available from: https://dx.doi.org/10.1002/cam4.70138.
      More: https://is.muni.cz/publication/2436038/en
    52. Stromal cells engineered to express T cell factors induce robust CLL cell proliferation in vitro and in PDX co-transplantations allowing the identification of RAF inhibitors as anti-proliferative drug
      HOFERKOVÁ, Eva, Václav ŠEDA, Soňa CESNÁRIKOVÁ, Jan VERNER, Tomáš LOJA, Květoslava MATULOVÁ, Hana SKUHROVÁ FRANCOVÁ, Eva ONDROUŠKOVÁ, Daniel FILIP, Nicolas BLAVET, Miroslav BOUDNÝ, Gabriela MLADONICKÁ PAVLASOVÁ, Josef VEČEŘA, Laura ONDRIŠOVÁ, Petra PAVELKOVÁ, Kryštof HLAVÁČ, Lenka KOŠŤÁLOVÁ, Androniki MICHAELOU, Šárka POSPÍŠILOVÁ, Jana DORAZILOVÁ, Václav CHOCHOLA, Josef JAROŠ, Michael DOUBEK, Marie JAROŠOVÁ, Aleš HAMPL, Lucy VOJTOVÁ, Leoš KŘEN, Jiří MAYER and Marek MRÁZ. Stromal cells engineered to express T cell factors induce robust CLL cell proliferation in vitro and in PDX co-transplantations allowing the identification of RAF inhibitors as anti-proliferative drug. Leukemia. LONDON: SPRINGERNATURE, 2024, vol. 38, No 8, p. 1-13. ISSN 0887-6924. Available from: https://dx.doi.org/10.1038/s41375-024-02284-w.
      More: https://is.muni.cz/publication/2412660/en
    53. Survival in multiple myeloma and SARS-COV-2 infection through the COVID-19 pandemic: Results from the epicovideha registry
      MUSTO, Pellegrino, Jon SALMANTON-GARCIA, Nicola SGHERZA, Rui BERGANTIM, Francesca FARINA, Andreas GLENTHOJ, Cengiz Seval GULDANE, Barbora WEINBERGEROVÁ, Valentina BONUOMO, Yavuz M BILGIN, van Doesum JAAP, Ozren JAKSIC, Benjamin VISEK, Iker FALCES-ROMERO, Monia MARCHETTI, Julio DAVILA-VALLS, Sonia MARTIN-PEREZ, Marcio NUCCI, Alberto LOPEZ-GARCIA, Federico ITRI, Caterina BUQUICCHIO, Luisa VERGA, Klara PIUKOVICS, Milan NAVRATIL, Graham P COLLINS, Moraima JIMENEZ, Nicola S FRACCHIOLLA, Jorge LABRADOR, Lucia PREZIOSO, Elena ROSSI, Natasha COLOVIC, Stef MEERS, Austin KULASEKARARAJ, Annarosa CUCCARO, Ola BLENNOW, Toni VALKOVIC, Uluhan SILI, Marie-Pierre LEDOUX, Josip BATINIC, Francesco PASSAMONTI, Marina MACHADO, Rafael F DUARTE, Christian Bjorn POULSEN, Gustavo-Adolfo MENDEZ, Ildefonso ESPIGADO, Fatih DEMIRKAN, Martin CERNAN, Chiara CATTANEO, Verena PETZER, Gabriele MAGLIANO, Carolina GARCIA-VIDAL, Shaimaa EL-ASHWAH, Maria GOMES-DA-SILVA, Antonio VENA, Irati ORMAZABAL-VELEZ, van Praet JENS, Michelina DARGENIO, Cristina DE-RAMON, Del Principe Maria ILARIA, Joyce MARQUES-DE-ALMEIDA, Dominik WOLF, Tomas SZOTKOWSKI, Ales OBR, Goekce Melis COLAK, Anna NORDLANDER, Macarena IZUZQUIZA, Alba CABIRTA, Giovanni Paolo Maria ZAMBROTTA, Raul CORDOBA, Pavel ZAK, Emanuele AMMATUNA, Jiri MAYER, Osman ILHAN, Ramon GARCIA-SANZ, Martina QUATTRONE, Elena ARELLANO, Raquel NUNES-RODRIGUES, Ziad EMARAH, Tommaso Francesco AIELLO, Michaela HANAKOVA, Zdenek RACIL, Martina BAVASTRO, Alessandro LIMONGELLI, Laman RAHIMLI, Francesco MARCHESI, Oliver A CORNELY and Livio PAGANO. Survival in multiple myeloma and SARS-COV-2 infection through the COVID-19 pandemic: Results from the epicovideha registry. Hematological Oncology. Hoboken: WILEY-BLACKWELL, 2024, vol. 42, No 1, p. 1-15. ISSN 0278-0232. Available from: https://dx.doi.org/10.1002/hon.3240.
      More: https://is.muni.cz/publication/2368919/en
    54. The mortality of COVID-19 in CML patients from 2020 until 2022: results from the EPICOVIDEHA survey
      EL-ASHWAH, Shaimaa, Jon SALMANTON-GARCIA, Yavuz M BILGIN, Federico ITRI, Pavel ZAK, Barbora WEINBERGEROVÁ, Luisa VERGA, Ali S OMRANI, Maria Gomes da SILVA, Tomas SZOTKOWSKI, Monia MARCHETTI, Caterina BUQUICCHIO, Marcio NUCCI, Martin SCHOENLEIN, Francesca FARINA, Caroline BESSON, Lucia PREZIOSO, Summiya NIZAMUDDIN, Julio DAVILA-VALLS, Sonia MARTIN-PEREZ, Valentina BONUOMO, Van Doesum JAAP, Maria Chiara TISI, Francesco PASSAMONTI, Gustavo-Adolfo MENDEZ, Stef MEERS, Johan MAERTENS, Alberto LOPEZ-GARCIA, Andreas GLENTHOJ, Matteo BONNANI, Ikhwan RINALDI, Irati ORMAZABAL-VELEZ, Jorge LABRADOR, Austin KULASEKARARAJ, Ildefonso ESPIGADO, Fatih DEMIRKAN, De Jonge NICK, Graham P COLLINS, Maria CALBACHO, Ola BLENNOW, Murtadha AL-KHABORI, Tatjana ADZIC-VUKICEVIC, Elena ARELLANO, Bojana MISKOVIC, Milos MLADENOVIC, Anna NORDLANDER, Zdenek RACIL, Emanuele AMMATUNA, Raul CORDOBA, Ditte Stampe HERSBY, Stefanie GRAEFE, Ziad EMARAH, Michaela HANAKOVA, Maria Vittoria SACCHI, Marriyam IJAZ, Laman RAHIMLI, Nunes Rodrigues RAQUEL, Giovanni Paolo Maria ZAMBROTTA, Francesco MARCHESI, Oliver A CORNELY and Livio PAGANO. The mortality of COVID-19 in CML patients from 2020 until 2022: results from the EPICOVIDEHA survey. LEUKEMIA & LYMPHOMA. LONDON: INFORMA HEALTHCARE, 2024, vol. 65, No 2, p. 199-208. ISSN 1042-8194. Available from: https://dx.doi.org/10.1080/10428194.2023.2280886.
      More: https://is.muni.cz/publication/2369026/en
    55. The non-canonical BAF chromatin remodeling complex is a novel target of spliceosome dysregulation in SF3B1-mutated chronic lymphocytic leukemia
      HAGERSTRAND, Daniel, Blaz ODER, Diego CORTESE, Ying QU, Amrei BINZER-PANCHAL, Cecilia OSTERHOLM, Teresa Del Peso SANTOS, Leily RABBANI, Hassan Foroughi ASL, Aron SKAFTASON, Viktor LJUNGSTROM, August LUNDHOLM, Maria KOUTROUMANI, Zahra HAIDER, Cecilia JYLHA, John MOLLSTEDT, Larry MANSOURI, Karla PLEVOVÁ, Andreas AGATHANGELIDIS, Lydia SCARFO, Marine ARMAND, Alice F MUGGEN, Neil E KAY, Tait SHANAFELT, Davide ROSSI, Lukas M ORRE, Šárka POSPÍŠILOVÁ, Konstantin BARYLYUK, Frederic DAVI, Mattias VESTERLUND, Anton W LANGERAK, Janne LEHTIO, Paolo GHIA, Kostas STAMATOPOULOS, Lesley-Ann SUTTON and Richard ROSENQUIST. The non-canonical BAF chromatin remodeling complex is a novel target of spliceosome dysregulation in SF3B1-mutated chronic lymphocytic leukemia. Leukemia. LONDON: SPRINGERNATUR, 2024, 14 pp. ISSN 0887-6924. Available from: https://dx.doi.org/10.1038/s41375-024-02379-4.
      More: https://is.muni.cz/publication/2447550/en
    56. The SNP rs460089 in the gene promoter of the drug transporter OCTN1 has prognostic value for treatment-free remission in chronic myeloid leukemia patients treated with imatinib
      POLAKOVA, Katerina Machova, Ali ALBEER, Vaclava POLIVKOVA, Monika KRUTSKA, Katerina VLCANOVA, Nikola CURIK, Alice FABARIUS, Hana KLAMOVA, Birgit SPIESS, Cornelius F WALLER, Tim H BRUEMMENDORF, Jolanta DENGLER, Volker KUNZMANN, Andreas BURCHERT, Petra BELOHLAVKOVA, Satu MUSTJOKI, Edgar FABER, Jiří MAYER, Daniela ŽÁČKOVÁ, Panayiotis PANAYIOTIDIS, Johan RICHTER, Henrik HJORTH-HANSEN, Magdalena KAMINSKA, Magdalena PLONKA, Elzbieta SZCZEPANEK, Monika SZAREJKO, Grazyna BOBER, Iwona HUS, Olga GRZYBOWSKA-IZYDORCZYK, Ewa WASILEWSKA, Edyta PACZKOWSKA, Joanna NIESIOBEDZKA-KREZEL, Krzysztof GIANNOPOULOS, Francois X MAHON, Tomasz SACHA, Susanne SAUSSELE and Markus PFIRRMANN. The SNP rs460089 in the gene promoter of the drug transporter OCTN1 has prognostic value for treatment-free remission in chronic myeloid leukemia patients treated with imatinib. Leukemia. London: Nature Publishing Group, 2024, 8 pp. ISSN 0887-6924. Available from: https://dx.doi.org/10.1038/s41375-023-02109-2.
      More: https://is.muni.cz/publication/2370258/en
    57. The 1+Million Genomes Minimal Dataset for Cancer
      RIBA, Michela, Cinzia SALA, Aedin C CULHANE, Asmund FLOBAK, Attila PATOCS, Kjetil BOYE, Karla PLEVOVÁ, Šárka POSPÍŠILOVÁ, Giorgia GANDOLFI, Marco J MORELLI, Gabriele BUCCI, Anders EDSJO, Ulrik LASSEN, Fatima AL-SHAHROUR, Nuria LOPEZ-BIGAS, Randi HOVLAND, Edwin CUPPEN, Alfonso VALENCIA, Helene A POIREL, Richard ROSENQUIST, Serena SCOLLEN, Juan Arenas MARQUEZ, Jeroen BELIEN, De Nicolo ARCANGELA, De Maria RUGGERO, David TORRENTS and Giovanni TONON. The 1+Million Genomes Minimal Dataset for Cancer. Nature genetics. Berlin: Nature Publishing Group, 2024, vol. 56, No 5, p. 733-736. ISSN 1061-4036. Available from: https://dx.doi.org/10.1038/s41588-024-01721-x.
      More: https://is.muni.cz/publication/2407780/en
    58. Therapeutic strategies and treatment sequencing in patients with chronic lymphocytic leukemia: An international study of ERIC, the European Research Initiative on CLL
      CHATZIKONSTANTINOU, Thomas, Lydia SCARFO, Eva MINGA, Georgios KARAKATSOULIS, Dimitra CHAMOU, Jana KOTAŠKOVÁ, Gloria IACOBONI, Christos DEMOSTHENOUS, Elisa ALBI, Miguel ALCOCEBA, Salem AL-SHEMARI, Therese AURRAN-SCHLEINITZ, Francesca BACCHIARRI, Sofia CHATZILEONTIADOU, Rosa COLLADO, Zadie DAVIS, de Deus Santos Marcos DANIEL, Maria DIMOU, Elena DMITRIEVA, David DONALDSON, Dos Santos GIMENA, Barbara DRETA, Maria EFSTATHOPOULOU, Shaimaa EL-ASHWAH, Alicia ENRICO, Andrzej FRYGIER, Sara GALIMBERTI, Andrea GALITZIA, Eva GIMENO, Valerio GUARENTE, Romain GUIEZE, Sean HARROP, Eleftheria HATZIMICHAEL, Yair HERISHANU, Jose-angel HERNANDEZ-RIVAS, Ozren JAKSIC, Elzbieta KALICINSKA, Kamel LARIBI, Volkan KARAKUS, Arnon P KATER, Bonnie KHO, Maria KISLOVA, Eliana KONSTANTINOU, Maya KOREN-MICHOWITZ, Ioannis KOTSIANIDIS, Zuzana KUBOVA, Jorge LABRADOR, Deepesh LAD, Luca LAURENTI, Thomas LONGVAL, Alberto LOPEZ-GARCIA, Juan MARQUET, Stanislava MASLEJOVA, Carlota MAYOR-BASTIDA, Biljana MIHALJEVIC, Ivana MILOSEVIC, Fatima MIRAS, Riccardo MOIA, Marta MORAWSKA, Uttam K NATH, Almudena NAVARRO-BAILON, Jacopo OLIVIERI, Irina PANOVSKA-STAVRIDIS, Maria PAPAIOANNOU, Cheyenne PIERIE, Anna PUIGGROS, Gianluigi REDA, Gian M RIGOLIN, Rosa RUCHLEMER, Mattia SCHIPANI, Annett SCHIWITZA, Yandong SHEN, Tereza SHOKRALLA, Martin SIMKOVIC, Svetlana SMIRNOVA, Dina S A SOLIMAN, Stephan STILGENBAUER, Tamar TADMOR, Kristina TOMIC, Eric TSE, Theodoros VASSILAKOPOULOS, Andrea VISENTIN, Candida VITALE, George VRACHIOLIAS, Vojin VUKOVIC, Renata WALEWSKA, Zhenshu XU, Munci YAGCI, Lucrecia YANEZ, Mohamed YASSIN, Jana ZUCHNICKA, David OSCIER, Alessandro GOZZETTI, Panagiotis PANAGIOTIDIS, Francesc BOSCH, Paolo SPORTOLETTI, Blanca ESPINET, Gerassimos A PANGALIS, Viola M POPOV, Stephen MULLIGAN, Maria ANGELOPOULOU, Fatih DEMIRKAN, Tomas PAPAJIK, Bella BIDERMAN, Roberta MURRU, Marta COSCIA, Constantine TAM, Antonio CUNEO, Gianluca GAIDANO, Rainer CLAUS, Niki STAVROYIANNI, Livio TRENTIN, Darko ANTIC, Lukas SMOLEJ, Olga B KALASHNIKOVA, Mark CATHERWOOD, Martin SPACEK, Šárka POSPÍŠILOVÁ, Michael DOUBEK, Eugene NIKITIN, Anastasia CHATZIDIMITRIOU, Paolo GHIA and Kostas STAMATOPOULOS. Therapeutic strategies and treatment sequencing in patients with chronic lymphocytic leukemia: An international study of ERIC, the European Research Initiative on CLL. HemaSphere. Hoboken: Wiley, 2024, vol. 8, No 9, p. 1-7. ISSN 2572-9241. Available from: https://dx.doi.org/10.1002/hem3.70004.
      More: https://is.muni.cz/publication/2439137/en
    59. Unveiling the dynamics and molecular landscape of a rare chronic lymphocytic leukemia subpopulation driving refractoriness: insights from single-cell RNA sequencing
      KURUCOVÁ, Terézia, Kamila RÉBLOVÁ, Pavlína JANOVSKÁ, Jakub Paweł PORC, Veronika NAVRKALOVÁ, Šárka PAVLOVÁ, Jitka MALČÍKOVÁ, Karla PLEVOVÁ, Boris TICHÝ, Michael DOUBEK, Vítězslav BRYJA, Jana KOTAŠKOVÁ and Šárka POSPÍŠILOVÁ. Unveiling the dynamics and molecular landscape of a rare chronic lymphocytic leukemia subpopulation driving refractoriness: insights from single-cell RNA sequencing. Molecular oncology. Hoboken: Wiley, 2024, 13 pp. ISSN 1574-7891. Available from: https://dx.doi.org/10.1002/1878-0261.13663.
      More: https://is.muni.cz/publication/2407762/en
    60. Whole genome sequencing and characterization of <i>Pantoea agglomerans</i> DBM 3797, endophyte, isolated from fresh hop (<i>Humulus lupulus</i> L.)
      PATAKOVA, Petra, Maryna VASYLKIVSKA, Karel SEDLAR, Katerina JURECKOVA, Matěj BEZDÍČEK, Petra LOVECKA, Barbora BRANSKA, Petr KASTANEK and Karel KROFTA. Whole genome sequencing and characterization of <i>Pantoea agglomerans</i> DBM 3797, endophyte, isolated from fresh hop (<i>Humulus lupulus</i> L.). Frontiers in Microbiology. Switzerland: Frontiers Research Foundation, 2024, vol. 15, February 2024, p. 1-15. ISSN 1664-302X. Available from: https://dx.doi.org/10.3389/fmicb.2024.1305338.
      More: https://is.muni.cz/publication/2409519/en
    61. Why are not all eligible chronic myeloid leukemia patients willing to attempt tyrosine kinase inhibitor discontinuation? A Czech nationwide analysis related to the TKI stopping trial HALF
      ŽÁČKOVÁ, Daniela, Lukáš SEMERÁD, Edgar FABER, Hana KLAMOVÁ, Lukáš STEJSKAL, Petra BĚLOHLÁVKOVÁ, Michal KARAS, Eduard CMUNT, Olga ČERNÁ, Jiřina PROCHÁZKOVÁ, Petra ČIČÁTKOVÁ, Anežka KVETKOVÁ, Tomáš HORŇÁK, Ivana SKOUMALOVÁ, Dana SRBOVÁ, Cyril ŠÁLEK, David BUFFA, Jaroslava VOGLOVÁ, Tomáš JURČEK, Adam FOLTA, Ivana JEŽÍŠKOVÁ, Hana ŽIŽKOVÁ, Kateřina MACHOVÁ POLÁKOVÁ, Tomáš PAPAJÍK, Pavel ŽÁK, Pavel JINDRA, Adam SVOBODNÍK, Radka ŠTĚPÁNOVÁ and Jiří MAYER. Why are not all eligible chronic myeloid leukemia patients willing to attempt tyrosine kinase inhibitor discontinuation? A Czech nationwide analysis related to the TKI stopping trial HALF. Leukemia. LONDON: SPRINGERNATURE, 2024, vol. 38, No 4, p. 893-897. ISSN 0887-6924. Available from: https://dx.doi.org/10.1038/s41375-024-02215-9.
      More: https://is.muni.cz/publication/2387657/en

    2023

    1. Age, successive waves, immunization, and mortality in elderly COVID-19 hematological patients: EPICOVIDEHA findings
      ROSSI, Giuseppe, Jon SALMANTON-GARCIA, Chiara CATTANEO, Francesco MARCHESI, Julio DAVILA-VALLS, Sonia MARTIN-PEREZ, Federico ITRI, Alberto LOPEZ-GARCIA, Andreas GLENTHOJ, da Silva Maria GOMES, Caroline BESSON, Monia MARCHETTI, Barbora WEINBERGEROVÁ, Ozren JAKSIC, Moraima JIMENEZ, Yavuz M BILGIN, Van Doesum JAAP, Francesca FARINA, Pavel ZAK, Luisa VERGA, Graham P COLLINS, Valentina BONUOMO, Van Praet JENS, Marcio NUCCI, Stef MEERS, Ildefonso ESPIGADO, Nicola S FRACCHIOLLA, Toni VALKOVIC, Christian Bjorn POULSEN, Natasha COLOVIC, Giulia DRAGONETTI, Marie-Pierre LEDOUX, Carlo TASCINI, Caterina BUQUICCHIO, Ola BLENNOW, Francesco PASSAMONTI, Marina MACHADO, Jorge LABRADOR, Rafael F DUARTE, Martin SCHOENLEIN, Lucia PREZIOSO, Iker FALCES-ROMERO, Austin KULASEKARARAJ, Carolina GARCIA-VIDAL, Noemi FERNANDEZ, Ghaith ABU-ZEINAH, Irati ORMAZABAL-VELEZ, Tatjana ADZIC-VUKICEVIC, Klaera PIUKOVICS, Igor STOMA, Annarosa CUCCARO, Gabriele MAGLIANO, Tomaes SZOTKOWSKI, Tomaes-Jose GONZALEZ-LOPEZ, Shaimaa EL-ASHWAH, Rui BERGANTIM, Uluhan SILI, Johan MAERTENS, Fatih DEMIRKAN, De Ramon CRISTINA, Verena PETZER, Del Principe Maria ILARIA, Milan NAVRATIL, Michelina DARGENIO, Guldane Cengiz SEVAL, Michail SAMARKOS, Zdenek RACIL, Laeszlo Imre PINCZES, Tobias LAHMER, Alessandro BUSCA, Gustavo-Adolfo MENDEZ, Antonio VENA, Monika M BIERNAT, Maria MERELLI, Maria CALBACHO, Aleksandra BARAC, Martina BAVASTRO, Alessandro LIMONGELLI, Osman ILHAN, Dominik WOLF, Gokce Melis COLAK, Ramon GARCIA-SANZ, Ziad EMARAH, Bojana MISKOVIC, Stefanie K GRAFE, Milos MLADENOVIC, Tommaso Francesco AIELLO, Lucia NUNEZ-MARTIN-BUITRAGO, Anna NORDLANDER, Elena ARELLANO, Giovanni Paolo Maria ZAMBROTTA, Emanuele AMMATUNA, Alba CABIRTA, Maria Vittoria SACCHI, Raquel Nunes RODRIGUES, Ditte Stampe HERSBY, Michaela HANAKOVA, Laman RAHIMLI, Raul CORDOBA, Oliver A CORNELY and Livio PAGANO. Age, successive waves, immunization, and mortality in elderly COVID-19 hematological patients: EPICOVIDEHA findings. International journal of infectious diseases. OXON: ELSEVIER SCI LTD, 2023, vol. 137, December 2023, p. 98-110. ISSN 1201-9712. Available from: https://dx.doi.org/10.1016/j.ijid.2023.10.013.
      More: https://is.muni.cz/publication/2371844/en
    2. Alterations of cohesin complex genes in acute myeloid leukemia: differential co-mutations, clinical presentation and impact on outcome
      ECKARDT, Jan-Niklas, Sebastian STASIK, Christoph ROLLIG, Tim SAUER, Sebastian SCHOLL, Andreas HOCHHAUS, Martina CRYSANDT, Tim H BRUEMMENDORF, Ralph NAUMANN, Bjoern STEFFEN, Volker KUNZMANN, Hermann EINSELE, Markus SCHAICH, Andreas BURCHERT, Andreas NEUBAUER, Kerstin SCHAEFER-ECKART, Christoph SCHLIEMANN, Stefan W KRAUSE, Regina HERBST, Mathias HAENEL, Maher HANOUN, Ulrich KAISER, Martin KAUFMANN, Zdeněk RÁČIL, Jiří MAYER, Tiago CERQUEIRA, Frank KROSCHINSKY, Wolfgang E BERDEL, Hubert SERVE, Carsten MUELLER-TIDOW, Uwe PLATZBECKER, Claudia D BALDUS, Johannes SCHETELIG, Timo SIEPMANN, Martin BORNHAEUSER, Jan Moritz MIDDEKE and Christian THIEDE. Alterations of cohesin complex genes in acute myeloid leukemia: differential co-mutations, clinical presentation and impact on outcome. Blood Cancer Journal. LONDON: NATURE PUBLISHING GROUP, 2023, vol. 13, No 1, p. 1-9. ISSN 2044-5385. Available from: https://dx.doi.org/10.1038/s41408-023-00790-1.
      More: https://is.muni.cz/publication/2292757/en
    3. Analysis of rare driving events in pediatric acute myeloid leukemia
      NOORT, Sanne, van Oosterwijk JOLIEKE, Jing MA, Elizabeth A R GARFINKLE, Stephanie NANCE, Michael WALSH, Guangchun SONG, Dirk REINHARDT, Martina PIGAZZI, Franco LOCATELLI, Henrik HASLE, Jonas ABRAHAMSSON, Marie JAROŠOVÁ, Charikleia KELAIDI, Sophia POLYCHRONOPOULOU, Marry M VAN DEN HEUVEL-EIBRINK, Maarten FORNEROD, Tanja A GRUBER and C Michel ZWAAN. Analysis of rare driving events in pediatric acute myeloid leukemia. haematologica. PAVIA: FERRATA STORTI FOUNDATION, 2023, vol. 108, No 1, p. 48-60. ISSN 0390-6078. Available from: https://dx.doi.org/10.3324/haematol.2021.280250.
      More: https://is.muni.cz/publication/2292759/en
    4. Bleeding pattern and consumption of factor VIII concentrate in adult patients with haemophilia A without inhibitors in the Czech Republic between 2013 and 2021 (Czech National Haemophilia Programme registry data)
      ROMANOVÁ, Gabriela, Petr SMEJKAL, Petra OVESNÁ, Eva DRBOHLAVOVA, Petr DULICEK, Zdenka HAJSMANOVA, Antonin HLUSI, Radka HRDLICKOVA, Jana ULLRYCHOVA, Ivan VONKE, Jan BLATNÝ, Zuzana CERMAKOVA, Ester ZAPOTOCKA and Miroslav PENKA. Bleeding pattern and consumption of factor VIII concentrate in adult patients with haemophilia A without inhibitors in the Czech Republic between 2013 and 2021 (Czech National Haemophilia Programme registry data). Annals of hematology. New York: Springer Verlag, 2023, vol. 102, No 11, p. 3261-3270. ISSN 0939-5555. Available from: https://dx.doi.org/10.1007/s00277-023-05453-6.
      More: https://is.muni.cz/publication/2360048/en
    5. Clinical features and prognostic factors of Magnusiomyces (Saprochaete) infections in haematology. A multicentre study of SEIFEM/Fungiscope
      ILARIA, Del Principe Maria, Danila SEIDEL, Marianna CRISCUOLO, Michelina DARGENIO, Zdeněk RÁČIL, Monica PIEDIMONTE, Francesco MARCHESI, Gianpaolo NADALI, Philipp KOEHLER, Nicola FRACCHIOLLA, Chiara CATTANEO, Nikolai KLIMKO, Angelica SPOLZINO, Deniz Yilmaz KARAPINAR, Hayati DEMIRASLAN, Rafael F DUARTE, Judit DEMETER, Marta STANZANI, Lorella Maria Antonia MELILLO, Claudia Maria BASILICO, Simone CESARO, Giovangiacinto PATERNO, Catello CALIFANO, Mario DELIA, Elisa BUZZATTI, Alessandro BUSCA, Oliver A CORNELY, Livio PAGANO, Nael ALAKEL, Valentina Arsi ARSENIJEVI'C, Vincent CAMUS, Iker FALCES-ROMERO, Levy ITZHAK, Michal KOUBA, Rodrigo MARTINO, Petr SEDLACEK and Barbora WEINBERGEROVÁ. Clinical features and prognostic factors of Magnusiomyces (Saprochaete) infections in haematology. A multicentre study of SEIFEM/Fungiscope. Mycoses. Hoboken: Wiley-Blackwell, 2023, vol. 66, No 1, p. 35-46. ISSN 0933-7407. Available from: https://dx.doi.org/10.1111/myc.13524.
      More: https://is.muni.cz/publication/2250035/en
    6. Czech Women’s Point of Views on Immediate Breast Reconstruction after Mastectomy due to BRCA Gene Mutation or Breast Cancer
      VENTRUBA, Tomáš, Michal JEŠETA, Luboš MINÁŘ, Jindřich VOMELA, Dagmar BRANČÍKOVÁ, Jana ŽÁKOVÁ and Pavel VENTRUBA. Czech Women’s Point of Views on Immediate Breast Reconstruction after Mastectomy due to BRCA Gene Mutation or Breast Cancer. Healthcare. Basel: MDPI, 2023, vol. 11, No 12, p. 1-15. ISSN 2227-9032. Available from: https://dx.doi.org/10.3390/healthcare11121755.
      More: https://is.muni.cz/publication/2291641/en
    7. Daratumumab with lenalidomide and dexamethasone in relapsed or refractory multiple myeloma patients – real world evidence analysis
      ŠTORK, Martin, Ivan SPICKA, Jakub RADOCHA, Jiri MINARIK, Tomas JELINEK, Alexandra JUNGOVA, Petr PAVLICEK, Lenka POSPISILOVA, Frantisek SEDLAK, Jan STRAUB, Tomas PIKA, Zdeňka KNECHTOVÁ, Anna FIDRICHOVA, Ivanna BOICHUK, Sabina ŠEVČÍKOVÁ, Vladimir MAISNAR, Roman HAJEK and Luděk POUR. Daratumumab with lenalidomide and dexamethasone in relapsed or refractory multiple myeloma patients – real world evidence analysis. Annals of Hematology. NEW YORK: SPRINGER, 2023, vol. 102, No 6, p. 1501-1511. ISSN 0939-5555. Available from: https://dx.doi.org/10.1007/s00277-023-05188-4.
      More: https://is.muni.cz/publication/2278163/en
    8. Different prognostic impact of recurrent gene mutations in chronic lymphocytic leukemia depending on IGHV gene somatic hypermutation status: a study by ERIC in HARMONY
      MANSOURI, Larry, Birna THORVALDSDOTTIR, Lesley-Ann SUTTON, Georgios KARAKATSOULIS, Manja MEGGENDORFER, Helen PARKER, Ferran NADEU, Christian BRIEGHEL, Stamatia LAIDOU, Riccardo MOIA, Davide ROSSI, Mark CATHERWOOD, Jana KOTAŠKOVÁ, Julio DELGADO, Ana E RODRIGUEZ-VICENTE, Rocio BENITO, Gian Matteo RIGOLIN, Silvia BONFIGLIO, Lydia SCARFO, Mattias MATTSSON, Zadie DAVIS, Ajay GOGIA, Lata RANI, Panagiotis BALIAKAS, Hassan FOROUGHI-ASL, Cecilia JYLHA, Aron SKAFTASON, Inmaculada RAPADO, Fatima MIRAS, Joaquin MARTINEZ-LOPEZ, de la Serna JAVIER, Jesus Maria Hernandez RIVAS, Patrick THORNTON, Maria Jose LARRAYOZ, Maria Jose CALASANZ, Viktoria FESUS, Zoltan MATRAI, Csaba BODOR, Karin E SMEDBY, Blanca ESPINET, Anna PUIGGROS, Ritu GUPTA, Lars BULLINGER, Francesc BOSCH, Barbara TAZON-VEGA, Fanny BARAN-MARSZAK, David OSCIER, Florence GUYEN-KHAC, Thorsten ZENZ, Maria Jose TEROL, Antonio CUNEO, Maria HERNANDEZ-SANCHEZ, Šárka POSPÍŠILOVÁ, Ken MILLS, Gianluca GAIDANO, Carsten U NIEMANN, Elias CAMPO, Jonathan C STREFFORD, Paolo GHIA, Kostas STAMATOPOULOS and Richard ROSENQUIST. Different prognostic impact of recurrent gene mutations in chronic lymphocytic leukemia depending on IGHV gene somatic hypermutation status: a study by ERIC in HARMONY. Leukemia. London: SPRINGERNATURE, 2023, vol. 37, No 2, p. 339-347. ISSN 0887-6924. Available from: https://dx.doi.org/10.1038/s41375-022-01802-y.
      More: https://is.muni.cz/publication/2349283/en
    9. Distinct p53 phosphorylation patterns in chronic lymphocytic leukemia patients are reflected in the activation of circumjacent pathways upon DNA damage
      MANČÍKOVÁ, Veronika, Michaela PEŠOVÁ, Šárka PAVLOVÁ, Robert HELMA, Kristýna ZÁVACKÁ, Václav HEJRET, Petr TAUŠ, Jakub HYNŠT, Karla PLEVOVÁ, Jitka MALČÍKOVÁ and Šárka POSPÍŠILOVÁ. Distinct p53 phosphorylation patterns in chronic lymphocytic leukemia patients are reflected in the activation of circumjacent pathways upon DNA damage. MOLECULAR ONCOLOGY. ENGLAND: WILEY, 2023, vol. 17, No 1, p. 82-97. ISSN 1574-7891. Available from: https://dx.doi.org/10.1002/1878-0261.13337.
      More: https://is.muni.cz/publication/2239430/en
    10. Empiric vs Preemptive Antifungal Strategy in High-Risk Neutropenic Patients on Fluconazole Prophylaxis: A Randomized Trial of the European Organization for Research and Treatment of Cancer
      MAERTENS, Johan, Tom LODEWYCK, J Peter DONNELLY, Sylvain CHANTEPIE, Christine ROBIN, Nicole BLIJLEVENS, Pascal TURLURE, Dominik SELLESLAG, Frederic BARON, Mickael AOUN, Werner J HEINZ, Hartmut BERTZ, Zdeněk RÁČIL, Bernard VANDERCAM, Lubos DRGONA, Valerie COITEUX, Cristina Castilla LLORENTE, Cornelia SCHAEFER-PROKOP, Marianne PAESMANS, Lieveke AMEYE, Liv MEERT, Kin Jip CHEUNG, Deborah A HEPLER, Juergen LOEFFLER, Rosemary BARNES, Oscar MARCHETTI, Paul VERWEIJ, Frederic LAMOTH, Pierre-Yves BOCHUD, Michael SCHWARZINGER and Catherine CORDONNIER. Empiric vs Preemptive Antifungal Strategy in High-Risk Neutropenic Patients on Fluconazole Prophylaxis: A Randomized Trial of the European Organization for Research and Treatment of Cancer. Clinical Infectious Diseases. CARY: OXFORD UNIV PRESS INC, 2023, vol. 76, No 4, p. 674-682. ISSN 1058-4838. Available from: https://dx.doi.org/10.1093/cid/ciac623.
      More: https://is.muni.cz/publication/2251446/en
    11. European Competence Network on Mastocytosis (ECNM): 20-Year Jubilee, Updates, and Future Perspectives
      VALENT, Peter, Karin HARTMANN, Patrizia BONADONNA, Wolfgang SPERR, Marek NIEDOSZYTKO, Hanneke C KLUIN-NELEMANS, Olivier HERMINE, Karl SOTLAR, Gregor HOERMANN, Boguslaw NEDOSZYTKO, Sigurd BROESBY-OLSEN, Roberta ZANOTTI, Magdalena LANGE, Michael DOUBEK, Knut BROCKOW, Ivan ALVAREZ-TWOSE, Judit VARKONYI, Selim YAVUZ, Gunnar NILSSON, Deepti RADIA, Clive GRATTAN, Juliana SCHWAAB, Theo GILLEN, Hanneke N G Oude ELBERINK, Hans HAEGGLUND, Frank SIEBENHAAR, Emir HADZIJUSUFOVIC, Vito SABATO, Jiří MAYER, Andreas REITER, Alberto ORFAO, Hans-Peter HORNY, Massimo TRIGGIANI and Michel AROCK. European Competence Network on Mastocytosis (ECNM): 20-Year Jubilee, Updates, and Future Perspectives. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE. AMSTERDAM: ELSEVIER, 2023, vol. 11, No 6, p. 1706-1717. ISSN 2213-2198. Available from: https://dx.doi.org/10.1016/j.jaip.2023.02.021.
      More: https://is.muni.cz/publication/2301605/en
    12. Expansions of tumor-reactive Vdelta1 gamma-delta T cells in newly diagnosed patients with chronic myeloid leukemia
      KNIGHT, Andrea, Martin PISKÁČEK, Michal JURAJDA, Jiřina PROCHÁZKOVÁ, Zdeněk RÁČIL, Daniela ŽÁČKOVÁ and Jiří MAYER. Expansions of tumor-reactive Vdelta1 gamma-delta T cells in newly diagnosed patients with chronic myeloid leukemia. Cancer immunology, immunotherapy. NEW YORK: SPRINGER, 2023, vol. 72, No 5, p. 1209-1224. ISSN 0340-7004. Available from: https://dx.doi.org/10.1007/s00262-022-03312-3.
      More: https://is.muni.cz/publication/2233738/en
    13. Extensive, 3.8 Mb-Sized Deletion of 22q12 in a Patient with Bilateral Schwannoma, Intellectual Disability, Sensorineural Hearing Loss, and Epilepsy
      TRIZULJAK, Jakub, Jakub DUBEN, Ivona BLAHÁKOVÁ, Zuzana VRZALOVÁ, Kateřina STAŇO KOZUBÍK, Jiří ŠTIKA, Lenka RADOVÁ, Veronika BERGEROVÁ, Soňa MEJSTŘÍKOVÁ, Věra HOŘÍNOVÁ, Radim JANČÁLEK, Šárka POSPÍŠILOVÁ and Michael DOUBEK. Extensive, 3.8 Mb-Sized Deletion of 22q12 in a Patient with Bilateral Schwannoma, Intellectual Disability, Sensorineural Hearing Loss, and Epilepsy. Molecular Syndromology. Basel: S. Karger, 2023, vol. 14, No 5, p. 439-448. ISSN 1661-8769. Available from: https://dx.doi.org/10.1159/000528744.
      More: https://is.muni.cz/publication/2339257/en
    14. Gemtuzumab ozogamicin plus midostaurin in conjunction with standard intensive therapy for FLT3-mutated acute myeloid leukemia patients - Czech Center experience
      WEINBERGEROVÁ, Barbora, Martin ČERŇAN, Tomáš KABUT, Lukáš SEMERÁD, Natália PODSTAVKOVÁ, Tomáš SZOTKOWSKI, Ivana JEŽÍŠKOVÁ and Jiří MAYER. Gemtuzumab ozogamicin plus midostaurin in conjunction with standard intensive therapy for FLT3-mutated acute myeloid leukemia patients - Czech Center experience. Haematologica. PAVIA: FERRATA STORT, 2023, vol. 108, No 10, p. 2826-2829. ISSN 0390-6078. Available from: https://dx.doi.org/10.3324/haematol.2022.282263.
      More: https://is.muni.cz/publication/2300078/en
    15. Genetic findings in Czech patients with limb girdle muscular dystrophy
      ZÍDKOVÁ, Jana, Tereza KRAMÁŘOVÁ, Johana KOPČILOVÁ, Kamila RÉBLOVÁ, Jana HABERLOVÁ, Radim MAZANEC, Stanislav VOHÁŇKA, Andrea GŘEGOŘOVÁ, Martina LANGOVÁ, Tomáš HONZÍK, Jana ŠOUKALOVÁ, Hana OŠLEJŠKOVÁ, Pavla SOLAŘOVÁ, Emilie VYHNÁLKOVÁ and Lenka FAJKUSOVÁ. Genetic findings in Czech patients with limb girdle muscular dystrophy. Clinical Genetics. Hoboken: Wiley, 2023, vol. 104, No 5, p. 542-553. ISSN 0009-9163. Available from: https://dx.doi.org/10.1111/cge.14407.
      More: https://is.muni.cz/publication/2355821/en
    16. Germline variant of CTC1 gene in a patient with pulmonary fibrosis and myelodysplastic syndrome
      DOUBKOVÁ, Martina, Zuzana VRZALOVÁ, Marianna ŠTEFÁNIKOVÁ, Libor ČERVINEK, Kateřina STAŇO KOZUBÍK, Ivona BLAHÁKOVÁ, Šárka POSPÍŠILOVÁ and Michael DOUBEK. Germline variant of CTC1 gene in a patient with pulmonary fibrosis and myelodysplastic syndrome. MULTIDISCIPLINARY RESPIRATORY MEDICINE. PAVIA: PAGEPRESS PUBL, 2023, vol. 18, June 2023, p. 1-5. ISSN 1828-695X. Available from: https://dx.doi.org/10.4081/mrm.2023.909.
      More: https://is.muni.cz/publication/2297217/en
    17. Glasdegib plus intensive or non-intensive chemotherapy for untreated acute myeloid leukemia: results from the randomized, phase 3 BRIGHT AML 1019 trial
      SEKERES, Mikkael A, Pau MONTESINOS, Jan NOVAK, Jianxiang WANG, Deepa JEYAKUMAR, Benjamin TOMLINSON, Jiří MAYER, Erin JOU, Tadeusz ROBAK, David C TAUSSIG, Herve DOMBRET, Akil MERCHANT, Naveed SHAIK, Thomas BRIEN, Whijae ROH, Xueli LIU, Wendy MA, Christine G DIRIENZO, Geoffrey CHAN and Jorge E CORTES. Glasdegib plus intensive or non-intensive chemotherapy for untreated acute myeloid leukemia: results from the randomized, phase 3 BRIGHT AML 1019 trial. Leukemia. London: Nature Publishing Group, 2023, vol. 37, No 10, p. 2017-2026. ISSN 0887-6924. Available from: https://dx.doi.org/10.1038/s41375-023-02001-z.
      More: https://is.muni.cz/publication/2348884/en
    18. High-dose aciclovir in CMV infection prophylaxis after allogeneic HSCT: a single-center long-term experience
      KABUT, Tomáš, Barbora WEINBERGEROVÁ, František FOLBER, Martina LENGEROVÁ and Jiří MAYER. High-dose aciclovir in CMV infection prophylaxis after allogeneic HSCT: a single-center long-term experience. Bone Marrow Transplantation. LONDON: SPRINGERNATURE, 2023, vol. 58, No 11, p. 1229-1236. ISSN 0268-3369. Available from: https://dx.doi.org/10.1038/s41409-023-02081-6.
      More: https://is.muni.cz/publication/2348885/en
    19. Impact of SARS-CoV-2 vaccination and monoclonal antibodies on outcome post-CD19-directed CAR T-cell therapy: an EPICOVIDEHA survey
      DOESUM, Jaap A van, Jon SALMANTON-GARCIA, Francesco MARCHESI, Di Blasi ROBERTA, Iker FALCES-ROMERO, Alba CABIRTA, Francesca FARINA, Caroline BESSON, Barbora WEINBERGEROVÁ, Van Praet JENS, Martin SCHOENLEIN, Alberto LOPEZ-GARCIA, Sylvain LAMURE, Anna GUIDETTI, De Ramon-Sanchez CRISTINA, Josip BATINIC, Eleni GAVRIILAKI, Athanasios TRAGIANNIDIS, Maria Chiara TISI, Gaetan PLANTEFEVE, Verena PETZER, Irati ORMAZABAL-VELEZ, de Almeida Joyce MARQUES, Monia MARCHETTI, Johan MAERTENS, Marina MACHADO, Austin KULASEKARARAJ, Jose-angel HERNANDEZ-RIVAS, Maria Gomes da SILVA, Noemi FERNANDEZ, Ildefonso ESPIGADO, Lubos DRGONA, Giulia DRAGONETTI, Elisabetta METAFUNI, Maria CALBACHO, Ola BLENNOW, Dominik WOLF, van Anrooij BJORN, Raquel Nunes RODRIGUES, Anna NORDLANDER, Juan-Alberto MARTIN-GONZALEZ, Raphael LIEVIN, Moraima JIMENEZ, Stefanie K GRAFE, Ramon GARCIA-SANZ, Raul CORDOBA, Laman RAHIMLI, van Meerten TOM, Oliver A CORNELY and Livio PAGANO. Impact of SARS-CoV-2 vaccination and monoclonal antibodies on outcome post-CD19-directed CAR T-cell therapy: an EPICOVIDEHA survey. Blood advances. AMSTERDAM: ELSEVIER, 2023, vol. 7, No 11, p. 2645-2655. ISSN 2473-9529. Available from: https://dx.doi.org/10.1182/bloodadvances.2022009578.
      More: https://is.muni.cz/publication/2368940/en
    20. Improved outcomes over time and higher mortality in CMV seropositive allogeneic stem cell transplantation patients with COVID-19; An infectious disease working party study from the European Society for Blood and Marrow Transplantation registry
      LJUNGMAN, Per, Gloria TRIDELLO, Jose Luis PINANA, Fabio CICERI, Henrik SENGELOEV, Alexander KULAGIN, Stephan MIELKE, Zeynep Arzu YEGIN, Matthew COLLIN, Sigrun EINARDOTTIR, Sophie Ducastelle LEPRETRE, Johan MAERTENS, Antonio CAMPOS, Elisabetta METAFUNI, Herbert PICHLER, František FOLBER, Carlos SOLANO, Emma NICHOLSON, Meltem Kurt YUEKSEL, Kristina CARLSON, Beatriz AGUADO, Caroline BESLEY, Jenny BYRNE, Immaculada HERAS, Fiona DIGNAN, Nicolaus KROEGER, Christine ROBIN, Anjum KHAN, Stig LENHOFF, Anna GRASSI, Veronika DOBSINSKA, Nuno MIRANDA, Maria-Jose JIMENEZ, Ipek YONAL-HINDILERDEN, Keith WILSON, Dina AVERBUCH, Simone CESARO, Alienor XHAARD, Nina KNELANGE, Jan STYCZYNSKI, Malgorzata MIKULSKA and de la Camara RAFAEL. Improved outcomes over time and higher mortality in CMV seropositive allogeneic stem cell transplantation patients with COVID-19; An infectious disease working party study from the European Society for Blood and Marrow Transplantation registry. Frontiers in immunology. LAUSANNE: Frontiers Media S.A., 2023, vol. 14, March 2023, p. 1-11. ISSN 1664-3224. Available from: https://dx.doi.org/10.3389/fimmu.2023.1125824.
      More: https://is.muni.cz/publication/2279446/en
    21. Increasing incidence rate of breast cancer in cystic fibrosis-relationship between pathogenesis, oncogenesis and prediction of the treatment effect in the context of worse clinical outcome and prognosis of cystic fibrosis due to estrogens
      ŠŤASTNÁ, Nela, Kristián BRAT, Lukáš HOMOLA, Audun OS and Dagmar BRANČÍKOVÁ. Increasing incidence rate of breast cancer in cystic fibrosis-relationship between pathogenesis, oncogenesis and prediction of the treatment effect in the context of worse clinical outcome and prognosis of cystic fibrosis due to estrogens. Orphanet Journal of Rare Diseases. London: England, 2023, vol. 18, No 1, p. 1-7. ISSN 1750-1172. Available from: https://dx.doi.org/10.1186/s13023-023-02671-z.
      More: https://is.muni.cz/publication/2281518/en
    22. JAK2V617F mutation and circulating extracellular vesicles in essential thrombocythemia
      ASWAD, Mohamed Hussam, Jarmila KISSOVÁ, Petra OVESNÁ, Lucie ŘÍHOVÁ and Miroslav PENKA. JAK2V617F mutation and circulating extracellular vesicles in essential thrombocythemia. CLINICAL HEMORHEOLOGY AND MICROCIRCULATION. AMSTERDAM: IOS PRESS, 2023, vol. 84, No 4, p. 359-368. ISSN 1386-0291. Available from: https://dx.doi.org/10.3233/CH-221678.
      More: https://is.muni.cz/publication/2291837/en
    23. Low incidence of severe acute and chronic graft-versus-host disease in a long-term retrospective study with ATG Grafalon routine use
      KOVÁCSOVÁ, Flóra, František FOLBER, Barbora WEINBERGEROVÁ, Radka ŠTĚPÁNOVÁ, Tomáš KABUT, Miroslav TOMÍŠKA, Marta KREJČÍ and Jiří MAYER. Low incidence of severe acute and chronic graft-versus-host disease in a long-term retrospective study with ATG Grafalon routine use. Annals of hematology. New York: Springer Verlag, 2023, vol. 102, No 12, p. 3587-3591. ISSN 0939-5555. Available from: https://dx.doi.org/10.1007/s00277-023-05479-w.
      More: https://is.muni.cz/publication/2339261/en
    24. Management of pheochromocytomas and paragangliomas: Review of current diagnosis and treatment options
      EID, Michal, Jakub FOUKAL, Dana SOCHOROVÁ, Štěpán TUČEK, Karel STARÝ, Zdeněk KALA, Jiří MAYER, Radim NĚMEČEK, Jan TRNA and Lumír KUNOVSKÝ. Management of pheochromocytomas and paragangliomas: Review of current diagnosis and treatment options. Cancer Medicine. Hoboken: John Wiley & Sons Ltd., 2023, vol. 12, No 13, p. 13942-13957. ISSN 2045-7634. Available from: https://dx.doi.org/10.1002/cam4.6010.
      More: https://is.muni.cz/publication/2291626/en
    25. Mast cell leukemia: clinical and molecular features and survival outcomes of patients in the ECNM Registry
      KENNEDY, Vanessa E, Cecelia PERKINS, Andreas REITER, Mohamad JAWHAR, Johannes LUEBKE, Hanneke C KLUIN-NELEMANS, William SHOMALI, Cheryl LANGFORD, Justin ABUEL, Olivier HERMINE, Marek NIEDOSZYTKO, Aleksandra GORSKA, Andrzej MITAL, Patrizia BONADONNA, Roberta ZANOTTI, Ilaria TANASI, Mattias MATTSSON, Hans HAGGLUND, Massimo TRIGGIANI, Akif Selim YAVUZ, Jens PANSE, Deborah CHRISTEN, Marc HEIZMANN, Khalid SHOUMARIYEH, Sabine MUELLER, Chiara ELENA, Luca MALCOVATI, Nicolas FIORELLI, Friederike WORTMANN, Vladan VUCINIC, Knut BROCKOW, Christos FOKOLOROS, Sotirios G PAPAGEORGIOU, Christine BREYNAERT, Dominique BULLENS, Michael DOUBEK, Anja ILERHAUS, Irena ANGELOVA-FISCHER, Oleksii SOLOMIANYI, Judit VARKONYI, Vito SABATO, Axel RUEFER, Tanja Daniela SCHUG, Maud A W HERMANS, Anna Belloni FORTINA, Francesca CAROPPO, Horia BUMBEA, Theo GULEN, Karin HARTMANN, Hanneke Oude ELBERINK, Juliana SCHWAAB, Michel AROCK, Peter VALENT, Wolfgang R SPERR and Jason GOTLIB. Mast cell leukemia: clinical and molecular features and survival outcomes of patients in the ECNM Registry. Blood advances. AMSTERDAM: ELSEVIER, 2023, vol. 7, No 9, p. 1713-1724. ISSN 2473-9529. Available from: https://dx.doi.org/10.1182/bloodadvances.2022008292.
      More: https://is.muni.cz/publication/2301603/en
    26. MicroRNA Profiling of Self-Renewing Human Neural Stem Cells Reveals Novel Sets of Differentially Expressed microRNAs During Neural Differentiation In Vitro
      FEDOROVÁ, Veronika, Kateřina AMRUZ ČERNÁ, Jan OPPELT, Veronika POSPÍŠILOVÁ, Tomáš BÁRTA, Marek MRÁZ and Dáša BOHAČIAKOVÁ. MicroRNA Profiling of Self-Renewing Human Neural Stem Cells Reveals Novel Sets of Differentially Expressed microRNAs During Neural Differentiation In Vitro. Stem Cell Reviews and Reports. NEW YORK: SPRINGER, 2023, vol. 19, No 5, p. 1524-1539. ISSN 2629-3269. Available from: https://dx.doi.org/10.1007/s12015-023-10524-2.
      More: https://is.muni.cz/publication/2278237/en
    27. Molnupiravir compared to nirmatrelvir/ritonavir for COVID-19 in high-risk patients with haematological malignancy in Europe. A matched-paired analysis from the EPICOVIDEHA registry
      SALMANTON-GARCÍA, Jon, Francesco MARCHESI, Philipp KOEHLER, Barbora WEINBERGEROVÁ, Natasa ČOLOVIĆ, Iker FALCES-ROMERO, Caterina BUQUICCHIO, Francesca FARINA, Jens van PRAET, Monika M BIERNAT, Federico ITRI, Lucia PREZIOSO, Carlo TASCINI, Antonio VENA, Alessandra ROMANO, Mario DELIA, Julio DÁVILA-VALLS, Sonia MARTÍN-PÉREZ, Esperanza LAVILLA-RUBIRA, Tatjana ADŽIĆ-VUKIČEVIĆ, Daniel GARCÍA-BORDALLO, Alberto LÓPEZ-GARCÍA, Mariana CRISCUOLO, Verena PETZER, Nicola S FRACCHIOLLA, Ildefonso ESPIGADO, Uluhan SILI, Stef MEERS, Nurettin ERBEN, Chiara CATTANEO, Athanasios TRAGIANNIDIS, Eleni GAVRIILAKI, Martin SCHÖNLEIN, Mirjana MITROVIC, Nikola PANTIC, Maria MERELLI, Jorge LABRADOR, Hernández-Rivas JOSÉ-ÁNGEL, Andreas GLENTHØJ, Guillemette FOUQUET, Maria Ilaria del PRINCIPE, Michelina DARGENIO, María CALBACHO, Caroline BESSON, Milena KOHN, Stefanie GRÄFE, Ditte Stampe HERSBY, Elena ARELLANO, Gökçe Melis ÇOLAK, Dominik WOLF, Monia MARCHETTI, Anna NORDLANDER, Ola BLENNOW, Raul CORDOBA, Bojana MIŠKOVIĆ, Miloš MLADENOVIĆ, Martina BAVASTRO, Alessandro LIMONGELLI, Laman RAHIMLI, Livio PAGANO and Oliver A CORNELY. Molnupiravir compared to nirmatrelvir/ritonavir for COVID-19 in high-risk patients with haematological malignancy in Europe. A matched-paired analysis from the EPICOVIDEHA registry. International Journal of Antimicrobial Agents. AMSTERDAM: ELSEVIER, 2023, vol. 62, No 4, p. 1-9. ISSN 0924-8579. Available from: https://dx.doi.org/10.1016/j.ijantimicag.2023.106952.
      More: https://is.muni.cz/publication/2376658/en
    28. Momelotinib in Myelofibrosis Patients With Thrombocytopenia: Post Hoc Analysis From Three Randomized Phase 3 Trials
      KILADJIAN, Jean-Jacques, Alessandro M VANNUCCHI, Aaron T GERDS, Vikas GUPTA, Srdan VERSTOVSEK, Miklos EGYED, Uwe PLATZBECKER, Jiří MAYER, Sebastian GROSICKI, Arpad ILLES, Tomasz WOZNY, Stephen T OH, Donal MCLORNAN, Ilya KIRGNER, Sung-Soo YOON, Claire N HARRISON, Barbara KLENCKE, Mei HUANG, Jun KAWASHIMA and Ruben MESA. Momelotinib in Myelofibrosis Patients With Thrombocytopenia: Post Hoc Analysis From Three Randomized Phase 3 Trials. HemaSphere. Philadelphia: Lippincott Williams & Wilkins, 2023, vol. 7, No 11, p. 1-15. ISSN 2572-9241. Available from: https://dx.doi.org/10.1097/HS9.0000000000000963.
      More: https://is.muni.cz/publication/2348899/en
    29. Momelotinib long-term safety and survival in myelofibrosis: integrated analysis of phase 3 randomized controlled trials
      VERSTOVSEK, Srdan, Ruben MESA, Vikas GUPTA, David LAVIE, Viviane DUBRUILLE, Nathalie CAMBIER, Uwe PLATZBECKER, Marek HUS, Blanca XICOY, Stephen T OH, Jean-Jacques KILADJIAN, Alessandro M VANNUCCHI, Aaron GERDS, Miklos EGYED, Jiří MAYER, Tomasz SACHA, Jun KAWASHIMA, Marc MORRIS, Mei HUANG and Claire HARRISON. Momelotinib long-term safety and survival in myelofibrosis: integrated analysis of phase 3 randomized controlled trials. Blood advances. AMSTERDAM: ELSEVIER, 2023, vol. 7, No 14, p. 3582-3591. ISSN 2473-9529. Available from: https://dx.doi.org/10.1182/bloodadvances.2022009311.
      More: https://is.muni.cz/publication/2348886/en
    30. More Than 2% of Circulating Tumor Plasma Cells Defines Plasma Cell Leukemia-Like Multiple Myeloma
      JELINEK, Tomas, Renata BEZDĚKOVÁ, David ZIHALA, Tereza SEVCIKOVA, Anjana Anilkumar SITHARA, Lenka POSPISILOVA, Sabina ŠEVČÍKOVÁ, Petra POLACKOVA, Martin ŠTORK, Zdeňka KNECHTOVÁ, Ondrej VENGLAR, Veronika KAPUSTOVA, Tereza POPKOVA, Ludmila MURONOVA, Zuzana CHYRA, Matous HRDINKA, Michal SIMICEK, Garcés JUAN-JOSE, Noemi PUIG, Cedena MARIA-TERESA, Artur JURCZYSZYN, Jorge J CASTILLO, Miroslav PENKA, Jakub RADOCHA, Maria Victoria MATEOS, Jesús F SAN-MIGUEL, Bruno PAIVA, Luděk POUR, Lucie ŘÍHOVÁ and Roman HAJEK. More Than 2% of Circulating Tumor Plasma Cells Defines Plasma Cell Leukemia-Like Multiple Myeloma. Journal of clinical oncology. PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS, 2023, vol. 41, No 7, p. 1383-1393. ISSN 0732-183X. Available from: https://dx.doi.org/10.1200/JCO.22.01226.
      More: https://is.muni.cz/publication/2228626/en
    31. Mutated IKZF1 is an independent marker of adverse risk in acute myeloid leukemia
      ECKARDT, Jan-Niklas, Sebastian STASIK, Christoph ROELLIG, Andreas PETZOLD, Tim SAUER, Sebastian SCHOLL, Andreas HOCHHAUS, Martina CRYSANDT, Tim H BRUEMMENDORF, Ralph NAUMANN, Bjoern STEFFEN, Volker KUNZMANN, Hermann EINSELE, Markus SCHAICH, Andreas BURCHERT, Andreas NEUBAUER, Kerstin SCHAEFER-ECKART, Christoph SCHLIEMANN, Stefan W KRAUSE, Regina HERBST, Mathias HAENEL, Maher HANOUN, Ulrich KAISER, Martin KAUFMANN, Zdeněk RÁČIL, Jiří MAYER, Uta OELSCHLAEGEL, Wolfgang E BERDEL, Gerhard EHNINGER, Hubert SERVE, Carsten MUELLER-TIDOW, Uwe PLATZBECKER, Claudia D BALDUS, Andreas DAHL, Johannes SCHETELIG, Martin BORNHAEUSER, Jan Moritz MIDDEKE and Christian THIEDE. Mutated IKZF1 is an independent marker of adverse risk in acute myeloid leukemia. Leukemia. London: Nature Publishing Group, 2023, vol. 37, No 12, p. 2395-2403. ISSN 0887-6924. Available from: https://dx.doi.org/10.1038/s41375-023-02061-1.
      More: https://is.muni.cz/publication/2351119/en
    32. New Multilocus Sequence Typing Scheme for Enterococcus faecium Based on Whole Genome Sequencing Data
      BEZDÍČEK, Matěj, Jana HANSLIKOVA, Marketa NYKRYNOVA, Kristýna DUFKOVÁ, Iva KOCMANOVA, Petra KUBACKOVA, Jiří MAYER and Martina LENGEROVÁ. New Multilocus Sequence Typing Scheme for Enterococcus faecium Based on Whole Genome Sequencing Data. Microbiology Spectrum. WASHINGTON: AMER SOC MICROBIOLOGY, 2023, vol. 11, No 4, p. 1-9. ISSN 2165-0497. Available from: https://dx.doi.org/10.1128/spectrum.05107-22.
      More: https://is.muni.cz/publication/2294397/en
    33. Nirmatrelvir/ritonavir in COVID-19 patients with haematological malignancies: a report from the EPICOVIDEHA registry
      SALMANTON-GARCIA, Jon, Francesco MARCHESI, da Silva Maria GOMES, Francesca FARINA, Julio DAVILA-VALLS, Yavuz M BILGIN, Andreas GLENTHOJ, Iker FALCES-ROMERO, Van Doesum JAAP, Jorge LABRADOR, Caterina BUQUICCHIO, Shaimaa EL-ASHWAH, Verena PETZER, Van Praet JENS, Martin SCHOENLEIN, Michelina DARGENIO, Gustavo-Adolfo MENDEZ, Stef MEERS, Federico ITRI, Antonio GIORDANO, Laszlo Imre PINCZES, Ildefonso ESPIGADO, Zlate STOJANOSKI, Alberto LOPEZ-GARCIA, Lucia PREZIOSO, Ozren JAKSIC, Antonio VENA, Nicola S FRACCHIOLLA, Tomas Jose GONZALEZ-LOPEZ, Natasa COLOVIC, Mario DELIA, Barbora WEINBERGEROVÁ, Monia MARCHETTI, de Almeida Joyce MARQUES, Olimpia FINIZIO, Caroline BESSON, Monika M BIERNAT, Toni VALKOVIC, Tobias LAHMER, Annarosa CUCCARO, Irati ORMAZABAL-VELEZ, Josip BATINIC, Noemi FERNANDEZ, De Jonge NICK, Carlo TASCINI, Amalia N ANASTASOPOULOU, Remy DULERY, Del Principe Maria ILARIA, Gaetan PLANTEFEVE, Mario Virgilio PAPA, Marcio NUCCI, Moraima JIMENEZ, Avinash AUJAYEB, Jose-angel HERNANDEZ-RIVAS, Maria MERELLI, Chiara CATTANEO, Ola BLENNOW, Anna NORDLANDER, Alba CABIRTA, Gina VARRICCHIO, Maria Vittoria SACCHI, Raul CORDOBA, Elena ARELLANO, Stefanie K GRAFE, Dominik WOLF, Ziad EMARAH, Emanuele AMMATUNA, Ditte Stampe HERSBY, Sonia MARTIN-PEREZ, Raquel Nunes RODRIGUES, Laman RAHIMLI, Livio PAGANO and Oliver A CARTNEY. Nirmatrelvir/ritonavir in COVID-19 patients with haematological malignancies: a report from the EPICOVIDEHA registry. EClinicalMedicine. AMSTERDAM: ELSEVIER, 2023, vol. 58, April 2023, p. 1-19. ISSN 2589-5370. Available from: https://dx.doi.org/10.1016/j.eclinm.2023.101939.
      More: https://is.muni.cz/publication/2368980/en
    34. Other malignancies in the history of CLL: an international multicenter study conducted by ERIC, the European Research Initiative on CLL, in HARMONY
      CHATZIKONSTANTINOU, Thomas, Lydia SCARFÒ, Georgios KARAKATSOULIS, Eva MINGA, Dimitra CHAMOU, Gloria IACOBONI, Jana KOTAŠKOVÁ, Christos DEMOSTHENOUS, Lukas SMOLEJ, Stephen MULLIGAN, Miguel ALCOCEBA, Salem AL-SHEMARI, Thérèse AURRAN-SCHLEINITZ, Francesca BACCHIARRI, Mar BELLIDO, Fontanet BIJOU, Anne CALLEJA, Angeles MEDINA, Mehreen Ali KHAN, Ramona CASSIN, Sofia CHATZILEONTIADOU, Rosa COLLADO, Amy CHRISTIAN, Zadie DAVIS, Maria DIMOU, David DONALDSON, Gimena Dos SANTOS, Barbara DRETA, Maria EFSTATHOPOULOU, Shaimaa EL-ASHWAH, Alicia ENRICO, Alberto FRESA, Sara GALIMBERTI, Andrea GALITZIA, Rocío GARCÍA-SERRA, Eva GIMENO, Isabel GONZÁLEZ-GASCÓN-Y-MARÍN, Alessandro GOZZETTI, Valerio GUARENTE, Romain GUIEZE, Ajay GOGIA, Ritu GUPTA, Sean HARROP, Eleftheria HATZIMICHAEL, Yair HERISHANU, Hernández-Rivas JOSÉ-ÁNGEL, Luca INCHIAPPA, Ozren JAKSIC, Susanne JANSSEN, Elżbieta KALICIŃSKA, Laribi KAMEL, Volkan KARAKUS, Arnon P KATER, Bonnie KHO, Maria KISLOVA, Eliana KONSTANTINOU, Maya KOREN-MICHOWITZ, Ioannis KOTSIANIDIS, Robert J KREITMAN, Jorge LABRADOR, Deepesh LAD, Levin MARK-DAVID, Ilana LEVY, Thomas LONGVAL, Alberto LOPEZ-GARCIA, Juan MARQUET, Lucia MARTIN-RODRÍGUEZ, Marc MAYNADIÉ, Stanislava MASLEJOVA, Carlota MAYOR-BASTIDA, Biljana MIHALJEVIC, Ivana MILOSEVIC, Fatima MIRAS, Riccardo MOIA, Marta MORAWSKA, Roberta MURRU, Uttam Kumar NATH, Almudena NAVARRO-BAILÓN, Ana C OLIVEIRA, Jacopo OLIVIERI, David OSCIER, Irina PANOVSKA-STAVRIDIS, Maria PAPAIOANNOU, Tomas PAPAJÍK, Zuzana KUBOVA, Punyarat PHUMPHUKHIEO, Cheyenne PIERIE, Anna PUIGGROS, Lata RANI, Gianluigi REDA, Gian Matteo RIGOLIN, Rosa RUCHLEMER, Marcos Daniel de Deus SANTOS, Mattia SCHIPANI, Annett SCHIWITZA, Yandong SHEN, Martin SIMKOVIC, Svetlana SMIRNOVA, Dina Sameh Abdelrahman SOLIMAN, Martin SPACEK, Tamar TADMOR, Kristina TOMIC, Eric TSE, Theodoros VASSILAKOPOULOS, Andrea VISENTIN, Candida VITALE, Julia von TRESCKOW, George VRACHIOLIAS, Vojin VUKOVIC, Renata WALEWSKA, Ewa WASIK-SZCZEPANEK, Zhenshu XU, Munci YAGCI, Lucrecia YAÑEZ, Mohamed YASSIN, Jana ZUCHNICKA, Maria ANGELOPOULOU, Darko ANTIC, Bella BIDERMAN, Mark CATHERWOOD, Rainer CLAUS, Marta COSCIA, Antonio CUNEO, Fatih DEMIRKAN, Blanca ESPINET, Gianluca GAIDANO, Olga B KALASHNIKOVA, Luca LAURENTI, Eugene NIKITIN, Gerassimos A PANGALIS, Panagiotis PANAGIOTIDIS, Viola Maria POPOV, Sarka POSPISILOVA, Paolo SPORTOLETTI, Niki STAVROYIANNI, Constantine TAM, Livio TRENTIN, Anastasia CHATZIDIMITRIOU, Francesc BOSCH, Michael DOUBEK, Paolo GHIA and Kostas STAMATOPOULOS. Other malignancies in the history of CLL: an international multicenter study conducted by ERIC, the European Research Initiative on CLL, in HARMONY. EClinicalMedicine. AMSTERDAM: ELSEVIER, 2023, vol. 65, November 2023, p. 1-14. ISSN 2589-5370. Available from: https://dx.doi.org/10.1016/j.eclinm.2023.102307.
      More: https://is.muni.cz/publication/2365503/en
    35. Outcome of COVID-19 in allogeneic stem cell transplant recipients: Results from the EPICOVIDEHA registry
      BUSCA, Alessandro, Jon SALMANTON-GARCIA, Francesco MARCHESI, Francesca FARINA, Guldane Cengiz SEVAL, Van Doesum JAAP, Nick C DE JONGE, Nathan C BAHR, Johan MAERTENS, Joseph S MELETIADIS, Nicola S FRACCHIOLLA, Barbora WEINBERGEROVÁ, Luisa VERGA, Zdenek RACIL, Moraima JIMENEZ, Andreas GLENTHOJ, Ola BLENNOW, Alina Daniela TANASE, Martin SCHOENLEIN, Lucia PREZIOSO, Nina F KHANNA, Rafael F DUARTE, Pavel ZAK, Marcio NUCCI, Marina MACHADO, Austin KULASEKARARAJ, Ildefonso ESPIGADO, De Kort ELIZABETH, Jose-Maria Ribera-Santa SUSANA, Monia MARCHETTI, Gabriele MAGLIANO, Iker FALCES-ROMERO, Osman ILHAN, Emanuele AMMATUNA, Sofia ZOMPI, Panagiotis TSIRIGOTIS, Anastasia ANTONIADOU, Giovanni Paolo Maria ZAMBROTTA, Anna NORDLANDER, Linda Katharina KARLSSON, Michaela HANAKOVA, Giulia DRAGONETTI, Alba CABIRTA, Berg Venemyr CAROLINE, Stefanie GRAEFE, Van Praet JENS, Athanasios TRAGIANNIDIS, Verena PETZER, Alberto LOPEZ-GARCIA, Federico ITRI, Ana GROH, Eleni GAVRIILAKI, Michelina DARGENIO, Laman A RAHIMLI, Oliver A CORNELY and Livio PAGANO. Outcome of COVID-19 in allogeneic stem cell transplant recipients: Results from the EPICOVIDEHA registry. Frontiers in immunology. LAUSANNE: Frontiers Media S.A., 2023, vol. 14, February 2023, p. 1-9. ISSN 1664-3224. Available from: https://dx.doi.org/10.3389/fimmu.2023.1125030.
      More: https://is.muni.cz/publication/2279455/en
    36. Overall survival of patients with cHL who progress after autologous stem cell transplant: results in the novel agent era
      DESAI, Sanjal H, Michael A SPINNER, Andrew M EVENS, Alice SYKOROVA, Veronika BACHANOVA, Gaurav GOYAL, Brad KAHL, Kathleen DORRITIE, Jacues AZZI, Vaishalee P KENKRE, Cheryl CHANG, Jozef MICHALKA, Stephen M ANSELL, Brendon FUSCO, Nuttavut SUMRANSUB, Haris HATIC, Raya SABA, Uroosa IBRAHAM, Elyse I HARRIS, Harsh SHAH, Nina WAGNER-JOHNSTON, Sally ARAI, Grzegorz S NOWAKOWSKI, Heidi MOCIKOVA, Deepa JAGADEESH, Kristie A BLUM, Catherine DIEFENBACH, Siddharth IYENGAR, K C RAPPAZZO, Firas BAIDOUN, Yun CHOI, Vit PROCHAZKA, Ranjana H ADVANI and Ivana MICALLEF. Overall survival of patients with cHL who progress after autologous stem cell transplant: results in the novel agent era. Blood advances. AMSTERDAM: ELSEVIER, 2023, vol. 7, No 23, p. 7295-7303. ISSN 2473-9529. Available from: https://dx.doi.org/10.1182/bloodadvances.2023011205.
      More: https://is.muni.cz/publication/2368941/en
    37. Prognostic Impact of Organomegaly in Mastocytosis: An Analysis of the European Competence Network on Mastocytosis
      LUEBKE, Johannes, Juliana SCHWAAB, Deborah CHRISTEN, Hanneke Oude ELBERINK, Bart SPAN, Marek NIEDOSZYTKO, Aleksandra GORSKA, Magdalena LANGE, Karoline V GLEIXNER, Emir HADZIJUSUFOVIC, Oleksii SOLOMIANYI, Irena ANGELOVA-FISCHER, Roberta ZANOTTI, Massimiliano BONIFACIO, Patrizia BONADONNA, Khalid SHOUMARIYEH, von Bubnoff NIKOLAS, Sabine MUELLER, Cecelia PERKINS, Chiara ELENA, Luca MALCOVATI, Hans HAGGLUND, Mattias MATTSSON, Roberta PARENTE, Judit VARKONYI, Anna Belloni FORTINA, Francesca CAROPPO, Alexander ZINK, Knut BROCKOW, Christine BREYNAERT, Dominique BULLENS, Akif Selim YAVUZ, Michael DOUBEK, Vito SABATO, Tanja SCHUG, Dietger NIEDERWIESER, Karin HARTMANN, Massimo TRIGGIANI, Jason GOTLIB, Olivier HERMINE, Michel AROCK, Hanneke C KLUIN-NELEMANS, Jens PANSE, Wolfgang R SPERR, Peter VALENT, Andreas REITER and Mohamad JAWHAR. Prognostic Impact of Organomegaly in Mastocytosis: An Analysis of the European Competence Network on Mastocytosis. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE. AMSTERDAM: ELSEVIER, 2023, vol. 11, No 2, p. 581-595. ISSN 2213-2198. Available from: https://dx.doi.org/10.1016/j.jaip.2022.10.051.
      More: https://is.muni.cz/publication/2365494/en
    38. Prognostic Significance of Immune-checkpoint Molecule PD-L1 in Classical Hodgkin Lymphoma: A Clinicopathologic Study of 120 Cases
      KUBEŠ, Václav, Leoš KŘEN, Filip SOKOL, Jozef MICHALKA, Jan MUŽÍK, Tomáš ARPÁŠ, Zdenka KŘENOVÁ and Zdeněk KRÁL. Prognostic Significance of Immune-checkpoint Molecule PD-L1 in Classical Hodgkin Lymphoma: A Clinicopathologic Study of 120 Cases. In vivo. ATHENS: Greece : International Institute of Anticancer Research, 2023, vol. 37, No 4, p. 1735-1742. ISSN 0258-851X. Available from: https://dx.doi.org/10.21873/invivo.13261.
      More: https://is.muni.cz/publication/2306558/en
    39. První český pacient s deficitem aminoacylázy 1 (The first Czech patient with aminoacylase I deficiency)
      PROCHÁZKOVÁ, Dagmar, Romana BORSKÁ, Petr CHRASTINA, Lenka FAJKUSOVÁ, Petra KONEČNÁ, Kateřina SLABÁ, Jan ŠENKYŘÍK, Karolína PEŠKOVÁ, Petr JABANDŽIEV and Tomáš HONZÍK. První český pacient s deficitem aminoacylázy 1 (The first Czech patient with aminoacylase I deficiency). CESKA A SLOVENSKA NEUROLOGIE A NEUROCHIRURGIE. CZECH REPUBLIC: CZECH MEDICAL SOC, 2023, vol. 86, No 1, p. 83-85. ISSN 1210-7859. Available from: https://dx.doi.org/10.48095/cccsnn202383.
      More: https://is.muni.cz/publication/2267718/en
    40. Rapid Identification of Pseudomonas aeruginosa International High-Risk Clones Based on High-Resolution Melting Analysis
      DUFKOVÁ, Kristýna, Matěj BEZDÍČEK, Markéta NYKRÝNOVÁ, Iva KOCMANOVÁ, Petra KUBÁČKOVÁ, Jana HANSLIKOVA, Karolina FEJKOVA, Jiří MAYER and Martina LENGEROVÁ. Rapid Identification of Pseudomonas aeruginosa International High-Risk Clones Based on High-Resolution Melting Analysis. Microbiology Spectrum. WASHINGTON: AMER SOC MICROBIOLOGY, 2023, vol. 11, No 1, p. 1-9. ISSN 2165-0497. Available from: https://dx.doi.org/10.1128/spectrum.03571-22.
      More: https://is.muni.cz/publication/2292838/en
    41. Revisiting coexisting chromosomal abnormalities in NPM1-mutated AML in light of the revised ELN 2022 classification
      ANGENENDT, Linus, Christoph ROELLIG, Pau MONTESINOS, Farhad RAVANDI, Gunnar JULIUSSON, Christian RECHER, Raphael ITZYKSON, Zdeněk RÁČIL, Andrew H WEI and Christoph SCHLIEMANN. Revisiting coexisting chromosomal abnormalities in NPM1-mutated AML in light of the revised ELN 2022 classification. Blood. Washington DC, USA: American Society of Hematology, 2023, vol. 141, No 4, p. 433-435. ISSN 0006-4971. Available from: https://dx.doi.org/10.1182/blood.2022018582.
      More: https://is.muni.cz/publication/2381697/en
    42. ROSEWOOD: A Phase II Randomized Study of Zanubrutinib Plus Obinutuzumab Versus Obinutuzumab Monotherapy in Patients With Relapsed or Refractory Follicular Lymphoma
      ZINZANI, Pier Luigi, Jiří MAYER, Christopher R FLOWERS, Fontanet BIJOU, Ana C De OLIVEIRA, Yuqin SONG, Qingyuan ZHANG, Michele MERLI, Krimo BOUABDALLAH, Peter GANLY, Huilai ZHANG, Roderick JOHNSON, Alejandro Martín GARCÍA-SANCHO, Mariano Provencio PULLA, Marek TRNĚNÝ, Sam YUEN, Herve TILLY, Edwin KINGSLEY, Gayane TUMYAN, Sarit E ASSOULINE, Rebecca AUER, Elena IVANOVA, Pil KIM, Sha HUANG, Richard DELARUE and Judith TROTMAN. ROSEWOOD: A Phase II Randomized Study of Zanubrutinib Plus Obinutuzumab Versus Obinutuzumab Monotherapy in Patients With Relapsed or Refractory Follicular Lymphoma. Journal of Clinical Oncology. PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS, 2023, vol. 41, No 33, p. 5107-5117, 13 pp. ISSN 0732-183X. Available from: https://dx.doi.org/10.1200/JCO.23.00775.
      More: https://is.muni.cz/publication/2348897/en
    43. Safety of AFM11 in the treatment of patients with B-cell malignancies: findings from two phase 1 studies
      TOPP, Max, Monika DLUGOSZ-DANECKA, Aleksander B SKOTNICKI, Galina SALOGUB, Andreas VIARDOT, Andreas K KLEIN, Georg HESS, Christian S MICHEL, Sebastian GROSICKI, Alex GURAL, Sylvia E SCHWARZ, Kerstin PIETZKO, Ulrike GAERTNER, Andras STRASSZ, Leila ALLAND and Jiří MAYER. Safety of AFM11 in the treatment of patients with B-cell malignancies: findings from two phase 1 studies. Trials. LONDON: BMC, 2023, vol. 24, No 1, p. 1-11. ISSN 1745-6215. Available from: https://dx.doi.org/10.1186/s13063-022-06982-7.
      More: https://is.muni.cz/publication/2292839/en
    44. Unsupervised meta-clustering identifies risk clusters in acute myeloid leukemia based on clinical and genetic profiles
      ECKARDT, Jan-Niklas, Christoph ROELLIG, Klaus METZELER, Peter HEISIG, Sebastian STASIK, Julia-Annabell GEORGI, Frank KROSCHINSKY, Friedrich STOELZEL, Uwe PLATZBECKER, Karsten SPIEKERMANN, Utz KRUG, Jan BRAESS, Dennis GOERLICH, Cristina SAUERLAND, Bernhard WOERMANN, Tobias HEROLD, Wolfgang HIDDEMANN, Carsten MUELLER-TIDOW, Hubert SERVE, Claudia D BALDUS, Kerstin SCHAEFER-ECKART, Martin KAUFMANN, Stefan W KRAUSE, Mathias HAENEL, Wolfgang E BERDEL, Christoph SCHLIEMANN, Jiří MAYER, Maher HANOUN, Johannes SCHETELIG, Karsten WENDT, Martin BORNHAEUSER, Christian THIEDE and Jan Moritz MIDDEKE. Unsupervised meta-clustering identifies risk clusters in acute myeloid leukemia based on clinical and genetic profiles. Communications Medicine. LONDON: SPRINGERNATURE, 2023, vol. 3, No 1, p. 1-13. ISSN 2730-664X. Available from: https://dx.doi.org/10.1038/s43856-023-00298-6.
      More: https://is.muni.cz/publication/2291619/en
    45. Use of thrombopoietin receptor agonists in adults with immune thrombocytopenia: a systematic review and Central European expert consensus
      PULANIC, Drazen, Angelika BATOROVA, Imre BODO, Libor ČERVINEK, Ioana IONITA, Toshko LISSITCHKOV, Anahit MELIKYAN and Maria PODOLAK-DAWIDZIAK. Use of thrombopoietin receptor agonists in adults with immune thrombocytopenia: a systematic review and Central European expert consensus. Annals of hematology. New York: Springer Verlag, 2023, vol. 102, No 4, p. 715-727. ISSN 0939-5555. Available from: https://dx.doi.org/10.1007/s00277-023-05114-8.
      More: https://is.muni.cz/publication/2279440/en
    46. Zanubrutinib or Ibrutinib in Relapsed or Refractory Chronic Lymphocytic Leukemia
      BROWN, Jennifer, Barbara EICHHORST, Peter HILLMEN, Wojciech JURCZAK, Maciej KAZMIERCZAK, Nicole LAMANNA, Susan BRIEN, Constantine TAM, Lugui QIU, Keshu ZHOU, Martin SIMKOVIC, Jiří MAYER, Amanda GILLESPIE-TWARDY, Alessandra FERRAJOLI, Peter GANLY, Robert WEINKOVE, Sebastian GROSICKI, Andrzej MITAL, Tadeusz ROBAK, Anders OSTERBORG, Habte YIMER, Tommi SALMI, Megan-Der-Yu WANG, Lina FU, Jessica LI, Kenneth WU, Aileen COHEN and Mazyar SHADMAN. Zanubrutinib or Ibrutinib in Relapsed or Refractory Chronic Lymphocytic Leukemia. New England Journal of Medicine. Waltham: Massachussetts Medical Society, 2023, vol. 388, No 4, p. 319-332. ISSN 0028-4793. Available from: https://dx.doi.org/10.1056/NEJMoa2211582.
      More: https://is.muni.cz/publication/2243400/en
    47. Zanubrutinib Versus Ibrutinib in Relapsed/Refractory Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma: Interim Analysis of a Randomized Phase III Trial
      HILLMEN, Peter, Barbara EICHHORST, Jennifer R BROWN, Nicole LAMANNA, Susan M BRIEN, Constantine S TAM, Lugui QIU, Maciej KAZMIERCZAK, Keshu ZHOU, Martin SIMKOVIC, Jiří MAYER, Amanda GILLESPIE-TWARDY, Mazyar SHADMAN, Alessandra FERRAJOLI, Peter S GANLY, Robert WEINKOVE, Sebastian GROSICKI, Andrzej MITAL, Tadeusz ROBAK, Anders OSTERBORG, Habte A YIMER, Tommi SALMI, Meng JI, Jessica YECIES, Adam IDOINE, Kenneth WU, Jane HUANG and Wojciech JURCZAK. Zanubrutinib Versus Ibrutinib in Relapsed/Refractory Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma: Interim Analysis of a Randomized Phase III Trial. Journal of clinical oncology. United States: LIPPINCOTT WILLIAMS & WILKINS, 2023, vol. 41, No 5, p. "1035"-"+", 12 pp. ISSN 0732-183X. Available from: https://dx.doi.org/10.1200/JCO.22.00510.
      More: https://is.muni.cz/publication/2279453/en
    48. 20 let diagnostiky maligní hypertermie v České a Slovenské republice. (20 years of malignant hyperthermia in Czechia and Slovakia)
      KLINCOVÁ, Martina, Dagmar ŠTĚPÁNKOVÁ, Ivana SCHRÖDEROVÁ, Eva KLABUSAYOVÁ, Edita OŠŤÁDALOVÁ, Iveta VALÁŠKOVÁ, Lenka FAJKUSOVÁ, Jana ZÍDKOVÁ, Renata GAILLYOVÁ and Petr ŠTOURAČ. 20 let diagnostiky maligní hypertermie v České a Slovenské republice. (20 years of malignant hyperthermia in Czechia and Slovakia). ANESTEZIOLOGIE A INTENZIVNI MEDICINA. CZECH REPUBLIC: NAKLADATELSKE STREDISKO C L S J E PURKYNE, 2023, vol. 34, No 3, p. 103-109. ISSN 1214-2158. Available from: https://dx.doi.org/10.36290/aim.2023.045.
      More: https://is.muni.cz/publication/2362998/en

    2022

    1. A GP1BA Variant in a Czech Family with Monoallelic Bernard-Soulier Syndrome
      SKALNÍKOVÁ, Magdalena, Kateřina STAŇO KOZUBÍK, Jakub TRIZULJAK, Zuzana VRZALOVÁ, Lenka RADOVÁ, Kamila RÉBLOVÁ, Radka HOLBOVÁ, Terézia KURUCOVÁ, Hana SVOZILOVÁ, Jiří ŠTIKA, Ivona BLAHÁKOVÁ, Barbara DVOŘÁČKOVÁ, Marie PRUDKOVÁ, Olga STEHLÍKOVÁ, Michal ŠMÍDA, Leoš KŘEN, Petr SMEJKAL, Šárka POSPÍŠILOVÁ and Michael DOUBEK. A GP1BA Variant in a Czech Family with Monoallelic Bernard-Soulier Syndrome. International Journal of Molecular Sciences. Basel: Multidisciplinary Digital Publishing Institute, 2022, vol. 23, No 2, p. 1-13. ISSN 1422-0067. Available from: https://dx.doi.org/10.3390/ijms23020885.
      More: https://is.muni.cz/publication/1863063/en
    2. Aggressive systemic mastocytosis with diffuse bone marrow (18) F-FDG uptake
      KOUKALOVÁ, Renata, Jiří VAŠINA, Jiří ŠTIKA, Michael DOUBEK and Petr SZTURZ. Aggressive systemic mastocytosis with diffuse bone marrow (18) F-FDG uptake. Nuklearmedizin-Nuclear Medicine. Stuttgart: Schattauer GmbH-Verlag Medizin Naturwissenschaften, 2022, vol. 61, No 01, p. 58-61. ISSN 0029-5566. Available from: https://dx.doi.org/10.1055/a-1650-9704.
      More: https://is.muni.cz/publication/1834338/en
    3. B-cell malignancies treated with targeted drugs and SARS-CoV-2 infection: A European Hematology Association Survey (EPICOVIDEHA)
      INFANTE, Maria Stefania, Jon SALMANTON-GARCIA, Ana FERNANDEZ-CRUZ, Francesco MARCHESI, Ozren JAKSIC, Barbora WEINBERGEROVÁ, Caroline BESSON, Rafael F DUARTE, Federico ITRI, Toni VALKOVIC, Tomas SZOTKOVSKI, Alessandro BUSCA, Anna GUIDETTI, Andreas GLENTHOJ, Graham P COLLINS, Valentina BONUOMO, Uluhan SILI, Guldane Cengiz SEVAL, Marina MACHADO, Raul CORDOBA, Ola BLENNOW, Ghaith ABU-ZEINAH, Sylvain LAMURE, Austin KULASEKARARAJ, Iker FALCES-ROMERO, Chiara CATTANEO, Van Doesum JAAP, Klara PIUKOVICS, Ali S OMRANI, Gabriele MAGLIANO, Marie-Pierre LEDOUX, de Ramon CRISTINA, Alba CABIRTA, Luisa VERGA, Alberto LOPEZ-GARCIA, Da Silva Maria GOMES, Zlate STOJANOSKI, Stef MEERS, Tobias LAHMER, Sonia MARTIN-PEREZ, Julio DAVILA-VALS, Van Praet JENS, Michail SAMARKOS, Yavuz M BILGIN, Linda Katharina KARLSSON, Josip BATINIC, Anna NORDLANDER, Martin SCHONLEIN, Martin HOENIGL, Zdenek RACIL, Milos MLADENOVIC, Michaela HANAKOVA, Giovanni Paolo Maria ZAMBROTTA, De Jonge NICK, Tatjana ADZIC-VUKICEVIC, Raquel NUNES-RODRIGUES, Lucia PREZIOSO, Milan NAVRATIL, Monia MARCHETTI, Annarosa CUCCARO, Maria CALBACHO, Antonio GIORDANO, Oliver A CORNELY, Jose-Angel HERNANDEZ-RIVAS and Livio PAGANO. B-cell malignancies treated with targeted drugs and SARS-CoV-2 infection: A European Hematology Association Survey (EPICOVIDEHA). Frontiers in Oncology. Lausanne: Frontiers Media S.A., 2022, vol. 12, October 2022, p. 1-17. ISSN 2234-943X. Available from: https://dx.doi.org/10.3389/fonc.2022.992137.
      More: https://is.muni.cz/publication/2251387/en
    4. BRD4 degradation blocks expression of MYC and multiple forms of stem cell resistance in Ph+ chronic myeloid leukemia
      PETER, Barbara, Gregor EISENWORT, Irina SADOVNIK, Karin BAUER, Michael WILLMANN, Thomas RUELICKE, Daniela BERGER, Gabriele STEFANZL, Georg GREINER, Gregor HOERMANN, Alexandra KELLER, Dominik WOLF, Martin ČULEN, Georg E WINTER, Thomas HOFFMANN, Ana-Iris SCHIEFER, Wolfgang R SPERR, Johannes ZUBER, Jiří MAYER and Peter VALENT. BRD4 degradation blocks expression of MYC and multiple forms of stem cell resistance in Ph+ chronic myeloid leukemia. American Journal of Hematology. Hoboken: John Wiley & Sons, 2022, vol. 97, No 9, p. 1215-1225. ISSN 0361-8609. Available from: https://dx.doi.org/10.1002/ajh.26650.
      More: https://is.muni.cz/publication/2237999/en
    5. Can Schlafen 11 Help to Stratify Ovarian Cancer Patients Treated with DNA-Damaging Agents?
      BEDNAŘÍKOVÁ, Markéta, Jitka HAUSNEROVÁ, Lucie EHRLICHOVÁ, Květoslava MATULOVÁ, Eliška GAZÁRKOVÁ, Luboš MINÁŘ and Vít WEINBERGER. Can Schlafen 11 Help to Stratify Ovarian Cancer Patients Treated with DNA-Damaging Agents? Cancers. Basel: MDPI, 2022, vol. 14, No 10, p. 1-13. ISSN 2072-6694. Available from: https://dx.doi.org/10.3390/cancers14102353.
      More: https://is.muni.cz/publication/1858546/en
    6. Cardio-Oncology Rehabilitation and Telehealth: Rationale for Future Integration in Supportive Care of Cancer Survivors
      BAŤALÍK, Ladislav, Katerina FILAKOVA, Ivana RADKOVCOVA, Filip DOSBABA, Petr WINNIGE, Daniela VLAŽNÁ, Katerina BATALIKOVA, Marián FELŠŐCI, Marios STEFANAKIS, David LISKA, Jannis PAPATHANASIOU, Andrea POKORNÁ, Andrea JANÍKOVÁ, Sebastian RUTKOWSKI and Garyfallia PEPERA. Cardio-Oncology Rehabilitation and Telehealth: Rationale for Future Integration in Supportive Care of Cancer Survivors. FRONTIERS IN CARDIOVASCULAR MEDICINE. LAUSANNE: FRONTIERS MEDIA SA, 2022, vol. 9, April 2022, p. 1-11. ISSN 2297-055X. Available from: https://dx.doi.org/10.3389/fcvm.2022.858334.
      More: https://is.muni.cz/publication/1861717/en
    7. CAR-T cells for the treatment of relapsed/refractory multiple myeloma in 2022: efficacy and toxicity
      KREJČÍ, Martin, Zdeněk ADAM, Marta KREJČÍ, Luděk POUR, Viera SANDECKÁ and Martin ŠTORK. CAR-T cells for the treatment of relapsed/refractory multiple myeloma in 2022: efficacy and toxicity. Neoplasma. BRATISLAVA: AEPRESS SRO, 2022, vol. 69, No 5, p. 1008-1018. ISSN 0028-2685. Available from: https://dx.doi.org/10.4149/neo_2022_220504N477.
      More: https://is.muni.cz/publication/2255060/en
    8. Clinical value of ALK and CD30 expression in mature systemic T cell lymphomas: analysis from the Czech Lymphoma Study Group database (NIHIL)
      JANÍKOVÁ, Andrea, Jozef MICHALKA, Renata CHLOUPKOVÁ, Natasa KOPALOVA, V. CAMPR, K. KAMARADOVA, Leoš KŘEN, D. BELADA, K. BENESOVA, J. DLOUHA, P. KLENER, V. PROCHÁZKA, H. MOCIKOVA, J. DURAS and M. TRNENY. Clinical value of ALK and CD30 expression in mature systemic T cell lymphomas: analysis from the Czech Lymphoma Study Group database (NIHIL). Annals of hematology. New York: Springer Verlag, 2022, vol. 101, No 4, p. 789-798. ISSN 0939-5555. Available from: https://dx.doi.org/10.1007/s00277-022-04759-1.
      More: https://is.muni.cz/publication/1863085/en
    9. COVID-19 and CAR T cells: a report on current challenges and future directions from the EPICOVIDEHA survey by EHA-IDWP
      BUSCA, Alessandro, Jon SALMANTON-GARCÍA, Paolo CORRADINI, Francesco MARCHESI, Alba CABIRTA, Roberta Di BLASI, Remy DULERY, Sylvain LAMURE, Francesca FARINA, Barbora WEINBERGEROVÁ, Josip BATINIĆ, Anna NORDLANDER, Alberto LÓPEZ-GARCÍA, Ľuboš DRGOŇA, Ildefonso ESPIGADO-TOCINO, Iker FALCES-ROMERO, Ramón GARCÍA-SANZ, Carolina GARCÍA-VIDAL, Anna GUIDETTI, Nina KHANNA, Austin KULASEKARARAJ, Johan MAERTENS, Martin HOENIGL, Nikolai KLIMKO, Philipp KOEHLER, Antonio PAGLIUCA, Francesco PASSAMONTI, Oliver A CORNELY and Livio PAGANO. COVID-19 and CAR T cells: a report on current challenges and future directions from the EPICOVIDEHA survey by EHA-IDWP. Blood advances. AMSTERDAM: ELSEVIER, 2022, vol. 6, No 7, p. 2427-2433. ISSN 2473-9529. Available from: https://dx.doi.org/10.1182/bloodadvances.2021005616.
      More: https://is.muni.cz/publication/2262319/en
    10. COVID-19 in vaccinated adult patients with hematological malignancies: preliminary results from EPICOVIDEHA
      PAGANO, Livio, Jon SALMANTON-GARCÍA, Francesco MARCHESI, Alberto LÓPEZ-GARCÍA, Sylvain LAMURE, Federico ITRI, Maria GOMES-SILVA, Giulia DRAGONETTI, Iker FALCES-ROMERO, Jaap van DOESUM, Uluhan SILI, Jorge LABRADOR, Maria CALBACHO, Yavuz M BILGIN, Barbora WEINBERGEROVÁ, Laura SERRANO, José-María Ribera-Santa SUSANA, Sandra MALAK, José LOUREIRO-AMIGO, Andreas GLENTHØJ, Raúl CÓRDOBA-MASCUÑANO, Raquel NUNES-RODRIGUES, Tomás-José GONZÁLEZ-LÓPEZ, Linda Katharina KARLSSON, María-Josefa JIMÉNEZ-LORENZO, José-Ángel HERNÁNDEZ-RIVAS, Ozren JAKSIC, Zdeněk RÁČIL, Alessandro BUSCA, Paolo CORRADINI, Martin HOENIGL, Nikolai KLIMKO, Philipp KOEHLER, Antonio PAGLIUCA, Francesco PASSAMONTI and Oliver A CORNELY. COVID-19 in vaccinated adult patients with hematological malignancies: preliminary results from EPICOVIDEHA. Blood. Washington DC, USA: American Society of Hematology, 2022, vol. 139, No 10, p. 1588-1592. ISSN 0006-4971. Available from: https://dx.doi.org/10.1182/blood.2021014124.
      More: https://is.muni.cz/publication/1853630/en
    11. Cryptococcal Pneumonia: An Unusual Complication in a COVID-19 Patient
      ŠTINGL, Jan, Julie HYLMAROVÁ, Martina LENGEROVÁ, Jan MALÁSKA and Jan STAŠEK. Cryptococcal Pneumonia: An Unusual Complication in a COVID-19 Patient. Diagnostics. Basel: MDPI, 2022, vol. 12, No 8, p. 1-7. ISSN 2075-4418. Available from: https://dx.doi.org/10.3390/diagnostics12081944.
      More: https://is.muni.cz/publication/2225482/en
    12. Cytogenetics in Chronic Lymphocytic Leukemia: ERIC Perspectives and Recommendations
      BALIAKAS, Panagiotis, Blanca ESPINET, Clemens MELLINK, Marie JAROŠOVÁ, Anastasia ATHANASIADOU, Paolo GHIA, Arnon P KATER, David OSCIER, Claudia HAFERLACH and Kostas STAMATOPOULOS. Cytogenetics in Chronic Lymphocytic Leukemia: ERIC Perspectives and Recommendations. HemaSphere. Philadelphia: Lippincott Williams & Wilkins, 2022, vol. 6, No 4, p. 1-7. ISSN 2572-9241. Available from: https://dx.doi.org/10.1097/HS9.0000000000000707.
      More: https://is.muni.cz/publication/2211017/en
    13. Design of the VIALE-M phase III trial of venetoclax and oral azacitidine maintenance therapy in acute myeloid leukemia
      IVANOV, Vladimir, Su-Peng YEH, Jiří MAYER, Lalit SAINI, Ali UNAL, Michael BOYIADZIS, David M HOFFMAN, Kingston KANG, Sadiya N ADDO, Wellington L MENDES and Amir T FATHI. Design of the VIALE-M phase III trial of venetoclax and oral azacitidine maintenance therapy in acute myeloid leukemia. Future Oncology. London: Future Medicine Ltd., 2022, vol. 18, No 26, p. 2879-2889. ISSN 1479-6694. Available from: https://dx.doi.org/10.2217/fon-2022-0450.
      More: https://is.muni.cz/publication/2247606/en
    14. Does an Endometrial Cancer Diagnosis among Asymptomatic Patients Improve Prognosis?
      VINKLEROVÁ, Petra, Petra OVESNÁ, Markéta BEDNAŘÍKOVÁ, Luboš MINÁŘ, Michal FELSINGER, Jitka HAUSNEROVÁ and Vít WEINBERGER. Does an Endometrial Cancer Diagnosis among Asymptomatic Patients Improve Prognosis? Cancers. Basel: MDPI, 2022, vol. 14, No 1, p. 1-11. ISSN 2072-6694. Available from: https://dx.doi.org/10.3390/cancers14010115.
      More: https://is.muni.cz/publication/1816307/en
    15. Duplication of 8q24 in Chronic Lymphocytic Leukemia: Cytogenetic and Molecular Biologic Analysis of MYC Aberrations
      ONDROUŠKOVÁ, Eva, Michaela BOHÚNOVÁ, Kristýna ZÁVACKÁ, Patrik ČECH, Petra ŠMUHAŘOVÁ, Miroslav BOUDNÝ, Martina ORŠULOVÁ, Anna PANOVSKÁ, Lenka RADOVÁ, Michael DOUBEK, Karla PLEVOVÁ and Marie JAROŠOVÁ. Duplication of 8q24 in Chronic Lymphocytic Leukemia: Cytogenetic and Molecular Biologic Analysis of MYC Aberrations. Frontiers in Oncology. Lausanne: Frontiers Media S.A., 2022, vol. 12, June 2022, p. 1-11. ISSN 2234-943X. Available from: https://dx.doi.org/10.3389/fonc.2022.859618.
      More: https://is.muni.cz/publication/2211030/en
    16. Effective NPM1 plasmid standards selection for minimal/measurable residual disease monitoring in acute myeloid leukemia.
      FOLTA, Adam, Markéta SASINKOVA, Anna ĎURINÍKOVÁ, Marie DRNCOVÁ, Barbora WEINBERGEROVÁ, Jiří MAYER and Ivana JEŽÍŠKOVÁ. Effective NPM1 plasmid standards selection for minimal/measurable residual disease monitoring in acute myeloid leukemia. Molecular Biology Reports. DORDRECHT: SPRINGER, 2022, vol. 49, No 8, p. 8169-8172. ISSN 0301-4851. Available from: https://dx.doi.org/10.1007/s11033-022-07363-8.
      More: https://is.muni.cz/publication/1862251/en
    17. Efficacy of encorafenib and cetuximab therapy in a young patient with a rare concomitant KRAS and BRAF mutation in primary rectal cancer and wild-type KRAS status in metastases: A case report and literature review
      EID, Michal, Martina JELÍNKOVÁ, Jiří ŠÁNA and Ondřej SLABÝ. Efficacy of encorafenib and cetuximab therapy in a young patient with a rare concomitant KRAS and BRAF mutation in primary rectal cancer and wild-type KRAS status in metastases: A case report and literature review. Current Problems in Cancer: Case Reports. Amsterdam: Elsevier, 2022, vol. 8, December 2022, p. 1-4. ISSN 2666-6219. Available from: https://dx.doi.org/10.1016/j.cpccr.2022.100207.
      More: https://is.muni.cz/publication/2242241/en
    18. Evolution of TP53 abnormalities during CLL disease course is associated with telomere length changes
      OLBERTOVÁ, Helena, Karla PLEVOVÁ, Šárka PAVLOVÁ, Jitka MALCIKOVA, Jana KOTAŠKOVÁ, Kamila STRÁNSKÁ, Michaela ŠPUNAROVÁ, Martin TRBUŠEK, Veronika NAVRKALOVÁ, Barbara DVOŘÁČKOVÁ, Nikola TOM, Karol PÁL, Marie JAROŠOVÁ, Yvona BRYCHTOVÁ, Anna PANOVSKÁ, Michael DOUBEK and Šárka POSPÍŠILOVÁ. Evolution of TP53 abnormalities during CLL disease course is associated with telomere length changes. BMC Cancer. London: BMC, 2022, vol. 22, No 1, p. 1-11. ISSN 1471-2407. Available from: https://dx.doi.org/10.1186/s12885-022-09221-z.
      More: https://is.muni.cz/publication/2245079/en
    19. Genetic mechanism for the loss of PRAME in B cell lymphomas
      MRÁZ, Marek. Genetic mechanism for the loss of PRAME in B cell lymphomas. Journal of Clinical Investigation. Ann Arbor: AMER SOC CLINICAL INVESTIGATION INC, 2022, vol. 132, No 14, p. nestrankovano, 1 pp. ISSN 0021-9738. Available from: https://dx.doi.org/10.1172/JCI160983.
      More: https://is.muni.cz/publication/2239435/en
    20. Characteristics and outcome of patients with core-binding factor acute myeloid leukemia and FLT3-ITD: results from an international collaborative study
      KAYSER, Sabine, Michael KRAMER, David MARTINEZ-CUADRON, Justin GRENET, Klaus H METZELER, Zuzana ŠUSTKOVÁ, Marlise R LUSKIN, Andrew M BRUNNER, Michelle A ELLIOTT, Cristina GIL, Sandra Casal MARINI, Zdeněk RÁČIL, Petr CETKOVSKY, Jan NOVAK, Alexander E PERL, Uwe PLATZBECKER, Friedrich STOELZEL, Anthony D HO, Christian THIEDE, Richard M STONE, Christoph ROELLIG, Pau MONTESINOS, Richard F SCHLENK and Mark J LEVIS. Characteristics and outcome of patients with core-binding factor acute myeloid leukemia and FLT3-ITD: results from an international collaborative study. Haematologica. PAVIA: FERRATA STORTI FOUNDATION, 2022, vol. 107, No 4, p. 836-843. ISSN 0390-6078. Available from: https://dx.doi.org/10.3324/haematol.2021.278645.
      More: https://is.muni.cz/publication/2251509/en
    21. Impact of BCR::ABL1 transcript type on RT-qPCR amplification performance and molecular response to therapy
      SALMON, M., H. E. WHITE, Hana ZIZKOVA, A. GOTTSCHALK, Eliska MOTLOVA, N. CERVEIRA, D. COLOMER, D. CORIU, G. N. FRANKE, E. GOTTARDI, B. IZZO, Tomáš JURČEK, T. LION, V. SCHAFER, C. VENTURI, P. VIGNERI, M. ZAWADA, Jan ZUNA, Lenka HOVORKOVA, Jitka KOBLIHOVA, Hana KLAMOVA, Marketa MARKOVA STASTNA, Dana SRBOVA, Adela BENESOVA, Vaclava POLIVKOVA, Daniela ŽÁČKOVÁ, Jiří MAYER, I. ROEDER, I. GLAUCHE, T. ERNST, A. HOCHHAUS, K. M. POLAKOVA and N. C. P. CROSS. Impact of BCR::ABL1 transcript type on RT-qPCR amplification performance and molecular response to therapy. Leukemia. LONDON: Springer, 2022, vol. 36, No 7, p. 1879-1886. ISSN 0887-6924. Available from: https://dx.doi.org/10.1038/s41375-022-01612-2.
      More: https://is.muni.cz/publication/1874629/en
    22. Impact of the Types and Relative Quantities of IGHV Gene Mutations in Predicting Prognosis of Patients With Chronic Lymphocytic Leukemia
      KAUFMAN, Matthew, Xiao-Jie YAN, Wentian LI, Emanuela M GHIA, Anton W LANGERAK, Laura Z RASSENTI, Chrysoula BELESSI, Neil E KAY, Frederic DAVI, John C BYRD, Šárka POSPÍŠILOVÁ, Jennifer R BROWN, Mark CATHERWOOD, Zadie DAVIS, David OSCIER, Marco MONTILLO, Livio TRENTIN, Richard ROSENQUIST, Paolo GHIA, Jacqueline C BARRIENTOS, Jonathan E KOLITZ, Steven L ALLEN, Kanti R RAI, Kostas STAMATOPOULOS, Thomas J KIPPS, Donna NEUBERG and Nicholas CHIORAZZI. Impact of the Types and Relative Quantities of IGHV Gene Mutations in Predicting Prognosis of Patients With Chronic Lymphocytic Leukemia. Frontiers in Oncology. Lausanne: Frontiers Media S.A., 2022, vol. 12, July 2022, p. 1-12. ISSN 2234-943X. Available from: https://dx.doi.org/10.3389/fonc.2022.897280.
      More: https://is.muni.cz/publication/2239436/en
    23. In Vitro and In Vivo Models of CLL-T Cell Interactions: Implications for Drug Testing
      HOFERKOVÁ, Eva, Soňa KADÁKOVÁ and Marek MRÁZ. In Vitro and In Vivo Models of CLL-T Cell Interactions: Implications for Drug Testing. CANCERS. SWITZERLAND: MDPI, 2022, vol. 14, No 13, p. 3087-3107. ISSN 2072-6694. Available from: https://dx.doi.org/10.3390/cancers14133087.
      More: https://is.muni.cz/publication/1875240/en
    24. Ixazomib, Lenalidomide and Dexamethasone in Relapsed and Refractory Multiple Myeloma in Routine Clinical Practice: Extended Follow-Up Analysis and the Results of Subsequent Therapy
      MINARIK, Jiri, Jakub RADOCHA, Alexandra JUNGOVA, Jan STRAUB, Tomas JELINEK, Tomas PIKA, Luděk POUR, Petr PAVLICEK, Lubica HARVANOVA, Lenka POSPISILOVA, Petra KRHOVSKA, Denisa NOVAKOVA, Pavel JINDRA, Ivan SPICKA, Hana PLONKOVA, Martin ŠTORK, Jaroslav BACOVSKY, Vladimir MAISNAR and Roman HAJEK. Ixazomib, Lenalidomide and Dexamethasone in Relapsed and Refractory Multiple Myeloma in Routine Clinical Practice: Extended Follow-Up Analysis and the Results of Subsequent Therapy. Cancers. Basel: MDPI, 2022, vol. 14, No 20, p. 1-13. ISSN 2072-6694. Available from: https://dx.doi.org/10.3390/cancers14205165.
      More: https://is.muni.cz/publication/2249587/en
    25. Limited efficacy of daratumumab in multiple myeloma with extramedullary disease
      JELINEK, Tomas, Tereza SEVCIKOVA, David ZIHALA, Tereza POPKOVA, Veronika KAPUSTOVA, Lucie BROSKEVICOVA, Lenka CAPKOVA, Lucie ŘÍHOVÁ, Renata BEZDĚKOVÁ, Sabina ŠEVČÍKOVÁ, Vladimir ZIDLIK, Martin HAVEL, Hana PLONKOVA, Alexandra JUNGOVA, Jiri MINARIK, Martin ŠTORK, Luděk POUR, Petr PAVLICEK, Ivan SPICKA, Vladimir MAISNAR, Jakub RADOCHA, Michal SIMICEK and Roman HAJEK. Limited efficacy of daratumumab in multiple myeloma with extramedullary disease. Leukemia. London: Nature Publishing Group, 2022, vol. 36, No 1, p. 288-291. ISSN 0887-6924. Available from: https://dx.doi.org/10.1038/s41375-021-01343-w.
      More: https://is.muni.cz/publication/1787325/en
    26. Low levels of minimal residual disease after induction chemotherapy for BCR-ABL1-negative acute lymphoblastic leukaemia in adults are clinically relevant
      SALEK, Cyril, František FOLBER, Eva FRONKOVA, Pavla PECHERKOVA, Hana JELINKOVA, Štěpán HRABOVSKÝ, Jan M. HORACEK, Petr CETKOVSKY, Jiří MAYER, Jan TRKA and Michael DOUBEK. Low levels of minimal residual disease after induction chemotherapy for BCR-ABL1-negative acute lymphoblastic leukaemia in adults are clinically relevant. British journal of haematology. England: Wiley-Blackwell, 2022, vol. 196, No 3, p. 706-710. ISSN 0007-1048. Available from: https://dx.doi.org/10.1111/bjh.17966.
      More: https://is.muni.cz/publication/1824604/en
    27. Lyn Phosphorylates and Controls ROR1 Surface Dynamics During Chemotaxis of CLL Cells
      DAVE, Zankruti, Olga VONDÁLOVÁ BLANÁŘOVÁ, Štěpán ČADA, Pavlína JANOVSKÁ, Nikodém ZEZULA, Martin BĚHAL, Kateřina HANÁKOVÁ, Sri Ranjani GANJI, Pavel KREJČÍ, Kristína GÖMÖRYOVÁ, Helena PESCHELOVÁ, Michal ŠMÍDA, Zbyněk ZDRÁHAL, Šárka PAVLOVÁ, Jana KOTAŠKOVÁ, Šárka POSPÍŠILOVÁ and Vítězslav BRYJA. Lyn Phosphorylates and Controls ROR1 Surface Dynamics During Chemotaxis of CLL Cells. Frontiers in Cell and Developmental Biology. Frontiers Media SA, 2022, vol. 10, February 2022, p. 1-11. ISSN 2296-634X. Available from: https://dx.doi.org/10.3389/fcell.2022.838871.
      More: https://is.muni.cz/publication/1843559/en
    28. Malignant hyperthermia in Czechia and Slovakia
      KLINCOVÁ, Martina, Dagmar ŠTĚPÁNKOVÁ, Ivana SCHRÖDEROVÁ, Eva KLABUSAYOVÁ, Edita OŠŤÁDALOVÁ, Iveta VALÁŠKOVÁ, Lenka FAJKUSOVÁ, Jana ZÍDKOVÁ, Renata GAILLYOVÁ and Petr ŠTOURAČ. Malignant hyperthermia in Czechia and Slovakia. British Journal of Anaesthesia. OXFORD: ELSEVIER, 2022, vol. 129, No 2, p. "e41"-"e43", 3 pp. ISSN 0007-0912. Available from: https://dx.doi.org/10.1016/j.bja.2022.04.029.
      More: https://is.muni.cz/publication/2239460/en
    29. Memory B-cell like chronic lymphocytic leukaemia is associated with specific methylation profile of WNT5A promoter and undetectable expression of WNT5A gene
      POPPOVÁ, Lucie, Šárka PAVLOVÁ, Beatriz GONZALEZ, Jana KOTAŠKOVÁ, Karla PLEVOVÁ, Gabrijela DUMBOVIC, Pavlína JANOVSKÁ, Vojtěch BYSTRÝ, Anna PANOVSKÁ, Lucie BEZDĚKOVÁ, Stanislava MAŠLEJOVÁ, Yvona BRYCHTOVÁ, Michael DOUBEK, Marcela KRZYŽÁNKOVÁ, Marek BORSKÝ, Jiří MAYER, Vítězslav BRYJA, Sergio ALONSO and Šárka POSPÍŠILOVÁ. Memory B-cell like chronic lymphocytic leukaemia is associated with specific methylation profile of WNT5A promoter and undetectable expression of WNT5A gene. Epigenetics. Philadelphia: TAYLOR & FRANCIS INC, 2022, vol. 17, No 12, p. 1628-1635. ISSN 1559-2294. Available from: https://dx.doi.org/10.1080/15592294.2022.2050004.
      More: https://is.muni.cz/publication/2245078/en
    30. Minimal Residual Disease–Guided Intermittent Dosing in Patients With Cancer: Successful Treatment of Chemoresistant Anaplastic Large Cell Lymphoma Using Intermittent Lorlatinib Dosing
      POKORNÁ, Petra, Giannoula KLEMENT, Alžběta VAŠÍKOVÁ, Veronika KANDEROVÁ, Marta JEŽOVÁ, Kristýna NOSKOVÁ, Peter MÚDRY, Michal KÝR, Tomáš MERTA, Viera BAJČIOVÁ, Zdenka KŘENOVÁ, Hana PÁLOVÁ, Lenka ZDRAŽILOVÁ DUBSKÁ, Ondřej SLABÝ, Dalibor VALÍK and Jaroslav ŠTĚRBA. Minimal Residual Disease–Guided Intermittent Dosing in Patients With Cancer: Successful Treatment of Chemoresistant Anaplastic Large Cell Lymphoma Using Intermittent Lorlatinib Dosing. JCO PRECISION ONCOLOGY. PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS, 2022, vol. 6, June 2022, p. 1-7. ISSN 2473-4284. Available from: https://dx.doi.org/10.1200/PO.21.00525.
      More: https://is.muni.cz/publication/1863363/en
    31. Molecular profiling and clinical implications of patients with acute myeloid leukemia and extramedullary manifestations
      ECKARDT, J. N., F. STOLZEL, D. KUNADT, C. ROLLIG, S. STASIK, L. WAGENFUHR, K. JOHRENS, F. KUITHAN, A. KRAMER, S. SCHOLL, A. HOCHHAUS, M. CRYSANDT, T. H. BRUMMENDORF, R. NAUMANN, B. STEFFEN, V. KUNZMANN, H. EINSELE, M. SCHAICH, A. BURCHERT, A. NEUBAUER, K. SCHAFER ECKART, C. SCHLIEMANN, S. W. KRAUSE, R. HERBST, M. HANEL, M. HANOUN, U. KAISER, M. KAUFMANN, Zdeněk RÁČIL, Jiří MAYER, F. KROSCHINSKY, W. E. BERDEL, G. EHNINGER, H. SERVE, C. MULLER TIDOW, U. PLATZBECKER, C. D. BALDUS, J. SCHETELIG, M. BORNHAUSER, C. THIEDE and J. M. MIDDEKE. Molecular profiling and clinical implications of patients with acute myeloid leukemia and extramedullary manifestations. JOURNAL OF HEMATOLOGY & ONCOLOGY. LONDON: BMC, 2022, vol. 15, No 1, p. 1-13. ISSN 1756-8722. Available from: https://dx.doi.org/10.1186/s13045-022-01267-7.
      More: https://is.muni.cz/publication/1874625/en
    32. Next-generation sequencing in children with epilepsy: The importance of precise genotype–phenotype correlation
      HORÁK, Ondřej, Martina BUREŠOVÁ, Senad KOLÁŘ, Klára ŠPANĚLOVÁ, Barbora JEŘÁBKOVÁ, Renata GAILLYOVÁ, Katarína ČESKÁ, Kamila RÉBLOVÁ, Jana ŠOUKALOVÁ, Jana ZÍDKOVÁ, Lenka FAJKUSOVÁ, Hana OŠLEJŠKOVÁ, Ivan REKTOR and Pavlína DANHOFER. Next-generation sequencing in children with epilepsy: The importance of precise genotype–phenotype correlation. EPILEPSY & BEHAVIOR. SAN DIEGO: ACADEMIC PRESS INC ELSEVIER SCIENCE, 2022, vol. 128, March 2022, p. 1-6. ISSN 1525-5050. Available from: https://dx.doi.org/10.1016/j.yebeh.2022.108564.
      More: https://is.muni.cz/publication/2223041/en
    33. Outcome of infection with omicron SARS-CoV-2 variant in patients with hematological malignancies: An EPICOVIDEHA survey report
      BLENNOW, Ola, Jon SALMANTON-GARCIA, Piotr NOWAK, Federico ITRI, Van Doesum JAAP, Alberto LOPEZ-GARCIA, Francesca FARINA, Ozren JAKSIC, Laszlo Imre PINCZES, Yavuz M BILGIN, Iker FALCES-ROMERO, Moraima JIMENEZ, Irati ORMAZABAL-VELEZ, Barbora WEINBERGEROVÁ, Remy DULERY, Zlate STOJANOSKI, Tobias LAHMER, Noemi FERNANDEZ, Jose-angel HERNANDEZ-RIVAS, Verena PETZER, De Jonge NICK, Andreas GLENTHOJ, De Ramon CRISTINA, Monika M BIERNAT, Nicola FRACCHIOLLA, Avinash AUJAYEB, Van Praet JENS, Martin SCHONLEIN, Gustavo-Adolfo MENDEZ, Chiara CATTANEO, Anna GUIDETTI, Mariarita SCIUME, Emanuele AMMATUNA, Raul CORDOBA, Nicole GARCIA-POUTON, Stefanie GRAEFE, Alba CABIRTA, Dominik WOLF, Anna NORDLANDER, Ramon GARCIA-SANZ, Mario DELIA, Berg Venemyr CAROLINE, Clara BRONES, Di Blasi ROBERTA, De Kort ELIZABETH, Stef MEERS, Sylvain LAMURE, Laura SERRANO, Maria MERELLI, Nicola COPPOLA, Rui BERGANTIM, Caroline BESSON, Milena KOHN, Jessica PETITI, Carolina GARCIA-VIDAL, Michelina DARGENIO, Francois DANION, Marina MACHADO, Rebeca BAILEN-ALMOROX, Martin HOENIGL, Giulia DRAGONETTI, Louis Yi Ann CHAI, Chi Shan KHO, Matteo BONANNI, Raphael LIEVIN, Francesco MARCHESI, Oliver A CORNELY and Livio PAGANO. Outcome of infection with omicron SARS-CoV-2 variant in patients with hematological malignancies: An EPICOVIDEHA survey report. American Journal of Hematology. Hoboken: John Wiley & Sons, 2022, vol. 97, No 8, p. "E312"-"E317", 6 pp. ISSN 0361-8609. Available from: https://dx.doi.org/10.1002/ajh.26626.
      More: https://is.muni.cz/publication/2243401/en
    34. Paraphocaeicola brunensis gen. nov., sp. nov., Carrying Two Variants of nimB Resistance Gene from Bacteroides fragilis, and Caecibacteroides pullorum gen. nov., sp. nov., Two Novel Genera Isolated from Chicken Caeca
      KRÁLOVÁ, Stanislava, Lenka DAVIDOVA-GERZOVA, Adam VALCEK, Matěj BEZDÍČEK, Ivan RYCHLÍK, Veronika REZACOVA and Alois ČÍŽEK. Paraphocaeicola brunensis gen. nov., sp. nov., Carrying Two Variants of nimB Resistance Gene from Bacteroides fragilis, and Caecibacteroides pullorum gen. nov., sp. nov., Two Novel Genera Isolated from Chicken Caeca. Microbiology Spectrum. American Society for Microbiology, 2022, vol. 10, No 1, p. 1-21. ISSN 2165-0497. Available from: https://dx.doi.org/10.1128/spectrum.01954-21.
      More: https://is.muni.cz/publication/1835963/en
    35. Polatuzumab vedotin plus bendamustine and rituximab in patients with relapsed/refractory diffuse large B-cell lymphoma in the real world
      VODICKA, Prokop, Katerina BENESOVA, Andrea JANÍKOVÁ, Vit PROCHAZKA, David BELADA, Heidi MOCIKOVA, Katerina STEINEROVA, Juraj DURAS, Josef KARBAN, Veronika HANACKOVA, Alice SYKOROVA, Ales OBR and Marek TRNENY. Polatuzumab vedotin plus bendamustine and rituximab in patients with relapsed/refractory diffuse large B-cell lymphoma in the real world. European Journal of Haematology. Hoboken: Wiley-Blackwell, 2022, vol. 109, No 2, p. 162-165. ISSN 0902-4441. Available from: https://dx.doi.org/10.1111/ejh.13784.
      More: https://is.muni.cz/publication/2249571/en
    36. Postremission cytopenia management in patients with acute myeloid leukemia treated with venetoclax and azacitidine in VIALE-A
      PRATZ, Keith W, Courtney D DINARDO, Dominik SELLESLAG, Junmin LI, Kazuhito YAMAMOTO, Marina KONOPLEVA, Don STEVENS, Hagop KANTARJIAN, Fabiola TRAINA, Adriano VENDITTI, Jiří MAYER, Melissa MONTEZ, Huan JIN, Yinghui DUAN, Deanna BRACKMAN, Jiuhong ZHA, Jalaja POTLURI, Michael WERNER and Brian A JONAS. Postremission cytopenia management in patients with acute myeloid leukemia treated with venetoclax and azacitidine in VIALE-A. American Journal of Hematology. Hoboken: John Wiley & Sons, 2022, vol. 97, No 11, p. "E416"-"E419", 4 pp. ISSN 0361-8609. Available from: https://dx.doi.org/10.1002/ajh.26692.
      More: https://is.muni.cz/publication/2247608/en
    37. Predictors of Short- and Long-Term Mortality in Ischemic Stroke: A Community-Based Study in Brno, Czech Republic
      BRYNDZIAR, Tomáš, Dominika MATYSKOVÁ, Petra ŠEDOVÁ, Silvie BĚLAŠKOVÁ, Miroslav ZVOLSKÝ, Josef BEDNAŘÍK, Robert D. BROWN and Robert MIKULÍK. Predictors of Short- and Long-Term Mortality in Ischemic Stroke: A Community-Based Study in Brno, Czech Republic. Cerebrovascular Diseases. Basel: S. Karger AG, 2022, vol. 51, No 3, p. 296-303. ISSN 1015-9770. Available from: https://dx.doi.org/10.1159/000519937.
      More: https://is.muni.cz/publication/1805223/en
    38. Real-world evidence of efficacy and safety of pomalidomide and dexamethasone in relapsed/refractory multiple myeloma patients: Czech registry data
      SANDECKÁ, Viera, Luděk POUR, Ivan ŠPIČKA, Jiří MINAŘÍK, Jakub RADOCHA, Tomáš JELÍNEK, Petr PAVLÍČEK, Alexandra JUNGOVÁ, Petr KESSLER, Marek WRÓBEL, Martin ŠTORK, Jan ŠTRAUB, Tomáš PIKA, Lenka ČÁPKOVÁ, Sabina ŠEVČÍKOVÁ, Vladimír MAISNAR and Roman HÁJEK. Real-world evidence of efficacy and safety of pomalidomide and dexamethasone in relapsed/refractory multiple myeloma patients: Czech registry data. Neoplasma. BRATISLAVA: AEPRESS SRO, 2022, vol. 69, No 6, p. 1474-1479. ISSN 0028-2685. Available from: https://dx.doi.org/10.4149/neo_2022_220813N827.
      More: https://is.muni.cz/publication/2255057/en
    39. Refined diagnostic criteria for bone marrow mastocytosis: a proposal of the European competence network on mastocytosis
      ZANOTTI, R., M. BONIFACIO, G. LUCCHINI, W. R. SPERR, L. SCAFFIDI, B. VAN ANROOIJ, H. N. C. O. ELBERINK, J. ROSSIGNOL, O. HERMINE, A. GORSKA, M. LANGE, E. HADZIJUSUFOVIC, C. MIETHING, S. MULLER, C. PERKINS, W. SHOMALI, C. ELENA, A. ILLERHAUS, M. JAWHAR, R. PARENTE, F. CAROPPO, O. SOLOMIANYI, A. ZINK, M. MATTSSON, A. S. YAVUZ, J. PANSE, J. VARKONYI, Michael DOUBEK, V. SABATO, C. BREYNAERT, V. VUCINIC, T. SCHUG, H. HAGGLUND, F. WORTMANN, K. BROCKOW, I. ANGELOVA-FISCHER, A. B. FORTINA, M. TRIGGIANI, A. REITER, K. HARTMANN, L. MALCOVATI, J. GOTLIB, K. SHOUMARIYEH, M. NIEDOSZYTKO, M. AROCK, H. C. KLUIN-NELEMANS, P. BONADONNA and P. VALENT. Refined diagnostic criteria for bone marrow mastocytosis: a proposal of the European competence network on mastocytosis. Leukemia. London: Nature Publishing Group, 2022, vol. 36, No 2, p. 516-524. ISSN 0887-6924. Available from: https://dx.doi.org/10.1038/s41375-021-01406-y.
      More: https://is.muni.cz/publication/1834277/en
    40. Rilzabrutinib, an Oral BTK Inhibitor, in Immune Thrombocytopenia
      KUTER, D. J., M. EFRAIM, Jiří MAYER, Marek TRNĚNÝ, V. MCDONALD, R. BIRD, T. REGENBOGEN, M. GARG, Z. KAPLAN, N. TZVETKOV, P. Y. CHOI, A. J. G. JANSEN, Milan KOSTAL, R. BAKER, Jaromir GUMULEC, E. J. LEE, I. CUNNINGHAM, I. GONCALVES, M. WARNER, R. BOCCIA, T. GERNSHEIMER, W. GHANIMA, O. BANDMAN, R. BURNS, A. NEALE, D. THOMAS, P. ARORA, B. ZHENG and Cooper N. RILZABRUTINIB. Rilzabrutinib, an Oral BTK Inhibitor, in Immune Thrombocytopenia. New England Journal of Medicine. Waltham: Massachussetts Medical Society, 2022, vol. 386, No 15, p. 1421-1431. ISSN 0028-4793. Available from: https://dx.doi.org/10.1056/NEJMoa2110297.
      More: https://is.muni.cz/publication/1863066/en
    41. Role of miR-653 and miR-29c in downregulation of CYP1A2 expression in hepatocellular carcinoma
      KRKOŠKA, Martin, Jana NEKVINDOVA, Kateřina NEVĚDĚLOVÁ, Veronika ZUBANOVA, Lenka RADOVÁ, Jan VONDRACEK, Jarmila HERUDKOVA, Ondřej SLABÝ, Igor KISS, Lucia BOHOVICOVÁ, Pavel FABIAN, Zuzana TYLICHOVA, Zdeněk KALA, Petr KYSELA, Lenka OSTŘÍŽKOVÁ, Vladimir PALICKA and Alena HYRŠLOVÁ VACULOVÁ. Role of miR-653 and miR-29c in downregulation of CYP1A2 expression in hepatocellular carcinoma. Pharmacological Reports. KRAKOW: POLISH ACAD SCIENCES INST PHARMACOLOGY, 2022, vol. 74, No 1, p. 148-158. ISSN 1734-1140. Available from: https://dx.doi.org/10.1007/s43440-021-00338-9.
      More: https://is.muni.cz/publication/1805239/en
    42. Sequencing Independent Molecular Typing of Staphylococcus aureus Isolates: Approach for Infection Control and Clonal Characterization
      DUFKOVÁ, Kristýna, Matěj BEZDÍČEK, Kristina CUPROVA, Dagmar PANTUCKOVA, Marketa NYKRYNOVA, Eva BRHELOVA, Iva KOCMANOVA, Silvie HODOVA, Marketa HANSLIANOVA, Tomas JUREN, Břetislav LIPOVÝ, Jiří MAYER and Martina LENGEROVÁ. Sequencing Independent Molecular Typing of Staphylococcus aureus Isolates: Approach for Infection Control and Clonal Characterization. Microbiology Spectrum. WASHINGTON: American Society for Microbiology, 2022, vol. 10, No 1, p. 1-10. ISSN 2165-0497. Available from: https://dx.doi.org/10.1128/spectrum.01817-21.
      More: https://is.muni.cz/publication/2211021/en
    43. Simultaneous Onset of Haematological Malignancy and COVID: An Epicovideha Survey
      CATTANEO, Chiara, Jon SALMANTON-GARCIA, Francesco MARCHESI, Shaimaa EL-ASHWAH, Federico ITRI, Barbora WEINBERGEROVÁ, Da Silva Maria GOMES, Michelina DARGENIO, Julio DAVILA-VALLS, Sonia MARTIN-PEREZ, Francesca FARINA, Van Doesum JAAP, Toni VALKOVIC, Caroline BESSON, Christian Bjorn POULSEN, Alberto LOPEZ-GARCIA, Pavel ZAK, Martin SCHONLEIN, Klara PIUKOVICS, Ozren JAKSIC, Alba CABIRTA, Natasha ALI, Uluhan SILI, Nicola FRACCHIOLLA, Giulia DRAGONETTI, Tatjana ADZIC-VUKICEVIC, Monia MARCHETTI, Marina MACHADO, Andreas GLENTHOJ, Olimpia FINIZIO, Fatih DEMIRKAN, Ola BLENNOW, Maria Chiara TISI, Ali S OMRANI, Milan NAVRATIL, Zdenek RACIL, Jan NOVAK, Gabriele MAGLIANO, Moraima JIMENEZ, Carolina GARCIA-VIDAL, Nurettin ERBEN, Del Principe Maria ILARIA, Caterina BUQUICCHIO, Rui BERGANTIM, Josip BATINIC, Murtadha AL-KHABORI, Luisa VERGA, Tomas SZOTKOWSKI, Michail SAMARKOS, Irati ORMAZABAL-VELEZ, Stef MEERS, Johan MAERTENS, Laszlo Imre PINCZES, Martin HOENIGL, Lubos DRGONA, Annarosa CUCCARO, Yavuz M BILGIN, Avinash AUJAYEB, Laman RAHIMLI, Stefanie GRAFE, Mariarita SCIUME, Milos MLADENOVIC, Gokce Melis COLAK, Maria Vittoria SACCHI, Anna NORDLANDER, Caroline Berg VENEMYR, Michaela HANAKOVA, Nicole GARCIA-POUTON, Ziad EMARAH, Giovanni Paolo Maria ZAMBROTTA, Raquel Nunes RODRIGUES, Raul CORDOBA, Gustavo-Adolfo MENDEZ, Monika M BIERNAT, Oliver A CORNELY and Livio PAGANO. Simultaneous Onset of Haematological Malignancy and COVID: An Epicovideha Survey. Cancers. Basel: MDPI, 2022, vol. 14, No 22, p. 1-16. ISSN 2072-6694. Available from: https://dx.doi.org/10.3390/cancers14225530.
      More: https://is.muni.cz/publication/2251355/en
    44. Single and multiple point NRAS mutations in acute myeloid leukemia: a study of 327 well molecularly characterized patients.
      ĎURINÍKOVÁ, Anna, Adam FOLTA, Filip PARDY, Jan SVATOŇ, Marie DRNCOVÁ, Barbora WEINBERGEROVÁ, Petr CETKOVSKY, Zdeněk RÁČIL, Pavel JINDRA, Tomas SZOTKOWSKI, Pavel ZAK, Jiří MAYER and Ivana JEŽÍŠKOVÁ. Single and multiple point NRAS mutations in acute myeloid leukemia: a study of 327 well molecularly characterized patients. LEUKEMIA & LYMPHOMA. ABINGDON: TAYLOR & FRANCIS LTD, 2022, vol. 63, No 13, p. 3237-3240. ISSN 1042-8194. Available from: https://dx.doi.org/10.1080/10428194.2022.2116931.
      More: https://is.muni.cz/publication/2219718/en
    45. Standardization of molecular monitoring of CML: results and recommendations from the European treatment and outcome study
      WHITE, Helen E, Matthew SALMON, Francesco ALBANO, Christina Sos Auour ANDERSEN, Stefan BALABANOV, Gueorgui BALATZENKO, Gisela BARBANY, Jean-Michel CAYUELA, Nuno CERVEIRA, Pascale COCHAUX, Dolors COLOMER, Daniel CORIU, Joana DIAMOND, Christian DIETZ, Stephanie DULUCQ, Marie ENGVALL, Georg N FRANKE, Egle GINEIKIENE-VALENTINE, Michal GNIOT, Maria Teresa GOMEZ-CASARES, Enrico GOTTARDI, Chloe HAYDEN, Sandrine HAYETTE, Andreas HEDBLOM, Anca ILEA, Barbara IZZO, Antonio JIMENEZ-VELASCO, Tomáš JURČEK, Veli KAIRISTO, Stephen E LANGABEER, Thomas LION, Nora MEGGYESI, Semir MESANOVIC, Luboslav MIHOK, Gerlinde MITTERBAUER-HOHENDANNER, Sylvia MOECKEL, Nicole NAUMANN, Olivier NIBOUREL, Oppliger Leibundgut ELISABETH, Panayiotis PANAYIOTIDIS, Helena PODGORNIK, Christiane POTT, Inmaculada RAPADO, Susan J ROSE, Vivien SCHAEFER, Tasoula TOULOUMENIDOU, Christopher VEIGAARD, Bianca VENNIKER-PUNT, Claudia VENTURI, Paolo VIGNERI, Ingvild VORKINN, Elizabeth WILKINSON, Renata ZADRO, Magdalena ZAWADA, Hana ZIZKOVA, Martin C MUELLER, Susanne SAUSSELE, Thomas ERNST, Katerina MACHOVA POLAKOVA, Andreas HOCHHAUS and Nicholas C P CROSS. Standardization of molecular monitoring of CML: results and recommendations from the European treatment and outcome study. Leukemia. London: Nature Publishing Group, 2022, vol. 36, No 7, p. 1834-1842. ISSN 0887-6924. Available from: https://dx.doi.org/10.1038/s41375-022-01607-z.
      More: https://is.muni.cz/publication/2247605/en
    46. Stereotactic Body Radiotherapy (SBRT) of Pancreatic Cancer-A Critical Review and Practical Consideration
      BURKOŇ, Petr, Jan TRNA, Marek SLÁVIK, Radim NĚMEČEK, Tomáš KAZDA, Petr POSPÍŠIL, Milan DASTYCH, Michal EID, Ivo NOVOTNY, Tomáš PROCHÁZKA and Miroslav VRZAL. Stereotactic Body Radiotherapy (SBRT) of Pancreatic Cancer-A Critical Review and Practical Consideration. Biomedicines. Basel: MDPI, 2022, vol. 10, No 10, p. 1-23. ISSN 2227-9059. Available from: https://dx.doi.org/10.3390/biomedicines10102480.
      More: https://is.muni.cz/publication/2233281/en
    47. Successful early use of anti-SARS-CoV-2 monoclonal neutralizing antibodies in SARS-CoV-2 infected hematological patients - A Czech multicenter experience
      WEINBERGEROVÁ, Barbora, Ivo DEMEL, Benjamin VISEK, Jan VALKA, Martin CERNAN, Pavel JINDRA, Jan NOVAK, Lukas STEJSKAL, Flóra KOVÁCSOVÁ, Tomáš KABUT, Tomas SZOTKOWSKI, Roman HAJEK, Pavel ZAK, Petr CETKOVSKY, Zdeněk KRÁL and Jiří MAYER. Successful early use of anti-SARS-CoV-2 monoclonal neutralizing antibodies in SARS-CoV-2 infected hematological patients - A Czech multicenter experience. Hematological Oncology. MALDEN, USA: WILEY-BLACKWELL, 2022, vol. 40, No 2, p. 280-286. ISSN 0278-0232. Available from: https://dx.doi.org/10.1002/hon.2974.
      More: https://is.muni.cz/publication/1853633/en
    48. Synthesis and Profiling of Highly Selective Inhibitors of Methyltransferase DOT1L Based on Carbocyclic C-Nucleosides
      KHIRSARIYA, PrashantKumar, Patrik POSPÍŠIL, Lukáš MAIER, Miroslav BOUDNÝ, Martin BABÁŠ, Ondřej KROUTIL, Marek MRÁZ, Robert VÁCHA and Kamil PARUCH. Synthesis and Profiling of Highly Selective Inhibitors of Methyltransferase DOT1L Based on Carbocyclic C-Nucleosides. Journal of Medicinal Chemistry. Washington: American Chemical Society, 2022, vol. 65, No 7, p. 5701-5723. ISSN 0022-2623. Available from: https://dx.doi.org/10.1021/acs.jmedchem.1c02228.
      More: https://is.muni.cz/publication/1854512/en
    49. Tesidolumab (LFG316) for treatment of C5-variant patients with paroxysmal nocturnal hemoglobinuria
      NISHIMURA, Jun-ichi, Kiyoshi ANDO, Masayoshi MASUKO, Hideyoshi NOJI, Yoshikazu ITO, Jiří MAYER, Laimonas GRISKEVICIUS, Christoph BUCHER, Florian MULLERSHAUSEN, Peter GERGELY, Izabela ROZENBERG, Anna SCHUBART, Raghav CHAWLA, Jean-Michel RONDEAU, Michael ROGUSKA, Igor SPLAWSKI, Mark T KEATING, Leslie JOHNSON, Rambabu DANEKULA, Morten BAGGER, Yoko WATANABE, Borje HARALDSSON and Yuzuru KANAKURA. Tesidolumab (LFG316) for treatment of C5-variant patients with paroxysmal nocturnal hemoglobinuria. Haematologica. PAVIA: FERRATA STORTI FOUNDATION, 2022, vol. 107, No 6, p. 1483-1488. ISSN 0390-6078. Available from: https://dx.doi.org/10.3324/haematol.2020.265868.
      More: https://is.muni.cz/publication/2247544/en
    50. The Absence of Retroelement Activity Is Characteristic for Childhood Acute Leukemias and Adult Acute Lymphoblastic Leukemia
      URAZBAKHTIN, Shamil, Anastasia SMIRNOVA, Anastasiya VOLAKHAVA, Elena ZERKALENKOVA, Maria SALYUTINA, Michael DOUBEK, Hana JELINKOVA, Nelly KHUDAINAZAROVA, Egor VOLCHKOV, Laima BELYAEVA, Ekaterina KOMECH, Šárka PAVLOVÁ, Yuri LEBEDEV, Karla PLEVOVÁ, Yulia OLSHANSKAYA, Alexander KOMKOV and Ilgar MAMEDOV. The Absence of Retroelement Activity Is Characteristic for Childhood Acute Leukemias and Adult Acute Lymphoblastic Leukemia. International Journal of Molecular Sciences. Basel: Multidisciplinary Digital Publishing Institute, 2022, vol. 23, No 3, p. 1756-1768. ISSN 1422-0067. Available from: https://dx.doi.org/10.3390/ijms23031756.
      More: https://is.muni.cz/publication/2212611/en
    51. The EHA Research Roadmap: Malignant Lymphoid Diseases
      DREYLING, Martin, Marc ANDRE, Nicola GOKBUGET, Herve TILLY, Mats JERKEMAN, John GRIBBEN, Andres FERRERI, Pierre MOREL, Stephan STILGENBAUER, Christopher FOX, Maria Ribera JOSE, Sonja ZWEEGMAN, Igor AURER, Csaba BODOR, Birgit BURKHARDT, Christian BUSKE, Dollores Caballero MARIA, Elias CAMPO, Bjoern CHAPUY, Andrew DAVIES, de Leval LAURENCE, Jeanette DOORDUIJN, Massimo FEDERICO, Philippe GAULARD, Francesca GAY, Paolo GHIA, Kirsten GRONBAEK, Hartmut GOLDSCHMIDT, Marie-Jose KERSTEN, Barbara KIESEWETTER, Judith LANDMAN-PARKER, Le Gouill STEVEN, Georg LENZ, Sirpa LEPPA, Armando LOPEZ-GUILLERMO, Elizabeth MACINTYRE, Maria Victoria Mateos MANTEGA, Philippe MOREAU, Carol MORENO, Bertrand NADEL, Jessica OKOSUN, Roger OWEN, Šárka POSPÍŠILOVÁ, Christiane POTT, Tadeusz ROBAK, Michelle SPINA, Kostas STAMATOPOULOS, Jan STARY, Karin TARTE, Allessandra TEDESCHI, Catherine THIEBLEMONT, Ralf Ulrich TRAPPE, Lorenz H TRUMPER and Gilles SALLES. The EHA Research Roadmap: Malignant Lymphoid Diseases. HemaSphere. Philadelphia: Lippincott Williams & Wilkins, 2022, vol. 6, No 6, p. 1-18. ISSN 2572-9241. Available from: https://dx.doi.org/10.1097/HS9.0000000000000726.
      More: https://is.muni.cz/publication/2211019/en
    52. Transcription factor c-Myb: novel prognostic factor in osteosarcoma
      ŘÍHOVÁ, Kamila, Monika DÚCKA, Iva STANICZKOVÁ ZAMBO, Ladislava VYMĚTALOVÁ, Martin ŠRÁMEK, Filip TRČKA, Jan VERNER, Stanislav DRÁPELA, Radek FEDR, Tereza SUCHÁNKOVÁ, Barbora PAVLATOVSKÁ, Eva ONDROUŠKOVÁ, Irena KUBELKOVÁ, Danica ZAPLETALOVÁ, Štěpán TUČEK, Peter MÚDRY, Dagmar ADÁMKOVÁ KRÁKOROVÁ, Lucia KNOPFOVÁ, Jan ŠMARDA, Karel SOUČEK, Lubor BORSIG and Petr BENEŠ. Transcription factor c-Myb: novel prognostic factor in osteosarcoma. Clinical & Experimental Metastasis. Springer, 2022, vol. 39, No 2, p. 375-390. ISSN 0262-0898. Available from: https://dx.doi.org/10.1007/s10585-021-10145-4.
      More: https://is.muni.cz/publication/1819457/en
    53. Treat COVID-19, but Not Only COVID-19: Stroke Matters as Well
      ŠEDOVÁ, Petra, R. D. BROWN, Tomáš BRYNDZIAR, Jiří JARKOVSKÝ, Ales TOMEK, Martin SRAMEK, Ondrej SKODA, Tereza SRAMKOVA, Simona LITTNEROVÁ and Robert MIKULÍK. Treat COVID-19, but Not Only COVID-19: Stroke Matters as Well. Cerebrovascular Diseases. BASEL: KARGER, 2022, vol. 51, No 1, p. 52-59. ISSN 1015-9770. Available from: https://dx.doi.org/10.1159/000517968.
      More: https://is.muni.cz/publication/1787520/en
    54. Unexpected Heterogeneity of Newly Diagnosed Multiple Myeloma Patients with Plasmacytomas
      ŠTORK, Martin, Sabina ŠEVČÍKOVÁ, Tomas JELINEK, Jiri MINARIK, Jakub RADOCHA, Tomas PIKA, Lenka POSPISILOVA, Ivan SPICKA, Jan STRAUB, Petr PAVLICEK, Alexandra JUNGOVA, Zdeňka KNECHTOVÁ, Viera SANDECKÁ, Vladimir MAISNAR, Rroman HAJEK and Luděk POUR. Unexpected Heterogeneity of Newly Diagnosed Multiple Myeloma Patients with Plasmacytomas. Biomedicines. Basel: MDPI, 2022, vol. 10, No 10, p. 1-15. ISSN 2227-9059. Available from: https://dx.doi.org/10.3390/biomedicines10102535.
      More: https://is.muni.cz/publication/2224424/en
    55. Very rare near-haploid acute lymphoblastic leukemia resistant to immunotherapy and CAR-T therapy in 19-year-old male patient
      ARPÁŠ, Tomáš, Hana JELÍNKOVÁ, Štěpán HRABOVSKÝ, Martina ORŠULOVÁ, Zuzana VRZALOVÁ, Veronika NAVRKALOVÁ, Eva BRHELOVÁ, Lenka BRYJOVÁ, Alena BULIKOVÁ, Eva ONDROUŠKOVÁ, Markéta ŠEJNOHOVÁ, František FOLBER, Petra ŠEDOVÁ, Jiří MAYER, Šárka POSPÍŠILOVÁ, Marie JAROŠOVÁ and Michael DOUBEK. Very rare near-haploid acute lymphoblastic leukemia resistant to immunotherapy and CAR-T therapy in 19-year-old male patient. CLINICAL CASE REPORTS. ENGLAND: WILEY, 2022, vol. 10, No 3, p. 1-5. ISSN 2050-0904. Available from: https://dx.doi.org/10.1002/ccr3.5545.
      More: https://is.muni.cz/publication/2211899/en
    56. Vitality and growth rate of agar plate-cultivated Antarctic microautotrophs: Analysis of PSII functioning by chlorophyll fluorescence parameters
      MANOVÁ, Anna, Blanka HÝŽOVÁ, Diana Darriba CANORA, Ana Castrillo ANTOLIN and Kristýna DUFKOVÁ. Vitality and growth rate of agar plate-cultivated Antarctic microautotrophs: Analysis of PSII functioning by chlorophyll fluorescence parameters. Czech polar reports. Brno: Masaryk University, 2022, vol. 12, No 2, p. 269-279. ISSN 1805-0689. Available from: https://dx.doi.org/10.5817/CPR2022-2-20.
      More: https://is.muni.cz/publication/2267698/en

    2021

    1. Asciminib and ponatinib exert synergistic anti-neoplastic effects on CML cells expressing BCR-ABL1(T315I)-compound mutations
      GLEIXNER, K. V., Y. FILIK, D. BERGER, C. SCHEWZIK, G. STEFANZL, I. SADOVNIK, L. DEGENFELD-SCHONBURG, G. EISENWORT, M. SCHNEEWEISS-GLEIXNER, K. BYRGAZOV, W. R. SPERR, Jiří MAYER, T. LION and P. VALENT. Asciminib and ponatinib exert synergistic anti-neoplastic effects on CML cells expressing BCR-ABL1(T315I)-compound mutations. AMERICAN JOURNAL OF CANCER RESEARCH. MADISON: E-CENTURY PUBLISHING CORP, 2021, vol. 11, No 9, p. 4470-4484. ISSN 2156-6976.
      More: https://is.muni.cz/publication/1834329/en
    2. Bioinformatic strategies for the analysis of genomic aberrations detected by targeted NGS panels with clinical application
      HYNŠT, Jakub, Veronika NAVRKALOVÁ, Karol PÁL and Šárka POSPÍŠILOVÁ. Bioinformatic strategies for the analysis of genomic aberrations detected by targeted NGS panels with clinical application. PeerJ. London: PEERJ INC, 2021, vol. 9, MAR 2021, p. 1-29. ISSN 2167-8359. Available from: https://dx.doi.org/10.7717/peerj.10897.
      More: https://is.muni.cz/publication/1768001/en
    3. Causes of Exocrine Pancreatic Insufficiency Other Than Chronic Pancreatitis
      KUNOVSKÝ, Lumír, Petr DÍTĚ, Petr JABANDŽIEV, Michal EID, Karolina POREDSKÁ, Jitka VACULOVÁ, Dana SOCHOROVÁ, Pavel JANEČEK, Pavla TESAŘÍKOVÁ, Martin BLAHO, Jan TRNA, Jan HLAVSA and Zdeněk KALA. Causes of Exocrine Pancreatic Insufficiency Other Than Chronic Pancreatitis. Journal of Clinical Medicine. Basel: MDPI, 2021, vol. 10, No 24, p. 1-22. ISSN 2077-0383. Available from: https://dx.doi.org/10.3390/jcm10245779.
      More: https://is.muni.cz/publication/1812479/en
    4. Complete Genome Sequence of the Type Strain Tepidimonas taiwanensis LMG 22826T, a Thermophilic Alkaline Protease and Polyhydroxyalkanoate Producer
      HERMANKOVA, Kristyna, Xenie KOURILOVA, Iva PERNICOVA, Matěj BEZDÍČEK, Martina LENGEROVÁ, Stanislav OBRUCA and Karel SEDLAR. Complete Genome Sequence of the Type Strain Tepidimonas taiwanensis LMG 22826T, a Thermophilic Alkaline Protease and Polyhydroxyalkanoate Producer. GENOME BIOLOGY AND EVOLUTION. OXFORD: OXFORD UNIV PRESS, 2021, vol. 13, No 12, p. 1-5. ISSN 1759-6653. Available from: https://dx.doi.org/10.1093/gbe/evab280.
      More: https://is.muni.cz/publication/1837019/en
    5. COVID-19 infection in adult patients with hematological malignancies: a European Hematology Association Survey (EPICOVIDEHA)
      PAGANO, L., J. SALMANTON-GARCIA, F. MARCHESI, A. BUSCA, P. CORRADINI, M. HOENIGL, N. KLIMKO, P. KOEHLER, A. PAGLIUCA, F. PASSAMONTI, L. VERGA, B. VISEK, O. ILHAN, G. NADALI, Barbora WEINBERGEROVÁ, R. CORDOBA-MASCUNANO, M. MARCHETTI, G. P. COLLINS, F. FARINA, C. CATTANEO, A. CABIRTA, M. GOMES-SILVA, F. ITRI, J. VAN DOESUM, M. P. LEDOUX, M. CERNAN, O. JAKSIC, R. F. DUARTE, G. MAGLIANO, A. S. OMRANI, N. S. FRACCHIOLLA, A. KULASEKARARAJ, T. VALKOVIC, C. B. POULSEN, M. MACHADO, A. GLENTHOJ, I. STOMA, Zdenek RACIL, K. PIUKOVICS, Milan NAVRATIL, Z. EMARAH, U. SILI, J. MAERTENS, O. BLENNOW, R. BERGANTIM, C. GARCIA-VIDAL, L. PREZIOSO, A. GUIDETTI, M. I. DEL PRINCIPE, M. POPOVA, N. DE JONGE, I. ORMAZABAL-VELEZ, N. FERNANDEZ, I. FALCES-ROMERO, A. CUCCARO, S. MEERS, C. BUQUICCHIO, D. ANTIC, M. AL-KHABORI, R. GARCIA-SANZ, M. M. BIERNAT, M. C. TISI, E. SAL, L. RAHIMLI, N. COLOVIC, M. SCHONLEIN, M. CALBACHO, C. TASCINI, C. MIRANDA-CASTILLO, N. KHANNA, G. A. MENDEZ, V. PETZER, J. NOVAK, C. BESSON, R. DULERY, S. LAMURE, M. NUCCI, G. ZAMBROTTA, Pavel ZAK, G. C. SEVAL, V. BONUOMO, Jiří MAYER, A. LOPEZ-GARCIA, M. V. SACCHI, S. BOOTH, F. CICERI, M. OBERTI, M. SALVINI, M. IZUZQUIZA, R. NUNES-RODRIGUES, E. AMMATUNA, Ales OBR, R. HERBRECHT, L. NUNEZ-MARTIN-BUITRAGO, V. MANCINI, H. SHWAYLIA, M. SCIUME, J. ESSAME, M. NYGAARD, J. BATINIC, Y. GONZAGA, I. REGALADO-ARTAMENDI, L. K. KARLSSON, M. SHAPETSKA, Michaela HANAKOVA, S. EL-ASHWAH, Z. BORBENYI, G. M. COLAK, A. NORDLANDER, G. DRAGONETTI, A. M. E. MARAGLINO, A. RINALDI, C. DE RAMON-SANCHEZ and O. A. CORNELY. COVID-19 infection in adult patients with hematological malignancies: a European Hematology Association Survey (EPICOVIDEHA). JOURNAL OF HEMATOLOGY & ONCOLOGY. LONDON: BMC, 2021, vol. 14, No 1, p. 1-15. ISSN 1756-8722. Available from: https://dx.doi.org/10.1186/s13045-021-01177-0.
      More: https://is.muni.cz/publication/1801283/en
    6. COVID-19 severity and mortality in patients with CLL: an update of the international ERIC and Campus CLL study
      CHATZIKONSTANTINOU, T., A. KAPETANAKIS, L. SCARFO, G. KARAKATSOULIS, D. ALLSUP, A. A. CABRERO, M. ANDRES, D. ANTIC, M. BAILE, P. BALIAKAS, D. BRON, A. CAPASSO, S. CHATZILEONTIADOU, R. CORDOBA, J.G. CORREA, C. CUELLAR-GARCIA, L. DE PAOLI, M. R. DE PAOLIS, G. DEL POETA, C. DEMOSTHENOUS, M. DIMOU, D. DONALDSON, Michael DOUBEK, M. EFSTATHOPOULOU, B. EICHHORST, S. EL-ASHWAH, A. ENRICO, B. ESPINET, L. FARINA, A. FERRARI, M. FOGLIETTA, H. FREDERIKSEN, M. FURSTENAU, J. A. GARCIA-MARCO, R. GARCIA-SERRA, M. GENTILE, E. GIMENO, A. GLENTHOJ, M. G. DA SILVA, O. GUTWEIN, Y. K. HAKOBYAN, Y. HERISHANU, J. A. HERNANDEZ-RIVAS, T. HEROLD, I. INNOCENTI, G. ITCHAKI, O. JAKSIC, A. JANSSENS, O. B. KALASHNIKOVA, E. KALICINSKA, L. K. KARLSSON, A. P. KATER, S. KERSTING, J. LABRADOR, D. LAD, L. LAURENTI, M. D. LEVIN, E. LISTA, A. LOPEZ-GARCIA, L. MALERBA, R. MARASCA, M. MARCHETTI, J. MARQUET, M. MATTSSON, F. R. MAURO, I. MILOSEVIC, F. MIRAS, M. MORAWSKA, M. MOTTA, T. MUNIR, R. MURRU, C. U. NIEMANN, R. N. RODRIGUES, J. OLIVIERI, L. ORSUCCI, M. PAPAIOANNOU, M. A. PAVLOVSKY, I. PISKUNOVA, V. M. POPOV, F. M. QUAGLIA, G. QUARESMINI, K. QVIST, G. REDA, G. M. RIGOLIN, R. RUCHLEMER, G. SAGHUMYAN, A. SHRESTHA, M. SIMKOVIC, M. SPACEK, P. SPORTOLETTI, O. STANCA, N. STAVROYIANNI, T. TADMOR, D. TE RAA, S. H. TONINO, L. TRENTIN, E. VAN DER SPEK, M. VAN GELDER, R. VAN KAMPEN, M. VARETTONI, A. VISENTIN, C. VITALE, E. WASIK-SZCZEPANEK, T. WROBEL, L. Y. SAN SEGUNDO, M. YASSIN, M. COSCIA, A. RAMBALDI, E. MONTSERRAT, R. FOA, A. CUNEO, K. STAMATOPOULOS and P. GHIA. COVID-19 severity and mortality in patients with CLL: an update of the international ERIC and Campus CLL study. Leukemia. London: Nature Publishing Group, 2021, vol. 35, No 12, p. 3444-3454. ISSN 0887-6924. Available from: https://dx.doi.org/10.1038/s41375-021-01450-8.
      More: https://is.muni.cz/publication/1824585/en
    7. COVID-19's natural course among ambulatory monitored outpatients
      WEINBERGEROVÁ, Barbora, Jiří MAYER, Štěpán HRABOVSKÝ, Zuzana NOVÁKOVÁ, Zdeněk POSPÍŠIL, Lucie MARTYKÁNOVÁ, Katerina HORTOVA, Lucie MANDELOVA, Karel HEJDUK, Renata CHLOUPKOVÁ, Michal POSPÍŠIL, Martina DOUBKOVÁ, Vladimír MAREK, Renata NOVOTNA, Martin DOLEČEK, Hana MATĚJOVSKÁ KUBEŠOVÁ, Kristián BRAT, Radana PAŘÍZKOVÁ, Petr HUSA, Marek MECHL, Zdeněk KRÁL and Martina LENGEROVÁ. COVID-19's natural course among ambulatory monitored outpatients. Nature Scientific Reports. London: NATURE RESEARCH, 2021, vol. 11, No 1, p. 1-16. ISSN 2045-2322. Available from: https://dx.doi.org/10.1038/s41598-021-89545-1.
      More: https://is.muni.cz/publication/1778180/en
    8. Cryopreserved buffy-coat-derived platelets reconstituted in platelet additive solution: A safe and available product with sufficient haemostatic effectiveness
      LEJDAROVÁ, Hana, Rita PACASOVA, Lenka TESAROVA, Irena KOUTNA, Nadezda POLOKOVA, Simona MICHLICKOVA and Martin DOLEČEK. Cryopreserved buffy-coat-derived platelets reconstituted in platelet additive solution: A safe and available product with sufficient haemostatic effectiveness. Doleček Martin. TRANSFUSION AND APHERESIS SCIENCE. OXFORD: PERGAMON-ELSEVIER SCIENCE LTD, 2021, vol. 60, No 3, p. 1-7. ISSN 1473-0502. Available from: https://dx.doi.org/10.1016/j.transci.2021.103110.
      More: https://is.muni.cz/publication/1776117/en
    9. Current view of neoadjuvant chemotherapy in primarily resectable pancreatic adenocarcinoma
      EID, Michal, Lenka OSTŘÍŽKOVÁ, Lumír KUNOVSKÝ, Dagmar BRANČÍKOVÁ, Zdeněk KALA, Jan HLAVSA, Pavel JANEČEK, Ivana KOSÍKOVÁ, Monika BLAŽKOVÁ, Ondřej SLABÝ and Jiří MAYER. Current view of neoadjuvant chemotherapy in primarily resectable pancreatic adenocarcinoma. Neoplasma. Bratislava: Slovak Academy of Sciences, 2021, vol. 68, No 1, p. 1-9. ISSN 0028-2685. Available from: https://dx.doi.org/10.4149/neo_2020_200408N372.
      More: https://is.muni.cz/publication/1777417/en
    10. Dasatinib treatment long-term results among imatinib-resistant/intolerant patients with chronic phase chronic myeloid leukemia are favorable in daily clinical practice
      ŽÁČKOVÁ, Daniela, Hana KLAMOVA, Petra BELOHLAVKOVA, Lukas STEJSKAL, Tereza NEČASOVÁ, Lukáš SEMERÁD, Barbora WEINBERGEROVÁ, Dana SRBOVA, Jaroslava VOGLOVA, Petra ČIČÁTKOVÁ, Zuzana ŠUSTKOVÁ, Tomáš HORŇÁK, Jana BARANOVÁ, Jiřina PROCHÁZKOVÁ and Jiří MAYER. Dasatinib treatment long-term results among imatinib-resistant/intolerant patients with chronic phase chronic myeloid leukemia are favorable in daily clinical practice. LEUKEMIA & LYMPHOMA. LONDON: TAYLOR & FRANCIS, 2021, vol. 62, No 1, p. 194-202. ISSN 1042-8194. Available from: https://dx.doi.org/10.1080/10428194.2020.1827242.
      More: https://is.muni.cz/publication/1695400/en
    11. Deciphering the complex circulating immune cell microenvironment in chronic lymphocytic leukaemia using patient similarity networks
      MIKULKOVA, Zuzana, Gayane MANUKYAN, Peter TURCSANYI, Milos KUDELKA, Renata URBANOVA, Jakub SAVARA, Eliska OCHODKOVA, Yvona BRYCHTOVÁ, Jan MOLINSKY, Martin SIMKOVIC, David STAROSTKA, Jan NOVAK, Ondrej JANCA, Martin DIHEL, Pavlina RYZNEROVA, Lekaa MOHAMMAD, Tomas PAPAJIK and Eva KRIEGOVA. Deciphering the complex circulating immune cell microenvironment in chronic lymphocytic leukaemia using patient similarity networks. Nature Scientific Reports. London: NATURE RESEARCH, 2021, vol. 11, No 1, p. 1-13. ISSN 2045-2322. Available from: https://dx.doi.org/10.1038/s41598-020-79121-4.
      More: https://is.muni.cz/publication/1771058/en
    12. Digital PCR can provide improved BCR-ABL1 detection in chronic myeloid leukemia patients in deep molecular response and sensitivity of standard quantitative methods using EAC assays
      SMITALOVÁ, Dagmar, D. DVORAKOVA, Zdeněk RÁČIL and Marianna ROMŽOVÁ. Digital PCR can provide improved BCR-ABL1 detection in chronic myeloid leukemia patients in deep molecular response and sensitivity of standard quantitative methods using EAC assays. Practical Laboratory Medicine. AMSTERDAM: ELSEVIER, 2021, vol. 25, MAY, p. nestrankovano, 6 pp. ISSN 2352-5517. Available from: https://dx.doi.org/10.1016/j.plabm.2021.e00210.
      More: https://is.muni.cz/publication/1782161/en
    13. Distribution of SARS-CoV-2 Lineages in the Czech Republic, Analysis of Data from the First Year of the Pandemic
      KLEMPT, Petr, Ondrej BRZON, Martin KASNY, Katerina KVAPILOVA, Petr HUBACEK, Ales BRIKSI, Matěj BEZDÍČEK, Vladimira KOUDELAKOVA, Martina LENGEROVÁ, Marian HAJDUCH, Pavel DREVINEK, Šárka POSPÍŠILOVÁ, Eva KRIEGOVA, Milan MACEK and Petr KVAPIL. Distribution of SARS-CoV-2 Lineages in the Czech Republic, Analysis of Data from the First Year of the Pandemic. Microorganisms. Basel: MDPI, 2021, vol. 9, No 8, p. 1-12. ISSN 2076-2607. Available from: https://dx.doi.org/10.3390/microorganisms9081671.
      More: https://is.muni.cz/publication/1831970/en
    14. Diversity and Evolution of Clostridium beijerinckii and Complete Genome of the Type Strain DSM 791(T)
      SEDLAR, Karel, Marketa NYKRYNOVA, Matěj BEZDÍČEK, Barbora BRANSKA, Martina LENGEROVÁ, Petra PATAKOVA and Helena SKUTKOVA. Diversity and Evolution of Clostridium beijerinckii and Complete Genome of the Type Strain DSM 791(T). PROCESSES. Vilnius: MDPI, 2021, vol. 9, No 7, p. 1-16. ISSN 2227-9717. Available from: https://dx.doi.org/10.3390/pr9071196.
      More: https://is.muni.cz/publication/1831973/en
    15. Early and late stage MPN patients show distinct gene expression profiles in CD34(+) cells
      BAUMEISTER, Julian, Tiago MAIE, Nicolas CHATAIN, Lin GAN, Barbora WEINBERGEROVÁ, Marcelo A. S. DE TOLEDO, Joerg ESCHWEILER, Angela MAURER, Jiří MAYER, Blanka KUBEŠOVÁ, Zdeněk RÁČIL, Andreas SCHUPPERT, Ivan COSTA, Steffen KOSCHMIEDER, Tim H. BRUMMENDORF and Deniz GEZER. Early and late stage MPN patients show distinct gene expression profiles in CD34(+) cells. Annals of Hematology. New York: Springer Verlag, 2021, vol. 100, No 12, p. 2943-2956. ISSN 0939-5555. Available from: https://dx.doi.org/10.1007/s00277-021-04615-8.
      More: https://is.muni.cz/publication/1787478/en
    16. Evaluation of two CE-IVD tests for BCR-ABL1 transcript monitoring of chronic myeloid leukemia patients
      FOLTA, Adam, Tomas JURCEK, Blanka KUBESOVA, Daniela ŽÁČKOVÁ, Lukáš SEMERÁD, Jiří MAYER and Ivana JEŽÍŠKOVÁ. Evaluation of two CE-IVD tests for BCR-ABL1 transcript monitoring of chronic myeloid leukemia patients. LEUKEMIA & LYMPHOMA. LONDON: INFORMA HEALTHCARE, 2021, vol. 62, No 5, p. 1239-1242. ISSN 1042-8194. Available from: https://dx.doi.org/10.1080/10428194.2020.1861274.
      More: https://is.muni.cz/publication/1730584/en
    17. Flavobacterium flabelliforme sp. nov. and Flavobacterium geliluteum sp. nov., Two Multidrug-Resistant Psychrotrophic Species Isolated From Antarctica
      KRÁLOVÁ, Stanislava, Hans-Jürgen BUSSE, Matěj BEZDÍČEK, Megan SANDOVAL-POWERS, Markéta NYKRÝNOVÁ, Eva STAŇKOVÁ, Daniel KRSEK and Ivo SEDLÁČEK. Flavobacterium flabelliforme sp. nov. and Flavobacterium geliluteum sp. nov., Two Multidrug-Resistant Psychrotrophic Species Isolated From Antarctica. Frontiers in Microbiology. Frontiers Media S.A., 2021, vol. 12, October, p. 729977-729996. ISSN 1664-302X. Available from: https://dx.doi.org/10.3389/fmicb.2021.729977.
      More: https://is.muni.cz/publication/1799702/en
    18. FoxO1-GAB1 axis regulates homing capacity and tonic AKT activity in chronic lymphocytic leukemia
      ŠEDA, Václav, Eva VOJÁČKOVÁ, Laura ONDRIŠOVÁ, Lenka KOŠŤÁLOVÁ, Sonali SHARMA, Tomáš LOJA, Gabriela MLADONICKÁ PAVLASOVÁ, Daniel ZICHA, Marie KUDLIČKOVÁ PEŠKOVÁ, Jan KŘIVÁNEK, Květoslava MATULOVÁ, Leoš KŘEN, V. BENES, Markéta LITZMANOVÁ, Marek BORSKÝ, Jan OPPELT, Jan VERNER, Šárka POSPÍŠILOVÁ, Yvona BRYCHTOVÁ, Anna PANOVSKÁ, Z. TAN, S.X. ZHANG, Michael DOUBEK, Kateřina AMRUZ ČERNÁ, Jiří MAYER and Marek MRÁZ. FoxO1-GAB1 axis regulates homing capacity and tonic AKT activity in chronic lymphocytic leukemia. Blood. Washington DC, USA: American Society of Hematology, 2021, vol. 138, No 9, p. 758-772. ISSN 0006-4971. Available from: https://dx.doi.org/10.1182/blood.2020008101.
      More: https://is.muni.cz/publication/1813384/en
    19. Functional analysis of germlineETV6 W380Rmutation causing inherited thrombocytopenia and secondary acute lymphoblastic leukemia or essential thrombocythemia
      STAŇO KOZUBÍK, Kateřina, Lenka RADOVÁ, Kamila RÉBLOVÁ, Michal ŠMÍDA, Marketa KUBRICANOVA ZALIOVA, Jiří BALOUN, Michaela PEŠOVÁ, Zuzana VRZALOVÁ, František FOLBER, Soňa MEJSTŘÍKOVÁ, Šárka POSPÍŠILOVÁ and Michael DOUBEK. Functional analysis of germlineETV6 W380Rmutation causing inherited thrombocytopenia and secondary acute lymphoblastic leukemia or essential thrombocythemia. Platelets. PHILADELPHIA: TAYLOR & FRANCIS INC, 2021, vol. 32, No 6, p. 838-841. ISSN 0953-7104. Available from: https://dx.doi.org/10.1080/09537104.2020.1802416.
      More: https://is.muni.cz/publication/1765766/en
    20. Genomic arrays identify high-risk chronic lymphocytic leukemia with genomic complexity: a multicenter study
      LEEKSMA, A. C., P. BALIAKAS, T. MOYSIADIS, A. PUIGGROS, Karla PLEVOVÁ, A. M. VAND ER KEVIE-KERSEMAEKERS, H. POSTHUMA, A. E. RODRIGUEZ-VICENTE, A. N. TRAN, G. BARBANY, L. MANSOURI, R. GUNNARSSON, H. PARKER, E. VAN DEN BERG, M. BELLIDO, Z. DAVIS, M. WALL, I. SCARPELLI, A. OSTERBORG, L. HANSSON, Marie JAROŠOVÁ, P. GHIA, P. PODDIGHE, B. ESPINET, Šárka POSPÍŠILOVÁ, C. TAM, L. YSEBAERT, F. NGUYEN-KHAC, D. OSCIER, C. HAFERLACH, J. SCHOUMANS, M. STEVENS-KROEF, E. ELDERING, K. STAMATOPOULOS, R. ROSENQUIST, J. C. STREFFORD, C. MELLINK and A. P. KATER. Genomic arrays identify high-risk chronic lymphocytic leukemia with genomic complexity: a multicenter study. Haematologica. PAVIA: FERRATA STORTI FOUNDATION, 2021, vol. 106, No 1, p. 87-97. ISSN 0390-6078. Available from: https://dx.doi.org/10.3324/haematol.2019.239947.
      More: https://is.muni.cz/publication/1739856/en
    21. Genomic landscape of B-other acute lymphoblastic leukemia in an adult retrospective cohort with a focus on BCR-ABL1-like subtype
      HRABOVSKÝ, Štěpán, Zuzana VRZALOVÁ, Jiří ŠTIKA, H. JELINKOVA, Marie JAROŠOVÁ, Veronika NAVRKALOVÁ, Jiří MARTENEK, František FOLBER, C. SALEK, JM. HORACEK, Šárka POSPÍŠILOVÁ, Jiří MAYER and Michael DOUBEK. Genomic landscape of B-other acute lymphoblastic leukemia in an adult retrospective cohort with a focus on BCR-ABL1-like subtype. Acta Oncologica. ABINGDON: TAYLOR & FRANCIS LTD, 2021, vol. 60, No 6, p. 760-770. ISSN 0284-186X. Available from: https://dx.doi.org/10.1080/0284186X.2021.1900908.
      More: https://is.muni.cz/publication/1782159/en
    22. Hierarchical distribution of somatic variants in newly diagnosed chronic myeloid leukaemia at diagnosis and early follow-up
      ROMŽOVÁ, Marianna, Dagmar SMITALOVÁ, Jakub HYNŠT, Nikola TOM, Tomáš LOJA, Zdeňka HERUDKOVÁ, Tomáš JURČEK, Lukas STEJSKAL, Daniela ŽÁČKOVÁ, Jiří MAYER, Zdeněk RÁČIL and Martin ČULEN. Hierarchical distribution of somatic variants in newly diagnosed chronic myeloid leukaemia at diagnosis and early follow-up. British journal of haematology. Hoboken: Wiley-Blackwell, 2021, vol. 194, No 3, p. 604-612. ISSN 0007-1048. Available from: https://dx.doi.org/10.1111/bjh.17659.
      More: https://is.muni.cz/publication/1786441/en
    23. Higher-order connections between stereotyped subsets: implications for improved patient classification in CLL
      AGATHANGELIDIS, A., A. CHATZIDIMITRIOU, K. GEMENETZI, V. GIUDICELLI, M. KARYPIDOU, Karla PLEVOVÁ, Z. DAVIS, X.J. YAN, S. JEROMIN, C. SCHNEIDER, L.B. PEDERSEN, R.C. TSCHUMPER, L.A. SUTTON, P. BALIAKAS, L. SCARFO, E.J. VAN GASTEL, M. ARMAND, E. TAUSCH, B. BIDERMAN, C. BAER, D. BAGNARA, A. NAVARRO, A.L. DE SEPTENVILLE, V. GUIDO, G. MITTERBAUER-HOHENDANNER, A. DIMOVSKI, C. BRIEGHEL, S. LAWLESS, M. MEGGENDORFER, Kamila STRÁNSKÁ, M. RITGEN, M. FACCO, C. TRESOLDI, A. VISENTIN, A. PATRIARCA, M. CATHERWOOD, L. BONELLO, A. SUDARIKOV, K. VANURA, M. ROUMELIOTI, H.S. FRANCOVA, T. MOYSIADIS, S. VERONESE, K. GIANNOPOULOS, L. MANSOURI, T. KARAN-DJURASEVIC, R. SANDALTZOPOULOS, C. BODOR, F. FAIS, A. KATER, I. PANOVSKA, D. ROSSI, S. ALSHEMMARI, P. PANAGIOTIDIS, P. COSTEAS, B. ESPINET, D. ANTIC, L. FORONI, M. MONTILLO, L. TRENTIN, N. STAVROYIANNI, G. GAIDANO, P.F. DI CELLE, C. NIEMANN, E. CAMPO, A. ANAGNOSTOPOULOS, C. POTT, K. FISCHER, M. HALLEK, D. OSCIER, S. STILGENBAUER, C. HAFERLACH, D. JELINEK, N. CHIORAZZI, Šárka POSPÍŠILOVÁ, M.P. LEFRANC, S. KOSSIDA, A.W. LANGERAK, Cx. BELESSI, F. DAVI, R. ROSENQUIST, P. GHIA and K. STAMATOPOULOS. Higher-order connections between stereotyped subsets: implications for improved patient classification in CLL. Blood. Washington DC, USA: American Society of Hematology, 2021, vol. 137, No 10, p. 1365-1376. ISSN 0006-4971. Available from: https://dx.doi.org/10.1182/blood.2020007039.
      More: https://is.muni.cz/publication/1813390/en
    24. Higher-order immunoglobulin repertoire restrictions in CLL: the illustrative case of stereotyped subsets 2 and 169
      GEMENETZI, K., F. PSOMOPOULOS, A. A. CARRILES, M. GOUNARI, C. MINICI, Karla PLEVOVÁ, LA SUTTON, M. TSAGIOPOULOU, P. BALIAKAS, K. PASENTSIS, A. ANAGNOSTOPOULOS, R. SANDALTZOPOULOS, R. ROSENQUIST, F. DAVI, Šárka POSPÍŠILOVÁ, P. GHIA, K. STAMATOPOULOS, M. DEGANO and A. CHATZIDIMITRIOU. Higher-order immunoglobulin repertoire restrictions in CLL: the illustrative case of stereotyped subsets 2 and 169. Blood. Washington DC, USA: American Society of Hematology, 2021, vol. 137, No 14, p. 1895-1904. ISSN 0006-4971. Available from: https://dx.doi.org/10.1182/blood.2020005216.
      More: https://is.muni.cz/publication/1836780/en
    25. Home-Based Aerobic and Resistance Exercise Interventions in Cancer Patients and Survivors: A Systematic Review
      BAŤALÍK, Ladislav, Petr WINNIGE, Filip DOSBABA, Daniela VLAŽNÁ and Andrea JANÍKOVÁ. Home-Based Aerobic and Resistance Exercise Interventions in Cancer Patients and Survivors: A Systematic Review. Cancers. Basel: MDPI, 2021, vol. 13, No 8, p. 1-17. ISSN 2072-6694. Available from: https://dx.doi.org/10.3390/cancers13081915.
      More: https://is.muni.cz/publication/1761358/en
    26. How to select older patients with acute myeloid leukemia fit for intensive treatment?
      ŠUSTKOVÁ, Zuzana, Lukáš SEMERÁD, Barbora WEINBERGEROVÁ and Jiří MAYER. How to select older patients with acute myeloid leukemia fit for intensive treatment? Hematological Oncology. MALDEN, USA: WILEY-BLACKWELL, 2021, vol. 39, No 2, p. 151-161. ISSN 0278-0232. Available from: https://dx.doi.org/10.1002/hon.2798.
      More: https://is.muni.cz/publication/1679122/en
    27. Hypermethylation of CD19 promoter enables antigen-negative escape to CART-19 in vivo and in vitro
      LEDEREROVÁ, Aneta, Lenka DOSTÁLOVÁ, Veronika KOZLOVÁ, Helena PESCHELOVÁ, Adriana LADUNGOVÁ, Martin ČULEN, Tomáš LOJA, Jan VERNER, Šárka POSPÍŠILOVÁ, Michal ŠMÍDA and Veronika MANČÍKOVÁ. Hypermethylation of CD19 promoter enables antigen-negative escape to CART-19 in vivo and in vitro. Journal for ImmunoTherapy of Cancer. Switzerland: Springer International Publishing AG, 2021, vol. 9, No 8, p. 1-8. ISSN 2051-1426. Available from: https://dx.doi.org/10.1136/jitc-2021-002352.
      More: https://is.muni.cz/publication/1813004/en
    28. Characteristics and outcome of patients with acute myeloid leukaemia and t(8;16)(p11;p13): results from an International Collaborative Study
      KAYSER, S., R. K. HILLS, R. LANGOVA, M. KRAMER, F. GUIJARRO, Zuzana ŠUSTKOVÁ, E. H. ESTEY, C. M. SHAW, Zdeněk RÁČIL, Jiří MAYER, Pavel ZAK, M. R. BAER, A. M. BRUNNER, T. SZOTKOWSKI, Petr CETKOVSKY, D. GRIMWADE, R. B. WALTER, A. K. BURNETT, A. D. HO, G. EHNINGER, C. MULLER-TIDOW, U. PLATZBECKER, C. THIEDE, C. ROLLIG, A. SCHULZ, G. WARSOW, B. BRORS, J. ESTEVE, N. H. RUSSELL, R. F. SCHLENK and M. J. LEVIS. Characteristics and outcome of patients with acute myeloid leukaemia and t(8;16)(p11;p13): results from an International Collaborative Study. British journal of haematology. England: Wiley-Blackwell, 2021, vol. 192, No 5, p. 832-842. ISSN 0007-1048. Available from: https://dx.doi.org/10.1111/bjh.17336.
      More: https://is.muni.cz/publication/1774323/en
    29. Chromothripsis in Chronic Lymphocytic Leukemia: A Driving Force of Genome Instability
      ZÁVACKÁ, Kristýna and Karla PLEVOVÁ. Chromothripsis in Chronic Lymphocytic Leukemia: A Driving Force of Genome Instability. Frontiers in Oncology. Lausanne: Frontiers Media S.A., 2021, vol. 11, November 2021, p. 1-9. ISSN 2234-943X. Available from: https://dx.doi.org/10.3389/fonc.2021.771664.
      More: https://is.muni.cz/publication/1832343/en
    30. Identification and functional characterization of new missense SNPs in the coding region of the TP53 gene
      DOFFE, Flora, Vincent CARBONNIER, Manon TISSIER, Bernard LEROY, Isabelle MARTINS, Johanna S. M. MATTSSON, Patrick MICKE, Šárka PAVLOVÁ, Šárka POSPÍŠILOVÁ, Jana ŠMARDOVÁ, Andreas C. JOERGER, Klas G. WIMAN, Guido KROEMER and Thierry SOUSSI. Identification and functional characterization of new missense SNPs in the coding region of the TP53 gene. Cell Death and Differentiation. London: Springer Nature, 2021, vol. 28, No 5, p. 1477-1492. ISSN 1350-9047. Available from: https://dx.doi.org/10.1038/s41418-020-00672-0.
      More: https://is.muni.cz/publication/1727497/en
    31. Identification of Clinically Relevant Subgroups of Chronic Lymphocytic Leukemia Through Discovery of Abnormal Molecular Pathways
      TAUŠ, Petr, Šárka POSPÍŠILOVÁ and Karla PLEVOVÁ. Identification of Clinically Relevant Subgroups of Chronic Lymphocytic Leukemia Through Discovery of Abnormal Molecular Pathways. Frontiers in Genetics. Laussane: FRONTIERS MEDIA SA, 2021, vol. 12, JUN, p. 627964-627973. ISSN 1664-8021. Available from: https://dx.doi.org/10.3389/fgene.2021.627964.
      More: https://is.muni.cz/publication/1813393/en
    32. IL4-STAT6 signaling induces CD20 in chronic lymphocytic leukemia and this axis is repressed by PI3K delta inhibitor idelalisib
      ŠANDOVÁ, Veronika, Gabriela MLADONICKÁ PAVLASOVÁ, Václav ŠEDA, Kateřina AMRUZ ČERNÁ, Sonali SHARMA, Veronika PALUŠOVÁ, Yvona BRYCHTOVÁ, Šárka POSPÍŠILOVÁ, S.M. FERNANDES, Anna PANOVSKÁ, Michael DOUBEK, M.S. DAVIDS, J.R. BROWN, Jiří MAYER and Marek MRÁZ. IL4-STAT6 signaling induces CD20 in chronic lymphocytic leukemia and this axis is repressed by PI3K delta inhibitor idelalisib. haematologica. PAVIA: FERRATA STORTI FOUNDATION, 2021, vol. 106, No 11, p. 2995-2999. ISSN 0390-6078. Available from: https://dx.doi.org/10.3324/haematol.2021.278644.
      More: https://is.muni.cz/publication/1813380/en
    33. Immunohistochemical biomarkers are prognostic relevant in addition to the ESMO-ESGO-ESTRO risk classification in endometrial cancer
      VREDE, S. W., W. J. VAN WEELDEN, N. C. M. VISSER, J. BULTEN, L. J. M. VAN DER PUTTEN, K. VAN DE VIJVER, M. SANTACANA, E. COLAS, A. GIL-MORENO, C. P. MOIOLA, G. MANCEBO, C. KRAKSTAD, J. TROVIK, I. S. HALDORSEN, J. HUVILA, M. KOSKAS, Vít WEINBERGER, Markéta BEDNAŘÍKOVÁ, Jitka HAUSNEROVÁ, A. A. VAN DER WURFF, X. MATIAS-GUIU, F. AMANT, M. P. L. M. SNIJDERS, H. V. N. KUSTERS-VANDEVELDE, C. REIJNEN and J. M. A. PIJNENBORG. Immunohistochemical biomarkers are prognostic relevant in addition to the ESMO-ESGO-ESTRO risk classification in endometrial cancer. Gynecologic Oncology. SAN DIEGO: ACADEMIC PRESS INC ELSEVIER SCIENCE, 2021, vol. 161, No 3, p. 787-794. ISSN 0090-8258. Available from: https://dx.doi.org/10.1016/j.ygyno.2021.03.031.
      More: https://is.muni.cz/publication/1807759/en
    34. Impact of PTPN11 mutations on clinical outcome analyzed in 1529 patients with acute myeloid leukemia
      STASIK, S., J. N. ECKARDT, M. KRAMER, C. ROLLIG, A. KRAMER, S. SCHOLL, A. HOCHHAUS, M. CRYSANDT, T. H. BRUMMENDORF, R. NAUMANN, B. STEFFEN, V. KUNZMANN, H. EINSELE, M. SCHAICH, A. BURCHERT, A. NEUBAUER, K. SCHAFER-ECKART, C. SCHLIEMANN, S. KRAUSE, R. HERBST, M. HANEL, N. FRICKHOFEN, R. NOPPENEY, U. KAISER, C. D. BALDUS, M. KAUFMANN, Zdeněk RÁČIL, U. PLATZBECKER, W. E. BERDEL, Jiří MAYER, H. SERVE, C. MULLER-TIDOW, G. EHNINGER, M. BORNHAUSER, J. SCHETELIG, J. M. MIDDEKE and C. THIEDE. Impact of PTPN11 mutations on clinical outcome analyzed in 1529 patients with acute myeloid leukemia. BLOOD ADVANCES. WASHINGTON: AMER SOC HEMATOLOGY, 2021, vol. 5, No 17, p. 3279-3289. ISSN 2473-9529. Available from: https://dx.doi.org/10.1182/bloodadvances.2021004631.
      More: https://is.muni.cz/publication/1801293/en
    35. Incidence of Stroke and Ischemic Stroke Subtypes: A Community-Based Study in Brno, Czech Republic
      ŠEDOVÁ, Petra, Robert D. BROWN, Miroslav ZVOLSKY, Silvia BELASKOVA, Michaela VOLNA, Jana BALUCHOVA, Josef BEDNAŘÍK and Robert MIKULÍK. Incidence of Stroke and Ischemic Stroke Subtypes: A Community-Based Study in Brno, Czech Republic. Cerebrovascular Diseases. BASEL: KARGER, 2021, vol. 50, No 1, p. 54-61. ISSN 1015-9770. Available from: https://dx.doi.org/10.1159/000512180.
      More: https://is.muni.cz/publication/1718976/en
    36. Integrative Genomic Analysis of Pediatric Myeloid-Related Acute Leukemias Identifies Novel Subtypes and Prognostic Indicators
      FORNEROD, M., J. MA, S. NOORT, Y. LIU, M. P. WALSH, L. SHI, S. NANCE, Y. L. LIU, Y. Y. WANG, G. C. SONG, T. LAMPRECHT, J. EASTON, H. L. MULDER, D. YERGEAU, J. MYERS, J. L. KAMENS, E. A. OBENG, M. PIGAZZI, Marie JAROŠOVÁ, C. KELAIDI, S. POLYCHRONOPOULOU, J. K. LAMBA, S. D. BAKER, J. E. RUBNITZ, D. REINHARDT, M. M. VAN DEN HEUVEL-EIBRINK, F. LOCATELLI, H. HASLE, J. M. KLCO, J. R. DOWNING, J. H. ZHANG, S. POUNDS, C. M. ZWAAN and T. A. GRUBER. Integrative Genomic Analysis of Pediatric Myeloid-Related Acute Leukemias Identifies Novel Subtypes and Prognostic Indicators. BLOOD CANCER DISCOVERY. PHILADELPHIA: AMER ASSOC CANCER RESEARCH, 2021, vol. 2, No 6, p. 586-599. ISSN 2643-3230. Available from: https://dx.doi.org/10.1158/2643-3230.BCD-21-0049.
      More: https://is.muni.cz/publication/1824557/en
    37. LncRNAs in adaptive immunity: role in physiological and pathological conditions
      ZENI, Pedro and Marek MRÁZ. LncRNAs in adaptive immunity: role in physiological and pathological conditions. RNA Biology. Philadelphia: Taylor & Francis Inc, 2021, vol. 18, No 5, p. 619-632. ISSN 1547-6286. Available from: https://dx.doi.org/10.1080/15476286.2020.1838783.
      More: https://is.muni.cz/publication/1710016/en
    38. Loss-of-Function Mutations of BCOR Are an Independent Marker of Adverse Outcomes in Intensively Treated Patients with Acute Myeloid Leukemia
      ECKARDT, J. N., S. STASIK, M. KRAMER, C. ROLLIG, A. KRAMER, S. SCHOLL, A. HOCHHAUS, M. CRYSANDT, T. H. BRUMMENDORF, R. NAUMANN, B. STEFFEN, V. KUNZMANN, H. EINSELE, M. SCHAICH, A. BURCHERT, A. NEUBAUER, K. SCHAFER-ECKART, C. SCHLIEMANN, S. W. KRAUSE, R. HERBST, M. HANEL, N. FRICKHOFEN, R. NOPPENEY, U. KAISER, C. D. BALDUS, M. KAUFMANN, Zdeněk RÁČIL, U. PLATZBECKER, W. E. BERDEL, Jiří MAYER, H. SERVE, C. MULLER-TIDOW, G. EHNINGER, F. STOLZEL, F. KROSCHINSKY, J. SCHETELIG, M. BORNHAUSER, C. THIEDE and J. M. MIDDEKE. Loss-of-Function Mutations of BCOR Are an Independent Marker of Adverse Outcomes in Intensively Treated Patients with Acute Myeloid Leukemia. Cancers. BASEL: MDPI, 2021, vol. 13, No 9, p. 1-15. ISSN 2072-6694. Available from: https://dx.doi.org/10.3390/cancers13092095.
      More: https://is.muni.cz/publication/1774641/en
    39. Low-burden TP53 mutations in CLL: clinical impact and clonal evolution within the context of different treatment options
      MALČÍKOVÁ, Jitka, Šárka PAVLOVÁ, Barbara KUNT VONKOVÁ, Lenka RADOVÁ, Karla PLEVOVÁ, Jana KOTAŠKOVÁ, Karol PÁL, Barbara DVOŘÁČKOVÁ, Marcela ŽENATOVÁ, Jakub HYNŠT, Eva ONDROUŠKOVÁ, Anna PANOVSKÁ, Yvona BRYCHTOVÁ, Kristýna ZÁVACKÁ, Boris TICHÝ, Nikola TOM, Jiří MAYER, Michael DOUBEK and Šárka POSPÍŠILOVÁ. Low-burden TP53 mutations in CLL: clinical impact and clonal evolution within the context of different treatment options. Blood. Washington DC, USA: American Society of Hematology, 2021, vol. 138, No 25, p. 2670-2685. ISSN 0006-4971. Available from: https://dx.doi.org/10.1182/blood.2020009530.
      More: https://is.muni.cz/publication/1836757/en
    40. LYmphoid NeXt-Generation Sequencing (LYNX) Panel A Comprehensive Capture-Based Sequencing Tool for the Analysis of Prognostic and Predictive Markers in Lymphoid Malignancies
      NAVRKALOVÁ, Veronika, Karla PLEVOVÁ, Jakub HYNŠT, Karol PÁL, Andrea MAREČKOVÁ, Tomáš REIGL, Hana JELÍNKOVÁ, Zuzana VRZALOVÁ, Kamila STRÁNSKÁ, Šárka PAVLOVÁ, Anna PANOVSKÁ, Andrea JANÍKOVÁ, Michael DOUBEK, Jana KOTAŠKOVÁ and Šárka POSPÍŠILOVÁ. LYmphoid NeXt-Generation Sequencing (LYNX) Panel A Comprehensive Capture-Based Sequencing Tool for the Analysis of Prognostic and Predictive Markers in Lymphoid Malignancies. The journal of molecular diagnostics. Bethesda, MD: American Society for Investigative Pathology/Association for Molecular Pathology, 2021, vol. 23, No 8, p. 959-974. ISSN 1525-1578. Available from: https://dx.doi.org/10.1016/j.jmoldx.2021.05.007.
      More: https://is.muni.cz/publication/1836805/en
    41. miR-29 Modulates CD40 Signaling in Chronic Lymphocytic Leukemia by Targeting TRAF4: an Axis Affected by BCR inhibitors
      SHARMA, Sonali, Gabriela MLADONICKÁ PAVLASOVÁ, Václav ŠEDA, Kateřina AMRUZ ČERNÁ, Eva VOJÁČKOVÁ, Daniel FILIP, Laura ONDRIŠOVÁ, Veronika ŠANDOVÁ, Lenka KOŠŤÁLOVÁ, Pedro FARIA ZENI, Marek BORSKÝ, Jan OPPELT, Květoslava LIŠKOVÁ, Leoš KŘEN, Andrea JANÍKOVÁ, Šárka POSPÍŠILOVÁ, Stacey M. FERNANDES, Medhat SHEHATA, Laura Z. RASSENTI, Ulrich JAEGER, Michael DOUBEK, Matthew S. DAVIDS, Jennifer R. BROWN, Jiří MAYER, Thomas J. KIPPS and Marek MRÁZ. miR-29 Modulates CD40 Signaling in Chronic Lymphocytic Leukemia by Targeting TRAF4: an Axis Affected by BCR inhibitors. Blood. Washington, DC: American Society of Hematology, 2021, vol. 137, No 18, p. 2481-2494. ISSN 0006-4971. Available from: https://dx.doi.org/10.1182/blood.2020005627.
      More: https://is.muni.cz/publication/1710496/en
    42. Molecular status 36 months after TKI discontinuation in CML is highly predictive for subsequent loss of MMR-final report from AFTER-SKI
      RICHTER, J., A. LUBKING, S. SODERLUND, K. LOTFI, B. MARKEVARN, A. SJALANDER, L. STENKE, S. DENEBERG, E. AHLSTRAND, K. MYHR-ERIKSSON, P. PANAYIOTIDIS, T. GEDDE-DAHL, Daniela ŽÁČKOVÁ, Jiří MAYER, U. OLSSON-STROMBERG, F. X. MAHON, S. SAUSSELE, H. HJORTH-HANSEN and P. KOSKENVESA. Molecular status 36 months after TKI discontinuation in CML is highly predictive for subsequent loss of MMR-final report from AFTER-SKI. Leukemia. London: Nature Publishing Group, 2021, vol. 35, No 8, p. 2416-2418. ISSN 0887-6924. Available from: https://dx.doi.org/10.1038/s41375-021-01173-w.
      More: https://is.muni.cz/publication/1764396/en
    43. New Trends in the Detection of Gynecological Precancerous Lesions and Early-Stage Cancers
      HOLCAKOVA, Jitka, Martin BARTOSIK, Milan ANTON, Luboš MINÁŘ, Jitka HAUSNEROVÁ, Markéta BEDNAŘÍKOVÁ, Vít WEINBERGER and Roman HRSTKA. New Trends in the Detection of Gynecological Precancerous Lesions and Early-Stage Cancers. Cancers. BASEL: MDPI, 2021, vol. 13, No 24, p. 1-23. ISSN 2072-6694. Available from: https://dx.doi.org/10.3390/cancers13246339.
      More: https://is.muni.cz/publication/1819484/en
    44. Outcome of COVID-19 infection in 50 multiple myeloma patients treated with novel drugs: single-center experience
      KREJČÍ, Marta, Luděk POUR, Zdeněk ADAM, Viera SANDECKÁ, Martin ŠTORK, Sabina ŠEVČÍKOVÁ, Martin KREJČÍ, Zdeňka KNECHTOVÁ and Zdeněk KRÁL. Outcome of COVID-19 infection in 50 multiple myeloma patients treated with novel drugs: single-center experience. Annals of hematology. New York: Springer Verlag, 2021, vol. 100, No 10, p. 2541-2546. ISSN 0939-5555. Available from: https://dx.doi.org/10.1007/s00277-021-04594-w.
      More: https://is.muni.cz/publication/1802378/en
    45. Ph(-)myeloproliferative neoplasms and the related risk factors for stroke occurrence: Results from a registry of patients treated with Anagrelide
      KOSTAL, Milan, Jiri SCHWARZ, Petra OVESNÁ, Miroslav PENKA and Petr DULICEK. Ph(-)myeloproliferative neoplasms and the related risk factors for stroke occurrence: Results from a registry of patients treated with Anagrelide. JOURNAL OF THROMBOSIS AND THROMBOLYSIS. DORDRECHT: SPRINGER, 2021, vol. 51, No 1, p. 112-119. ISSN 0929-5305. Available from: https://dx.doi.org/10.1007/s11239-020-02175-8.
      More: https://is.muni.cz/publication/1673164/en
    46. Přehled a použití validovaných algoritmů využívajících vysoce senzitivní metodu stanovení srdečního troponinu k časné diagnostice akutního infarktu myokardu (Overview and application of validated algorithms using high-sensitivity cardiac troponin assays for early diagnosis of acute myocardial infarction)
      JAKUBO, Vladimír, Tomáš ONDRÚŠ, Miroslava BEŇOVSKÁ, Martin DOLEČEK, Andrea KŘIVANOVÁ, Hana ŠIMÁČKOVÁ, Tomáš ZATOČIL, Petr KALA, Jiří PAŘENICA and Petr LOKAJ. Přehled a použití validovaných algoritmů využívajících vysoce senzitivní metodu stanovení srdečního troponinu k časné diagnostice akutního infarktu myokardu (Overview and application of validated algorithms using high-sensitivity cardiac troponin assays for early diagnosis of acute myocardial infarction). COR ET VASA. PRAGUE: CZECH SOC CARDIOLOGY & CZECH SOC CARDIOVASCULAR SURGERY, 2021, vol. 63, No 6, p. 703-709. ISSN 0010-8650. Available from: https://dx.doi.org/10.33678/cor.2021.064.
      More: https://is.muni.cz/publication/1852740/en
    47. Rapid high-resolution melting genotyping scheme for Escherichia coli based on MLST derived single nucleotide polymorphisms
      BEZDÍČEK, Matěj, Marketa NYKRYNOVA, Karel SEDLAR, Stanislava KRÁLOVÁ, Jana HANSLIKOVA, Aja KOMPRDOVA, Helena SKUTKOVA, Iva KOCMANOVA, Jiří MAYER and Martina LENGEROVÁ. Rapid high-resolution melting genotyping scheme for Escherichia coli based on MLST derived single nucleotide polymorphisms. Scientific Reports. London: Nature Research, 2021, vol. 11, No 1, p. "16572", 11 pp. ISSN 2045-2322. Available from: https://dx.doi.org/10.1038/s41598-021-96148-3.
      More: https://is.muni.cz/publication/1791665/en
    48. Rekonstrukce prsou u pacientek s BRCA mutací a karcinomem prsu - náš přístup. (Breast reconstruction in patients with BRCA mutation and breast cancer - our approach)
      VENTRUBA, Tomáš, Dagmar BRANČÍKOVÁ, Pavel VENTRUBA, Luboš MINÁŘ, Michal FELSINGER and Jindřich VOMELA. Rekonstrukce prsou u pacientek s BRCA mutací a karcinomem prsu - náš přístup. (Breast reconstruction in patients with BRCA mutation and breast cancer - our approach). Česká gynekologie. Praha: Care Comm s.r.o., 2021, vol. 86, No 6, p. 374-380. ISSN 1210-7832. Available from: https://dx.doi.org/10.48095/cccg2021374.
      More: https://is.muni.cz/publication/1815799/en
    49. RGDS-Modified Superporous Poly(2-Hydroxyethyl Methacrylate)-Based Scaffolds as 3D In Vitro Leukemia Model
      SVOZILOVÁ, Hana, Z. PLICHTA, V. PROKS, Radana STUDENÁ, Jiří BALOUN, Michael DOUBEK, Šárka POSPÍŠILOVÁ and D. HORAK. RGDS-Modified Superporous Poly(2-Hydroxyethyl Methacrylate)-Based Scaffolds as 3D In Vitro Leukemia Model. International Journal of Molecular Sciences. Basel: Multidisciplinary Digital Publishing Institute, 2021, vol. 22, No 5, p. 2376-2392. ISSN 1422-0067. Available from: https://dx.doi.org/10.3390/ijms22052376.
      More: https://is.muni.cz/publication/1813387/en
    50. Risk factors of thrombosis in a cohort of 206 patients with BCR-ABL1 negative myeloproliferative neoplasms
      ASWAD, Mohamed Hussam, Jarmila KISSOVÁ, Petra OVESNÁ and Miroslav PENKA. Risk factors of thrombosis in a cohort of 206 patients with BCR-ABL1 negative myeloproliferative neoplasms. Neoplasma. Bratislava: Slovenská akademie vied, 2021, vol. 68, No 6, p. 1341-1350. ISSN 0028-2685. Available from: https://dx.doi.org/10.4149/neo_2021_210729N1068.
      More: https://is.muni.cz/publication/1798681/en
    51. Rituximab induces rapid blood repopulation by CLL cells mediated through their release from immune niches and complement exhaustion
      BORSKÝ, Marek, Viera HRABČÁKOVÁ, Jitka NOVOTNÁ, Yvona BRYCHTOVÁ, Michael DOUBEK, Anna PANOVSKÁ, Petr MULLER, Jiří MAYER, Martin TRBUŠEK and Marek MRÁZ. Rituximab induces rapid blood repopulation by CLL cells mediated through their release from immune niches and complement exhaustion. Leukemia Research. OXFORD: PERGAMON-ELSEVIER SCIENCE LTD, 2021, vol. 111, December 2021, p. 1-11. ISSN 0145-2126. Available from: https://dx.doi.org/10.1016/j.leukres.2021.106684.
      More: https://is.muni.cz/publication/1836826/en
    52. RPS15 mutations rewire RNA translation in chronic lymphocytic leukemia
      NTOUFA, S., M. GEROUSI, S. LAIDOU, F. PSOMOPOULOS, G. TSIOLAS, T. MOYSIADIS, N. PAPAKONSTANTINOU, L. MANSOURI, A. ANAGNOSTOPOULOS, N. STAVROGIANNI, Šárka POSPÍŠILOVÁ, Karla PLEVOVÁ, A.M. MAKRIS, R. ROSENQUIST and K. STAMATOPOULOS. RPS15 mutations rewire RNA translation in chronic lymphocytic leukemia. BLOOD ADVANCES. WASHINGTON: AMER SOC HEMATOLOGY, 2021, vol. 5, No 13, p. 2788-2792. ISSN 2473-9529. Available from: https://dx.doi.org/10.1182/bloodadvances.2020001717.
      More: https://is.muni.cz/publication/1813386/en
    53. Significant current epidemiological trend: Haematological malignancies as subsequent primary tumours in cancer patients
      PEHALOVÁ, Lucie, Denisa KREJČÍ, Jana HALÁMKOVÁ, Lenka ŠMARDOVÁ, Lenka ŠNAJDROVÁ and Ladislav DUŠEK. Significant current epidemiological trend: Haematological malignancies as subsequent primary tumours in cancer patients. Cancer Epidemiology. Oxford: Elsevier, 2021, vol. 72, June 2021, p. 1-8. ISSN 1877-7821. Available from: https://dx.doi.org/10.1016/j.canep.2021.101929.
      More: https://is.muni.cz/publication/1763416/en
    54. STAT3 and TP53 mutations associate with poor prognosis in anaplastic large cell lymphoma
      LOBELLO, Cosimo, Boris TICHÝ, Vojtěch BYSTRÝ, Lenka RADOVÁ, Daniel FILIP, Marek MRÁZ, I.A. MONTES-MOJARRO, N. PROKOPH, H. LAROSE, H.C. LIANG, G.G. SHARMA, L. MOLOGNI, D. BELADA, K. KAMARADOVA, F. FEND, C. GAMBACORTI-PASSERINI, O. MERKEL, Suzanne Dawn TURNER, Andrea JANÍKOVÁ and Šárka POSPÍŠILOVÁ. STAT3 and TP53 mutations associate with poor prognosis in anaplastic large cell lymphoma. Leukemia. London: Nature Publishing Group, 2021, vol. 35, No 5, p. 1500-1505. ISSN 0887-6924. Available from: https://dx.doi.org/10.1038/s41375-020-01093-1.
      More: https://is.muni.cz/publication/1781892/en
    55. Successful early treatment combining remdesivir with high-titer convalescent plasma among COVID-19-infected hematological patients
      WEINBERGEROVÁ, Barbora, Jiří MAYER, Tomáš KABUT, Štěpán HRABOVSKÝ, Jiřina PROCHÁZKOVÁ, Zdeněk KRÁL, Vladimír HEROUT, Rita PACASOVÁ, Lenka ZDRAŽILOVÁ DUBSKÁ, Petr HUSA, Petr BEDNAR, Daniel RUZEK and Martina LENGEROVÁ. Successful early treatment combining remdesivir with high-titer convalescent plasma among COVID-19-infected hematological patients. Hematological Oncology. MALDEN, USA: WILEY-BLACKWELL, 2021, vol. 39, No 5, p. 715-720. ISSN 0278-0232. Available from: https://dx.doi.org/10.1002/hon.2908.
      More: https://is.muni.cz/publication/1810317/en
    56. Survival benefit of ixazomib, lenalidomide and dexamethasone (IRD) over lenalidomide and dexamethasone (Rd) in relapsed and refractory multiple myeloma patients in routine clinical practice
      MINARIK, J., T. PIKA, J. RADOCHA, A. JUNGOVA, J. STRAUB, T. JELINEK, Luděk POUR, P. PAVLICEK, M. MISTRIK, Lucie BROŽOVÁ, P. KRHOVSKA, K. MACHALKOVA, P. JINDRA, I. SPICKA, H. PLONKOVA, Martin ŠTORK, J. BACOVSKY, L. CAPKOVA, M. SYKORA, P. KESSLER, L. STEJSKAL, A. HEINDORFER, J. ULLRYCHOVA, T. SKACEL, V. MAISNAR and R. HAJEK. Survival benefit of ixazomib, lenalidomide and dexamethasone (IRD) over lenalidomide and dexamethasone (Rd) in relapsed and refractory multiple myeloma patients in routine clinical practice. BMC Cancer. LONDON: BMC, 2021, vol. 21, No 1, p. 1-13. ISSN 1471-2407. Available from: https://dx.doi.org/10.1186/s12885-020-07732-1.
      More: https://is.muni.cz/publication/1773340/en
    57. The clinical significance of circulating microparticles concerning thrombosis in BCR/ABL1-negative myeloproliferative neoplasms
      ASWAD, Mohamed Hussam, Jarmila KISSOVÁ, Petra OVESNÁ, Lucie ŘÍHOVÁ and Miroslav PENKA. The clinical significance of circulating microparticles concerning thrombosis in BCR/ABL1-negative myeloproliferative neoplasms. In vivo. Athens: International Institute of Anticancer Research, 2021, vol. 35, No 6, p. 3345-3353. ISSN 0258-851X. Available from: https://dx.doi.org/10.21873/invivo.12632.
      More: https://is.muni.cz/publication/1798682/en
    58. The Clinical Significance of DJ1 and L1CAM Serum Level Monitoring in Patients with Endometrial Cancer
      BEDNAŘÍKOVÁ, Markéta, Petra VINKLEROVÁ, Jana GOTTWALDOVÁ, Petra OVESNÁ, Jitka HAUSNEROVÁ, Luboš MINÁŘ, Michal FELSINGER, Dalibor VALÍK, Zdeňka ČERMÁKOVÁ and Vít WEINBERGER. The Clinical Significance of DJ1 and L1CAM Serum Level Monitoring in Patients with Endometrial Cancer. Journal of Clinical Medicine. Basel: MDPI, 2021, vol. 10, No 12, p. 1-14. ISSN 2077-0383. Available from: https://dx.doi.org/10.3390/jcm10122640.
      More: https://is.muni.cz/publication/1786894/en
    59. The combination of endoluminal radiofrequency ablation and metal stent implantation for the treatment of malignant biliary stenosis-Randomized study
      ANDRAŠINA, Tomáš, Tomáš ROHAN, Jiří PÁNEK, Petra KOVALČÍKOVÁ, Lumír KUNOVSKÝ, Lenka OSTŘÍŽKOVÁ and Vlastimil VÁLEK. The combination of endoluminal radiofrequency ablation and metal stent implantation for the treatment of malignant biliary stenosis-Randomized study. European journal of radiology. Ireland: Elsevier Science Ireland Ltd, 2021, vol. 142, September 2021, p. 1-7. ISSN 0720-048X. Available from: https://dx.doi.org/10.1016/j.ejrad.2021.109830.
      More: https://is.muni.cz/publication/1793187/en
    60. The cutoff for estrogen and progesterone receptor expression in endometrial cancer revisited: a European Network for Individualized Treatment of Endometrial Cancer collaboration study
      WEELDEN, Willem Janvan, Casper REIJNEN, Heidi V.N. KÜSTERS-VANDEVELDE, Johan BULTEN, Peter BULT, Samuel LEUNG, Nicole C.M. VISSER, Maria SANTACANA, Peter BRONSERT, Marc HIRSCHFELD, Eva COLAS, Antonio GIL-MORENO, Armando REQUES, Gemma MANCEBO, Jutta HUVILA, Martin KOSKAS, Vít WEINBERGER, Markéta BEDNAŘÍKOVÁ, Jitka HAUSNEROVÁ, Marc P.L.M. SNIJDERS, Xavier MATIAS-GUIU and Frédéric AMANT. The cutoff for estrogen and progesterone receptor expression in endometrial cancer revisited: a European Network for Individualized Treatment of Endometrial Cancer collaboration study. Human Pathology. Philadelphia: Elseveir, 2021, vol. 109, March 2021, p. 80-91. ISSN 0046-8177. Available from: https://dx.doi.org/10.1016/j.humpath.2020.12.003.
      More: https://is.muni.cz/publication/1735416/en
    61. The impact of anti-mould prophylaxis on Aspergillus PCR blood testing for the diagnosis of invasive aspergillosis.
      CRUCIANI, M., P. L. WHITE, C. MENGOLI, J. LÖFFLER, C. O. MORTON, L. KLINGSPOR, D. BUCHHEIDT, J. MAERTENS, W. J. HEINZ, T. R. ROGERS, Barbora WEINBERGEROVÁ, A. WARRIS, DEA. LOCKHART, B. JONES, C. CORDONNIER, J. P. DONELLY and R. A. BARNES. The impact of anti-mould prophylaxis on Aspergillus PCR blood testing for the diagnosis of invasive aspergillosis. Journal of Antimicrobial Chemotherapy. Oxford: Oxford University Press, 2021, vol. 76, No 3, p. 635-638. ISSN 0305-7453. Available from: https://dx.doi.org/10.1093/jac/dkaa498.
      More: https://is.muni.cz/publication/1738798/en
    62. The Role of Circulating MicroRNAs in Patients with Early-Stage Pancreatic Adenocarcinoma
      EID, Michal, Paraskevi KAROUSI, Lumír KUNOVSKÝ, Štěpán TUČEK, Dagmar BRANČÍKOVÁ, Zdeněk KALA, Ondřej SLABÝ, Jiří MAYER, Christos K. KONTOS and Jan TRNA. The Role of Circulating MicroRNAs in Patients with Early-Stage Pancreatic Adenocarcinoma. Biomedicines. Basel: MDPI, 2021, vol. 9, No 10, p. 1-17. ISSN 2227-9059. Available from: https://dx.doi.org/10.3390/biomedicines9101468.
      More: https://is.muni.cz/publication/1799497/en
    63. The Unfolded Protein Response Is a Major Driver of LCN2 Expression in BCR-ABL- and JAK2V617F-Positive MPN
      TILLMANN, S., K. OLSCHOK, S. K. SCHRODER, M. BUTOW, J. BAUMEISTER, M. KALMER, V. PREUSSGER, Barbora WEINBERGEROVÁ, K. KRICHELDORF, Jiří MAYER, Blanka KUBEŠOVÁ, Zdeněk RÁČIL, M. WESSIEPE, J. ESCHWEILER, S. ISFORT, T. H. BRUMMENDORF, W. BECKER, M. SCHEMIONEK, R. WEISKIRCHEN, S. KOSCHMIEDER and N. CHATAIN. The Unfolded Protein Response Is a Major Driver of LCN2 Expression in BCR-ABL- and JAK2V617F-Positive MPN. Cancers. BASEL: MDPI, 2021, vol. 13, No 16, p. 1-18. ISSN 2072-6694. Available from: https://dx.doi.org/10.3390/cancers13164210.
      More: https://is.muni.cz/publication/1801083/en
    64. Trichoderma longibrachiatum and Aspergillus fischeri Infection as a Cause of Skin Graft Failure in a Patient with Critical Burns after Liver Transplantation
      LIPOVÝ, Břetislav, Filip RAŠKA, Iva KOCMANOVA, Marketa HANSLIANOVA, Martin HLADÍK, Jakub HOLOUBEK, Matěj BEZDÍČEK and Ctirad MACHÁČEK. Trichoderma longibrachiatum and Aspergillus fischeri Infection as a Cause of Skin Graft Failure in a Patient with Critical Burns after Liver Transplantation. Journal of Fungi. BASEL: MDPI, 2021, vol. 7, No 6, p. 1-10. ISSN 2309-608X. Available from: https://dx.doi.org/10.3390/jof7060487.
      More: https://is.muni.cz/publication/1782960/en
    65. Tumor Characteristic Variations between Symptomatic and Asymptomatic Endometrial Cancer
      VINKLEROVÁ, Petra, Markéta BEDNAŘÍKOVÁ, Luboš MINÁŘ, Michal FELSINGER, Jitka HAUSNEROVÁ, Petra OVESNÁ and Vít WEINBERGER. Tumor Characteristic Variations between Symptomatic and Asymptomatic Endometrial Cancer. Healthcare. Basel: MDPI, 2021, vol. 9, No 7, p. 1-9. ISSN 2227-9032. Available from: https://dx.doi.org/10.3390/healthcare9070902.
      More: https://is.muni.cz/publication/1784539/en
    66. Two Novel Mutations in the JAG1 Gene in Pediatric Patients with Alagille Syndrome: The First Case Series in Czech Republic
      PROCHÁZKOVÁ, Dagmar, Romana BORSKÁ, Lenka FAJKUSOVÁ, Petra KONEČNÁ, Eliška HLOUŠKOVÁ, Zdeněk PAVLOVSKÝ, Ondřej SLABÝ and Šárka POSPÍŠILOVÁ. Two Novel Mutations in the JAG1 Gene in Pediatric Patients with Alagille Syndrome: The First Case Series in Czech Republic. Diagnostics. Basel: MDPI, 2021, vol. 11, No 6, p. 1-7. ISSN 2075-4418. Available from: https://dx.doi.org/10.3390/diagnostics11060983.
      More: https://is.muni.cz/publication/1772979/en
    67. Urine immunofixation negativity is not necessary for complete response in intact immunoglobulin multiple myeloma: Retrospective real-world confirmation
      RADOCHA, Jakub, Tomas JELINEK, Luděk POUR, Ivan SPICKA, Jiri MINARIK, Tereza POPKOVA, Alexandra JUNGOVA, Petr PAVLICEK, Lucie BROŽOVÁ, Martin ŠTORK, Frantisek SEDLAK, Petra KRHOVSKA, Vladimir MAISNAR, Adriana HEINDORFER, Michal SYKORA, Marek WROBEL, Peter MIKULA, Petr KESSLER, Jana ULLRYCHOVA and Roman HAJEK. Urine immunofixation negativity is not necessary for complete response in intact immunoglobulin multiple myeloma: Retrospective real-world confirmation. International Journal of Laboratory Hematology. MALDEN: WILEY-BLACKWELL, 2021, vol. 43, No 5, p. "E244"-"E247", 4 pp. ISSN 1751-5521. Available from: https://dx.doi.org/10.1111/ijlh.13460.
      More: https://is.muni.cz/publication/1773329/en
    68. 3D Printed Skin-Wash Sampler for Sweat Sampling in Cystic Fibrosis Diagnosis Using Capillary Electrophoretic Ion Ratio Analysis
      MALÁ, Miriam, Petra ITTERHEIMOVÁ, Lukáš HOMOLA, Jana VINOHRADSKÁ and Petr KUBÁŇ. 3D Printed Skin-Wash Sampler for Sweat Sampling in Cystic Fibrosis Diagnosis Using Capillary Electrophoretic Ion Ratio Analysis. Separations. Basel: MDPI, 2021, vol. 8, No 12, p. 1-10. ISSN 2297-8739. Available from: https://dx.doi.org/10.3390/separations8120234.
      More: https://is.muni.cz/publication/1808458/en

    2020

    1. A five-year follow-up of untreated patients with chronic lymphocytic leukaemia treated with ofatumumab and chlorambucil: final analysis of the Complement 1 phase 3 trial
      OFFNER, F., T. ROBAK, A. JANSSENS, K. G. BABU, J. KLOCZKO, S. GROSICKI, Jiří MAYER, P. PANAGIOTIDIS, A. SCHUH, A. PETTITT, M. MONTILLO, O. WERNER, G. VINCENT, S. KHANNA and P. HILLMEN. A five-year follow-up of untreated patients with chronic lymphocytic leukaemia treated with ofatumumab and chlorambucil: final analysis of the Complement 1 phase 3 trial. British journal of haematology. England: Wiley-Blackwell, 2020, vol. 190, No 5, p. 736-740. ISSN 0007-1048. Available from: https://dx.doi.org/10.1111/bjh.16625.
      More: https://is.muni.cz/publication/1681898/en
    2. Allogeneic hematopoietic cell transplantation improves outcome of adults with t(6;9) acute myeloid leukemia: results from an international collaborative study
      KAYSER, Sabine, Robert K. HILLS, Marlise R. LUSKIN, Andrew M. BRUNNER, Christine TERRE, Jorg WESTERMANN, Kamal MENGHRAJANI, Carole SHAW, Maria R. BAER, Michelle A. ELLIOTT, Alexander E. PERL, Zdeněk RÁČIL, Jiří MAYER, Pavel ZAK, Tomas SZOTKOWSKI, Stephane DE BOTTON, David GRIMWADE, Karin MAYER, Roland B. WALTER, Alwin KRAMER, Alan K. BURNETT, Anthony D. HO, Uwe PLATZBECKER, Christian THIEDE, Gerhard EHNINGER, Richard M. STONE, Christoph ROLLIG, Martin S. TALLMAN, Elihu H. ESTEY, Carsten MULLER-TIDOW, Nigel H. RUSSELL, Richard F. SCHLENK and Mark J. LEVIS. Allogeneic hematopoietic cell transplantation improves outcome of adults with t(6;9) acute myeloid leukemia: results from an international collaborative study. Haematologica. PAVIA: FERRATA STORTI FOUNDATION, 2020, vol. 105, No 1, p. 161-169. ISSN 0390-6078. Available from: https://dx.doi.org/10.3324/haematol.2018.208678.
      More: https://is.muni.cz/publication/1623358/en
    3. Analysis of chronic myeloid leukaemia during deep molecular response by genomic PCR: a traffic light stratification model with impact on treatment-free remission
      MACHOVA POLAKOVA, Katerina, Hana ZIZKOVA, Jan ZUNA, Eliska MOTLOVA, Lenka HOVORKOVA, Andrea GOTTSCHALK, Ingmar GLAUCHE, Jitka KOBLIHOVA, Pavla PECHERKOVA, Hana KLAMOVA, Marketa STASTNA MARKOVA, Dana SRBOVA, Adela BENESOVA, Vaclava POLIVKOVA, Tomáš JURČEK, Daniela ŽÁČKOVÁ, Jiří MAYER, Thomas ERNST, Francois X. MAHON, Susanne SAUSSELE, Ingo ROEDERVIEW, Nicholas C. P. CROSS and Andreas HOCHHAUS. Analysis of chronic myeloid leukaemia during deep molecular response by genomic PCR: a traffic light stratification model with impact on treatment-free remission. Leukemia. London: Nature Publishing Group, 2020, vol. 34, No 8, p. 2113-2124. ISSN 0887-6924. Available from: https://dx.doi.org/10.1038/s41375-020-0882-1.
      More: https://is.muni.cz/publication/1681536/en
    4. Analysis of serum lipids, cardiovascular risk, and indication for statin use during nilotinib and imatinib therapy in de novo CML patients ? results from real-life prospective study
      HORŇÁK, Tomáš, Lukáš SEMERÁD, Daniela ŽÁČKOVÁ, Barbora WEINBERGEROVÁ, Zuzana ŠUSTKOVÁ, Jiřina PROCHÁZKOVÁ, Petra BELOHLAVKOVA, Lukas STEJSKAL, Peter ROHON, Edgar FABER, Pavel ZAK, Jiří MAYER and Zdeněk RÁČIL. Analysis of serum lipids, cardiovascular risk, and indication for statin use during nilotinib and imatinib therapy in de novo CML patients ? results from real-life prospective study. LEUKEMIA & LYMPHOMA. LONDON: TAYLOR & FRANCIS, 2020, vol. 61, No 2, p. 494-496. ISSN 1042-8194. Available from: https://dx.doi.org/10.1080/10428194.2019.1672054.
      More: https://is.muni.cz/publication/1623156/en
    5. ATR-CHK1 pathway as a therapeutic target for acute and chronic leukemias
      BOUDNÝ, Miroslav and Martin TRBUŠEK. ATR-CHK1 pathway as a therapeutic target for acute and chronic leukemias. CANCER TREATMENT REVIEWS. OXFORD: ELSEVIER SCI LTD, 2020, vol. 88, AUG, p. 102026-102037. ISSN 0305-7372. Available from: https://dx.doi.org/10.1016/j.ctrv.2020.102026.
      More: https://is.muni.cz/publication/1720316/en
    6. Baseline Chest Computed Tomography as Standard of Care in High-Risk Hematology Patients
      STEMLER, Jannik, Caroline BRUNS, Sibylle C. MELLINGHOFF, Nael ALAKEL, Hamdi AKAN, Michelle ANANDA-RAJAH, Jutta AUBERGER, Peter BOJKO, Pranatharthi H CHANDRASEKAR, Methee CHAYAKULKEEREE, Jossé A. COZZI, Elizabeth A. DE KORT, Andreas H. GROLL, Christopher H. HEATH, Larissa HENZE, Marcos Hernandes JIMENEZ, Souha S. KANJ, Nina KHANNA, Michael KOLDENHOFF, Dong-Gun LEE, Alina MAGER, Francesco MARCHESI, Rodrigo MARTINO-BUFARULL, Marcio NUCCI, Jarmo OKSI, Livio PAGANO, Bob PHILLIPS, Juergen PRATTES, Athina PYRPASOPOULOU, Werner RABITSCH, Enrico SCHALK, Martin SCHMIDT-HIEBER, Neeraj SIDHARTHAN, Pere SOLER-PALACÍN, Anat STERN, Barbora WEINBERGEROVÁ, Aline EL-ZAKHEM, Oliver A. CORNELY and Philipp KOEHLER. Baseline Chest Computed Tomography as Standard of Care in High-Risk Hematology Patients. Journal of Fungi. St. Alban-Anlage: MDPI, 2020, vol. 6, No 1, p. 1-13. ISSN 2309-608X. Available from: https://dx.doi.org/10.3390/jof6010036.
      More: https://is.muni.cz/publication/1663184/en
    7. Blastic plasmacytoid dendritic cell neoplasm: First retrospective study in the Czech Republic
      CERNAN, M., T. SZOTKOWSKI, M. HISEMOVA, P. CETKOVSKY, L. SRAMKOVA, J. STARY, Zdeněk RÁČIL, Jiří MAYER, J. SRAMEK, P. JINDRA, B. VISEK, P. ZAK, J. NOVAK, T. KOZAK, T. FURST and T. PAPAJIK. Blastic plasmacytoid dendritic cell neoplasm: First retrospective study in the Czech Republic. Neoplasma. Bratislava: Slovenská akademie vied, 2020, vol. 67, No 3, p. 650-659. ISSN 0028-2685. Available from: https://dx.doi.org/10.4149/neo_2020_190507N407.
      More: https://is.muni.cz/publication/1670349/en
    8. Bronchoalveolar lavage fluid and serum 1,3-beta-d-glucan testing for invasive pulmonary aspergillosis diagnosis in hematological patients: the role of factors affecting assay performance
      WEINBERGEROVÁ, Barbora, Tomáš KABUT, Iva KOCMANOVÁ, Martina LENGEROVÁ, Zdeněk POSPÍŠIL, Zdeněk KRÁL and Jiří MAYER. Bronchoalveolar lavage fluid and serum 1,3-beta-d-glucan testing for invasive pulmonary aspergillosis diagnosis in hematological patients: the role of factors affecting assay performance. Scientific Reports. London: Nature Publishing Group, 2020, vol. 10, No 1, p. 1-9. ISSN 2045-2322. Available from: https://dx.doi.org/10.1038/s41598-020-75132-3.
      More: https://is.muni.cz/publication/1687463/en
    9. CD20 is dispensable for B-cell receptor signaling but is required for proper actin polymerization, adhesion and migration of malignant B cells
      KOZLOVÁ, Veronika, Aneta LEDEREROVÁ, Adriana LADUNGOVÁ, Helena PESCHELOVÁ, Pavlína JANOVSKÁ, A. SLUSARCZYK, J. DOMAGALA, Pavel KOPČIL, Viera VAKULOVÁ, Jan OPPELT, Vítězslav BRYJA, Michael DOUBEK, Jiří MAYER, Šárka POSPÍŠILOVÁ and Michal ŠMÍDA. CD20 is dispensable for B-cell receptor signaling but is required for proper actin polymerization, adhesion and migration of malignant B cells. Plos one. San Francisco: Public Library Science, 2020, vol. 15, No 3, p. 0229170-229189. ISSN 1932-6203. Available from: https://dx.doi.org/10.1371/journal.pone.0229170.
      More: https://is.muni.cz/publication/1662456/en
    10. Clinical features and survival of patients with indolent systemic mastocytosis defined by the updated WHO classification
      TRIZULJAK, Jakub, W. R. SPERR, Lucie NEKVINDOVA, H. O. ELBERINK, K. V. GLEIXNER, A. GORSKA, M. LANGE, K. HARTMANN, A. ILLERHAUS, M. BONIFACIO, C. PERKINS, C. ELENA, L. MALCOVATI, A. B. FORTINA, K. SHOUMARIYEH, M. JAWHAR, R. ZANOTTI, P. BONADONNA, F. CAROPPO, A. ZINK, M. TRIGGIANI, R. PARENTE, Bubnoff N. VON, A. S. YAVUZ, H. HAGGLUND, M. MATTSSON, J. PANSE, N. JAEKEL, A. KILBERTUS, O. HERMINE, M. AROCK, D. FUCHS, V. SABATO, K. BROCKOW, A. BRETTERKLIEBER, M. NIEDOSZYTKO, Anrooij B. VAN, A. REITER, J. GOTLIB, H. C. KLUIN-NELEMANS, Jiří MAYER, Michael DOUBEK and P. VALENT. Clinical features and survival of patients with indolent systemic mastocytosis defined by the updated WHO classification. Allergy. Hoboken: Wiley, 2020, vol. 75, No 8, p. 1927-1938. ISSN 0105-4538. Available from: https://dx.doi.org/10.1111/all.14248.
      More: https://is.muni.cz/publication/1743659/en
    11. Clonal hierarchy of main molecular lesions in acute myeloid leukaemia
      HERUDKOVÁ, Zdeňka, Martin ČULEN, Adam FOLTA, Ivana JEŽÍŠKOVÁ, Jana CERNA, Tomáš LOJA, Nikola TOM, Jiri SMEJKAL, Lukáš SEMERÁD, Dana DVOŘÁKOVÁ, Jiří MAYER and Zdeněk RÁČIL. Clonal hierarchy of main molecular lesions in acute myeloid leukaemia. British journal of haematology. Hoboken: Wiley-Blackwell, 2020, vol. 190, No 4, p. 562-572. ISSN 0007-1048. Available from: https://dx.doi.org/10.1111/bjh.16341.
      More: https://is.muni.cz/publication/1660276/en
    12. Correlation of survival length after pancreaticoduodenectomy for pancreatic head adenocarcinoma depending on tumor characteristics detected by means of computed tomography and resection margins status
      PROCHÁZKA, Vladimír, Jan HLAVSA, Lumír KUNOVSKÝ, Martina FARKAŠOVÁ, Martin POTRUSIL, Tomáš ANDRAŠINA, Alexandra LITAVCOVÁ, Jan MAZANEC, Jiří DOLINA, Lenka OSTŘÍŽKOVÁ, Michal EID, Petra KOVALČÍKOVÁ, Tomáš PAVLÍK and Zdeněk KALA. Correlation of survival length after pancreaticoduodenectomy for pancreatic head adenocarcinoma depending on tumor characteristics detected by means of computed tomography and resection margins status. Neoplasma. Bratislava: Slovenská akademie vied, 2020, vol. 67, No 6, p. 1319-1328. ISSN 0028-2685. Available from: https://dx.doi.org/10.4149/neo_2020_190923N955.
      More: https://is.muni.cz/publication/1720996/en
    13. Diagnosis of Bloom Syndrome in a Patient with Short Stature, Recurrence of Malignant Lymphoma, and Consanguineous Origin
      TRIZULJAK, Jakub, Terezie PETRUCHOVÁ, Ivona BLAHÁKOVÁ, Zuzana VRZALOVÁ, Vera HORINOVA, Martina DOUBKOVÁ, Jozef MICHALKA, Jiří MAYER, Šárka POSPÍŠILOVÁ and Michael DOUBEK. Diagnosis of Bloom Syndrome in a Patient with Short Stature, Recurrence of Malignant Lymphoma, and Consanguineous Origin. Molecular Syndromology. BASEL: Karger, 2020, vol. 11, No 2, p. 73-82. ISSN 1661-8769. Available from: https://dx.doi.org/10.1159/000507006.
      More: https://is.muni.cz/publication/1673241/en
    14. Donor-derived DNA variability in fingernails of acute myeloid leukemia patients after allogeneic hematopoietic stem cell transplantation detected by direct PCR
      ROBEŠOVÁ, Blanka, Marie DRNCOVA, Adam FOLTA, Marta KREJČÍ, František FOLBER, Zuzana ŠUSTKOVÁ, Jiří MAYER and Ivana JEŽÍŠKOVÁ. Donor-derived DNA variability in fingernails of acute myeloid leukemia patients after allogeneic hematopoietic stem cell transplantation detected by direct PCR. Bone Marrow Transplantation. London: Nature Publishing Group, 2020, vol. 55, No 6, p. 1021-1022. ISSN 0268-3369. Available from: https://dx.doi.org/10.1038/s41409-020-0938-x.
      More: https://is.muni.cz/publication/1674063/en
    15. Efficacy of bendamustine and rituximab in unfit patients with previously untreated chronic lymphocytic leukemia. Indirect comparison with ibrutinib in a real-world setting. A GIMEMA-ERIC and US study
      CUNEO, A., A. R. MATO, G. M. RIGOLIN, A. PICIOCCHI, M. GENTILE, L. LAURENTI, J. N. ALLAN, J. M. PAGEL, DM BRANDER, B. T. HILL, A. WINTER, N. LAMANNA, C. S. TAM, R. JACOBS, F. LANSIGAN, P. M. BARR, M. SHADMAN, A. P. SKARBNIK, J. F. J. PU, A. R. SEHGAL, S. J. SCHUSTER, N. I. N. SHAH, C. S. UJJANI, L. ROEKER, E. M. ORLANDI, A. BILLIO, L. TRENTIN, M. SPACEK, M. MARCHETTI, A. TEDESCHI, F. ILARIUCCI, G. GAIDANO, Michael DOUBEK, L. FARINA, S. MOLICA, F. DI RAIMONDO, M. COSCIA, F. R. MAURO, J. DE LA SERNA, A. M. PEREZ, I. FERRARINI, G. CIMINO, M. CAVALLARI, R. CUCCI, M. VIGNETTI, R. FOA and P. GHIA. Efficacy of bendamustine and rituximab in unfit patients with previously untreated chronic lymphocytic leukemia. Indirect comparison with ibrutinib in a real-world setting. A GIMEMA-ERIC and US study. Cancer Medicine. Houston: John Wiley & Sons Ltd., 2020, vol. 9, No 22, p. 8468-8479. ISSN 2045-7634. Available from: https://dx.doi.org/10.1002/cam4.3470.
      More: https://is.muni.cz/publication/1683656/en
    16. Elucidation of protein interactions necessary for the maintenance of the BCR-ABL signaling complex
      GREGOR, Tomáš, Michaela BOSÁKOVÁ, Alexandru NITĂ, Sara POOVAKULATHU ABRAHAM, Bohumil FAFÍLEK, Nicole ČERNOHORSKÁ, Jan RYNEŠ, Silvie TRANTÍRKOVÁ, Daniela ŽÁČKOVÁ, Jiří MAYER, Lukáš TRANTÍREK and Pavel KREJČÍ. Elucidation of protein interactions necessary for the maintenance of the BCR-ABL signaling complex. Cellular and molecular life sciences. BASEL: SPRINGER BASEL AG, 2020, vol. 77, No 19, p. 3885-3903. ISSN 1420-682X. Available from: https://dx.doi.org/10.1007/s00018-019-03397-7.
      More: https://is.muni.cz/publication/1681537/en
    17. European LeukemiaNet 2020 recommendations for treating chronic myeloid leukemia
      HOCHHAUS, A., M. BACCARANI, R. T. SILVER, C. SCHIFFER, J. F. APPERLEY, F. CERVANTES, R. E. CLARK, J. E. CORTES, M. W. DEININGER, F. GUILHOT, H. HJORTH-HANSEN, T. P. HUGHES, J. J. W. M. JANSSEN, H. M. KANTARJIAN, D. W. KIM, R. A. LARSON, J. H. LIPTON, F. X. MAHON, Jiří MAYER, F. NICOLINI, D. NIEDERWIESER, F. PANE, J. P. RADICH, D. REA, J. RICHTER, G. ROSTI, P. ROUSSELOT, G. SAGLIO, S. SAUSSELE, S. SOVERINI, J. L. STEEGMANN, A. TURKINA, A. ZARITSKEY and R. HEHLMANN. European LeukemiaNet 2020 recommendations for treating chronic myeloid leukemia. Leukemia. London: Nature Publishing Group, 2020, vol. 34, No 4, p. 966-984. ISSN 0887-6924. Available from: https://dx.doi.org/10.1038/s41375-020-0776-2.
      More: https://is.muni.cz/publication/1682197/en
    18. EZH2 mutations and impact on clinical outcome: an analysis in 1,604 patients with newly diagnosed acute myeloid leukemia
      STASIK, S., J. M. MIDDEKE, M. KRAMER, C. ROLLIG, A. KRAMER, S. SCHOLL, A. HOCHHAUS, M. CRYSANDT, T .H. BRUMMENDORF, R. NAUMANN, B. STEFFEN, V. KUNZMANN, H. EINSELE, M. SCHAICH, A. BURCHERT, A. NEUBAUER, K. SCHAFER-ECKART, C. SCHLIEMANN, S. KRAUSE, R. HERBST, M. HANEL, N. FRICKHOFEN, R. NOPPENEY, U. KAISER, C. D. BALDUS, M. KAUFMANN, Zdeněk RÁČIL, U. PLATZBECKER, W. E. BERDEL, Jiří MAYER, H. SERVE, C. MULLER-TIDOW, G. EHNINGER, M. BORNHAUSER, J. SCHETELIG and C. THIEDE. EZH2 mutations and impact on clinical outcome: an analysis in 1,604 patients with newly diagnosed acute myeloid leukemia. Haematologica. PAVIA: FERRATA STORTI FOUNDATION, 2020, vol. 105, No 5, p. "E228"-"E231", 4 pp. ISSN 0390-6078. Available from: https://dx.doi.org/10.3324/haematol.2019.222323.
      More: https://is.muni.cz/publication/1674773/en
    19. Frontline treatment with the combination obinutuzumab +/- chlorambucil for chronic lymphocytic leukemia outside clinical trials: Results of a multinational, multicenter study by ERIC and the Israeli CLL study group
      HERISHANU, Y., A. SHAULOV, R. FINEMAN, S. BASIC-KINDA, A. AVIV, E. WASIK-SZCZEPANEK, O. JAKSIC, M. ZDRENGHEA, U. GREENBAUM, I. MANDAC, M. SIMKOVIC, M. MORAWSKA, O. BENJAMINI, M. SPACEK, A. NEMETS, O. BAIREY, L. TRENTIN, R. RUCHLEMER, L. LAURENTI, O. S. CIOCAN, Michael DOUBEK, L. SHVIDEL, N. DALI, F. MIRAS, A. DE METEUR, M. DIMOU, F. R. MAURO, M. COSCIA, H. BUMBEA, R. SZASZ, T. TADMOR, O. GUTWEIN, M. GENTILE, L. SCARF, A. TEDESCHI, P. SPORTOLETTI, E. GIMENO VAZQUEZ, J. MARQUET, S. ASSOULINE, M. PAPAIOANNOU, A. BRAESTER, L. LEVATO, M. GREGOR, G. M. RIGOLIN, J. LOSCERTALES, A. M. PEREZ, M. R. NIJZIEL, V. M. POPOV, R. COLLADO, I. SLAVUTSKY, G. ITCHAKI, S. RINGELSTEIN, N. GOLDSCHMIDT, C. PERRY, S. LEVI, A. POLLIACK and P. GHIA. Frontline treatment with the combination obinutuzumab +/- chlorambucil for chronic lymphocytic leukemia outside clinical trials: Results of a multinational, multicenter study by ERIC and the Israeli CLL study group. American Journal of Hematology. Hoboken: John Wiley & Sons, 2020, vol. 95, No 6, p. 604-611. ISSN 0361-8609. Available from: https://dx.doi.org/10.1002/ajh.25766.
      More: https://is.muni.cz/publication/1673752/en
    20. Genetic and Non-Genetic Mechanisms of Resistance to BCR Signaling Inhibitors in B Cell Malignancies
      ONDRIŠOVÁ, Laura and Marek MRÁZ. Genetic and Non-Genetic Mechanisms of Resistance to BCR Signaling Inhibitors in B Cell Malignancies. Frontiers in Oncology. Lausanne: Frontiers Media S.A., 2020, vol. 10, OCT, p. 591577-591592. ISSN 2234-943X. Available from: https://dx.doi.org/10.3389/fonc.2020.591577.
      More: https://is.muni.cz/publication/1700261/en
    21. High-throughput sequencing of T-cell receptor alpha chain clonal rearrangements at the DNA level in lymphoid malignancies
      KOMKOV, Alexander, Anna MIROSHNICHENKOVA, Gaiaz NUGMANOV, Alexander POPOV, Mikhail POGORELYY, Eva ZAPLETALOVÁ, Hana JELINKOVA, Šárka POSPÍŠILOVÁ, Yuri LEBEDEV, Dmitriy CHUDAKOV, Yulia OLSHANSKAYA, Karla PLEVOVÁ, Michael MASCHAN and Ilgar MAMEDOV. High-throughput sequencing of T-cell receptor alpha chain clonal rearrangements at the DNA level in lymphoid malignancies. British Journal of Haematology. England: Wiley-Blackwell, 2020, vol. 188, No 5, p. 723-731. ISSN 0007-1048. Available from: https://dx.doi.org/10.1111/bjh.16230.
      More: https://is.muni.cz/publication/1678926/en
    22. Charakteristika souboru chlapců s Duchennovou a Beckerovou svalovou dystrofií - studie z jednoho nervosvalového centra (Characteristics of a cohort of boys with Duchenne and Becker muscular dystrophies - a study from a single neuromuscular centre)
      ROHLENOVA, M., K. MACHOVA, V. STARA, P. HEDVICAKOVA, J. ZIEG, T. DOUSOVA, Lenka FAJKUSOVÁ, J. VENCLOVA-ZACKOVA, O. SOUCEK and J. HABERLOVA. Charakteristika souboru chlapců s Duchennovou a Beckerovou svalovou dystrofií - studie z jednoho nervosvalového centra (Characteristics of a cohort of boys with Duchenne and Becker muscular dystrophies - a study from a single neuromuscular centre). Ceska a slovenska neurologie a neurochirurgie. Prague: CZECH MEDICAL SOC, 2020, vol. 83, No 3, p. 305-314. ISSN 1210-7859. Available from: https://dx.doi.org/10.14735/amcsnn2020305.
      More: https://is.muni.cz/publication/1683697/en
    23. In Ph+BCR-ABL1(P210+) acute lymphoblastic leukemia the e13a2 (B2A2) transcript is prevalent
      BACCARANI, M., I. IACOBUCCI, S. CHIARETTI, R. FOA, P. BALASUBRAMANIAN, E. PAIETTA, L. FORONI, S. JEROMIN, B. IZZO, O. SPINELLI, N. VARMA, S. MENIF, C. TERRAGNA, T. SETH, A. BIDET, D. CORIU, F. LUNGHI, Jiří MAYER, B. SCAPPINI, S. LANGABEER, J. MAIER, E. BURT, A. CANDONI, F. ALBANO, M. LUPPI, I. ZUPAN, T. LION, R. ZADRO, F. DI RAIMONDO, B. POOPAK, G. REGE-CAMBRIN, M. ANNUNZIATA, A. AYALA, V. SALINAS-VIEDMA, A. INES PADO, B. MILNER, S. GALIMBERTI, J. JANSSEN, V. POLLI, L. COMBA, B. BORSELLINO, O. ANNIBALI, M. CRUGNOLA and F. PASSAMONTI. In Ph+BCR-ABL1(P210+) acute lymphoblastic leukemia the e13a2 (B2A2) transcript is prevalent. Leukemia. London: Nature Publishing Group, 2020, vol. 34, No 3, p. 929-931. ISSN 0887-6924. Available from: https://dx.doi.org/10.1038/s41375-019-0591-9.
      More: https://is.muni.cz/publication/1740658/en
    24. Increasing procoagulant activity of circulating microparticles in patients living with HIV
      SNOPKOVÁ, Svatava, Miloslava MATÝŠKOVÁ, Kateřina HAVLÍČKOVÁ, Jiří JARKOVSKÝ, Michal SVOBODA, Jiřina ZAVŘELOVÁ, Radek SVAČINKA, Miroslav PENKA and Petr HUSA. Increasing procoagulant activity of circulating microparticles in patients living with HIV. Médecine et maladies infectiuses. ISSY-LES-MOULINEAUX: Elsevier France, 2020, vol. 50, No 7, p. 555-561. ISSN 0399-077X. Available from: https://dx.doi.org/10.1016/j.medmal.2019.09.013.
      More: https://is.muni.cz/publication/1606900/en
    25. International prognostic score for asymptomatic early-stage chronic lymphocytic leukemia
      CONDOLUCI, A., L. T. DI BERGAMO, P. LANGERBEINS, M. A. HOECHSTETTER, C. D. HERLING, L. DE PAOLI, J. DELGADO, K. G. RABE, M. GENTILE, Michael DOUBEK, F. R. MAURO, G. CHIODIN, M. MATTSSON, J. BAHLO, G. CUTRONA, Jana KOTAŠKOVÁ, C. DEAMBROGI, K. E. SMEDBY, V. SPINA, A. BRUSCAGGIN, W. WU, R. MOIA, E. BIANCHI, B. GERBER, E. ZUCCA, S. GILLESSEN, M. GHIELMINI, F. CAVALLI, G. STUSSI, M. A. HESS, T. S. BAUMANN, A. NERI, M. FERRARINI, R. ROSENQUIST, F. FORCONI, R. FOA, Šárka POSPÍŠILOVÁ, F. MORABITO, S. STILGENBAUER, H. DOHNER, S. A. PARIKH, W. G. WIERDA, E. MONTSERRAT, G. GAIDANO, M. HALLEK and D. ROSSI. International prognostic score for asymptomatic early-stage chronic lymphocytic leukemia. Blood. Washington DC, USA: American Society of Hematology, 2020, vol. 135, No 21, p. 1859-1869. ISSN 0006-4971. Available from: https://dx.doi.org/10.1182/blood.2019003453.
      More: https://is.muni.cz/publication/1730622/en
    26. Low Density Lipoprotein Receptor Variants in the Beta-Propeller Subdomain and Their Functional Impact
      DUŠKOVÁ, Lucie, Lucie NOHELOVÁ, Tomáš LOJA, Jana FIALOVÁ, Petra ZAPLETALOVÁ, Kamila RÉBLOVÁ, Lukáš TICHÝ, Tomáš FREIBERGER and Lenka FAJKUSOVÁ. Low Density Lipoprotein Receptor Variants in the Beta-Propeller Subdomain and Their Functional Impact. Frontiers in Genetics. Laussane: FRONTIERS MEDIA SA, 2020, vol. 11, JUN 2020, p. 1-10. ISSN 1664-8021. Available from: https://dx.doi.org/10.3389/fgene.2020.00691.
      More: https://is.muni.cz/publication/1677117/en
    27. Methodology and results of real-world cost-effectiveness of carfilzomib in combination with lenalidomide and dexamethasone in relapsed multiple myeloma using registry data
      CAMPIONI, M., I. AGIRREZABAL, R. HAJEK, J. MINARIK, Luděk POUR, I. SPICKA, S. GONZALEZ-MCQUIRE, P. JANDOVA and V. MAISNAR. Methodology and results of real-world cost-effectiveness of carfilzomib in combination with lenalidomide and dexamethasone in relapsed multiple myeloma using registry data. EUROPEAN JOURNAL OF HEALTH ECONOMICS. NEW YORK: SPRINGER, 2020, vol. 21, No 2, p. 219-233. ISSN 1618-7598. Available from: https://dx.doi.org/10.1007/s10198-019-01122-6.
      More: https://is.muni.cz/publication/1650197/en
    28. Needles in a haystack: Extremely rare invasive fungal infections reported in FungiScope (R)-Global Registry for Emerging Fungal Infections
      SALMANTON-GARCIA, Jon, Philipp KOEHLER, Anupma KINDO, Iker FALCES-ROMERO, Julio GARCIA-RODRIGUEZ, Zdeněk RÁČIL, Sharon C. A. CHEN, Nikolai KLIMKO, Guillaume DESOUBEAUX, George R. THOMPSON, Miguel-Angel BENITEZ-PENUELA, Jose-Yesid RODRIGUEZ, Donald C. SHEPPARD, Martin HOENIGL, Yohann LE GOVIC, Hamid BADALI, John W. BADDLEY, Jagdish CHANDER, Paul R. INGRAM, Diana L. PAKSTIS, Sibylle C. MELLINGHOFF, Serkan ATICI, Simone CESARO, Arunaloke CHAKRABARTI, Damien DUPONT, Gloria M. GONZALEZ, Lorant HATVANI, Raoul HERBRECHT, Galina KLYASOVA, Cornelia LASS-FLORL, Mihai MARES, Kathleen MULLANE, Donald C. VINH, Hilmar WISPLINGHOFF, Michaela LACKNER, Oliver A. CORNELY and Danila SEIDEL. Needles in a haystack: Extremely rare invasive fungal infections reported in FungiScope (R)-Global Registry for Emerging Fungal Infections. The Journal of infection. London: Academic Press, 2020, vol. 81, No 5, p. 802-815. ISSN 0163-4453. Available from: https://dx.doi.org/10.1016/j.jinf.2020.08.015.
      More: https://is.muni.cz/publication/1713497/en
    29. Novel Illumina-based next generation sequencing approach with one-round amplification provides early and reliable detection of BCR-ABL1 kinase domain mutations in chronic myeloid leukemia
      ROMŽOVÁ, Marianna, Dagmar SMITALOVÁ, Nikola TOM, Tomáš JURČEK, Martin ČULEN, Daniela ŽÁČKOVÁ, Jiří MAYER and Zdeněk RÁČIL. Novel Illumina-based next generation sequencing approach with one-round amplification provides early and reliable detection of BCR-ABL1 kinase domain mutations in chronic myeloid leukemia. British journal of haematology. England: Wiley-Blackwell, 2020, vol. 189, No 3, p. 469-474. ISSN 0007-1048. Available from: https://dx.doi.org/10.1111/bjh.16382.
      More: https://is.muni.cz/publication/1672824/en
    30. OCEAN: a randomized Phase III study of melflufen plus dexamethasone to treat relapsed refractory multiple myeloma
      SCHJESVOLD, F., P. ROBAK, Luděk POUR, J. ASCHAN and P. SONNEVELD. OCEAN: a randomized Phase III study of melflufen plus dexamethasone to treat relapsed refractory multiple myeloma. Future Oncology. London: Future Medicine Ltd., 2020, vol. 16, No 11, p. 631-641. ISSN 1479-6694. Available from: https://dx.doi.org/10.2217/fon-2020-0024.
      More: https://is.muni.cz/publication/1751716/en
    31. Performance of anti-CD19 chimeric antigen receptor T cells in genetically defined classes of chronic lymphocytic leukemia
      MANČÍKOVÁ, Veronika, Helena PESCHELOVÁ, Veronika KOZLOVÁ, Aneta LEDEREROVÁ, Adriana LADUNGOVÁ, Jan VERNER, Tomáš LOJA, František FOLBER, Jiří MAYER, Šárka POSPÍŠILOVÁ and Michal ŠMÍDA. Performance of anti-CD19 chimeric antigen receptor T cells in genetically defined classes of chronic lymphocytic leukemia. Journal for ImmunoTherapy of Cancer. Switzerland: Springer International Publishing AG, 2020, vol. 8, No 1, p. 000471-481. ISSN 2051-1426. Available from: https://dx.doi.org/10.1136/jitc-2019-000471.
      More: https://is.muni.cz/publication/1662457/en
    32. Pharmacokinetic Comparison of Subcutaneous and Intravenous Nadroparin Administration for Thromboprophylaxis in Critically Ill Patients on Vasopressors
      CIHLÁŘ, Radek, Vladimír ŠRÁMEK, Adriána PAPIEŽ, Miroslav PENKA and Pavel SUK. Pharmacokinetic Comparison of Subcutaneous and Intravenous Nadroparin Administration for Thromboprophylaxis in Critically Ill Patients on Vasopressors. PHARMACOLOGY. BASEL: KARGER, 2020, vol. 105, 1-2, p. 73-78. ISSN 0031-7012. Available from: https://dx.doi.org/10.1159/000502847.
      More: https://is.muni.cz/publication/1618917/en
    33. Preoperative risk stratification in endometrial cancer (ENDORISK) by a Bayesian network model: A development and validation study
      REIJNEN, C., E. GOGOU, N. C. M. VISSER, H. ENGERUD, J. RAMJITH, L. J. M. VAN DER PUTTEN, K. V. DE VIJVER, M. SANTACANA, P. BRONSERT, J. BULTEN, M. HIRSCHFELD, E. COLAS, A. GIL-MORENO, A. REQUES, G. MANCEBO, C. KRAKSTAD, J. TROVIK, I. S. HALDORSEN, J. HUVILA, M. KOSKAS, Vít WEINBERGER, Markéta BEDNAŘÍKOVÁ, Jitka HAUSNEROVÁ, A. A. M. VAN DER WURFF, X. MATIAS-GUIU, F. AMANT, L. F. A. G. MASSUGER, M. P. L. M. SNIJDERS, H. V. N. KUSTERS-VANDEVELDE, P. J. F. LUCAS and J. M. A. PIJNENBORG. Preoperative risk stratification in endometrial cancer (ENDORISK) by a Bayesian network model: A development and validation study. PLOS MEDICINE. SAN FRANCISCO: PUBLIC LIBRARY SCIENCE, 2020, vol. 17, No 5, p. 1-19. ISSN 1549-1277. Available from: https://dx.doi.org/10.1371/journal.pmed.1003111.
      More: https://is.muni.cz/publication/1681896/en
    34. PRIMA-1MET cytotoxic effect correlates with p53 protein reduction in TP53-mutated chronic lymphocytic leukemia cells
      JAŠKOVÁ, Zuzana, Šárka PAVLOVÁ, Jitka MALČÍKOVÁ, Yvona BRYCHTOVÁ and Martin TRBUŠEK. PRIMA-1MET cytotoxic effect correlates with p53 protein reduction in TP53-mutated chronic lymphocytic leukemia cells. Leukemia Research. Oxford: Pergamon Press, 2020, vol. 89, FEB 2020, p. 1-7. ISSN 0145-2126. Available from: https://dx.doi.org/10.1016/j.leukres.2019.106288.
      More: https://is.muni.cz/publication/1614689/en
    35. Profiling of biological and environmental risk factors in immunogenetic subgroups of chronic lymphocytic leukemia
      STRÁNSKÁ, Kamila, Karla PLEVOVÁ, Hana SKUHROVÁ FRANCOVÁ, Hana ŠKABRAHOVÁ, Magdalena VON JAGWITZ-BIEGNITZ, Lenka RADOVÁ, Anna PANOVSKÁ, Stanislava HROBKOVÁ, Yvona BRYCHTOVÁ, Renata URBANOVÁ, Lukáš SMOLEJ, Martin SIMKOVIC, Jana ZUCHNICKÁ, Lekaa MOHAMMADOVA, Martin ŠPAČEK, Jiří MAYER, Šárka POSPÍŠILOVÁ and Michael DOUBEK. Profiling of biological and environmental risk factors in immunogenetic subgroups of chronic lymphocytic leukemia. Biomedical Papers : Univerzita Palackého v Olomouci. Olomouc: PALACKY UNIV, MEDICAL FAC, CENTRAL LIBRARY, 2020, vol. 164, No 4, p. 425-434. ISSN 1213-8118. Available from: https://dx.doi.org/10.5507/bp.2019.046.
      More: https://is.muni.cz/publication/1692085/en
    36. Real-world data on efficacy and safety of obinutuzumab plus chlorambucil, rituximab plus chlorambucil, and rituximab plus bendamustine in the frontline treatment of chronic lymphocytic leukemia: TheGO-CLLEARStudy by the CzechCLLStudy Group
      PANOVSKÁ, Anna, Lucie BEZDĚKOVÁ, Lucie NEKVINDOVÁ, Martin SPACEK, Martin SIMKOVIC, Tomas PAPAJIK, Martin BREJCHA, Daniel LYSAK, Jana ZUCHNICKA, Jan NOVAK, David STAROSTKA, Hynek POUL, Filip VRBACKY, Pavel VODAREK, Renata URBANOVA, Karla PLEVOVÁ, Šárka POSPÍŠILOVÁ, Stanislava MASLEJOVA, Yvona BRYCHTOVÁ, Eva KORIŤÁKOVÁ, Lukas SMOLEJ and Michael DOUBEK. Real-world data on efficacy and safety of obinutuzumab plus chlorambucil, rituximab plus chlorambucil, and rituximab plus bendamustine in the frontline treatment of chronic lymphocytic leukemia: TheGO-CLLEARStudy by the CzechCLLStudy Group. Hematological Oncology. MALDEN, USA: WILEY-BLACKWELL, 2020, vol. 38, No 4, p. 509-516. ISSN 0278-0232. Available from: https://dx.doi.org/10.1002/hon.2744.
      More: https://is.muni.cz/publication/1673757/en
    37. Results from a multicenter, noninterventional registry study for multiple myeloma patients who received stem cell mobilization regimens with and without plerixafor
      MORRIS, Curly, Christian CHABANNON, Tamas MASSZI, Nigel RUSSELL, Hareth NAHI, Guido KOBBE, Marta KREJČÍ, Holger W. AUNER, David POHLREICH, Patrick HAYDEN, Grzegorz W. BASAK, Stig LENHOFF, Nicolaas SCHAAP, Anja VAN BIEZEN, Cora KNOL, Simona IACOBELLI, Qianying LIU, Marina CELANOVIC, Laurent GARDERET and Nicolaus KROGER. Results from a multicenter, noninterventional registry study for multiple myeloma patients who received stem cell mobilization regimens with and without plerixafor. Bone Marrow Transplantation. London: Nature Publishing Group, 2020, vol. 55, No 2, p. 356-366. ISSN 0268-3369. Available from: https://dx.doi.org/10.1038/s41409-019-0676-0.
      More: https://is.muni.cz/publication/1670357/en
    38. Revision and Update of the Consensus Definitions of Invasive Fungal Disease From the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium
      DONNELLY, J. P., S. C. CHEN, C. A. KAUFFMAN, W. J. STEINBACH, J. W. BADDLEY, P. E. VERWEIJ, C. J. CLANCY, J. R. WINGARD, S. R. LOCKHART, A. H. GROLL, T. C.. SORRELL, M. BASSETTI, H. AKAN, B. D. ALEXANDER, D. ANDES, E. AZOULAY, R. BIALEK, R. W. BRADSHER, S. BRETAGNE, T. CALANDRA, A. M. CALIENDO, E. CASTAGNOLA, M. CRUCIANI, M. CUENCA-ESTRELLA, C. F. DECKER, S. R. DESAI, B. FISHER, T. HARRISON, C. P. HEUSSEL, H. E. JENSEN, C. C. KIBBLER, D. P. KONTOYIANNIS, B. J. KULLBERG, K. LAGROU, F. LAMOTH, T. LEHRNBECHER, J. LOEFFLER, O. LORTHOLARY, J. MAERTENS, O.. MARCHETTI, K. A. MARR, H. MASUR, J. F. MEIS, C. O. MORRISEY, M. NUCCI, L. OSTROSKY-ZEICHNER, L. PAGANO, T. F. PATTERSON, J. R. PERFECT, Zdeněk RÁČIL, E. ROILIDES, M. RUHNKE, C. S. PROKOP, S. SHOHAM, M. A. SLAVIN, D. A. STEVENS, G. R. THOMPSON, J. A. VAZQUEZ, C. VISCOLI, T. J. WALSH, A. WARRIS, L. J. WHEAT, P. L. WHITE, T. E. ZAOUTIS and P. G. PAPPAS. Revision and Update of the Consensus Definitions of Invasive Fungal Disease From the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium. Clinical Infectious Diseases. Chicago, USA: The University of Chicago Press, 2020, vol. 71, No 6, p. 1367-1376. ISSN 1058-4838. Available from: https://dx.doi.org/10.1093/cid/ciz1008.
      More: https://is.muni.cz/publication/1698798/en
    39. Risk Factors in Ischemic Stroke Subtypes: a Community-Based Study in Brno, Czech Republic
      JACKOVÁ, Jana, Petra ŠEDOVÁ, Robert D., Jr. BROWN, Miroslav ZVOLSKÝ, Silvie BĚLAŠKOVÁ, Michaela VOLNÁ, Jana BALUCHOVÁ, Josef BEDNAŘÍK and Robert MIKULÍK. Risk Factors in Ischemic Stroke Subtypes: a Community-Based Study in Brno, Czech Republic. Journal of Stroke & Cerebrovascular Diseases. Amsterdam: Elsevier, 2020, vol. 29, No 2, p. 1-8. ISSN 1052-3057. Available from: https://dx.doi.org/10.1016/j.jstrokecerebrovasdis.2019.104503.
      More: https://is.muni.cz/publication/1619197/en
    40. Safety and efficacy of self-administered romiplostim in patients with immune thrombocytopenia: Results of an integrated database of five clinical trials
      KUTER, D. J., D. M. ARNOLD, F. RODEGHIERO, A. JANSSENS, D. SELLESLAG, R. BIRD, A. NEWLAND, Jiří MAYER, K. J. WANG and R. OLIE. Safety and efficacy of self-administered romiplostim in patients with immune thrombocytopenia: Results of an integrated database of five clinical trials. American Journal of Hematology. Hoboken: John Wiley & Sons, 2020, vol. 95, No 6, p. 643-651. ISSN 0361-8609. Available from: https://dx.doi.org/10.1002/ajh.25776.
      More: https://is.muni.cz/publication/1681899/en
    41. The EUTOS long-term survival (ELTS) score is superior to the Sokal score for predicting survival in chronic myeloid leukemia
      PFIRRMANN, M., R. E. CLARK, W. PREJZNER, M. LAUSEKER, M. BACCARANI, S. SAUSSELE, F. GUILHOT, S. HEIBL, R. HEHLMANN, E. FABER, A. TURKINA, G. OSSENKOPPELE, M. HOGLUND, A. ZARITSKEY, L. GRISKEVICIUS, U. OLSSON-STROMBERG, H. EVERAUS, P. KOSKENVESA, B. LABAR, T. SACHA, Daniela ŽÁČKOVÁ, F. CERVANTES, A. COLITA, I. ZUPAN, A. BOGDANOVIC, F. CASTAGNETTI, J. GUILHOT, J. HASFORD, A. HOCHHAUS and V. S. HOFFMANN. The EUTOS long-term survival (ELTS) score is superior to the Sokal score for predicting survival in chronic myeloid leukemia. Leukemia. London: Nature Publishing Group, 2020, vol. 34, No 8, p. 2138-2149. ISSN 0887-6924. Available from: https://dx.doi.org/10.1038/s41375-020-0931-9.
      More: https://is.muni.cz/publication/1673771/en
    42. The interval between progression and therapy initiation is the key prognostic parameter in relapsing diffuse large B cell lymphoma: analysis from the Czech Lymphoma Study Group database (NIHIL)
      JANÍKOVÁ, Andrea, Jozef MICHALKA, Zbyněk BORTLÍČEK, Renata CHLOUPKOVÁ, Vit CAMPR, Natasa KOPALOVA, Pavel KLENER, Katerina BENESOVA, Jitka HAMOUZOVA, David BELADA, Vit PROCHAZKA, Robert PYTLIK, Jan PIRNOS, Juraj DURAS, Heidi MOCIKOVA and Marek TRNENY. The interval between progression and therapy initiation is the key prognostic parameter in relapsing diffuse large B cell lymphoma: analysis from the Czech Lymphoma Study Group database (NIHIL). Annals of hematology. New York: Springer Verlag, 2020, vol. 99, No 7, p. 1583-1594. ISSN 0939-5555. Available from: https://dx.doi.org/10.1007/s00277-020-04099-y.
      More: https://is.muni.cz/publication/1670466/en
    43. The regulation and function of CD20: an "enigma" of B-cell biology and targeted therapy
      MLADONICKÁ PAVLASOVÁ, Gabriela and Marek MRÁZ. The regulation and function of CD20: an "enigma" of B-cell biology and targeted therapy. haematologica. PAVIA: FERRATA STORTI FOUNDATION, 2020, vol. 105, No 6, p. 1494-1506. ISSN 0390-6078. Available from: https://dx.doi.org/10.3324/haematol.2019.243543.
      More: https://is.muni.cz/publication/1663736/en
    44. The role of MYC in the transformation and aggressiveness of ?indolent? B-cell malignancies
      FILIP, Daniel and Marek MRÁZ. The role of MYC in the transformation and aggressiveness of ?indolent? B-cell malignancies. LEUKEMIA & LYMPHOMA. LONDON: INFORMA HEALTHCARE, 2020, vol. 61, No 3, p. 510-524. ISSN 1042-8194. Available from: https://dx.doi.org/10.1080/10428194.2019.1675877.
      More: https://is.muni.cz/publication/1611579/en
    45. Trends in One Month and One Year Hemorrhagic Stroke Case Fatality Rates in the Czech Republic between 1998 and 2015
      BRYNDZIAR, Tomáš, Petra ŠEDOVÁ, Robert D. Jr. BROWN, Eva FIŠEROVÁ, Miroslav ZVOLSKY, Josef BEDNAŘÍK and Robert MIKULÍK. Trends in One Month and One Year Hemorrhagic Stroke Case Fatality Rates in the Czech Republic between 1998 and 2015. Journal of Stroke and Cerebrovascular Diseases. Amsterdam: Elsevier, 2020, vol. 29, No 6, p. 1-7. ISSN 1052-3057. Available from: https://dx.doi.org/10.1016/j.jstrokecerebrovasdis.2020.104762.
      More: https://is.muni.cz/publication/1677827/en
    46. Types of congenital nonsyndromic ichthyoses
      PINKOVÁ, Blanka, Hana BUČKOVÁ, Romana BORSKÁ and Lenka FAJKUSOVÁ. Types of congenital nonsyndromic ichthyoses. Biomedical Papers, Olomouc: Palacky University. Olomouc: Palacky University, 2020, vol. 164, No 4, p. 357-365. ISSN 1213-8118. Available from: https://dx.doi.org/10.5507/bp.2020.050.
      More: https://is.muni.cz/publication/1734418/en
    47. WNT signaling inducing activity in ascites predicts poor outcome in ovarian cancer
      KOTRBOVÁ, Anna, Petra OVESNÁ, Tomáš GYBEĽ, Tomasz Witold RADASZKIEWICZ, Markéta BEDNAŘÍKOVÁ, Jitka HAUSNEROVÁ, Eva JANDÁKOVÁ, Luboš MINÁŘ, Igor CRHA, Vít WEINBERGER, Ludek ZAVESKY, Vítězslav BRYJA and Vendula POSPÍCHALOVÁ. WNT signaling inducing activity in ascites predicts poor outcome in ovarian cancer. Theranostics. Lake Haven: Ivyspring International Publisher, 2020, vol. 10, No 2, p. 537-552. ISSN 1838-7640. Available from: https://dx.doi.org/10.7150/thno.37423.
      More: https://is.muni.cz/publication/1627817/en

    2019

    1. A Novel Approach to Preoperative Risk Stratification in Endometrial Cancer: The Added Value of Immunohistochemical Markers
      WEINBERGER, Vít, Markéta BEDNAŘÍKOVÁ, Jitka HAUSNEROVÁ, Petra OVESNÁ, Petra VINKLEROVÁ, Luboš MINÁŘ, Michal FELSINGER, Eva JANDÁKOVÁ, Marta ČÍHALOVÁ and Michal ZIKÁN. A Novel Approach to Preoperative Risk Stratification in Endometrial Cancer: The Added Value of Immunohistochemical Markers. Frontiers in Oncology. Lausanne: Frontiers, 2019, vol. 9, APR 12 2019, p. 1-13. ISSN 2234-943X. Available from: https://dx.doi.org/10.3389/fonc.2019.00265.
      More: https://is.muni.cz/publication/1568018/en
    2. A novel germline mutation of the SFTPA1 gene in familial interstitial pneumonia
      DOUBKOVÁ, Martina, Kateřina STAŇO KOZUBÍK, Lenka RADOVÁ, Michaela PEŠOVÁ, Jakub TRIZULJAK, Karol PÁL, Klára SVOBODOVÁ, Kamila RÉBLOVÁ, Hana SVOZILOVÁ, Zuzana VRZALOVÁ, Šárka POSPÍŠILOVÁ and Michael DOUBEK. A novel germline mutation of the SFTPA1 gene in familial interstitial pneumonia. HUMAN GENOME VARIATION. LONDON: NATURE PUBLISHING GROUP, 2019, vol. 6, MAR, p. nestrankovano, 6 pp. ISSN 2054-345X. Available from: https://dx.doi.org/10.1038/s41439-019-0044-z.
      More: https://is.muni.cz/publication/1538917/en
    3. Activation-induced deaminase and its splice variants associate with trisomy 12 in chronic lymphocytic leukemia
      ZÁPRAŽNÁ, Kristína, Kamila RÉBLOVÁ, V. SVOBODOVA, Lenka RADOVÁ, Vojtěch BYSTRÝ, Jiří BALOUN, Kristina ĎURECHOVÁ, Nikola TOM, Tomáš LOJA, Martina BUREŠOVÁ, Kamila STRÁNSKÁ, Alexandra OLTOVÁ, Michael DOUBEK, M.L. ATCHISON, Martin TRBUŠEK, Jitka MALČÍKOVÁ and Šárka POSPÍŠILOVÁ. Activation-induced deaminase and its splice variants associate with trisomy 12 in chronic lymphocytic leukemia. Annals of hematology. New York: Springer Verlag, 2019, vol. 98, No 2, p. 423-435. ISSN 0939-5555. Available from: https://dx.doi.org/10.1007/s00277-018-3520-5.
      More: https://is.muni.cz/publication/1498916/en
    4. Advanced DNA fingerprint genotyping based on a model developed from real chip electrophoresis data
      SKUTKOVA, Helena, Martin VITEK, Matěj BEZDÍČEK, Eva BRHELOVÁ and Martina LENGEROVÁ. Advanced DNA fingerprint genotyping based on a model developed from real chip electrophoresis data. JOURNAL OF ADVANCED RESEARCH. AMSTERDAM: ELSEVIER SCIENCE BV, 2019, vol. 18, JUL 2019, p. 9-18. ISSN 2090-1232. Available from: https://dx.doi.org/10.1016/j.jare.2019.01.005.
      More: https://is.muni.cz/publication/1552356/en
    5. Allogeneic Stem Cell Transplantation for Blast Crisis Chronic Myeloid Leukemia in the Era of Tyrosine Kinase Inhibitors: A Retrospective Study by the EBMT Chronic Malignancies Working Party
      RADUJKOVIC, Aleksandar, Sascha DIETRICH, Henric-Jan BLOK, Arnon NAGLER, Francis AYUK, Juergen FINKE, Johanna TISCHER, Jiří MAYER, Yener KOC, Federica SORA, Jakob PASSWEG, Jenny L. BYRNE, Pavel JINDRA, Joan Hendrik VEELKEN, Gerard SOCIE, Johan MAERTENS, Nicolaas SCHAAP, Michael STADLER, Maija ITALA-REMES, Eleni THOLOULI, Mutlu ARAT, Vanderson ROCHA, Per LJUNGMAN, Ibrahim YAKOUB-AGHA, Nicolaus KROGER and Yves CHALANDON. Allogeneic Stem Cell Transplantation for Blast Crisis Chronic Myeloid Leukemia in the Era of Tyrosine Kinase Inhibitors: A Retrospective Study by the EBMT Chronic Malignancies Working Party. Biology of Blood and Marrow Transplantation. New York: Elsevier Science INC, 2019, vol. 25, No 10, p. 2008-2016. ISSN 1083-8791. Available from: https://dx.doi.org/10.1016/j.bbmt.2019.06.028.
      More: https://is.muni.cz/publication/1600359/en
    6. Application of mini-MLST and whole genome sequencing in low diversity hospital extended-spectrum beta-lactamase producing Klebsiella pneumoniae population
      BEZDÍČEK, Matěj, Marketa NYKRYNOVA, Kristina PLEVOVÁ, Eva BRHELOVÁ, Iva KOCMANOVA, Karel SEDLAR, Zdeněk RÁČIL, Jiří MAYER and Martina LENGEROVÁ. Application of mini-MLST and whole genome sequencing in low diversity hospital extended-spectrum beta-lactamase producing Klebsiella pneumoniae population. Plos one. San Francisco: Public Library of Science, 2019, vol. 14, No 8, p. 1-14. ISSN 1932-6203. Available from: https://dx.doi.org/10.1371/journal.pone.0221187.
      More: https://is.muni.cz/publication/1569780/en
    7. Association of rare non-coding SNVs in the lung-specific FOXF1 enhancer with a mitigation of the lethal ACDMPV phenotype
      SZAFRANSKI, Przemyslaw, Qian LIU, Justyna A. KAROLAK, Xiaofei SONG, Nicole DE LEEUW, Brigitte FAAS, Romana GERYCHOVÁ, Petr JANKŮ, Marta JEŽOVÁ, Iveta VALÁŠKOVÁ, Kathleen A. GIBBS, Lea F. SURREY, Virginie POISSON, Denis BERUBE, Luc L. OLIGNY, Jacques L. MICHAUD, Edwina POPEK and Pawel STANKIEWICZ. Association of rare non-coding SNVs in the lung-specific FOXF1 enhancer with a mitigation of the lethal ACDMPV phenotype. Human Genetics. NEW YORK: SPRINGER, 2019, vol. 138, 11-12, p. 1301-1311. ISSN 0340-6717. Available from: https://dx.doi.org/10.1007/s00439-019-02073-x.
      More: https://is.muni.cz/publication/1605616/en
    8. ATM and TP53 mutations show mutual exclusivity but distinct clinical impact in mantle cell lymphoma patients
      MAREČKOVÁ, Andrea, Jitka MALČÍKOVÁ, Nikola TOM, Karol PÁL, Lenka RADOVÁ, David ŠÁLEK, Andrea JANÍKOVÁ, Mojmír MOULIS, Jana ŠMARDOVÁ, Leoš KŘEN, Jiří MAYER and Martin TRBUŠEK. ATM and TP53 mutations show mutual exclusivity but distinct clinical impact in mantle cell lymphoma patients. LEUKEMIA & LYMPHOMA. LONDON: INFORMA HEALTHCARE, 2019, vol. 60, No 6, p. 1420-1428. ISSN 1042-8194. Available from: https://dx.doi.org/10.1080/10428194.2018.1542144.
      More: https://is.muni.cz/publication/1545496/en
    9. Bioinformatic pipelines for whole transcriptome sequencing data exploitation in leukemia patients with complex structural variants
      HYNŠT, Jakub, Karla PLEVOVÁ, Lenka RADOVÁ, Vojtěch BYSTRÝ, Karol PÁL and Šárka POSPÍŠILOVÁ. Bioinformatic pipelines for whole transcriptome sequencing data exploitation in leukemia patients with complex structural variants. PeerJ. London: PEERJ INC, 2019, vol. 7, JUN, p. 7071-7086. ISSN 2167-8359. Available from: https://dx.doi.org/10.7717/peerj.7071.
      More: https://is.muni.cz/publication/1567877/en
    10. Clinical impact of genomic analysis in children with B-acute lymphoblastic leukemia: A pilot study in Slovakia
      VASKA, A., M. MAKOHUSOVA, Karla PLEVOVÁ, K. SKALICKA, M. CERMAK, F. CHOVANEC, O. FABRI, P. SVEC and A. KOLENOVA. Clinical impact of genomic analysis in children with B-acute lymphoblastic leukemia: A pilot study in Slovakia. Neoplasma. Bratislava: Slovenská akademie vied, 2019, vol. 66, No 6, p. 1009-1018. ISSN 0028-2685. Available from: https://dx.doi.org/10.4149/neo_2019_190328N274.
      More: https://is.muni.cz/publication/1609499/en
    11. CLL cells cumulate genetic aberrations prior to the first therapy even in outwardly inactive disease phase (CLL cells cumulate genetic aberrations prior to the first therapy even in outwardly inactive disease phase.)
      HERNANDEZ-SANCHEZ, M., Jana KOTAŠKOVÁ, A.E. RODRIGUEZ, Lenka RADOVÁ, D. TAMBORERO, M. ABAIGAR, Karla PLEVOVÁ, R. BENITO, Nikola TOM, M. QUIJADA-ALAMO, Vasileios BIKOS, A.A. MARTIN, Karol PÁL, A. DE COCA, Michael DOUBEK, N. LOPEZ-BIGAS, J.M. HERNANDEZ-RIVAS and Šárka POSPÍŠILOVÁ. CLL cells cumulate genetic aberrations prior to the first therapy even in outwardly inactive disease phase (CLL cells cumulate genetic aberrations prior to the first therapy even in outwardly inactive disease phase.). Leukemia. London: Nature Publishing Group, 2019, vol. 33, No 2, p. 518-522. ISSN 0887-6924. Available from: https://dx.doi.org/10.1038/s41375-018-0255-1.
      More: https://is.muni.cz/publication/1492291/en
    12. Cytogenetic complexity in chronic lymphocytic leukemia: definitions, associations, and clinical impact
      BALIAKAS, P., S. JEROMIN, M. ISKAS, A. PUIGGROS, Karla PLEVOVÁ, F. NGUYEN-KHAC, Z. DAVIS, G.M. RIGOLIN, A. VISENTIN, A. XOCHELLI, J. DELGADO, F. BARAN-MARSZAK, E. STALIKA, P. ABRISQUETA, Kristina ĎURECHOVÁ, G. PAPAIOANNOU, V. ECLACHE, M. DIMOU, T. ILIAKIS, R. COLLADO, Michael DOUBEK, M.J. CALASANZ, N. RUIZ-XIVILLE, C. MORENO, Marie JAROŠOVÁ, A.C. LEEKSMA, P. PANAYIOTIDIS, H. PODGORNIK, F. CYMBALISTA, A. ANAGNOSTOPOULOS, L. TRENTIN, N. STAVROYIANNI, F. DAVI, P. GHIA, A.P. KATER, A. CUNEO, Šárka POSPÍŠILOVÁ, B. ESPINET, A. ATHANASIADOU, D. OSCIER, C. HAFERLACH and K. STAMATOPOULOS. Cytogenetic complexity in chronic lymphocytic leukemia: definitions, associations, and clinical impact. Blood. Washington DC, USA: American Society of Hematology, 2019, vol. 133, No 11, p. 1205-1216. ISSN 0006-4971. Available from: https://dx.doi.org/10.1182/blood-2018-09-873083.
      More: https://is.muni.cz/publication/1539523/en
    13. Deficiency and haploinsufficiency of histone macroH2A1.1 in mice recapitulate hematopoietic defects of human myelodysplastic syndrome
      BERESHCHENKO, Oxana, Oriana LO RE, Fedor NIKULENKOV, Sara FLAMINI, Jana KOTAŠKOVÁ, Tommaso MAZZA, Marguerite-Mari LE PANNERER, Marcus BUSCHBECK, Cesarina GIALLONGO, Giuseppe PALUMBO, Giovanni LI VOLTI, Valerio PAZIENZA, Libor ČERVINEK, Carlo RICCARDI, Lumír KREJČÍ, Šárka POSPÍŠILOVÁ, A. Francis STEWART and Manlio VINCIGUERRA. Deficiency and haploinsufficiency of histone macroH2A1.1 in mice recapitulate hematopoietic defects of human myelodysplastic syndrome. CLINICAL EPIGENETICS. LONDON: BMC, 2019, vol. 11, No 1, p. 1-14. ISSN 1868-7075. Available from: https://dx.doi.org/10.1186/s13148-019-0724-z.
      More: https://is.muni.cz/publication/1604822/en
    14. Detection and identification of fungi in bronchoalveolar lavage fluid from immunocompromised patients using panfungal PCR
      ŘÍČNÁ, Dita, Martina LENGEROVÁ, Matěj BEZDÍČEK, Iva KOCMANOVÁ, Lubos DRGONA, Barbora WEINBERGEROVÁ, Jiří MAYER and Zdeněk RÁČIL. Detection and identification of fungi in bronchoalveolar lavage fluid from immunocompromised patients using panfungal PCR. Folia microbiologica. Dordrecht: Springer, 2019, vol. 64, No 3, p. 421-428. ISSN 0015-5632. Available from: https://dx.doi.org/10.1007/s12223-018-00669-w.
      More: https://is.muni.cz/publication/1545498/en
    15. Detection of a deletion at 22q11 locus involving ZNF280A/ZNF280B/PRAME/GGTLC2 in B-cell malignancies: simply a consequence of an immunoglobulin lambda light chain rearrangement
      MRÁZ, Marek and Šárka POSPÍŠILOVÁ. Detection of a deletion at 22q11 locus involving ZNF280A/ZNF280B/PRAME/GGTLC2 in B-cell malignancies: simply a consequence of an immunoglobulin lambda light chain rearrangement. British journal of haematology. England: Wiley-Blackwell, 2019, vol. 186, No 4, p. "E91"-"E94", 4 pp. ISSN 0007-1048. Available from: https://dx.doi.org/10.1111/bjh.15922.
      More: https://is.muni.cz/publication/1550685/en
    16. Development and validation of a novel risk stratification algorithm for relapsed multiple myeloma
      HAJEK, Roman, Michel DELFORGE, Marc S. RAAB, Paul SCHOEN, Lucy DECOSTA, Ivan SPICKA, Jakub RADOCHA, Luděk POUR, Sebastian GONZALEZ-MCQUIRE and Walter BOUWMEESTER. Development and validation of a novel risk stratification algorithm for relapsed multiple myeloma. British journal of haematology. Hoboken: Wiley-Blackwell, 2019, vol. 187, No 4, p. 447-458. ISSN 0007-1048. Available from: https://dx.doi.org/10.1111/bjh.16105.
      More: https://is.muni.cz/publication/1623023/en
    17. Distinct cellular responses to replication stress leading to apoptosis or senescence
      LUKASOVA, Emilie, Martina REZACOVA, Alena BACIKOVA, Ludmila ŠEBEJOVÁ, Jirina VAVROVA and Stanislav KOZUBEK. Distinct cellular responses to replication stress leading to apoptosis or senescence. FEBS Open Bio. HOBOKEN: WILEY, 2019, vol. 9, No 5, p. 870-890. ISSN 2211-5463. Available from: https://dx.doi.org/10.1002/2211-5463.12632.
      More: https://is.muni.cz/publication/1613920/en
    18. DNA methylation and hydroxymethylation patterns in acute myeloid leukemia patients with mutations in DNMT3A and IDH1/2 and their combinations
      ŠESTÁKOVÁ, Šárka, Zdeněk KREJČÍK, Adam FOLTA, Eva CEROVSKÁ, Cyril ŠÁLEK, Michaela MERKEROVÁ DOSTÁLOVÁ, Pavla PECHERKOVÁ, Zdeněk RÁČIL, Jiří MAYER, Petr CETKOVSKÝ and Hana REMEŠOVÁ. DNA methylation and hydroxymethylation patterns in acute myeloid leukemia patients with mutations in DNMT3A and IDH1/2 and their combinations. Cancer Biomarkers. Amsterdam: IOS Press, 2019, vol. 25, No 1, p. 43-51. ISSN 1574-0153. Available from: https://dx.doi.org/10.3233/CBM-182176.
      More: https://is.muni.cz/publication/1545957/en
    19. DNA methylation profiles in chronic lymphocytic leukemia patients treated with chemoimmunotherapy
      TSAGIOPOULOU, M., N. PAPAKONSTANTINOU, T. MOYSIADIS, L. MANSOURI, V. LJUNGSTROM, M. DURAN-FERRER, A. MALOUSI, A.C. QUEIROS, Karla PLEVOVÁ, S. BHOI, P. KOLLIA, D. OSCIER, A. ANAGNOSTOPOULOS, L. TRENTIN, M. RITGEN, Šárka POSPÍŠILOVÁ, N. STAVROYIANNI, P. GHIA, J.I. MARTIN-SUBERO, C. POTT, R. ROSENQUIST and K. STAMATOPOULOS. DNA methylation profiles in chronic lymphocytic leukemia patients treated with chemoimmunotherapy. CLINICAL EPIGENETICS. LONDON: BMC, 2019, vol. 11, No 1, p. 177-188. ISSN 1868-7075. Available from: https://dx.doi.org/10.1186/s13148-019-0783-1.
      More: https://is.muni.cz/publication/1625079/en
    20. EPIDEMIOLOGY OF RARE DISEASES DETECTED BY NEWBORN SCREENING IN THE CZECH REPUBLIC
      DAVID, Jan, Petr CHRASTINA, Karolína PEŠKOVÁ, Viktor KOŽICH, David FRIEDECKÝ, Tomáš ADAM, Eva HLÍDKOVÁ, Hana VINOHRADSKÁ, Dana NOVOTNÁ, Monika HEDELOVÁ, Eva AL TAJI, Andrea HOLUBOVÁ, Veronika SKALICKÁ, Milan MACEK, Renata GAILLYOVÁ and Felix VOTAVA. EPIDEMIOLOGY OF RARE DISEASES DETECTED BY NEWBORN SCREENING IN THE CZECH REPUBLIC. Central European journal of public health. Praha: Česká lékařská společnost J.E. Purkyně, 2019, vol. 27, No 2, p. 153-159. ISSN 1210-7778. Available from: https://dx.doi.org/10.21101/cejph.a5441.
      More: https://is.muni.cz/publication/1545500/en
    21. First-line therapy for T cell lymphomas: a retrospective population-based analysis of 906 T cell lymphoma patients
      JANÍKOVÁ, Andrea, Renata CHLOUPKOVÁ, Vit CAMPR, Pavel KLENER, Jitka HAMOUZOVA, David BELADA, Vit PROCHAZKA, Robert PYTLIK, Jan PIRNOS, Juraj DURAS, Heidi MOCIKOVA, Zbyněk BORTLÍČEK, Natasa KOPALOVA, Jiří MAYER and Marek TRNENY. First-line therapy for T cell lymphomas: a retrospective population-based analysis of 906 T cell lymphoma patients. Annals of hematology. New York: Springer Verlag, 2019, vol. 98, No 8, p. 1961-1972. ISSN 0939-5555. Available from: https://dx.doi.org/10.1007/s00277-019-03694-y.
      More: https://is.muni.cz/publication/1611116/en
    22. Genetické a neurobiologické aspekty komorbidního výskytu poruch autistického spektra a epilepsie (Genetic and neurobio logical aspects of comorbid occurence of autism spectrum disorder and epilepsy)
      DANHOFER, Pavlína, Ondřej HORÁK, Štefánia AULICKÁ, Katarína ČESKÁ, Jana PEJČOCHOVÁ, Lenka FAJKUSOVÁ and Hana OŠLEJŠKOVÁ. Genetické a neurobiologické aspekty komorbidního výskytu poruch autistického spektra a epilepsie (Genetic and neurobio logical aspects of comorbid occurence of autism spectrum disorder and epilepsy). Ceska a slovenska neurologie a neurochirurgie. Praha: Nakladatelské a tiskové středisko ČLS JEP, 2019, vol. 82, No 2, p. 148-154. ISSN 1210-7859. Available from: https://dx.doi.org/10.14735/amcsnn2019148.
      More: https://is.muni.cz/publication/1587756/en
    23. Chromosomal Abnormalities and Prognosis in NPM1-Mutated Acute Myeloid Leukemia: A Pooled Analysis of Individual Patient Data From Nine International Cohorts
      ANGENENDT, Linus, Christoph ROLLIG, Pau MONTESINOS, David MARTINEZ-CUADRON, Eva BARRAGAN, Raimundo GARCIA, Carmen BOTELLA, Pilar MARTINEZ, Farhad RAVANDI, Tapan KADIA, Hagop M. KANTARJIAN, Jorge CORTES, Gunnar JULIUSSON, Vladimir LAZAREVIC, Martin HOGLUND, Soren LEHMANN, Christian RECHER, Arnaud PIGNEUX, Sarah BERTOLI, Pierre-Yves DUMAS, Herve DOMBRET, Claude PREUDHOMME, Jean-Baptiste MICOL, Christine TERRE, Zdeněk RÁČIL, Jan NOVAK, Pavel ZAK, Andrew H. WEI, Ing S. TIONG, Meaghan WALL, Elihu ESTEY, Carole SHAW, Rita EXELER, Lisa WAGENFUHR, Friedrich STOLZEL, Christian THIEDE, Matthias STELLJES, Georg LENZ, Jan-Henrik MIKESCH, Hubert SERVE, Gerhard EHNINGER, Wolfgang E. BERDEL, Michael KRAMER, Utz KRUG and Christoph SCHLIEMANN. Chromosomal Abnormalities and Prognosis in NPM1-Mutated Acute Myeloid Leukemia: A Pooled Analysis of Individual Patient Data From Nine International Cohorts. Journal of clinical oncology. ALEXANDRIA, VA: AMER SOC CLINICAL ONCOLOGY, 2019, vol. 37, No 29, p. 2632-2644. ISSN 0732-183X. Available from: https://dx.doi.org/10.1200/JCO.19.00416.
      More: https://is.muni.cz/publication/1600415/en
    24. Chronic Benign CD8+Proliferation: A Rare Affection that Can Mimic a Lymphoma Relapse
      OSOVSKA, Marcela, Andrea JANÍKOVÁ, Leoš KŘEN and Andrea MAREČKOVÁ. Chronic Benign CD8+Proliferation: A Rare Affection that Can Mimic a Lymphoma Relapse. CASE REPORTS IN HEMATOLOGY. LONDON: HINDAWI LTD, 2019, vol. 2019, No 4932616, p. 1-4. ISSN 2090-6560. Available from: https://dx.doi.org/10.1155/2019/4932616.
      More: https://is.muni.cz/publication/1531638/en
    25. Imatinib dose reduction in major molecular response of chronic myeloid leukemia: results from the German Chronic Myeloid Leukemia-Study IV
      MICHEL, Christian, Andreas BURCHERT, Andreas HOCHHAUS, Susanne SAUSSELE, Andreas NEUBAUER, Michael LAUSEKER, Stefan W. KRAUSE, Hans-Jochem KOLB, Dieter Kurt HOSSFELD, Christoph NERL, Gabriela M. BAERLOCHER, Dominik HEIM, Tim H. BRUMMENDORF, Alice FABARIUS, Claudia HAFERLACH, Brigitte SCHLEGELBERGER, Leopold BALLEISEN, Maria-Elisabeth GOEBELER, Mathias HANEL, Anthony HO, Jolanta DENGLER, Christiane FALGE, Robert MOHLE, Stephan KREMERS, Michael KNEBA, Frank STEGELMANN, Claus-Henning KOHNE, HW LINDEMANN, Hans-Walter WALLER, Karsten SPIEKERMANN, Wolfgang E. BERDEL, Lothar MULLER, Matthias EDINGER, Jiří MAYER, Dietrich W. BEELEN, Martin BENTZ, Hartmut LINK, Bernd HERTENSTEIN, Roland FUCHS, Martin WERNLI, Frank SCHLEGEL, Rudolf SCHLAG, Maike DE WIT, Lorenz TRUMPER, Holger HEBART, Markus HAHN, Joerg THOMALLA, Christof SCHEID, Philippe SCHAFHAUSEN, Walter VERBEEK, Michael J. ECKART, Winfried GASSMANN, Michael SCHENK, Peter BROSSART, Thomas WUNDISCH, Thomas GEER, Stephan BILDAT, Erhardt SCHAFER, Joerg HASFORD, Ruediger HEHLMANN and Markus PFIRRMANN. Imatinib dose reduction in major molecular response of chronic myeloid leukemia: results from the German Chronic Myeloid Leukemia-Study IV. Haematologica. PAVIA: FERRATA STORTI FOUNDATION, 2019, vol. 104, No 5, p. 955-962. ISSN 0390-6078. Available from: https://dx.doi.org/10.3324/haematol.2018.206797.
      More: https://is.muni.cz/publication/1635156/en
    26. Impact of gene mutations and chromosomal aberrations on progression-free survival in chronic lymphocytic leukemia patients treated with front-line chemoimmunotherapy: Clinical practice experience (Impact of gene mutations and chromosomal aberrations on progression-free survival in chronic lymphocytic leukemia patients treated with front-line chemoimmunotherapy: clinical practice experience)
      ŠPUNAROVÁ, Michaela, Nikola TOM, Šárka PAVLOVÁ, Marek MRÁZ, Yvona BRYCHTOVÁ, Michael DOUBEK, Anna PANOVSKÁ, Hana SKUHROVÁ FRANCOVÁ, Anna BRZOBOHATÁ, Šárka POSPÍŠILOVÁ, Jiří MAYER and Martin TRBUŠEK. Impact of gene mutations and chromosomal aberrations on progression-free survival in chronic lymphocytic leukemia patients treated with front-line chemoimmunotherapy: Clinical practice experience (Impact of gene mutations and chromosomal aberrations on progression-free survival in chronic lymphocytic leukemia patients treated with front-line chemoimmunotherapy: clinical practice experience). Leukemia Research. Oxford: PERGAMON-ELSEVIER SCIENCE LTD, 2019, vol. 81, JUN 2019, p. 75-81. ISSN 0145-2126. Available from: https://dx.doi.org/10.1016/j.leukres.2019.04.015.
      More: https://is.muni.cz/publication/1531396/en
    27. Inherited ichthyoses: molecular causes of the disease in Czech patients
      BORSKÁ, Romana, Blanka PINKOVÁ, Kamila RÉBLOVÁ, Hana BUČKOVÁ, Lenka KOPEČKOVÁ, Jitka NĚMEČKOVÁ, Alena PUCHMAJEROVÁ, Marcela MALÍKOVÁ, Markéta HERMANOVÁ and Lenka FAJKUSOVÁ. Inherited ichthyoses: molecular causes of the disease in Czech patients. ORPHANET JOURNAL OF RARE DISEASES. LONDON: BMC, 2019, vol. 14, No 92, p. 1-5. ISSN 1750-1172. Available from: https://dx.doi.org/10.1186/s13023-019-1076-7.
      More: https://is.muni.cz/publication/1548864/en
    28. Integrated epigenomic and transcriptomic analysis reveals TP63 as a novel player in clinically aggressive chronic lymphocytic leukemia
      PAPAKONSTANTINOU, N., S. NTOUFA, M. TSAGIOPOULOU, T. MOYSIADIS, S. BHOI, A. MALOUSI, F. PSOMOPOULOS, L. MANSOURI, S. LAIDOU, D. PAPAZOGLOU, M. GOUNARI, K. PASENTSIS, Karla PLEVOVÁ, V. KUCI-EMRULI, M. DURAN-FERRER, Z. DAVIS, S. EK, D. ROSSI, G. GAIDANO, M. RITGEN, D. OSCIER, N. STAVROYIANNI, Šárka POSPÍŠILOVÁ, F. DAVI, P. GHIA, A. HADZIDIMITRIOU, C. BELESSI, J.I. MARTIN-SUBERO, C. POTT, R. ROSENQUIST and K. STAMATOPOULOS. Integrated epigenomic and transcriptomic analysis reveals TP63 as a novel player in clinically aggressive chronic lymphocytic leukemia. International journal of cancer. HOBOKEN: International Union Against Cancer, 2019, vol. 144, No 11, p. 2695-2706. ISSN 0020-7136. Available from: https://dx.doi.org/10.1002/ijc.31999.
      More: https://is.muni.cz/publication/1534298/en
    29. JAK2V617F but not CALR mutations confer increased molecular responses to interferon-alpha via JAK1/STAT1 activation
      CZECH, Julia, Sabrina CORDUA, Barbora WEINBERGEROVÁ, Julian BAUMEISTER, Assja CREPCIA, Lijuan HAN, Tiago MAIÉ, Ivan G. COSTA, Bernd DENECKE, Angela MAURER, Claudia SCHUBERT, Kristina FELDBERG, Deniz GEZER, Tim H. BRÜMMENDORF, Gerhard MÜLLER-NEWEN, Jiří MAYER, Zdeněk RÁČIL, Blanka KUBEŠOVÁ, Trine KNUDSEN, Anders L. SØRENSEN, Morten HOLMSTRÖM, Lasse KJÆR, Vibe SKOV, Thomas S. LARSEN, Hans C. HASSELBALCH, Nicolas CHATAIN and Steffen KOSCHMIEDER. JAK2V617F but not CALR mutations confer increased molecular responses to interferon-alpha via JAK1/STAT1 activation. Leukemia. London: Nature Publishung, 2019, vol. 33, No 4, p. 995-1010. ISSN 0887-6924. Available from: https://dx.doi.org/10.1038/s41375-018-0295-6.
      More: https://is.muni.cz/publication/1476877/en
    30. Lenalidomide and dexamethasone in treatment of patients with relapsed and refractory multiple myeloma - analysis of data from the Czech Myeloma Group Registry of Monoclonal Gammopathies
      MAISNAR, V., Z. STEFANIKOVA, I. SPICKA, Luděk POUR, J. MINARIK, M. FLOCHOVA, J. RADOCHA, E. GREGORA, N. STECOVA, T. JELINEK, A. JUNGOVA, E. KRALIKOVA, Lucie BROŽOVÁ and R. HAJEK. Lenalidomide and dexamethasone in treatment of patients with relapsed and refractory multiple myeloma - analysis of data from the Czech Myeloma Group Registry of Monoclonal Gammopathies. Neoplasma. Bratislava: Slovenská akademie vied, 2019, vol. 66, No 3, p. 499-505. ISSN 0028-2685. Available from: https://dx.doi.org/10.4149/neo_2018_180824N644.
      More: https://is.muni.cz/publication/1605477/en
    31. Matched-paired analysis of patients treated for invasive mucormycosis: standard treatment versus posaconazole new formulations (MoveOn)
      SALMANTON-GARCIA, Jon, Danila SEIDEL, Philipp KOEHLER, Sibylle C. MELLINGHOFF, Raoul HERBRECHT, Nikolai KLIMKO, Zdeněk RÁČIL, Iker FALCES-ROMERO, Paul INGRAM, Angel BENITEZ-PENUELA, Jose RODRIGUEZ, Guillaume DESOUBEAUX, Aleksandra BARAC, Carolina GARCIA-VIDAL, Martin HOENIGL, Sanjay R. MEHTA, Matthew P. CHENG, Galina KLYASOVA, Werner J. HEINZ, Nousheen IQBAL, Robert KRAUSE, Helmut OSTERMANN, Olaf PENACK, Enrico SCHALK, Donald C. SHEPPARD, Birgit WILLINGER, Hilmar WISPLINGHOFF and J. Janne VEHRESCHILD. Matched-paired analysis of patients treated for invasive mucormycosis: standard treatment versus posaconazole new formulations (MoveOn). Journal of Antimicrobial Chemotherapy. OXFORD: Oxford University Press, 2019, vol. 74, No 11, p. 3315-3327. ISSN 0305-7453. Available from: https://dx.doi.org/10.1093/jac/dkz344.
      More: https://is.muni.cz/publication/1607046/en
    32. MicroRNA miR-34a downregulates FOXP1 during DNA damage response to limit BCR signalling in chronic lymphocytic leukaemia B cells (MicroRNA miR-34a downregulates FOXP1 during DNA damage response to limit BCR signalling in chronic lymphocytic leukaemia B cells.)
      AMRUZ ČERNÁ, Kateřina, Jan OPPELT, Václav CHOCHOLA, Kateřina MUSILOVÁ, Václav ŠEDA, Gabriela PAVLASOVÁ, Lenka RADOVÁ, M. ARIGONI, R.A. CALOGERO, V. BENES, Martin TRBUŠEK, Yvona BRYCHTOVÁ, Michael DOUBEK, Jiří MAYER, Šárka POSPÍŠILOVÁ and Marek MRÁZ. MicroRNA miR-34a downregulates FOXP1 during DNA damage response to limit BCR signalling in chronic lymphocytic leukaemia B cells (MicroRNA miR-34a downregulates FOXP1 during DNA damage response to limit BCR signalling in chronic lymphocytic leukaemia B cells.). Leukemia. London: Nature Publishing Group, 2019, vol. 33, No 2, p. 403-414. ISSN 0887-6924. Available from: https://dx.doi.org/10.1038/s41375-018-0230-x.
      More: https://is.muni.cz/publication/1492287/en
    33. MicroRNA-210 expression during childbirth and postpartum as a potential biomarker of acute fetal hypoxia
      VONKOVÁ, Barbara, Ivona BLAHÁKOVÁ, Lukáš HRUBAN, Petr JANKŮ and Šárka POSPÍŠILOVÁ. MicroRNA-210 expression during childbirth and postpartum as a potential biomarker of acute fetal hypoxia. Biomedical Papers. Olomouc: Univerzita Palackého v Olomouci, 2019, vol. 163, No 3, p. 259-264. ISSN 1213-8118. Available from: https://dx.doi.org/10.5507/bp.2018.075.
      More: https://is.muni.cz/publication/1570958/en
    34. Novel CHK1 inhibitor MU380 exhibits significant single-agent activity in TP53-mutated chronic lymphocytic leukemia cells
      BOUDNÝ, Miroslav, Jana ZEMANOVÁ, PrashantKumar KHIRSARIYA, Marek BORSKÝ, Jan VERNER, Jana ČERNÁ, Alexandra OLTOVÁ, Václav ŠEDA, Marek MRÁZ, Josef JAROŠ, Zuzana JAŠKOVÁ, Michaela ŠPUNAROVÁ, Yvona BRYCHTOVÁ, Karel SOUČEK, Stanislav DRÁPELA, Marie KAŠPÁRKOVÁ, Jiří MAYER, Kamil PARUCH and Martin TRBUŠEK. Novel CHK1 inhibitor MU380 exhibits significant single-agent activity in TP53-mutated chronic lymphocytic leukemia cells. Haematologica. PAVIA: FERRATA STORTI FOUNDATION, 2019, vol. 104, No 12, p. 2443-2455. ISSN 0390-6078. Available from: https://dx.doi.org/10.3324/haematol.2018.203430.
      More: https://is.muni.cz/publication/1582239/en
    35. Oct4-mediated reprogramming induces embryonic-like microRNA expression signatures in human fibroblasts
      PEŠKOVÁ, Lucie, Kateřina AMRUZ ČERNÁ, Jan OPPELT, Marek MRÁZ and Tomáš BÁRTA. Oct4-mediated reprogramming induces embryonic-like microRNA expression signatures in human fibroblasts. Scientific reports. LONDON: NATURE PUBLISHING GROUP, 2019, vol. 9, OCT 31 2019, p. 1-13. ISSN 2045-2322. Available from: https://dx.doi.org/10.1038/s41598-019-52294-3.
      More: https://is.muni.cz/publication/1579556/en
    36. Prognosis of patients with chronic myeloid leukemia presenting in advanced phase is defined mainly by blast count, but also by age, chromosomal aberrations and hemoglobin
      LAUSEKER, Michael, Katharina BACHL, Anna TURKINA, Edgar FABER, Witold PREJZNER, Ulla OLSSON-STROMBERG,, Michele BACCARANI, Elza LOMAIA, Daniela ŽÁČKOVÁ, Gert OSSENKOPPELE, Laimonas GRISKEVICIUS, Gabriele SCHUBERT-FRITSCHLE, Tomasz SACHA, Sonja HEIBL, Perttu KOSKENVESA, Andrija BOGDANOVIC, Richard E. CLARK, Joelle GUILHOT, Verena S. HOFFMANN, Joerg HASFORD, Andreas HOCHHAUS and Markus PFIRRMANN. Prognosis of patients with chronic myeloid leukemia presenting in advanced phase is defined mainly by blast count, but also by age, chromosomal aberrations and hemoglobin. American Journal of Hematology. Hoboken: John Wiley & Sons, 2019, vol. 94, No 11, p. 1236-1243. ISSN 0361-8609. Available from: https://dx.doi.org/10.1002/ajh.25628.
      More: https://is.muni.cz/publication/1605421/en
    37. Prognostic significance of mutation profile at diagnosis and mutation persistence during disease remission in adult acute myeloid leukaemia patients
      FOLTA, Adam, Martin ČULEN, Ivana JEŽÍŠKOVÁ, Zdeňka HERUDKOVÁ, Nikola TOM, Tereza HLUBINKOVÁ, Veronika JANEČKOVÁ, Anna ĎURINÍKOVÁ, Jan VYDRA, Lukáš SEMERÁD, Dana DVOŘÁKOVÁ, Hana REMEŠOVÁ, Ela CEROVSKÁ, Petr CETKOVSKÝ, Pavel JINDRA, Tomáš SZOTKOWSKI, Pavel ŽÁK, Jiří MAYER and Zdeněk RÁČIL. Prognostic significance of mutation profile at diagnosis and mutation persistence during disease remission in adult acute myeloid leukaemia patients. British journal of haematology. England: Wiley-Blackwell, 2019, vol. 186, No 2, p. 300-310. ISSN 0007-1048. Available from: https://dx.doi.org/10.1111/bjh.15916.
      More: https://is.muni.cz/publication/1552216/en
    38. Progresivní multifokální leukoencefalopatie - epidemiologie, imunitní odpověď, klinické rozdíly, léčba (Progressive multifocal leukoencephalopathy - epidemiology, immune response, clinical differences, treatment)
      SNOPKOVÁ, Svatava, Pavel ŠTOURAČ, Lenka FAŠANEKOVÁ, Matúš MIHALČIN, Kateřina HAVLÍČKOVÁ, Radek SVAČINKA, Pavlína VOLFOVÁ, P. SNOPEK and Petr HUSA. Progresivní multifokální leukoencefalopatie - epidemiologie, imunitní odpověď, klinické rozdíly, léčba (Progressive multifocal leukoencephalopathy - epidemiology, immune response, clinical differences, treatment). Čs. epidemiologie, mikrobiologie, imunologie. Praha: ČSL JEP, 2019, vol. 68, No 1, p. 24-31. ISSN 1210-7913.
      More: https://is.muni.cz/publication/1629458/en
    39. Prospective observational study in comorbid patients with chronic lymphocytic leukemia receiving first-line bendamustine with rituximab
      ŠPAČEK, Martin, Petra OBRTLÍKOVÁ, Stanislava HROBKOVÁ, Eduard CMUNT, Josef KARBAN, Jan MOLINSKÝ, Martin ŠIMKOVIČ, Heidi MOCIKOVÁ, Lekaa MOHAMMADOVÁ, Anna PANOVSKÁ, Jan NOVÁK, Marek TRNĚNÝ, Lukáš SMOLEJ and Michael DOUBEK. Prospective observational study in comorbid patients with chronic lymphocytic leukemia receiving first-line bendamustine with rituximab. Leukemia Research. OXFORD: PERGAMON-ELSEVIER SCIENCE LTD, 2019, vol. 79, APR 2019, p. 17-21. ISSN 0145-2126. Available from: https://dx.doi.org/10.1016/j.leukres.2019.02.002.
      More: https://is.muni.cz/publication/1545812/en
    40. Quality control and quantification in IG/TR next-generation sequencing marker identification: protocols and bioinformatic functionalities by EuroClonality-NGS
      KNECHT, H., Tomáš REIGL, M. KOTROVA, F. APPELT, P. STEWART, Vojtěch BYSTRÝ, Adam KREJČÍ, A. GRIONI, Karol PÁL, Kamila STRÁNSKÁ, Karla PLEVOVÁ, J. RIJNTJES, S. SONGIA, M. SVATON, E. FRONKOVA, J. BARTRAM, B. SCHEIJEN, D. HERRMANN, R. GARCIA-SANZ, J. HANCOCK, J. MOPPETT, J.J.M. VAN DONGEN, G. CAZZANIGA, F. DAVI, P.J.T.A. GROENEN, M. HUMMEL, E.A. MACINTYRE, K. STAMATOPOULOS, J. TRKA, A.W. LANGERAK, D. GONZALEZ, C. POTT, M. BRUGGEMANN and Nikos DARZENTAS. Quality control and quantification in IG/TR next-generation sequencing marker identification: protocols and bioinformatic functionalities by EuroClonality-NGS. Leukemia. London: Nature Publishing Group, 2019, vol. 33, No 9, p. 2254-2265. ISSN 0887-6924. Available from: https://dx.doi.org/10.1038/s41375-019-0499-4.
      More: https://is.muni.cz/publication/1569017/en
    41. Results of the European survey on the assessment of deep molecular response in chronic phase CML patients during tyrosine kinase inhibitor therapy (EUREKA registry)
      MOBIUS, Susanne, Thomas SCHENK, Danny HIMSEL, Jacqueline MAIER, Georg-Nikolaus FRANKE, Susanne SAUSSELE, Christiane POTT, Hajnalka ANDRIKOVICS, Nora MEGGYESI, Katerina MACHOVA-POLAKOVA, Hana ZIZKOVA, Tomáš JURČEK, Semir MESANOVIC, Renata ZADRO, Enrico GOTTARDI, Jens HAENIG, Peter SCHULD, Nicholas C. P. CROSS, Andreas HOCHHAUS and Thomas ERNST. Results of the European survey on the assessment of deep molecular response in chronic phase CML patients during tyrosine kinase inhibitor therapy (EUREKA registry). Journal of cancer research and clinical oncology. Springer-Verlag, 2019, vol. 145, No 6, p. 1645-1650. ISSN 0171-5216. Available from: https://dx.doi.org/10.1007/s00432-019-02910-6.
      More: https://is.muni.cz/publication/1593317/en
    42. Rituximab maintenance overcomes the negative prognostic factor of obesity in CLL: Subgroup analysis of the international randomized AGMT CLL-8a mabtenance trial
      EGLE, Alexander, Thomas MELCHARDT, Petra OBRTLIKOVA, Lukas SMOLEJ, Tomas KOZAK, Michael STEURER, Johannes ANDEL, Sonja BURGSTALLER, Eva MIKUSKOVA, Liana GERCHEVA, Thomas NOSSLINGER, Tomas PAPAPJIK, Miriam LADICKA, Michael GIRSCHIKOFSKY, Mikulas HRUBISKO, Ulrich JAGER, Daniela VOSKOVA, Martin PECHERSTORFER, Eva KRALIKOVA, Christina BURCOVEANU, Emil SPASOV, Andreas PETZER, Georgi MIHAYLOV, Julian RAYNOV, Horst OEXLE, August ZABERNIGG, Emilia FLOCHOVA, Stanislav PALASTHY, Olga STEHLÍKOVÁ, Michael DOUBEK, Petra ALTENHOFER, Lukas WEISS, Teresa MAGNES, Lisa PLEYER, Anton KLINGLER, Jiří MAYER and Richard GREIL. Rituximab maintenance overcomes the negative prognostic factor of obesity in CLL: Subgroup analysis of the international randomized AGMT CLL-8a mabtenance trial. Cancer Medicine. Houston: John Wiley & Sons Ltd., 2019, vol. 8, No 4, p. 1401-1405. ISSN 2045-7634. Available from: https://dx.doi.org/10.1002/cam4.1980.
      More: https://is.muni.cz/publication/1548863/en
    43. Rituximab maintenance significantly prolongs progression-free survival of patients with newly diagnosed mantle cell lymphoma treated with the Nordic MCL2 protocol and autologous stem cell transplantation
      KLENER, Pavel, David ŠÁLEK, Robert PYTLIK, Heidi MOCIKOVA, Kristina FORSTEROVA, Petra BLAHOVCOVA, Vit CAMPR, Vit PROCHAZKA, Ales OBR, Radek JAKSA, Jana KUNTSCHEROVA, Ludmila BOUDOVA, Roman KODET, Andrea JANÍKOVÁ and Marek TRNENY. Rituximab maintenance significantly prolongs progression-free survival of patients with newly diagnosed mantle cell lymphoma treated with the Nordic MCL2 protocol and autologous stem cell transplantation. American Journal of Hematology. Hoboken: John Wiley & Sons, 2019, vol. 94, No 2, p. "E50"-"E53", 4 pp. ISSN 0361-8609. Available from: https://dx.doi.org/10.1002/ajh.25362.
      More: https://is.muni.cz/publication/1612157/en
    44. Simplified novel prognostic score for real-life older adults with multiple myelomaregistry-based analysis
      RADOCHA, J., Roman HÁJEK, Lucie BROŽOVÁ, Luděk POUR, I. ŠPIČKA, J. MINAŘÍK, E. GREGORA, A. JUNGOVÁ, T. JELÍNEK, A. HEINDORFER, M. SÝKORA and V. MAISNAR. Simplified novel prognostic score for real-life older adults with multiple myelomaregistry-based analysis. Annals of hematology. New York: Springer Verlag, 2019, vol. 98, No 4, p. 951-962. ISSN 0939-5555. Available from: https://dx.doi.org/10.1007/s00277-018-3568-2.
      More: https://is.muni.cz/publication/1522198/en
    45. Single-agent ibrutinib in RESONATE-2 (TM) and RESONATE (TM) versus treatments in the real-world PHEDRA databases for patients with chronic lymphocytic leukemia
      SALLES, Gilles, Emmanuel BACHY, Lukáš SMOLEJ, Martin SIMKOVIC, Lucile BASEGGIO, Anna PANOVSKÁ, Herve BESSON, Nollaig HEALY, Jamie GARSIDE, Wafae IRAQI, Joris DIELS, Corinna PICK-LAUER, Martin SPACEK, Renata URBANOVA, Daniel LYSAK, Ruben HERMANS, Jessica LUNDBOM, Evelyne CALLET-BAUCHU and Michael DOUBEK. Single-agent ibrutinib in RESONATE-2 (TM) and RESONATE (TM) versus treatments in the real-world PHEDRA databases for patients with chronic lymphocytic leukemia. Annals of hematology. New York: Springer Verlag, 2019, vol. 98, No 12, p. 2749-2760. ISSN 0939-5555. Available from: https://dx.doi.org/10.1007/s00277-019-03830-8.
      More: https://is.muni.cz/publication/1606864/en
    46. Standardisation and consensus guidelines for minimal residual disease assessment in Philadelphia-positive acute lymphoblastic leukemia (Ph plus ALL) by real-time quantitative reverse transcriptase PCR of e1a2 BCR-ABL1
      PFEIFER, H., G. CAZZANIGA, V. H. J VAN DER VELDEN, J. M. CAYUELE, B. SCHAFER, O. SPINELLI, S. AKIKI, S. AVIGAD, I. BENDIT, K. BORG, H. CAVE, L. ELIA, S. C. RESHMI, G. GERRARD, S. HAYETTE, M. HERMANSON, A. JUH, Tomáš JURČEK, M. C. CHILLON, C. HOMBURG, G. MARTINELLI, V. KAIRISTO, T. LANGEN, T. LION, M. C. MUELLER, F. PANE, L. RAI, C. DAMM-WELK, T. SACHA, S. SCHNITTGER, T. TOULOUMENIDOU, H. VALERHAUGEN, P. VANDENBERGHE, J. ZUNA, H. SERVER, E. HERRMANN, S. MARKOVIC, J. J. M VAN DONGEN and O. G. OTTMANN. Standardisation and consensus guidelines for minimal residual disease assessment in Philadelphia-positive acute lymphoblastic leukemia (Ph plus ALL) by real-time quantitative reverse transcriptase PCR of e1a2 BCR-ABL1. Leukemia. London: Nature Publishing Group, 2019, vol. 33, No 8, p. 1910-1922. ISSN 0887-6924. Available from: https://dx.doi.org/10.1038/s41375-019-0413-0.
      More: https://is.muni.cz/publication/1593316/en
    47. Telomere dynamics in adult hematological malignancies
      OLBERTOVÁ, Helena, Karla PLEVOVÁ, Kamila STRÁNSKÁ and Šárka POSPÍŠILOVÁ. Telomere dynamics in adult hematological malignancies. Biomedical Papers. Univerzita Palackého v Olomouci, 2019, vol. 163, No 1, p. 1-7. ISSN 1213-8118. Available from: https://dx.doi.org/10.5507/bp.2018.084.
      More: https://is.muni.cz/publication/1614340/en
    48. The importance of complex karyotype in prognostication and treatment of chronic lymphocytic leukemia (CLL): a comprehensive review of the literature
      JAROŠOVÁ, Marie, Karla PLEVOVÁ, Jana KOTAŠKOVÁ, Michael DOUBEK and Šárka POSPÍŠILOVÁ. The importance of complex karyotype in prognostication and treatment of chronic lymphocytic leukemia (CLL): a comprehensive review of the literature. LEUKEMIA & LYMPHOMA. LONDON: INFORMA HEALTHCARE, 2019, vol. 60, No 10, p. 2348-2355. ISSN 1042-8194. Available from: https://dx.doi.org/10.1080/10428194.2019.1576038.
      More: https://is.muni.cz/publication/1574782/en
    49. Treatment of Relapsed/Refractory Hodgkin Lymphoma: Real-World Data from the Czech Republic and Slovakia
      KRÁL, Zdeněk, Jozef MICHALKA, Heidi MOCIKOVA, Jana MARKOVA, Alice SYKOROVA, David BELADA, Alexandra JUNGOVA, Samuel VOKURKA, Marie LUKASOVA, Vit PROCHAZKA, Juraj DURAS, Roman HAJEK, Ladislav DUŠEK, L'ubos DRGONA, Miriam LADICKA, Veronika BALLOVA and Andrei VRANOVSKY. Treatment of Relapsed/Refractory Hodgkin Lymphoma: Real-World Data from the Czech Republic and Slovakia. Journal of Cancer. Australia: IVYSPRING INT PUBL, 2019, vol. 10, No 21, p. 5041-5048. ISSN 1837-9664. Available from: https://dx.doi.org/10.7150/jca.29308.
      More: https://is.muni.cz/publication/1597497/en
    50. Triple malignancy (NET, GIST and pheochromocytoma) as a first manifestation of neurofibromatosis type-1 in an adult patient
      POREDSKÁ, Karolina, Lumír KUNOVSKÝ, Vladimír PROCHÁZKA, Jiří DOLINA, Miroslava CHOVANCOVÁ, Jakub VLAŽNÝ, Tomáš ANDRAŠINA, Michal EID, Petr JABANDŽIEV, Petr KYSELA and Zdeněk KALA. Triple malignancy (NET, GIST and pheochromocytoma) as a first manifestation of neurofibromatosis type-1 in an adult patient. Diagnostic Pathology. London: BioMed Central, 2019, vol. 14, No 77, p. 1-4. ISSN 1746-1596. Available from: https://dx.doi.org/10.1186/s13000-019-0848-7.
      More: https://is.muni.cz/publication/1547980/en
    51. Updated results from the phase 3 HELIOS study of ibrutinib, bendamustine, and rituximab in relapsed chronic lymphocytic leukemia/small lymphocytic lymphoma
      FRASER, G., P. CRAMER, F. DEMIRKAN, R.S. SILVA, S. GROSICKI, A. PRISTUPA, A. JANSSENS, Jiří MAYER, N.L. BARTLETT, M.S. DILHUYDY, H. PYLYPENKO, J. LOSCERTALES, A. AVIGDOR, S. RULE, D. VILLA, O. SAMOILOVA, P. PANAGIOTIDIS, A. GOY, M.A. PAVLOVSKY, C. KARLSSON, M. HALLEK, M. MAHLER, M. SALMAN, S. SUN, C. PHELPS, S. BALASUBRAMANIAN, A. HOWES and A. CHANAN-KHAN. Updated results from the phase 3 HELIOS study of ibrutinib, bendamustine, and rituximab in relapsed chronic lymphocytic leukemia/small lymphocytic lymphoma. Leukemia. London: Nature Publishing Group, 2019, vol. 33, No 4, p. 969-980. ISSN 0887-6924. Available from: https://dx.doi.org/10.1038/s41375-018-0276-9.
      More: https://is.muni.cz/publication/1522776/en
    52. Viewpoints of the target population regarding barriers and facilitators of colorectal cancer screening in the Czech Republic
      KROUPA, Radek, Monika BLAŽKOVÁ, Petra KOVALČÍKOVÁ, Milan DASTYCH, Tomáš PAVLÍK, Lumír KUNOVSKÝ and Jiří DOLINA. Viewpoints of the target population regarding barriers and facilitators of colorectal cancer screening in the Czech Republic. World Journal of Gastroenterology. Beijing, China: Baishideng, 2019, vol. 25, No 9, p. 1132-1141. ISSN 1007-9327. Available from: https://dx.doi.org/10.3748/wjg.v25.i9.1132.
      More: https://is.muni.cz/publication/1561396/en

    2018

    1. A novel germline mutation in GP1BA gene N-terminal domain in monoallelic Bernard-Soulier syndrome
      TRIZULJAK, Jakub, Kateřina STAŇO KOZUBÍK, Lenka RADOVÁ, Michaela PEŠOVÁ, Karol PÁL, Kamila RÉBLOVÁ, Olga STEHLÍKOVÁ, Petr SMEJKAL, Jiřina ZAVŘELOVÁ, M. PACEJKA, Jiří MAYER, Šárka POSPÍŠILOVÁ and Michael DOUBEK. A novel germline mutation in GP1BA gene N-terminal domain in monoallelic Bernard-Soulier syndrome. Platelets. PHILADELPHIA: TAYLOR & FRANCIS INC, 2018, vol. 29, No 8, p. 827-833. ISSN 0953-7104. Available from: https://dx.doi.org/10.1080/09537104.2018.1529300.
      More: https://is.muni.cz/publication/1498777/en
    2. Adjusted comparison of daratumumab monotherapy versus real-world historical control data from the Czech Republic in heavily pretreated and highly refractory multiple myeloma patients
      JELINEK, T., V. MAISNAR, Luděk POUR, I. SPICKA, J. MINARIK, E. GREGORA, P. KESSLER, M. SYKORA, H. FRANKOVA, D. ADAMOVA, M. WROBEL, P. MIKULA, Jiří JARKOVSKÝ, J. DIELS, X. GATOPOULOU, S. VESELA, H. BESSON, Lucie BROŽOVÁ, T. ITO and R. HAJEK. Adjusted comparison of daratumumab monotherapy versus real-world historical control data from the Czech Republic in heavily pretreated and highly refractory multiple myeloma patients. Current medical research and opinion. Oxon: Taylor & Francis, 2018, vol. 34, No 5, p. 775-783. ISSN 0300-7995. Available from: https://dx.doi.org/10.1080/03007995.2017.1410121.
      More: https://is.muni.cz/publication/1423208/en
    3. Altered fractionation radiotherapy combined with concurrent low-dose or high-dose cisplatin in head and neck cancer: A systematic review of literature and meta-analysis
      SZTURZ, Petr, Kristien WOUTERS, Naomi KIYOTA, Makoto TAHARA, Kumar PRABHASH, Vanita NORONHA, David ADELSTEIN and Jan B. VERMORKEN. Altered fractionation radiotherapy combined with concurrent low-dose or high-dose cisplatin in head and neck cancer: A systematic review of literature and meta-analysis. Oral oncology. AMSTERDAM: ELSEVIER SCIENCE BV, 2018, vol. 76, JAN 2018, p. 52-60. ISSN 1368-8375. Available from: https://dx.doi.org/10.1016/j.oraloncology.2017.11.025.
      More: https://is.muni.cz/publication/1446336/en
    4. Alternating R-CHOP and R-cytarabine is a safe and effective regimen for transplant-ineligible patients with a newly diagnosed mantle cell lymphoma
      KLENER, Pavel, Eva FRONKOVA, David BELADA, Kristina FORSTEROVA, Robert PYTLIK, Marketa KALINOVA, Martin SIMKOVIC, David ŠÁLEK, Heidi MOCIKOVA, Vít PROCHAZKA, Petra BLAHOVCOVA, Andrea JANÍKOVÁ, Jana MARKOVA, Ales OBR, Adela BERKOVA, Jozef KUBINYI, Martina VASKOVA, Ester MEJSTRIKOVA, Vít CAMPR, Radek JAKSA, Roman KODET, Kyra MICHALOVA, Jan TRKA and Marek TRNENY. Alternating R-CHOP and R-cytarabine is a safe and effective regimen for transplant-ineligible patients with a newly diagnosed mantle cell lymphoma. Hematological Oncology. MALDEN, USA: WILEY-BLACKWELL, 2018, vol. 36, No 1, p. 110-115. ISSN 0278-0232. Available from: https://dx.doi.org/10.1002/hon.2483.
      More: https://is.muni.cz/publication/1450957/en
    5. Analysis of Real-world Data on Postremission Therapy for Acute Myeloid Leukemia With Intermediate Risk Cytogenetics in First Complete Remission
      VYDRA, Jan, Cyril ŠÁLEK, Jiří SCHWARZ, Pavel ŽÁK, Jan NOVÁK, Veronika PETEČUKOVÁ, Pavla PECHERKOVÁ, Jiří MAYER, Petr CETKOVSKÝ and Zdeněk RÁČIL. Analysis of Real-world Data on Postremission Therapy for Acute Myeloid Leukemia With Intermediate Risk Cytogenetics in First Complete Remission. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA. DALLAS: CIG MEDIA GROUP, LP, 2018, vol. 18, No 2, p. 106-113. ISSN 2152-2650. Available from: https://dx.doi.org/10.1016/j.clml.2017.11.011.
      More: https://is.muni.cz/publication/1418465/en
    6. Association of HLA class I type with prevalence and outcome of patients with acute myeloid leukemia and mutated nucleophosmin
      KUZELOVA, Katerina, Barbora BRODSKA, Johannes SCHETELIG, Christoph ROLLING, Zdeněk RÁČIL, Juliane Stickel WALZ, Grzegorz HELBIG, Ota FUCHS, Milena VRANA, Pavla PECHERKOVA, Cyril SALEK and Jiří MAYER. Association of HLA class I type with prevalence and outcome of patients with acute myeloid leukemia and mutated nucleophosmin. Plos one. San Francisco: Public Library of Science, 2018, vol. 13, No 12, p. 1-12. ISSN 1932-6203. Available from: https://dx.doi.org/10.1371/journal.pone.0204290.
      More: https://is.muni.cz/publication/1482571/en
    7. Brenner tumor of the ovary - ultrasound features and clinical management of a rare ovarian tumor mimicking ovarian cancer
      WEINBERGER, Vít, Luboš MINÁŘ, Michal FELSINGER, Petra OVESNÁ, Markéta BEDNAŘÍKOVÁ, Marta ČÍHALOVÁ, Eva JANDÁKOVÁ, Jitka HAUSNEROVÁ, Barbora CHALOUPKOVA and Michal ZIKAN. Brenner tumor of the ovary - ultrasound features and clinical management of a rare ovarian tumor mimicking ovarian cancer. GINEKOLOGIA POLSKA. GDANSK: VIA MEDICA, 2018, vol. 89, No 7, p. 357-363. ISSN 0017-0011. Available from: https://dx.doi.org/10.5603/GP.a2018.0061.
      More: https://is.muni.cz/publication/1430638/en
    8. Casein kinase 1 is a therapeutic target in chronic lymphocytic leukemia
      JANOVSKÁ, Pavlína, Jan VERNER, Jiří KOHOUTEK, Lenka BRYJOVÁ, Michaela GREGOROVÁ, Marta DZIMKOVÁ, Hana ŠKABRAHOVÁ, Tomasz Witold RADASZKIEWICZ, Petra OVESNÁ, Olga VONDÁLOVÁ BLANÁŘOVÁ, Tereza NĚMCOVÁ, Zuzana HOFEROVA, Kateřina VAŠÍČKOVÁ, Lucie NESVADBOVÁ, Alexander EGLE, Šárka PAVLOVÁ, Lucie POPPOVÁ, Karla PLEVOVÁ, Šárka POSPÍŠILOVÁ and Vítězslav BRYJA. Casein kinase 1 is a therapeutic target in chronic lymphocytic leukemia. Blood. Washington DC, USA: American Society of Hematology, 2018, vol. 131, No 11, p. 1206-1218. ISSN 0006-4971. Available from: https://dx.doi.org/10.1182/blood-2017-05-786947.
      More: https://is.muni.cz/publication/1420883/en
    9. Comparison of Real-time Quantitative Polymerase Chain Reaction and Eight-color Flow Cytometry in Assessment of Minimal Residual Disease in Adult Acute Lymphoblastic Leukemia
      HRABOVSKÝ, Štěpán, František FOLBER, J.M. HORACEK, Olga STEHLÍKOVÁ, Hana JELÍNKOVÁ, Cyril SALEK and Michael DOUBEK. Comparison of Real-time Quantitative Polymerase Chain Reaction and Eight-color Flow Cytometry in Assessment of Minimal Residual Disease in Adult Acute Lymphoblastic Leukemia. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA. DALLAS: CIG MEDIA GROUP, LP, 2018, vol. 18, No 11, p. 743-748. ISSN 2152-2650. Available from: https://dx.doi.org/10.1016/j.clml.2018.06.030.
      More: https://is.muni.cz/publication/1473299/en
    10. C-terminal RUNX1 mutation in familial platelet disorder with predisposition to myeloid malignancies
      STAŇO KOZUBÍK, Kateřina, Lenka RADOVÁ, Michaela PEŠOVÁ, Kamila RÉBLOVÁ, Jakub TRIZULJAK, Karla PLEVOVÁ, Veronika FIAMOLI, J. GUMULEC, H. URBANKOVA, T. SZOTKOWSKI, Jiří MAYER, Šárka POSPÍŠILOVÁ and Michael DOUBEK. C-terminal RUNX1 mutation in familial platelet disorder with predisposition to myeloid malignancies. International journal of hematology. Tokyo: Springer Japan KK, 2018, vol. 108, No 6, p. 652-657. ISSN 0925-5710. Available from: https://dx.doi.org/10.1007/s12185-018-2514-3.
      More: https://is.muni.cz/publication/1474600/en
    11. Discontinuation of tyrosine kinase inhibitor therapy in chronic myeloid leukaemia (EURO-SKI): a prespecified interim analysis of a prospective, multicentre, non-randomised, trial
      SAUSSELE, S., J. RICHTER, J. GUILHOT, F.X. GRUBER, H. HJORTH-HANSEN, A. ALMEIDA, J.J.W.M. JANSSEN, Jiří MAYER, P. KOSKENVESA, P. PANAYIOTIDIS, U. OLSSON-STROMBERG, J. MARTINEZ-LOPEZ, P. ROUSSELOT, H. VESTERGAARD, H. EHRENCRONA, V. KAIRISTO, K.M. POLAKOVA, M.C. MULLER, S. MUSTJOKI, M.G. BERGER, A. FABARIUS, W.K. HOFMANN, A. HOCHHAUS, M. PFIRRMANN and F.X. MAHON. Discontinuation of tyrosine kinase inhibitor therapy in chronic myeloid leukaemia (EURO-SKI): a prespecified interim analysis of a prospective, multicentre, non-randomised, trial. Lancet Oncology. New York: Elsevier Science INC, 2018, vol. 19, No 6, p. 747-757. ISSN 1470-2045. Available from: https://dx.doi.org/10.1016/S1470-2045(18)30192-X.
      More: https://is.muni.cz/publication/1423286/en
    12. ERIC recommendations for TP53 mutation analysis in chronic lymphocytic leukemia-update on methodological approaches and results interpretation
      MALČÍKOVÁ, Jitka, E. TAUSCH, D. ROSSI, L.A. SUTTON, T. SOUSSI, T. ZENZ, A.P. KATER, C.U. NIEMANN, D. GONZALEZ, F. DAVI, M.G. DIAZ, C. MORENO, G. GAIDANO, K. STAMATOPOULOS, R. ROSENQUIST, S. STILGENBAUER, P. GHIA and Šárka POSPÍŠILOVÁ. ERIC recommendations for TP53 mutation analysis in chronic lymphocytic leukemia-update on methodological approaches and results interpretation. Leukemia. London: Nature Publishing Group, 2018, vol. 32, No 5, p. 1070-1080. ISSN 0887-6924. Available from: https://dx.doi.org/10.1038/s41375-017-0007-7.
      More: https://is.muni.cz/publication/1443198/en
    13. European guidelines for primary antifungal prophylaxis in adult haematology patients: summary of the updated recommendations from the European Conference on Infections in Leukaemia
      MAERTENS, J.A., C. GIRMENIA, R.J. BRÜGGEMANN, R.F. DUARTE, C.C. KIBBLER, P. LJUNGMAN, Zdeněk RÁČIL, P. RIBAUD, M.A. SLAVIN, O.A. CORNELY, Peter J. DONNELLY and C. CORDONNIER. European guidelines for primary antifungal prophylaxis in adult haematology patients: summary of the updated recommendations from the European Conference on Infections in Leukaemia. Journal of Antimicrobial Chemotherapy. Oxford: Oxford University Press, 2018, vol. 73, No 12, p. 3221-3230. ISSN 0305-7453. Available from: https://dx.doi.org/10.1093/jac/dky286.
      More: https://is.muni.cz/publication/1473187/en
    14. Expression of COBLL1 encoding novel ROR1 binding partner is robust predictor of survival in chronic lymphocytic leukemia (Expression of COBLL1 encoding novel ROR1 binding partner is robust predictor of survival in chronic lymphocytic leukemia.)
      PLEŠINGEROVÁ, Hana, Pavlína JANOVSKÁ, Ashish Kumar MISHRA, Lucie SMYČKOVÁ, Lucie POPPOVÁ, A. LIBRA, Karla PLEVOVÁ, Petra OVESNÁ, Lenka RADOVÁ, Michael DOUBEK, Šárka PAVLOVÁ, Šárka POSPÍŠILOVÁ and Vítězslav BRYJA. Expression of COBLL1 encoding novel ROR1 binding partner is robust predictor of survival in chronic lymphocytic leukemia (Expression of COBLL1 encoding novel ROR1 binding partner is robust predictor of survival in chronic lymphocytic leukemia.). Haematologica/the hematology journal. Fondazione Ferrata Storti, 2018, vol. 103, No 2, p. 313-324. ISSN 0390-6078. Available from: https://dx.doi.org/10.3324/haematol.2017.178699.
      More: https://is.muni.cz/publication/1404545/en
    15. Frontline bortezomib, rituximab, cyclophosphamide, doxorubicin, and prednisone (VR-CAP) versus rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) in transplantation-ineligible patients with newly diagnosed mantle cell lymphoma: final overall survival results of a randomised, open-label, phase 3 study
      ROBAK, Tadeusz, Jie JIN, Halyna PYLYPENKO, Gregor VERHOEF, Noppadol SIRITANARATKUL, Johannes DRACH, Markus RADERER, Jiří MAYER, Juliana PEREIRA, Gayane TUMYAN, Rumiko OKAMOTO, Susumu NAKAHARA, Peter HU, Carlos APPIANI, Sepideh NEMAT and Franco CAVALLI. Frontline bortezomib, rituximab, cyclophosphamide, doxorubicin, and prednisone (VR-CAP) versus rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) in transplantation-ineligible patients with newly diagnosed mantle cell lymphoma: final overall survival results of a randomised, open-label, phase 3 study. Lancet Oncology. New York: Elsevier Science INC, 2018, vol. 19, No 11, p. 1449-1458. ISSN 1470-2045. Available from: https://dx.doi.org/10.1016/S1470-2045(18)30685-5.
      More: https://is.muni.cz/publication/1484272/en
    16. Chromothripsis in acute myeloid leukemia: biological features and impact on survival
      FONTANA, M.C., G. MARCONI, J.D.M. FEENSTRA, E. FONZI, C. PAPAYANNIDIS, A.G.L. DI RORA, A. PADELLA, V. SOLLI, E. FRANCHINI, E. OTTAVIANI, A. FERRARI, C. BALDAZZI, N. TESTONI, I. IACOBUCCI, S. SOVERINI, T. HAFERLACH, V. GUADAGNUOLO, Lukáš SEMERÁD, Michael DOUBEK, M. STEURER, Zdeněk RÁČIL, S. PAOLINI, M. MANFRINI, M. CAVO, G. SIMONETTI, R. KRALOVICS and G. MARTINELLI. Chromothripsis in acute myeloid leukemia: biological features and impact on survival. Leukemia. London: Nature Publishing Group, 2018, vol. 32, No 7, p. 1609-1620. ISSN 0887-6924. Available from: https://dx.doi.org/10.1038/s41375-018-0035-y.
      More: https://is.muni.cz/publication/1430300/en
    17. Inflammatory bowel disease and Clostridium difficile infection: contrasting views of international clinical professionals
      STALLMACH, Andreas, Veli-Jukka ANTTILA, Markus HELL, Simon GWYNN, Paloma MERINO-AMADOR, Nicola PETROSILLO, Zdeněk RÁČIL, Tim WARREN, Christoph WENISCH and Mark WILCOX. Inflammatory bowel disease and Clostridium difficile infection: contrasting views of international clinical professionals. ZEITSCHRIFT FUR GASTROENTEROLOGIE. STUTTGART: GEORG THIEME VERLAG KG, 2018, vol. 56, No 7, p. 731-737. ISSN 0044-2771. Available from: https://dx.doi.org/10.1055/s-0044-100045.
      More: https://is.muni.cz/publication/1446056/en
    18. Insulin resistance is an underlying mechanism of impaired glucose metabolism during nilotinib therapy
      RÁČIL, Zdeněk, Eva KORIŤÁKOVÁ, Tomasz SACHA, Hana KLAMOVA, Petra BELOHLAVKOVA, Edgar FABER, Delphine REA, Ludmila MALASKOVA, Jiřina PROCHÁZKOVÁ, Daniela ŽÁČKOVÁ, Jaroslava VOGLOVA, Joanna WACLAW, Petr CETKOVSKY, Pavel ZAK and Jiří MAYER. Insulin resistance is an underlying mechanism of impaired glucose metabolism during nilotinib therapy. American Journal of Hematology. Hoboken: John Wiley & Sons, 2018, vol. 93, No 10, p. "E342"-"E345", 4 pp. ISSN 0361-8609. Available from: https://dx.doi.org/10.1002/ajh.25232.
      More: https://is.muni.cz/publication/1478081/en
    19. Labile plasma iron levels predict survival in patients with lower-risk myelodysplastic syndromes
      SWART, L. de, C. REINIERS, T. BAGGULEY, T. van MARREWIJK, D. BOWEN, E. HELLSTROM-LINDBERG, A. TATIC, A. SYMEONIDIS, G. HULS, J. CERMAK, A. A. van de LOOSDRECHT, H. GARELIUS, D. CULLIGAN, M. MACHETA, M. SPANOUDAKIS, P. PANAGIOTIDIS, Marta KREJČÍ, N. BLIJLEVENS, S. LANGEMEIJER, J. DROSTE, D. W. SWINKELS, A. de SMITH and T. de WITTE. Labile plasma iron levels predict survival in patients with lower-risk myelodysplastic syndromes. Haematologica. PAVIA: FERRATA STORTI FOUNDATION, 2018, vol. 103, No 1, p. 69-79. ISSN 0390-6078. Available from: https://dx.doi.org/10.3324/haematol.2017.171884.
      More: https://is.muni.cz/publication/1496858/en
    20. Low-burden TP53 mutations in chronic phase of myeloproliferative neoplasms: association with age, hydroxyurea administration, disease type and JAK2 mutational status (Low- burden TP53 mutations in chronic phase of myeloproliferative neoplasms: association with age, hydroxyurea administration, disease type and JAK2 mutational status.)
      KUBEŠOVÁ, Blanka, Šárka PAVLOVÁ, Jitka MALČÍKOVÁ, Jitka KABÁTHOVÁ, Lenka RADOVÁ, Nikola TOM, Boris TICHÝ, Karla PLEVOVÁ, Barbara KANTOROVÁ, Kristýna FIEDOROVÁ, M. SLAVIKOVA, Vojtěch BYSTRÝ, Jarmila KISSOVÁ, B. GISSLINGER, H. GISSLINGER, Miroslav PENKA, Jiří MAYER, R. KRALOVICS, Šárka POSPÍŠILOVÁ and Michael DOUBEK. Low-burden TP53 mutations in chronic phase of myeloproliferative neoplasms: association with age, hydroxyurea administration, disease type and JAK2 mutational status (Low- burden TP53 mutations in chronic phase of myeloproliferative neoplasms: association with age, hydroxyurea administration, disease type and JAK2 mutational status.). Leukemia. London: Nature Publishing Group, 2018, vol. 32, No 2, p. 450-461. ISSN 0887-6924. Available from: https://dx.doi.org/10.1038/leu.2017.230.
      More: https://is.muni.cz/publication/1404544/en
    21. miR-150 downregulation contributes to the high-grade transformation of follicular lymphoma by upregulating FOXP1 levels
      MUSILOVÁ, Kateřina, Ján DEVÁN, Kateřina AMRUZ ČERNÁ, Václav ŠEDA, Gabriela PAVLASOVÁ, Sonali SHARMA, Jan OPPELT, R. PYTLIK, V. PROCHAZKA, Z. PROUZOVA, Martin TRBUŠEK, L. ZLAMALIKOVA, K. LISKOVA, L. KRUZOVA, M. JAROSOVA, Andrea MAREČKOVÁ, C. KORNAUTH, I. SIMONITSCH-KLUPP, A.I. SCHIEFER, O. MERKEL, H. MOCIKOVA, P. BURDA, K.M. POLAKOVA, L. KREN, Jiří MAYER, C.S. ZENT, M. TRNENY, A.G. EVANS, Andrea JANÍKOVÁ and Marek MRÁZ. miR-150 downregulation contributes to the high-grade transformation of follicular lymphoma by upregulating FOXP1 levels. Blood. Washington DC, USA: American Society of Hematology, 2018, vol. 132, No 22, p. 2389-2400. ISSN 0006-4971. Available from: https://dx.doi.org/10.1182/blood-2018-06-855502.
      More: https://is.muni.cz/publication/1488089/en
    22. Moxetumomab pasudotox in relapsed/refractory hairy cell leukemia
      KREITMAN, R.J., C. DEARDEN, P.L. ZINZANI, J. DELGADO, L. KARLIN, T. ROBAK, D.E. GLADSTONE, P. LE COUTRE, S. DIETRICH, M. GOTIC, L. LARRATT, F. OFFNER, G. SCHILLER, R. SWORDS, L. BACON, M. BOCCHIA, K. BOUABDALLAH, D.A. BREEMS, A. CORTELEZZI, S. DINNER, Michael DOUBEK, B.T. GJERTSEN, M. GOBBI, A. HELLMANN, S. LEPRETRE, F. MALOISEL, F. RAVANDI, P. ROUSSELOT, M. RUMMEL, T. SIDDIQI, T. TADMOR, X. TROUSSARD, C.A. YI, G. SAGLIO, G.J. ROBOZ, K. BALIC, N. STANDIFER, P. HE, S. MARSHALL, W. WILSON, I. PASTAN, N.S. YAO and F. GILES. Moxetumomab pasudotox in relapsed/refractory hairy cell leukemia. Leukemia. London: Nature Publishing Group, 2018, vol. 32, No 8, p. 1768-1777. ISSN 0887-6924. Available from: https://dx.doi.org/10.1038/s41375-018-0210-1.
      More: https://is.muni.cz/publication/1443161/en
    23. Multiple productive IGH rearrangements denote oligoclonality even in immunophenotypically monoclonal CLL
      BRÁZDILOVÁ, Kamila, Karla PLEVOVÁ, Hana SKUHROVÁ FRANCOVÁ, Helena OLBERTOVÁ, Marek BORSKÝ, Vasileios BIKOS, Jitka MALČÍKOVÁ, Alexandra OLTOVÁ, Jana KOTAŠKOVÁ, Boris TICHÝ, Yvona BRYCHTOVÁ, Jiří MAYER, Michael DOUBEK and Šárka POSPÍŠILOVÁ. Multiple productive IGH rearrangements denote oligoclonality even in immunophenotypically monoclonal CLL. Leukemia. London: Nature Publishing Group, 2018, vol. 32, No 1, p. 234-236. ISSN 0887-6924. Available from: https://dx.doi.org/10.1038/leu.2017.274.
      More: https://is.muni.cz/publication/1400042/en
    24. New concepts in follicular lymphoma biology: From BCL2 to epigenetic regulators and non-coding RNAs
      DEVÁN, Ján, Andrea JANÍKOVÁ and Marek MRÁZ. New concepts in follicular lymphoma biology: From BCL2 to epigenetic regulators and non-coding RNAs. SEMINARS IN ONCOLOGY. PHILADELPHIA: W B SAUNDERS CO-ELSEVIER INC, 2018, vol. 45, 5-6, p. 291-302. ISSN 0093-7754. Available from: https://dx.doi.org/10.1053/j.seminoncol.2018.07.005.
      More: https://is.muni.cz/publication/1488078/en
    25. Overall Survival Benefit in Patients With Rituximab-Refractory Indolent Non-Hodgkin Lymphoma Who Received Obinutuzumab Plus Bendamustine Induction and Obinutuzumab Maintenance in the GADOLIN Study
      CHESON, B.D., N. CHUA, Jiří MAYER, G. DUECK, M. TRNENY, K. BOUABDALLAH, N. FOWLER, V. DELWAIL, O. PRESS, G. SALLES, J.G. GRIBBEN, A. LENNARD, P.J. LUGTENBURG, G. FINGERLE-ROWSON, F. MATTIELLO, A. KNAPP and L.H. SEHN. Overall Survival Benefit in Patients With Rituximab-Refractory Indolent Non-Hodgkin Lymphoma Who Received Obinutuzumab Plus Bendamustine Induction and Obinutuzumab Maintenance in the GADOLIN Study. Journal of clinical oncology. ALEXANDRIA: Lippincott Williams & Wilkins, 2018, vol. 36, No 22, p. "2259"-"+", 10 pp. ISSN 0732-183X. Available from: https://dx.doi.org/10.1200/JCO.2017.76.3656.
      More: https://is.muni.cz/publication/1477995/en
    26. Potential loss of prognostic significance of minimal residual disease assessment after R-CHOP-based induction in elderly patients with mantle cell lymphoma in the era of rituximab maintenance
      KLENER, Pavel, Eva FRONKOVA, Marketa KALINOVA, David BELADA, Kristina FORSTEROVA, Robert PYTLIK, Petra BLAHOVCOVA, Martin SIMKOVIC, David ŠÁLEK, Heidi MOCIKOVA, Vit PROCHAZKA, Andrea JANIKOVA, Martina VASKOVA, Ester MEJSTRIKOVA, Roman KODET, Jan TRKA and Marek TRNENY. Potential loss of prognostic significance of minimal residual disease assessment after R-CHOP-based induction in elderly patients with mantle cell lymphoma in the era of rituximab maintenance. Hematological Oncology. MALDEN, USA: WILEY-BLACKWELL, 2018, vol. 36, No 5, p. 773-778. ISSN 0278-0232. Available from: https://dx.doi.org/10.1002/hon.2550.
      More: https://is.muni.cz/publication/1489197/en
    27. Proven Invasive Pulmonary Aspergillosis in Stem Cell Transplant Recipient Due to Aspergillus sublatus, a Cryptic Species of A-nidulans
      CHRENKOVA, Vanda, Vit HUBKA, Petr CETKOVSKY, Michal KOUBA, Barbora WEINBERGEROVÁ, Pavlina LYSKOVA, Ludmila HORNOFOVA and Petr HUBACEK. Proven Invasive Pulmonary Aspergillosis in Stem Cell Transplant Recipient Due to Aspergillus sublatus, a Cryptic Species of A-nidulans. MYCOPATHOLOGIA. DORDRECHT: SPRINGER, 2018, vol. 183, No 2, p. 423-429. ISSN 0301-486X. Available from: https://dx.doi.org/10.1007/s11046-017-0223-8.
      More: https://is.muni.cz/publication/1416019/en
    28. Real-world Outcomes of Multiple Myeloma: Retrospective Analysis of the Czech Registry of Monoclonal Gammopathies
      HÁJEK, Roman, Jiří JARKOVSKÝ, Vladimír MAISNAR, Luděk POUR, Ivan ŠPIČKA, Jiří MINAŘÍK, Evžen GREGORA, Petr KESSLER, Michal SÝKORA, Hana FRAŇKOVÁ, Marco CAMPIONI, Lucy DECOSTA, Maarten TREUR, Sebastian GONZALEZ-MCQUIRE and Walter BOUWMEESTER. Real-world Outcomes of Multiple Myeloma: Retrospective Analysis of the Czech Registry of Monoclonal Gammopathies. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA. DALLAS: CIG MEDIA GROUP, LP, 2018, vol. 18, No 6, p. "E219"-"E240", 22 pp. ISSN 2152-2650. Available from: https://dx.doi.org/10.1016/j.clml.2018.04.003.
      More: https://is.muni.cz/publication/1472676/en
    29. Recommendations for the diagnosis and treatment of patients with polycythaemia vera
      HATALOVA, Antónia, Jiri SCHWARZ, Mirjana GOTIC, Miroslav PENKA, Mikulas HRUBISKO, Rajko KUSEC, Miklos EGYED, Martin GRIESSHAMMER, Maria PODOLAK-DAWIDZIAK, Andrzej HELLMANN, Sergiy KLYMENKO, Emilia NICULESCU-MIZII, Petro E. PETRIDES, Sebastian GROSICKI, Matjaz SEVER, Nathan CANTONI, Juergen THIELE, Dominik WOLF and Heinz GISSLINGER. Recommendations for the diagnosis and treatment of patients with polycythaemia vera. European Journal of Haematology. Hoboken: Wiley-Blackwell, 2018, vol. 101, No 5, p. 654-664. ISSN 0902-4441. Available from: https://dx.doi.org/10.1111/ejh.13156.
      More: https://is.muni.cz/publication/1456276/en
    30. Rituximab primarily targets an intra-clonal BCR signaling proficient CLL subpopulation characterized by high CD20 levels
      PAVLASOVÁ, Gabriela, Marek BORSKÝ, Veronika ŠANDOVÁ, Jan OPPELT, Kateřina AMRUZ ČERNÁ, Jitka NOVOTNÁ, Václav ŠEDA, Miloslava FOJTOVÁ, Jiří FAJKUS, Yvona BRYCHTOVÁ, Michael DOUBEK, Šárka POSPÍŠILOVÁ, Jiří MAYER and Marek MRÁZ. Rituximab primarily targets an intra-clonal BCR signaling proficient CLL subpopulation characterized by high CD20 levels. Leukemia. London: Nature Publishing Group, 2018, vol. 32, No 9, p. 2028-2031. ISSN 0887-6924. Available from: https://dx.doi.org/10.1038/s41375-018-0211-0.
      More: https://is.muni.cz/publication/1477620/en
    31. Role hormonální terapie u pacientek s karcinomem děložního těla (The role of hormonal therapy in patients with uterine carcinoma)
      VINKLEROVÁ, Petra, Luboš MINÁŘ, Michal FELSINGER, Milan ANTON, Pavel VENTRUBA, Markéta BEDNAŘÍKOVÁ, Jitka HAUSNEROVÁ, Eva JANDÁKOVÁ, Marta ČÍHALOVÁ and Vít WEINBERGER. Role hormonální terapie u pacientek s karcinomem děložního těla (The role of hormonal therapy in patients with uterine carcinoma). ČESKÁ GYNEKOLOGIE-CZECH GYNAECOLOGY. PRAGUE: NAKLADATELSKE STREDISKO C L S J E PURKYNE, 2018, vol. 83, No 4, p. 263-270. ISSN 1210-7832.
      More: https://is.muni.cz/publication/1526416/en
    32. Seshat: A Web service for accurate annotation, validation, and analysis of TP53 variants generated by conventional and next-generation sequencing
      TIKKANEN, T., B. LEROY, J.L. FOURNIER, R.A. RISQUES, Jitka MALČÍKOVÁ and T. SOUSSI. Seshat: A Web service for accurate annotation, validation, and analysis of TP53 variants generated by conventional and next-generation sequencing. Human Mutation. New York: Wiley-Liss, 2018, vol. 39, No 7, p. 925-933. ISSN 1059-7794. Available from: https://dx.doi.org/10.1002/humu.23543.
      More: https://is.muni.cz/publication/1489193/en
    33. Struma ovarii - ultrasound features of a rare tumor mimicking ovarian cancer
      WEINBERGER, Vít, Jana KADLECOVA, Luboš MINÁŘ, Michal FELSINGER, Milan ANTON, Petra OVESNÁ, Markéta BEDNAŘÍKOVÁ, Marta ČÍHALOVÁ, Eva JANDÁKOVÁ, Jitka HAUSNEROVÁ and Michal ZIKAN. Struma ovarii - ultrasound features of a rare tumor mimicking ovarian cancer. MEDICAL ULTRASONOGRAPHY. CLUJ-NAPOCA: SOC ROMANA ULTRASONOGRAFE MEDICINA BIOLOGIE-SRUMB, 2018, vol. 20, No 3, p. 355-361. ISSN 1844-4172. Available from: https://dx.doi.org/10.11152/mu-1526.
      More: https://is.muni.cz/publication/1450117/en
    34. Syndróm Dravetovej s mutáciou v SCN1A géne, genetické aspekty a klinické skúsenosti (SCN1A mutation positive Dravet syndrome, genetic aspects and clinical experiences)
      ČESKÁ, Katarína, Štefánia AULICKÁ, Pavlína DANHOFER, Ondřej HORÁK, Lenka FAJKUSOVÁ, Slávka POUCHLÁ and Hana OŠLEJŠKOVÁ. Syndróm Dravetovej s mutáciou v SCN1A géne, genetické aspekty a klinické skúsenosti (SCN1A mutation positive Dravet syndrome, genetic aspects and clinical experiences). Česká a slovenská neurologie a neurochirurgie. Praha: Česká lékařská společnost J.E. Purkyně, 2018, vol. 81, No 1, p. 55-59. ISSN 1210-7859. Available from: https://dx.doi.org/10.14735/amcsnn201855.
      More: https://is.muni.cz/publication/1418475/en
    35. The incidence of biopsy-proven transformation in follicular lymphoma in the rituximab era. A retrospective analysis from the Czech Lymphoma Study Group (CLSG) database
      JANÍKOVÁ, Andrea, Zbyněk BORTLÍČEK, Vít CAMPR, Natasa KOPALOVA, Katerina BENESOVA, Michaela HAMOUZOVA, David BELADA, Vit PROCHAZKA, Robert PYTLIK, Samuel VOKURKA, Jan PIRNOS, Juraj DURAS, Heidi MOCIKOVA, Jiří MAYER and Marek TRNENY. The incidence of biopsy-proven transformation in follicular lymphoma in the rituximab era. A retrospective analysis from the Czech Lymphoma Study Group (CLSG) database. Annals of hematology. New York: Springer Verlag, 2018, vol. 97, No 4, p. 669-678. ISSN 0939-5555. Available from: https://dx.doi.org/10.1007/s00277-017-3218-0.
      More: https://is.muni.cz/publication/1451657/en
    36. The influence of maintenance therapy of rituximab on the survival of elderly patients with follicular lymphoma. A retrospective analysis from the database of the Czech Lymphoma Study Group
      BELADA, David, Vit PROCHAZKA, Andrea JANÍKOVÁ, Vit CAMPR, Petra BLAHOVCOVA, Robert PYTLIK, Alice SYKOROVA, Pavel KLENER, Katerina BENESOVA, Jan PIRNOS, Juraj DURAS, Heidi MOCIKOVA and Marek TRNENY. The influence of maintenance therapy of rituximab on the survival of elderly patients with follicular lymphoma. A retrospective analysis from the database of the Czech Lymphoma Study Group. Leukemia Research. OXFORD: PERGAMON-ELSEVIER SCIENCE LTD, 2018, vol. 73, OCT 2018, p. 29-38. ISSN 0145-2126. Available from: https://dx.doi.org/10.1016/j.leukres.2018.08.019.
      More: https://is.muni.cz/publication/1455961/en
    37. The influence of mutational status and biological characteristics of acute myeloid leukemia on xenotransplantation outcomes in NOD SCID gamma mice
      ČULEN, Martin, Zdeňka KOSAŘOVÁ, Ivana JEŽÍŠKOVÁ, A. FOLTA, Jana CHOVANCOVÁ, Tomáš LOJA, Nikola TOM, Vojtěch BYSTRÝ, V. JANECKOVA, Dana DVOŘÁKOVÁ, Jiří MAYER and Zdeněk RÁČIL. The influence of mutational status and biological characteristics of acute myeloid leukemia on xenotransplantation outcomes in NOD SCID gamma mice. Journal of cancer research and clinical oncology. New York: Springer-Verlag, 2018, vol. 144, No 7, p. 1239-1251. ISSN 0171-5216. Available from: https://dx.doi.org/10.1007/s00432-018-2652-2.
      More: https://is.muni.cz/publication/1423213/en
    38. The significance of enzyme and transporter polymorphisms for imatinib plasma levels and achieving an optimal response in chronic myeloid leukemia patients
      BELOHLAVKOVA, Petra, Filip VRBACKY, Jaroslava VOGLOVA, Zdeněk RÁČIL, Daniela ŽÁČKOVÁ, Katerina HROCHOVA, Jana MALAKOVA, Jiří MAYER and Pavel ZAK. The significance of enzyme and transporter polymorphisms for imatinib plasma levels and achieving an optimal response in chronic myeloid leukemia patients. Archives of Medical Science. Poland: Termedia Publishing House, 2018, vol. 14, No 6, p. 1416-1423. ISSN 1734-1922. Available from: https://dx.doi.org/10.5114/aoms.2018.73538.
      More: https://is.muni.cz/publication/1491902/en
    39. ToTem: a tool for variant calling pipeline optimization
      TOM, Nikola, O. TOM, Jitka MALČÍKOVÁ, Šárka PAVLOVÁ, Blanka KUBEŠOVÁ, T. RAUSCH, M. KOLARIK, V. BENES, Vojtěch BYSTRÝ and Šárka POSPÍŠILOVÁ. ToTem: a tool for variant calling pipeline optimization. BMC Bioinformatics. London: BioMed Central, 2018, vol. 19, JUN, p. 243-251. ISSN 1471-2105. Available from: https://dx.doi.org/10.1186/s12859-018-2227-x.
      More: https://is.muni.cz/publication/1443180/en
    40. Validation of multiple myeloma risk stratification indices in routine clinical practice: Analysis of data from the Czech Myeloma Group Registry of Monoclonal Gammopathies
      RADOCHA, Jakub, Vladimír MAISNAR, Luděk POUR, Ivan ŠPIČKA, Jiří MINAŘÍK, Lenka SZELIGOVÁ, Petr PAVLÍČEK, Alexandra JUNGOVÁ, Marta KREJČÍ, Tomáš PIKA, Jan STRAUB, Lucie BROŽOVÁ, Lukáš STEJSKAL, Adriana HEINDORFER, Pavel JINDRA, Petr KESSLER, Peter MIKULA, Michal SYKORA, Marek WRÓBEL, Jiří JARKOVSKÝ and Roman HAJEK. Validation of multiple myeloma risk stratification indices in routine clinical practice: Analysis of data from the Czech Myeloma Group Registry of Monoclonal Gammopathies. Cancer Medicine. Houston: John Wiley & Sons Ltd., 2018, vol. 7, No 8, p. 4132-4145. ISSN 2045-7634. Available from: https://dx.doi.org/10.1002/cam4.1620.
      More: https://is.muni.cz/publication/1455076/en
    41. Verification of Survival Predictors in Elderly Patients with Myelodysplastic Syndrome from Outpatient Clinical Practice
      KADLČKOVÁ, Eva, Peter ROHOŇ, Tomáš FÜRST, Libor ČERVINEK, Andrea JONÁŠOVÁ, Tomáš ŠÁLEK, Jiří TESAŘ and Yvetta STAVAŘOVÁ. Verification of Survival Predictors in Elderly Patients with Myelodysplastic Syndrome from Outpatient Clinical Practice. INTERNATIONAL JOURNAL OF GERONTOLOGY. TAIPEI: ELSEVIER TAIWAN, 2018, vol. 12, No 1, p. 27-31. ISSN 1873-9598. Available from: https://dx.doi.org/10.1016/j.ijge.2017.06.001.
      More: https://is.muni.cz/publication/1451477/en
Display details
Displayed: 1/11/2024 15:27